Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial resistance in the European Union in 2004 by 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial resistance in the
European Union in 2004
EFSA Publication; Helwigh, Birgitte
Publication date:
2006
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
EFSA Publication (2006). Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial resistance in the
European Union in 2004. Italy: European Food Safety Authority.  (The EFSA Journal).
TRENDS AND SOURCES 
OF ZOONOSES, ZOONOTIC 
AGENTS AND ANTIMICROBIAL
RESISTANCE IN THE 
EUROPEAN UNION IN 2004
February 2006
European Food Safety Authority
IS
S
N
 1830-5458

1 The EFSA Journal 2005 – 310
TRENDS AND SOURCES  
OF ZOONOSES, ZOONOTIC 
AGENTS AND ANTIMICROBIAL 
RESISTANCE IN THE  
EUROPEAN UNION IN 2004
March 2006
b169_EFSA_int_02_03_06.indd   1 2/03/06   15:16:31
2The EFSA Journal 2005 – 310
© European Food Safety Authority 2006
ISBN: 92-9199-016-7
Reproduction is authorised, provided the source is acknowledged, save where 
otherwise stated.
 
The views or positions expressed in this booklet do not necessarily represent in legal 
terms the ofﬁcial position of the European Food Safety Authority. The European Food 
Safety Authority assumes no responsibility or liability for any errors or inaccuracies 
that may appear.
b169_EFSA_int_02_03_06.indd   2 2/03/06   15:16:31
3 The EFSA Journal 2005 – 310
About EFSA
The European Food Safety Authority (EFSA) was established and funded by the 
European Community as an independent agency in 2002 following a series of food 
scares that caused the European public to voice concerns about food safety and the 
ability of regulatory authorities to fully protect consumers. 
In close collaboration with national authorities and in open consultation with its 
stakeholders, EFSA provides objective scientiﬁc advice on all matters with a direct or 
indirect impact on food and feed safety, including animal health and welfare and plant 
protection. EFSA is also consulted on nutrition in relation to Community legislation. 
EFSA’s work falls into two areas: risk assessment and risk communication. In particular, 
EFSA’s risk assessments provide risk managers (EU institutions with political accountability, 
i.e. the European Commission, European Parliament and Council) with a sound scientiﬁc 
basis for deﬁning policy-driven legislative or regulatory measures required to ensure a 
high level of consumer protection with regards to food and feed safety.
EFSA communicates to the public in an open and transparent way on all matters 
within its remit.
Collection and analysis of scientiﬁc data, identiﬁcation of emerging risks and scientiﬁc 
support to the Commission, particularly in case of a food crisis, are also part of EFSA’s 
mandate, as laid down in the founding Regulation (EC) No 178/2002 of 28 January 2002.
EFSA is responsible for examining the data on zoonoses, antimicrobial resistance and 
food-borne outbreaks collected from the Member States in accordance with Directive 
2003/99/EC and for preparing the Community Summary Report from the results. The 
Zoonoses Collaboration Centre (contracted by EFSA) in the Danish Institute for Food 
and Veterinary Research assisted EFSA in this task. 
Ofﬁcial seat:
Palazzo Ducale
Parco Ducale 3
I-43100 Parma
Italy
Operational and  
postal address:
Largo N. Palli 5/A
I-43100 Parma
Italy
Contacts:
Tel: +39 0521 036 111
Fax: +39 0521 036 110
E-mail: info@efsa.eu.int
www.efsa.eu.int
For more information about EFSA, please contact EFSA Communications Department
b169_EFSA_int_02_03_06.indd   3 2/03/06   15:16:31
4The EFSA Journal 2005 – 310
European Food Safety Authority 
The Community Summary Report on Trends and Sources of Zoonoses,  
Zoonotic Agents and Antimicrobial Resistance in the European Union in 2004
21 December 2005
EXECUTIVE SUMMARY
Zoonoses are diseases, which are transmissible from animals to humans. The infection 
can be acquired directly from animals, or through ingestion of contaminated foodstuffs. 
The seriousness of these diseases in humans can vary from mild symptoms to life 
threatening conditions. In order to prevent these diseases, it is important to identify 
which animals and foodstuffs are the main sources of these infections. For this purpose, 
information is collected from all over the European Union (EU) and analysed, so that the 
right control measures can be taken in a timely manner to protect human health.
This year’s annual Community Summary Report on Trends and Sources of Zoonoses, 
Zoonotic Agents and Antimicrobial Resistance reveals that by far the most frequently 
reported zoonotic diseases in humans are salmonellosis and campylobacteriosis. In 2004, 
192,703 salmonellosis and 183,961 campylobacteriosis cases were recorded in the 
Member States. In previous years the numbers of salmonellosis cases decreased, but 
from 2003 to 2004, with the expansion of the EU to include 10 new Member States, 
these ﬁgures increased again. In contrast, there has been a general increase in reported 
cases of campylobacteriosis over the last few years in the old Member States.
Every year, all of the European Union’s Member States submit information on the 
occurrence of zoonoses and food-borne disease outbreaks to the European Commission. 
This data collection currently covers 11 zoonotic diseases. This year, for the ﬁrst time, 
the European Food Safety Authority (EFSA) analysed the information and published the 
results in this annual Community Summary Report. 
In addition to the reported cases of salmonellosis and campylobacteriosis, Yersinia 
bacteria were reported to have caused over 10,000 human cases in the EU, and the other 
bacterial zoonoses – listeriosis, verotoxin producing Esherichia coli (VTEC) infections 
and brucellosis – each accounted for approximately 1,000-4,000 cases reported to the 
Commission. The numbers of reported listeriosis and VTEC cases seem to be increasing, 
while the reported numbers of brucellosis cases indicate a decline. The actual number 
of human tuberculosis cases caused by the bovine tuberculosis bacteria is hard to 
estimate due to incomplete data, but a total of 83 cases were reported in the EU. 
Listeriosis accounted for the highest number of reported fatalities (107 deaths) in 2004.
In general, parasitic zoonotic infections caused fewer human cases than zoonotic 
bacteria did. There were around 300-400 reported cases due to Trichinella and similar 
numbers of cases caused by Echinococcus parasites. Toxoplasma was responsible for 
almost 2,000 cases. Two humans contracted the rabies virus in the EU, but the infections 
originated from countries outside the EU. 
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Zoonotic bacteria were reported from a variety of different food categories and animal 
species. The highest Salmonella contamination rates were found in poultry and pigs 
and the fresh meat from these animals indicating that eggs, poultry meat and pork are 
major sources of human Salmonella infections. Poultry meat also showed the highest 
Campylobacter contamination levels. VTEC bacteria were mostly related to cattle and 
meat from these, whereas Yersinia bacteria were often reported both from pigs and cattle 
and their products. Ready-to-eat meat, dairy and ﬁshery products seemed to form the 
most signiﬁcant sources for Listeria monocytogenes, the cause of human listeriosis. 
Trichinella and Echinococcus parasites were very seldom detected in pigs and horses 
during meat inspections, although both of these parasites were found more often in wild 
animal species, indicating that wildlife is a reservoir for these parasites. This applies also 
to the rabies virus, where little evidence was found in domestic animals in contrast to 
ﬁndings in the wildlife. 
Information on food-borne disease outbreaks were collected in the past at the EU level 
but for the year 2004 it has been extensively summarised for the ﬁrst time. A total of 19 
Member States submitted this information on voluntary basis. These countries reported a 
total of 6,860 outbreaks with 42,447 people affected. Of these cases, there were 13 that 
resulted in death. Salmonella was the most frequently reported cause for these outbreaks.
The information submitted on antimicrobial resistance in zoonotic bacteria indicated 
that animals and food of animal origin might serve as reservoirs for resistant bacteria 
with the risk of direct or indirect transfer of resistant bacteria to humans. 
All of the 10 new Member States reported information for the ﬁrst time in 2004, adding 
some new features to EU total ﬁgures. Some new Members States reported relatively 
higher numbers of salmonellosis or trichinellosis cases in humans than were reported 
from the old Member States. In animals the Trichinella parasites and rabies virus were 
also in many new Member States more commonly found. 
Norway also takes part in the data collection system, as the only non-EU Member State 
making the overall picture more complete.
When interpreting the results in the report, one should bear in mind that the ﬁgures are 
in most cases not directly comparable between the countries due to differences in the 
reporting and monitoring procedures in place in the Member States.
 
b169_EFSA_int_02_03_06.indd   5 2/03/06   15:16:31
6The EFSA Journal 2005 – 310
TABLE OF CONTENT
Executive Summary 04
Table of content 06
1. INTRODUCTION 8
2. SUMMARY 10
 2.1. Zoonoses speciﬁc summaries 10
 2.2. Focus of the year 19
 2.3. General conclusions  21
3. INFORMATION ON SPECIFIC ZOONOSES 23
 3.1. Salmonella 23
  3.1.1. Salmonellosis in humans 23
  3.1.2. Salmonella in food 27
  3.1.3. Salmonella in animals 42
  3.1.4. Salmonella in feedingstuffs 54
  3.1.5. Salmonella serovars and phage types 60
  3.1.6. Antimicrobial resistance in Salmonella 74
  3.1.7. Summary on Salmonella 91
  3.1.8. Sources of Salmonella data 93
 3.2. Campylobacter 96
  3.2.1. Campylobacteriosis in humans 96
  3.2.2. Campylobacter in food 98
  3.2.3. Campylobacter in animals 102
  3.2.4. Campylobacter spp. distribution 105
  3.2.4. Antimicrobial resistance in Campylobacter 106
  3.2.5. Summary on Campylobacter 115
  3.2.6. Sources of Campylobacter data 116
 3.3. Listeria 117
  3.3.1. Listeriosis in humans 117
  3.3.2. Listeria in food 120
  3.3.3. Listeriosis in animals 126
  3.3.4. Summary on Listeria 126
  3.3.5. Sources of Listeria data 127
 3.4. Verotoxigenic Escherichia coli  128
  3.4.1. VTEC in humans 128
  3.4.2. VTEC in food 131
  3.4.3. VTEC in animals  133
  3.4.4. Summary on VTEC 135
  3.4.5. Sources of VTEC data 135
 3.5. Tuberculosis due to Mycobacterium bovis 136
  3.5.1. M. bovis in humans 136
  3.5.2. Tuberculosis due to M. bovis in animals 138
  3.5.3. Summary on M. bovis 141
  3.5.4. Sources of tuberculosis data 142
 3.6. Brucella 143
  3.6.1. Brucellosis in humans 143
  3.6.2. Brucella in food 145
  3.6.3. Brucella in animals 146
  3.6.4. Summary on Brucella 153
  3.6.5. Sources of Brucella data 154
b169_EFSA_int_02_03_06.indd   6 2/03/06   15:16:31
7 The EFSA Journal 2005 – 310
 3.7. Yersinia 155
  3.7.1. Yersiniosis in humans 155
  3.7.2. Yersinia enterocolitica in food 157
  3.7.3. Yersinia enterocolitica in animals  159
  3.7.4. Summary on Yersinia 161
  3.7.5. Sources of Yersinia data  162
 3.8. Trichinella  163
  3.8.1. Trichinellosis in humans 164
  3.8.2. Trichinella in animals 165
  3.8.3. Summary on Trichinella 168
  3.8.4. Sources of Trichinella data 168
 3.9. Echinococcus 169
  3.9.1. Echinococcosis in humans 170
  3.9.2. Echinococcus in animals  171
  3.9.3. Summary on Echinococcus 174
  3.9.4. Sources of Echinococcus data 174
 3.10. Toxoplasma 175
  3.10.1. Toxoplasmosis in humans 176
  3.10.2. Toxoplasma in animals 177
  3.10.3. Summary on Toxoplasma 178
  3.10.4. Sources of Toxoplasma data 178
 3.11. Other parasitic zoonoses reported 179
  3.11.1. Cysticerci 179
  3.11.2. Sarcocystis 179
 3.12. Rabies 181
  3.12.1. Rabies in humans 182
  3.12.2. Rabies in Animals  182
  3.12.3. Summary on rabies 185
  3.12.4. Sources of rabies data  186
4. INFORMATION ON ANTIMICROBIAL RESISTANCE IN SPECIFIC INDICATORS 187
 4.1. E. coli indicators 187
  4.1.1. E. coli indicators in food 187
  4.1.2. E. coli indicators in animals 187
  4.1.3. Summary on E. coli indicators 198
  4.1.4. Sources of E. coli indicators data 198
5. FOODBORNE OUTBREAKS  199
 5.1. General outbreak overview 199
 5.2. Foodborne outbreaks caused by Salmonella spp. 201
 5.3. Foodborne outbreaks caused by Campylobacter spp. 204
 5.4. Foodborne outbreaks caused by pathogenic E. coli  205
 5.5. Foodborne outbreaks caused by Yersinia spp. 205
 5.6. Foodborne outbreaks caused by other bacterial agents 206
 5.7. Foodborne outbreaks caused by viruses 207
 5.8. Foodborne outbreaks caused by parasites 209
 5.9. Foodborne outbreaks caused by marine biotoxins and other toxins 209
 5.10. Foodborne outbreaks caused by other agents 209
 5.11. Waterborne outbreaks 210
 5.12. Summary on foodborne outbreaks 210
 5.13. Sources of outbreak data 211
APPENDIX 1  212
APPENDIX 2  273
b169_EFSA_int_02_03_06.indd   7 2/03/06   15:16:32
8The EFSA Journal 2005 – 310
1. INTRODUCTION
The Community system for monitoring and collection of information on zoonoses was 
established by Council Directive 92/117/ECC (The Zoonoses Directive). This Directive 
sets rules for the Member States (MS) of European Union (EU) to collect, evaluate and 
report to the Commission, each year, data on speciﬁc zoonoses and zoonotic agents in 
animals, foodstuffs and feedingstuffs. At the end of the 1990’s, the Commission considered 
it necessary to revise the existing rules on monitoring and reporting of zoonoses. 
The aim was to improve the system, in particular regarding the comparability of data, 
and to extend the system to cover additional zoonoses on mandatory basis and certain 
other important aspects such as antimicrobial resistance and foodborne outbreaks. 
The new Zoonoses Directive 2003/99/EC was adopted by the Council and the European 
Parliament on 17 November 2003, and it instated as of 12 June 2004. Reporting according 
to the new rules in Directive 2003/99/EC will start with data collected during 2005. 
In 2004, data was collected according to the former Directive 92/117/EEC covering 11 
zoonotic agents and zoonoses: Salmonella, Campylobacter, Listeria monocytogenes, 
verotoxin producing E. coli, tuberculosis due to Mycobacterium bovis, Brucella, Yersinia, 
Trichinella, Echinococcus, Toxoplasma and rabies. In addition, data on antimicrobial 
resistance in Salmonella and Campylobacter and E. coli as well as foodborne outbreaks 
were reported. The European Food Safety Authority (EFSA) has been assigned the 
tasks of examining the data collected and preparing the Community Summary Report. 
The Zoonoses Collaboration Centre (the Danish Institute for Food and Veterinary Research) 
prepared the Community Summary report under the supervision of EFSA.
The 25 MS (EU-25), including the 10 new MS (EU-10), and Norway submitted national 
zoonoses reports for 2004. The 15 old MS (EU-15) and Norway have submitted zoonoses 
reports in previous years, and four of the new MS, Latvia, Lithuania, Cyprus and Slovenia 
reported on a voluntary basis already for 2003. 
For the ﬁrst year, MS submitted data using a new online zoonoses reporting system that 
was created and is maintained by the EFSA. All MS successfully reported national zoonoses 
data for 2004 using this system. This data, along with data submitted in subsequent 
years will be stored in a central data repository, facilitating data access and analysis.
INTRODUCTION
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The deadline for data submission was, exceptionally for this year, 5 July 2005. Data was 
frozen in the zoonoses database as of 2 August 2005. Any subsequent data submissions 
or amendments made by the MS were recorded in the database indicating the amendment 
date(s) and appear in the national zoonoses report. Data were extracted for analysis 
immediately following the freezing of the database and data amendments were incorporated 
within this dataset if at all possible. The draft Community Summary report was sent to 
MS for consultation and comments were collected by 29 November 2005. The utmost 
efforts were made to incorporate these comments and data amendments within the 
available time frame. 
The Community Summary Report is divided into 3 levels. Levels 1 and 2 are combined 
for this year, and they consist of a general summary and a Community assessment with 
interpretation of the trends and sources, covered by data analysis for each pathogen, 
as well as an overview of monitoring programmes implemented in the Community. 
The combined levels 1 and 2 are published in print form as well as on EFSA website and 
are made available to European Community stakeholders. Level 3 of the report consists 
of an overview of all data submitted by the MS. This level of the report is only available 
on EFSA website and in the CD ROM.
Monitoring and surveillance schemes for most zoonotic agents covered in this report 
are not harmonised between different MS, therefore ﬁndings presented in this report 
must be carefully interpreted. The data presented may not necessarily be derived 
from national sampling plans that are statistically modelled, and therefore, may not 
accurately represent the national situation on zoonoses. Results are generally not 
directly comparable between MS. 
Data presented in this report were chosen such that trends could be identiﬁed whenever 
possible. As a general rule, and as described, for food and animal samples, a minimum 
number of 25 samples tested were required to be selected for data analysis. Historical 
data and trends are presented whenever possible.
The human, animal and herd populations proﬁles of the MS from 1999 to 2004 are 
presented within the Appendix of the report, Table PO1 to PO3. 
INTRODUCTION
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2. SUMMARY
2.1. Zoonoses speciﬁc summaries 
Salmonella
Humans
A total of 192,703 cases of salmonellosis were reported by 24 MS in 2004. The incidence 
was 42.2 cases per 100,000 population, which represents an increase of 22% when 
compared with 2003. This increase is due mainly to the addition of the ten new MS 
reporting for the ﬁrst time. In the old MS, a general decreasing trend of salmonellosis has 
been observed in recent years. This decrease is most likely due to implementation of 
Salmonella control programmes in these countries. A quarter of all reported cases in EU-25 
are from children aged 0-4 years, and there is a seasonal peak during the late summer/
autumn. Salmonella Enteritidis serovar comprised 76% of all the reported cases in 2004. 
Foodstuffs
Data on Salmonella were reported for a wide range of foodstuffs. The majority of samples 
were collected from various types of meat and meat products. The lowest levels of 
contamination in poultry, pig, and bovine meat during the last ﬁve-year period have been 
reported from Finland, Sweden and Norway. 
Salmonella was detected at all levels of the poultry meat production, with the highest rates 
of contamination observed at the slaughterhouse and processing plants. Proportions of 
positive samples in poultry meat were generally lower than 10%, with the lowest proportions 
reported in countries with control programmes in the poultry production. At retail Salmonella 
was reported in fresh poultry meat ranging from 2% to 18.5% positive samples.
A general decreasing trend of Salmonella in table eggs was observed in those countries 
that had reported consistently. In pig meat, no clear trend was discernable, except for 
The Netherlands where a clear reduction was observed. Most countries reported Salmonella 
prevalences in pig meat below 10%. The contamination levels in bovine meat were 
generally considerably lower. Some MS reported contamination of ready-to-eat-meat 
products at the same level as in fresh meat. Such products constitute a particular risk 
to human health. In milk and dairy products Salmonella was rarely reported. Several 
surveys covering spices and herbs revealed relatively high Salmonella contamination. 
With a few exceptions, new MS generally reported similar levels of Salmonella in food as 
the old MS. 
Animals
The mandatory control program for Salmonella in breeding ﬂocks of fowl (Gallus gallus) 
ensures relatively comparable data within the Community. Overall, 6.3% of the laying 
hen breeding ﬂocks and 3.3% of the broiler breeding ﬂocks were found infected with 
Salmonella in the EU-25 MS. The levels of Salmonella infection in ﬂocks of laying hen 
breeders ranged up to 33%, and in ﬂocks of broiler breeders up to 37%, in the MS 
providing data according to the Directive. 
In ﬂocks of laying hens the levels of infection in the different MS ranged from 0 to 32.2% 
and in ﬂocks of broilers from 0 to 23.4%. Positive ﬂocks were also frequently reported 
among ﬂocks of turkeys, ducks and geese.
SUMMARY
b169_EFSA_int_02_03_06.indd   10 2/03/06   15:16:32
11 The EFSA Journal 2005 – 310
Few MS have active monitoring of Salmonella in pigs and cattle. The level of Salmonella 
in pig and cattle herds in the Nordic countries (Denmark, Finland, Norway and Sweden) 
remained low. In Italy the proportion of infected cattle herds was slightly higher and in 
The Netherlands, a relatively high proportion of the pig-fattening herds was infected.
Feedingstuffs 
The occurrence of Salmonella in ﬁshmeal decreased in most MS compared to previous 
years, whereas the overall levels of Salmonella in meat and bone meal and in compound 
feedingstuffs were comparable to previous years. The level of Salmonella contamination 
in feed of vegetable origin, mainly oil seeds and products thereof, varied considerably 
between MS. Salmonella Enteritidis and S. Typhimurium were detected in several types 
of feedingstuffs, however the levels were low.
Salmonella serovars
Overall, 86% of the isolates from human cases in the Community were serotyped. 
Salmonella Enteritidis and S. Typhimurium were the most commonly reported serovars 
from human infections, comprising 76% and 14% of the cases, respectively. Other 
serovars caused each 1% or less of the cases. Inclusion of the new MS increased the 
relative proportion of S. Enteritidis. 
Salmonella Enteritidis was the most commonly occurring serovar isolated from broiler 
meat, followed by S. Infantis and S. Typhimurium. However, the predominance of speciﬁc 
serovars in broiler meat varied greatly between the MS. 
Generally, table eggs are not monitored using culture methods. The data available from 
two MS showed that S. Enteritidis was also the predominating serovar reported in 
table eggs. The dominant serovars isolated from ﬂocks of laying hens and broilers were 
S. Enteritidis, S. Infantis and S. Typhimurium. However, the distribution of speciﬁc serovars 
varied greatly between the MS. Salmonella Typhimurium was the predominating serovar 
isolated from pigs and pig meat followed by S. Derby. Compared to 2003, the occurrence 
of S. Infantis in pig meat has increased. 
Several MS provided serovar information for bovine meat in 2004, but the monitoring 
data was too sparse for a Community evaluation of the serovar distribution. In cattle, 
S. Typhimurium and S. Dublin were the most frequently detected serovars during 
monitoring in 2004.
Antimicrobial resistance
From almost all countries, data was provided on antimicrobial resistance in Salmonella 
isolates from humans, various animal species and food of animal origin. Resistance to 
ampicillin, streptomycin, tetracycline and sulphonamide was common in Salmonella 
isolates from humans. Most MS also reported resistance to nalidixic acid, which is 
an indicator of emerging resistance to ﬂuoroquinolones. Among isolates from meat, 
resistance to ampicillin, nalidixic acid, streptomycin, tetracycline was common. 
Resistance to nalidixic acid occurred especially in broiler and poultry meat, whereas 
resistance to ﬂuoroquinolones was uncommon. Several MS reported high levels of 
resistance to ampicillin, streptomycin, tetracycline and sulphonamide in Salmonella 
from production animals. With some exceptions, resistance to nalidixic acid as well as 
ﬂuoroquinolones was low. Large variation in the occurrence of antimicrobial resistance 
among MS was evident.
SUMMARY
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Campylobacter
Humans
A total of 183,961 human cases of campylobacteriosis were reported from 21 MS in 
2004. The Community incidence was 47.6 cases per 100,000 population, ranging from 
0.1 to 249.6 in the reporting MS. By far the most common species reported was 
C. jejuni followed by C. coli.
The Community incidence increased by 32% from 2003. In all old MS except Spain 
and Sweden, an increasing national trend was observed. The new and old MS generally 
reported incidences within the same range with the exception of Czech Republic, who 
reported the highest incidence of human campylobacteriosis in the EU.
Foodstuffs
Food of poultry origin is the commodity most intensively sampled, and also where 
the majority of positive ﬁndings of Campylobacter in food occur. In meat, the highest 
prevalence (>80%) was reported in poultry meat at slaughter. At retail Campylobacter 
was reported in poultry meat in a range of 8.1% to 77%. Prevalences in pig meat and 
bovine meat at slaughter were considerably lower, ranging from no ﬁndings to 11.9%. 
Campylobacter were also isolated from a variety of other foodstuffs such as ﬁshery 
products, cheeses and vegetables.
Animals
The vast majority of the reported data on broiler ﬂocks were from the Nordic countries, 
where the prevalence ranged from 3.1% to 27.0%, decreasing in all Nordic countries 
from 2003 to 2004. In all MS, the Campylobacter positive samples from poultry, pigs 
and cattle were generally high, ranging up to 91.0%, 79.6% and 64.2%, respectively. 
The most common Campylobacter species isolated from poultry and poultry meat was 
C. jejuni. In pigs and cattle either C. jejuni or C. coli predominated.
Voluntary or mandatory control programmes on Campylobacter in broilers exist in 
6 MS and Norway. The control programmes have common traits, e.g. ensuring a high 
level of biosecurity in the ﬂocks and logistic slaughter (slaughtering positive ﬂocks at the 
end of the day). Furthermore, carcasses from positive ﬂocks may be frozen or subjected 
to heat treatment. 
Antimicrobial resistance
With few exceptions, 20-50% of all Campylobacter spp. isolates from humans reported 
by the MS were resistant to ﬂuoroquinolones, tetracyclines, quinolones and penicillins, 
whereas resistance to macrolides was generally at a low level. In isolates from animals 
and meat resistance to streptomycin, ﬂuoroquinolones, ampicillin and tetracycline was 
common, except in isolates from the Nordic countries. Furthermore, resistance to other 
antimicrobials, e.g. macrolides, varied between countries. In some MS the vast majority 
of Campylobacter isolates from poultry, pigs and sheep were resistant to quinolones and 
ﬂuoroquinolones. In some MS, the use of ﬂuoroquinolones in food animals has been 
restricted in order to prevent emergence and spread of ﬂuoroquinolone resistance.
SUMMARY
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Listeria monocytogenes
Humans
A total of 1,267 cases of listeriosis was reported from 21 MS in 2004. The reported 
incidence in EU in 2004 was 0.3 cases per 100,000 population which is similar to 2003. 
However, in countries with several years of data the incidence of listeriosis has increased 
when compared with the previous ﬁve years. Listeriosis is mainly reported to occur 
among adults and elderly people. A total of 107 deaths due listeriosis was recorded. 
All new MS reported a listeriosis incidence below the overall EU incidence in 2004.
Foodstuffs
Testing for Listeria monocytogenes in various types of foodstuffs was reported from 
21 MS and Norway covering mainly ready-to-eat foods. L. monocytogenes was isolated 
from many types of foodstuffs. Qualitative results varied considerably, and signiﬁcant 
ﬁndings above the critical contamination level (100 bacteria/g) were most commonly 
reported from ﬁshery products, and occasionally from meat products, cheeses and 
some ready-to-eat meat products. 
Animals
Clinical listeriosis was reported only from Sweden and mainly in sheep. 
Verotoxigenic Escherichia coli (VTEC)
Humans
A total of 4,143 cases of VTEC infections was reported from 17 MS in 2004. The incidence 
in EU was 1.3 cases per 100,000 population. The overall number of human cases 
reported increased compared to 2003. The majority of this increase was reported by the 
Czech Republic, who contributed with 42% of the total number of cases. By comparing 
only those MS who reported data for both years, the total number actually decreased 
by 3% from 2003 to 2004. The number of cases of HUS syndrome caused by VTEC 
remained similar to that reported in 2003. The percent of cases caused by the VTEC 
serotype O157 ranged widely, but in 6 countries serotype O157 constituted more than 
two thirds of the subtyped isolates. 
Foodstuffs
A total of 18 MS and Norway reported data on the occurrence of VTEC in foodstuffs. 
The majority of the positive samples were from raw milk and bovine meat. However, 
several MS also reported VTEC from pig, poultry and sheep meat, and some ﬁshery 
products. The variation in sample size and in type and quality of data did not justify 
comparisons between countries. 
Animals 
VTEC was detected in several animal species. The majority of positive samples were 
from cattle, indicating that cattle serve as an important reservoir for human exposure 
to VTEC. Positive ﬁndings were also reported from goats and sheep, pigs and poultry. 
Information on pathogenicity factors of the isolated VTEC strains was not provided. 
SUMMARY
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Tuberculosis due Mycobacterium bovis
Humans
The notiﬁcation systems for human tuberculosis does not always distinguish the cases 
caused by different species of Mycobacterium or only a subset of the isolates were 
speciated. Thus, a speciﬁc Community incidence for human M. bovis infections and an 
overall trend cannot be estimated. In 2004 the total number of reported human cases 
(86) was higher than in 2003 due to inclusion of data from Germany. 
Animals
Ten MS and Norway had an Ofﬁcially Tuberculosis Free (OTF) status in 2004. Most of the 
new MS do not yet have OTF status according to the EU legislation, but the level of 
M. bovis in cattle herds was relatively low in these countries. The risk of contracting 
domestic tuberculosis from animals in the OTF Member States as well as in the new MS 
is assumed to be extremely low, and domestic cases in these countries are usually 
reactivations of pre-existing infections in elderly or immunocompromised persons or 
infections in immigrants. No OTF MS reported contact with animals or food to be the 
suspected source of infection. 
Bovine tuberculosis was detected in few cattle herds in two of the 10 OTF MS. All the 
old non-OTF MS run eradication programmes against bovine tuberculosis and in most 
of the countries there has been a decrease in the proportion of infected herds since 
2001. In 2004, the proportion of infected herds was generally below 2% in these 
non-OTF old MS. 
Few MS reported isolation of M. bovis from sheep, goats, pigs or wildlife (deer, wild 
boars and badgers).
Brucella
Humans
A total of 1,337 cases of brucellosis were reported from 21 MS in 2004. The estimated 
Community incidence (EU-25) was 0.4 cases per 100,000 population. Overall, the human 
incidence of brucellosis in the EU-15 MS decreased from 1999 to 2003, and remained at 
the same level in 2004. During recent years, the highest incidences of human brucellosis 
have been recorded in the Mediterranean MS, and cases have primarily been caused 
by B. melitensis. Over the last ﬁve years, implementation of brucellosis eradication 
programmes has occurred, and a concurrent reduction of human brucellosis was 
observed in these MS. 
Foodstuffs
Few Member States reported testing of foodstuff (milk and milk products), for Brucella. 
Isolations were only from raw milk from Italy. 
Animals
By the end of 2004, 9 MS, regions in three other MS, and Norway were ofﬁcially free of 
brucellosis in cattle (OBF) as well as ofﬁcially free from brucellosis (B. melitensis) in 
sheep and goats (ObmF). Four MS and regions in three other MS were ofﬁcially free from 
brucellosis in sheep and goats alone. Regions in Italy were OBF alone. In 2004, no herds 
positive for brucellosis was detected in the OBF or ObmF MS, but some herds tested 
positive in the ofﬁcially free regions of the other MS. 
SUMMARY
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In the old non-OBF and non-ObmF MS no clear general trends were obvious and 
the overall occurrence of brucellosis among cattle, sheep and goat in the EU-15 MS 
remained approximately at the same level as in 2003. The proportion of infected herds 
was generally less than 1% in cattle and less than 4% in ovine and caprine herds in the 
old non-free MS. 
Most of the new MS have not obtained the OBF/ObmF status according to the EU 
legislation in 2004, even though brucellosis has been eradicated or was never registered 
in many of these MS. Compared to the old MS without OBF/ObmF status, human 
incidence and prevalence of brucellosis among cattle, sheep and goat herds was lower 
in the new MS without OBF/ObmF status.
Yersinia
Humans
Twenty MS reported a total of 10,381 cases of human yersiniosis in 2004, where two 
thirds of the cases were reported from Germany. The overall EU-25 incidence was 2.4 cases 
per 100,000 population. There has been no clear trend in the total number of cases 
reported within the EU from 2000 to 2004. But an increasing trend was observed in nine 
MS that reported and had notiﬁcation throughout the period. The most common subtype 
of Yersinia isolated from human cases was Y. enterocolitica, and mainly serotype O:3. 
Foodstuffs
The majority of the 9 MS reporting data on Yersinia in foodstuffs report data from fresh 
pig meat, and several on milk and dairy products, bovine meat and poultry meat as well. 
The occurrence of Yersinia in pig meat and bovine meat appears to be quite similar, and 
higher than the occurrence observed for other food sources. 
Animals
Few MS report isolation of Yersinia in animals. The bacteria was frequently found in pigs 
and cattle.
Trichinella
Humans
All MS and Norway included information about Trichinella in the national reports for 2004. 
A total of 270 cases of human trichinellosis was reported from 9 MS in the EU in 2004. 
The incidence was 0.06 cases per 100,000 population. This was a three-fold increase 
compared to 2003, and was mainly due to the inclusion of a high number of cases 
from Poland. For the EU-15 countries, there has been no clear trend in the number of 
cases over the last 6 years. As in previous years, the MS generally reported all or the 
majority of human sporadic cases and outbreaks to result from private import of meat 
or consumption abroad of meat not examined for Trichinella.
Animals
Pigs, horses, wild boars and carnivorous game are tested for Trichinella at slaughter. 
High numbers of meat samples from domestic pigs and horses were examined in the 
context of meat inspection by the MS. Trichinella was not detected in horses, and was 
detected in few samples from domestic pigs from a limited number of MS. A much higher 
prevalence of Trichinella was observed in the wildlife population, including wild boars, 
compared to the domestic animals, indicating that the wildlife serves as a reservoir for the 
parasite. Trichinella was primarily detected in animals in North-Eastern Europe and few 
other MS. A number of the new MS were among the countries with highest infection rates.
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Echinococcus
Humans
A total of 343 human cases caused by Echinococcus spp. was reported from 19 MS in 
2004, of which 2 MS reported no cases in 2004. The incidence was 0.1 case per 100,000 
population. At least 57% of the cases were caused by E. granulosus. No clear trend 
was observed in the overall number of human cases over the last 6 years. The number 
of human cases decreased from 2003 to 2004 by approximately 20% in the 17 MS that 
reported in both years. The reduction may be attributed to a signiﬁcant decrease of the 
number of cases reported from Spain. If Spain is removed from the calculation, there 
was an overall increase in the number of reported human cases. The largest increases 
were observed in Portugal and Lithuania. 
Animals
The majority of positive ﬁndings in farm animals were reported from the Mediterranean 
MS. Most of these MS reported a decreasing trend in the number of positive ﬁndings 
over the last ﬁve years. The other old MS (EU-15) reported either no ﬁndings or very low 
prevalences. Five new MS (EU-10) reported data on the occurrence of Echinococcus. 
High prevalences were reported in sheep and goats in Poland. 
E. multilocularis, the cause of alveolar echinococcosis in humans, was reported found in 
foxes in ﬁve MS and in wild boars in France. E. granulosus was found in other wildlife 
such as moose, reindeer and wolves.
Toxoplasma
Humans
Eighteen MS reported a total of 1,736 cases of human toxoplasmosis in 2004, of which 
45 cases were registered to be congenital infections. The EU incidence was 0.6 cases 
per 100,000 population. Since some EU-15 countries only notify subsets of the cases, 
this must be considered an underestimation. Only few MS have a routine surveillance for 
toxoplasmosis in pregnant women or newborns. Overall an increasing number of cases 
were reported from 2000 to 2004 following a parallel increase in the number of MS 
reporting human cases. The reported incidence was considerably higher in the new MS 
(EU-10) than in the old MS (EU-15). 
Several MS report that they provide advice to women on how to prevent Toxoplasma 
infections during pregnancy. 
Animals
Data on toxoplasmosis from animals in 2004 were mainly results from diagnostics. 
Toxoplasma was diagnosed in all animal species examined: cattle, sheep, goats, pigs, 
solipeds, dogs, cats and pigeons. In general the focus of toxoplasmosis in animals is on 
T. gondii as an important causative agent for abortions in sheep and goats rather than 
the food safety aspect.
SUMMARY
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Cysticerci and Sarcocystis
Belgium was the only Member State to report data on cysticercus (Taenia saginata) and 
sarcocystis in 2004. Only data from visual post mortem inspection of bovine carcasses 
at slaughterhouses was reported. Cysticercus was detected in 0.34% of 881,535 
carcasses. More than 99% of the infected carcasses were infected at a low level. 
Sarcocystic lesions were detected in 19 carcasses (0.002%). Infected carcasses were 
destroyed. The proportion of carcasses infected with these parasites did not change 
signiﬁcantly from 2003 to 2004. 
Rabies
Humans
In 2004, information on rabies was provided from all MS and Norway. Since 2001, only 
ﬁve human cases, all imported from countries outside EU, were reported. In 2004, two 
imported human case of rabies was reported from Austria and Germany.
Animals 
In 2004, twelve MS reported rabies cases in domestic animals, pet animals or wildlife, 
and the number of cases decreased to 1,683 compared to 2,130 cases in 2003. Forty-four 
percent of the animal cases in 2004 were in foxes. In most EU-15 Member States, cases 
reported from animals are very rare or have been absent for many years. The majority of 
rabies cases in domestic animals and pet animals were reported by the new MS, where 
wildlife (especially foxes) were frequently infected and constitutes a reservoir for infection 
of domestic animals. All MS with positive ﬁndings have eradication programmes in action 
or will begin eradication programmes in 2005.
Antimicrobial resistance in E. coli indicators 
A total of eighteen MS and Norway provided data on antimicrobial resistance in E. coli 
indicators in 2004. Data were generated through monitoring programmes. Low levels of 
antimicrobial resistance were reported for isolates from food (only 4 MS reported data). 
A large variation in the prevalence of resistance in E. coli indicators isolates from animals 
(cattle, pigs and Gallus gallus) was observed. The Nordic countries reported a relatively 
low prevalence of resistance to penicillins, quinolones and tetracyclines, as compared 
to other EU countries. In general, the highest prevalence of resistance was reported in 
isolates from Gallus gallus, followed by isolates from pigs and cattle.
Foodborne outbreaks
Analysing and evaluation of reported data on foodborne disease outbreaks was presented 
more extensively in 2004 than in previous years. Data was received from 20 MS and 
Norway. All new MS, except Cyprus and Malta, reported outbreaks in 2004. The data 
received was generally complete and of a high quality. However, the data differed 
between MS and some MS, particularly the most populous, provided aggregated data 
for outbreaks. This meant that details on settings and sources of outbreaks were not 
available for the majority of outbreaks. Some MS only reported the number of hospitalised 
cases, leading to some overestimation of the hospitalisation rates. 
SUMMARY
b169_EFSA_int_02_03_06.indd   17 2/03/06   15:16:33
18The EFSA Journal 2005 – 310
Fourteen MS and Norway provided information on their outbreak reporting systems. All MS 
reported systems of national data collection through centralised reporting and most MS 
had mandatory reporting systems. Many MS indicated that outbreaks are under-reported. 
A total of 6,860 outbreaks were reported in EU in 2004 affecting 42,447 persons 
of which 9.8% were hospitalised. Thirteen deaths were reported from outbreaks. 
Czech Republic and Germany reported the largest number of outbreaks, 2,334 and 
2,647 respectively, representing 72.6% of all outbreaks reported for 2004.
The most common cause of outbreaks in the EU in 2004 was Salmonella, causing the 
largest number of outbreaks (73.9% of the reported outbreaks) and by far the largest 
number of persons involved (68.9%). The hospitalisation rate was 10.8%. Salmonella 
outbreaks were reported in all 20 MS that provided data on outbreaks and in Norway. 
S. Enteritidis and S. Typhimurium were the predominant serotype associated with 
outbreaks where the serotype was reported. Eggs, bakery products and meat products 
were the most important sources, and in approximately 50% of the outbreaks exposure 
took place in private homes or restaurants. 
Czech Republic reported proportionally more Salmonella outbreaks than any other 
country. Most were family outbreaks. The largest single outbreak of S. Enteritidis was 
reported from Greece resulting in 651 ill persons, with 247 hospitalisations and one 
death, with dry fruits and nuts identiﬁed as source. 
The second most common cause of outbreaks in 2004 was Campylobacter. A total of 1,243 
outbreaks (18% of outbreaks) was caused by Campylobacter. The outbreaks involved 
3,749 persons of which 4.2% were hospitalised. Outbreaks of campylobacteriosis were 
reported by 13 MS and Norway and C. jejuni was by far the species most commonly 
reported in outbreaks where speciation was reported. The majority of Campylobacter 
outbreaks, with a known source, were associated with broiler meat or water. 
Other major causes of foodborne outbreaks in the EU were pathogenic E. coli (1.3% of the 
outbreaks), foodborne viruses (1.3%) and Yersinia spp. (0.7%). Finland reported a large 
outbreak of Y. pseudotuberculosis (131 cases), where the source was grated carrots. 
Also outbreaks caused by staphylococcal enterotoxins, Cl. botulinum, Cl. perfringens, 
histamine and marine biotoxins were reported.
Only a few foodborne outbreaks caused by parasites were reported. Outbreaks caused by 
Trichinella, were reported by the Lithuania and Poland, the latter reporting four outbreaks 
involving a total of 157 persons. The sources of these outbreaks were pig or wild boar 
meat. The largest outbreak reported in 2004 was reported by Norway, involving 1,300 
people infected with Giardia by drinking contaminated water. 
SUMMARY
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Table 1. Overview of the existence of notiﬁcation systems for human zoonotic 
diseases in the Member States, 2004.
 
 A B CY CZ DK EST FIN F D GR H IRL I LV LT L M N PL P SK SLO ES S NL UK
Salmonellosis Y1 Y2 Y - Y Y Y N Y Y Y Y Y Y Y - - Y - Y Y Y Y3 Y N -
Campylobacteriosis Y1 Y Y Y Y Y Y N N Y Y Y Y Y Y - - Y - - Y Y Y3 Y N N
Listeriosis Y Y4 N Y Y Y Y Y Y Y Y Y Y Y Y - Y Y Y Y Y Y Y3 Y N N
VTEC Y1 Y - Y Y Y Y N Y Y5 Y Y5 Y Y Y - - Y - - Y Y Y3 Y Y N
Tuberculosis Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y - - Y - Y Y Y Y3 Y Y Y
Brucellosis Y Y Y Y N6 Y Y Y Y Y Y Y Y Y Y - - Y Y Y Y Y Y Y Y Y7,8
Yersiniosis Y Y4 - Y Y Y Y N Y - Y Y Y Y Y - - Y - - Y Y Y3 Y N N
Trichinellosis Y Y4 N Y N Y Y N Y Y Y Y Y Y Y - - Y Y Y Y Y Y Y Y N
Echinococcosis Y Y - Y N Y Y N Y Y Y Y Y Y Y - - Y - Y Y Y Y Y N N
Toxoplasmosis N Y2 N Y N Y Y N Y9 Y9 Y Y Y Y Y9 - - Y11 - - N Y Y3 N N Y10
Rabies Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y - - Y - - Y Y Y Y Y Y
Y=yes, N=no, - = no information
1. In Austria, clinical cases notiﬁable since 1996.
2. In Belgium, in the French Community.
3. In Spain, only hospitalised cases notiﬁable.
4. In Belgium, in the Flemish Community.
5. In Greece and Ireland, EHEC is notiﬁable.
6. In Denmark, only imported cases registered.
7. In United Kingdom, imported or laboratory infected cases occur.
8. In United Kingdom, reportable to all work related activities but not to all incidents.
9. In Germany, Greece and Lithuania, congenital cases only.
10. In United Kingdom, only Scotland.
11. In Norway, encephalitis cases are notiﬁable.
2.2. Focus of the year
The ten new MS, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, 
Poland, Slovakia and Slovenia, reported for the ﬁrst time on a mandatory basis in 2004. 
These new MS reported data for most zoonoses. Data quality was good and additional 
information, including historical data, was included in written reports. The occurrence of 
disease and results from monitoring and surveillance programs in these countries is the 
focus of the Community Summary Report in 2004.
Czech Republic, Slovakia and Slovenia all report rates of human salmonellosis greater 
than 160 cases per 100,000 population, noticeably higher than the total EU incidence 
(42.2 per 100,000). With the exception of the Czech Republic, who reported the highest 
incidence of human campylobacteriosis, the rest of the new MS generally reported 
incidences of campylobacteriosis within ranges previously reported by the old MS. 
Listeriosis reported by new MS represented only 4.7% of all cases reported, and all new 
MS reported incidences below the total EU incidence. The majority of the increase in total 
number of human VTEC cases was reported by the Czech Republic, who contributed 
with 42% of the total number of cases. Latvia, Lithuania and Poland reported also 
signiﬁcant numbers of trichinellosis cases, which increased the total number of trichinellosis 
cases in EU-25 by three fold. The incidence of toxoplasmosis in new MS was higher than 
the incidence in EU-15. Czech Republic and Poland reported the most of these cases.
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Food-borne outbreaks were reported by eight new MS. The Czech Republic reported 
proportionally more outbreaks than any other MS in the EU, predominantly caused by 
Salmonella. The Czech Republic reported also 547 Campylobacter outbreaks (44% of 
the outbreaks) affecting 1,555 people with 90 hospitalisations. Hungary reported one 
large waterborne outbreak of campylobacteriosis. Lithuania and Poland recorded 
together 8 outbreaks of trichinellosis.
With few exceptions, levels of Salmonella contamination in new MS that reported testing 
for in food, were similar to that of the old MS. Some higher prevalences were reported 
by Malta in fresh pig meat at slaughter (32.8% Salmonella positive) and by Cyprus in 
fresh broiler meat at processing (36.6% positive). New MS also reported testing for 
Campylobacter in food, particularly in poultry meat. Considerable prevalences (30-40%) 
were recorded by the Czech Republic, Slovenia and Cyprus.
Testing for Listeria monocytogenes in food was performed in all new MS across a variety 
of foods. The level of contamination was in general similar to the level in the old MS, 
although Estonia found 22.9% samples of ﬁshery products positive for L. monocytogenes. 
Seven new MS reported testing for VTEC in food. Cyprus, Estonia and Slovenia did not 
detect any VTEC from the samples tested. Poland reported 8.3% of bovine meat samples 
were positive and Latvia reported 4.9% of pigs tested were positive.
The new MS reported lower incidence of brucellosis in humans and animals compared 
to the old MS. This also applies to tuberculosis in cattle. Many of the new MS are 
seeking to receive an ofﬁcially free status regarding these diseases in accordance with 
the EU legislation.
The new MS reported the majority of rabies cases in animals, where wildlife (especially 
foxes) were frequently infected. Estonia, Hungary, Latvia, Lithuania, Poland and Slovakia 
reported cases both in farm animals, pets and wildlife. 
Some new Member States reported ﬁndings of parasites from slaughter animals. Lithuania, 
Poland and Slovakia found Trichinella in slaughter pigs, and Poland reported remarkable 
high Echinococcus ﬁndings in sheep, goats and pigs.
Data on antimicrobial resistance, primarily in Salmonella from humans, food and animals, 
was received from eight new MS: Czech Republic, Estonia, Hungary, Lithuania, Latvia, 
Poland, Slovakia and Slovenia. In general, the prevalence of antimicrobial resistance 
reported by new MS was similar to, or lower than, the prevalence reported by old MS. 
However, in many cases the reporting was based on a low number of samples, making 
comparison of prevalence between MS less valid.
In coming years the Community Report will beneﬁt from continued contribution by the 
new MS and trend analysis will be possible in future reports. 
SUMMARY
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2.3. General conclusions 
The Member States and Norway reported human cases of all the zoonoses covered by 
the reporting system. Findings of the zoonotic agents were reported from a variety of 
food categories and animal species.
Salmonella and Campylobacter are currently the leading causes of foodborne bacterial 
gastroenteritis in the European Community. The reported incidences of human salmonellosis 
and campylobacteriosis in EU were almost at the same level in 2004.
Despite many efforts to prevent and control Salmonella Enteritidis, this pathogen continues 
to be a major cause of gastrointestinal disease in the EU. Especially the new MS reported 
high incidences of S. Enteritidis infections in 2004, whereas decreasing trends are 
observed in several of the EU-15. It is generally accepted, that infections caused by 
S. Enteritidis are related to poultry (Gallus gallus) products and especially table eggs and 
egg products. This is supported by the fact that the majority of reported Salmonella 
outbreaks in the EU-25 were caused by S. Enteritidis in eggs and egg products. It is also 
notable that those MS having the lowest proportions of S. Enteritidis cases have control 
programmes running not only in the breeding ﬂocks in egg production line, but also in 
the laying hen ﬂocks producing table eggs, which includes restrictions such as heat 
treatment of table eggs from ﬂocks suspected of being infected.
Poultry, in particular broiler meat, is regarded the single most important source of human 
campylobacteriosis although other sources exist. Results from the monitoring of broiler 
ﬂocks and broiler meat in 2004 support this. Some countries have taken initiatives to 
actively control Campylobacter in the broiler production chain. In the primary production 
control is particularly aimed at improving bio-security, and there appears to be some 
effect of these efforts, as indicated by a decreasing level of positive broiler ﬂocks. At the 
slaughterhouse level, control efforts are mainly focused towards sorting of the positive 
and negative ﬂocks and diverting the positive ﬂocks for either freezing or heat treatment. 
Until now, only slight decreases in the incidence of human campylobacteriosis has been 
reported from these countries since the strategies were introduced. Continued research 
aiming at identifying new and more effective intervention strategies to further reduce the 
burden of human campylobacteriosis is therefore essential.
Twenty-four MS and Norway submitted data on antimicrobial resistance in isolates of 
Salmonella, Campylobacter and E. coli indicators from humans, various animal species and 
food of animal origin. In general resistance to ampicillin, streptomycin, tetracycline and 
sulfonamide was commonly reported. Most MS reported resistance to nalidixic acid, which 
is an indicator of emerging resistance to ﬂuoroquinolones. In general, large variation 
between MS was evident. The reporting of antimicrobial resistance in the MS, clearly 
demonstrates the presence of a reservoir of antimicrobial resistance in food animals and food 
of animal origin. Emergence of infections in humans, caused by resistant bacteria, originating 
from the animal reservoir, is a concern as effective treatment may be compromised.
While Campylobacter and Salmonella infections are the most frequently occurring 
zoonotic diseases, listeriosis and VTEC infections are the most severe zoonotic illnesses 
due to the high morbidity and mortality in vulnerable populations and in children. 
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Occurrence of Listeria monocytogenes is of particular concern in ready-to-eat and 
moderately preserved food because of its ability to grow at low temperatures. L. 
monocytogenes was reported in relatively high proportions from ﬁshery products, 
cheeses made from raw milk and some ready-to-eat meat products in 2004. Such products 
may constitute a risk for humans.
VTEC is characterised as an emerging disease in many countries, and is notorious for 
causing outbreaks. The incidence in EU in 2004 was similar to the incidence in 2003 and 
considerably lower than the incidence of salmonellosis and campylobacteriosis. VTEC 
infection may be associated with severe complications such as haemolytic uraemic 
syndrome (HUS) causing renal failure and destruction of the red blood cells particularly 
in children and the elderly. Farm animal species (in particular cattle) are regarded as 
reservoir of VTEC, and food of animal origin is considered to be the main sources of human 
foodborne infections. This is supported by the results testing of animals and foodstuffs in 
2004. The overall proportion of positive samples in foodstuffs was low though – below 1%. 
Yersinia spp. caused relatively high number of human cases in 2004, and there is an 
increasing trend among the countries, which have reported consistently over the 5 years. 
Yersinia was frequently reported in pigs, cattle and meat thereof, implicating that they 
may form the main source of the infections. 
Overall, the “classical” zoonoses: tuberculosis, brucellosis, and trichinellosis, as well as 
rabies, and echinococcosis are very rare diseases in EU. For tuberculosis caused by 
Mycobacterium bovis and brucellosis, the low numbers of reported cases indicate that 
the programmes for eradicating these diseases in the primary production are successful. 
Effective control programmes have been run also for rabies and echinococcosis in farm 
and wild animals. 
As in previous years, the vast majority of human cases caused by Trichinella was reported 
to result from private import of meat or consumption abroad of non-tested meat. Large 
numbers of samples from domestic pigs and horses are examined annually. In 2004, 
Trichinella was only detected in few samples from domestic pigs. In contrast, a much 
higher prevalence was observed in the wildlife population, including wild boars, indicating 
that wildlife may constitute a risk for infection of domestic animals reared in proximity to 
a wildlife reservoir. Wildlife forms a reservoir also for rabies and Echinococcus infections.
Ten new MS reported for the ﬁrst time on a mandatory basis in 2004. Most zoonoses were 
covered and data quality was good. The EU incidences of human campylobacteriosis, 
salmonellosis and trichinellosis have all increased with the inclusion of the new MS. 
However, it is not clear whether the higher incidences reported for these diseases are 
reﬂecting true differences or are a result of more intensive surveillance and reporting. 
SUMMARY
b169_EFSA_int_02_03_06.indd   22 2/03/06   15:16:34
23 The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
3. INFORMATION ON SPECIFIC ZOONOSES
3.1. Salmonella
Salmonella has long been recognised as an important zoonotic pathogen of economic 
signiﬁcance in animals and humans. Next to Campylobacter, it is the most reported 
foodborne zoonotic pathogen in the EU. The genus Salmonella is currently divided into 
two species: S. enterica and S. bongori. S. enterica is further divided into six subspecies 
and most Salmonella belong to the subspecies S. enterica subsp. enterica. Members of 
this subspecies have usually been named based on where the serovar or serotype was 
ﬁrst isolated. In the following text, the organisms are identiﬁed by genus followed by 
serovar, e.g. S. Typhimurium. More than 2,400 serovars of zoonotic Salmonella exist and 
the prevalence of the different serovars changes over time.
Human salmonellosis is usually characterised by acute onset of fever, abdominal pain, 
nausea, and sometimes vomiting. Symptoms are usually mild and most infections are 
self-limiting, lasting a few days. However, in some patients, the infection may be more 
serious and the associated dehydration can become life threatening. In these cases, 
as well as when Salmonella causes bloodstream infection, effective antimicrobials are 
essential for treatment. Salmonellosis has also been associated with long-term and 
sometimes chronic sequelae e.g. reactive arthritis.
There are numerous foodborne sources of Salmonella including a wide range of domestic 
and wild animals and variety of foodstuffs. Transmission often occurs when organisms 
are introduced in food preparation areas and are allowed to multiply in food e.g. due 
to inadequate storage temperatures, or because of inadequate cooking or cross 
contamination of cooked food. The organism may also be transmitted through direct 
contact with infected animals and faecally contaminated environments.
Overall, in EU S. Enteritidis and S. Typhimurium are the serovars most frequently 
associated with human illness. Human S. Enteritidis cases are most commonly associated 
with consumption of contaminated broiler meat and eggs, while S. Typhimurium cases 
are associated with consumption of contaminated pig, poultry and bovine meat, dairy 
products, and lamb.
In animals, sub-clinical infections are common. The organism may easily spread between 
animals in a herd or ﬂock without detection and animals may become intermittent or 
persistent carriers. Infected cows may succumb to fever, diarrhoea and abortion. Within 
calf herds, Salmonella may cause outbreaks of diarrhoea with high mortality. Fever and 
diarrhoea are less common in pigs than in cattle, and sheep, goats and poultry usually 
show no signs of infection.
3.1.1. Salmonellosis in humans
In 2004, all MS (except Luxembourg who did not provide data), reported cases of 
salmonellosis. Data reported here include all MS and Norway. There were 192,703 cases 
of salmonellosis in the EU, which represents an incidence of 42.2 per 100,000 population. 
This is an increase of 22% when compared with EU-15 2003 and the highest incidence 
since 1999 (Table SA1). Incidence ranged from 6.6 per 100,000 population in Portugal to 
300.9 per 100,000 population in Czech Republic.
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Table SA1. Number of human cases of salmonellosis 1999-2004 and incidences in 20041
2004
Cases/
100,000
population
2004 2003 2002
Number 
of cases
2001 2000 1999
Austria 89.5 7,286 (188) 8,251 8,322 7,219 7,017 7,058
Belgium 91.8 9,545 12,894 9,754 10,784 14,047 15,569
Cyprus 12.2 89 73 - - - -
Czech 
Republic
300.9 30,724 (248) - - - - -
Denmark 28.5 1,538 1,713 2,075 2,918 2,308 3,268
Estonia 10.0 135 (4) - - - - -
Finland 43.1 2,248 (1788) 2,290 2,357 2,731 2,624 2,789
France 10.6 6,352 6,199 6,575 7,456 7,684 8,184
Germany 69.0 56,947 (1071) 63,044 72,377 77,386 79,535 85,146
Greece 13.5 1,493 837 460 284 206 221
Hungary 74.7 7,557 - - - 11,507 -
Ireland 10.2 410 (68) 449 369 430 640 956
Italy 11.6 6,696 6,352 10,744 8,215 5,765 7,943
Latvia 22.4 520 (6) 799 - - - -
Lithuania 53.8 1,854 1,161 - - - -
Luxembourg - - 421 528 319 - 353
Malta 19.8 79 (2) - - - - -
Poland 41.8 15,958 - - - - -
Portugal 6.6 691 720 330 696 309 424
Slovakia 235.4 12,667 (43) - - - - -
Slovenia 162.6 3,247 3,980 - - - -
Spain2 16.8 7,109 8,558 8,047 7,968 6,366 5,954
Sweden 39.7 3,562 (2709) 3,794 3,892 4,508 4,617 4,884
The  
Netherlands 9.4 1,520 (293) 2,142 1,588 2,082 2,059 2,128
United 
Kingdom 24.3 14,476 (248) 16,343 16,318 18,419 16,988 19,819
EU-Total 42.2 192,703 140,020 143,736 151,415 161,672 164,696
Norway 34.2 1,567 (1134) 1,539 1,495 1,899 1,489 -
Note: Figures in brackets are reported imported cases, values are included in the total number of cases.
1. EU-Total incidence is based on population in reporting countries.
2. In Spain, only hospitalised cases notiﬁable.
The reported increase in incidence in 2004 is due to the higher incidence of salmonellosis 
in new MS reporting for the ﬁrst time. The Czech Republic and Slovakia report rates 
greater than 200 per 100,000 population. Trend data is not available for new MS as this 
is their ﬁrst year of reporting.
For those MS where data was available for the last ﬁve years, and salmonellosis is notiﬁable, 
the reported number of cases in 2004 was compared to the mean of the previous ﬁve 
years (Figure SA1). In seven of the nine MS with available trend data, a decreasing ﬁve-year 
trend was observed, whereas Portugal and Greece experienced an increasing trend. 
Explanations were not provided for these increases. Norway remained at a low steady 
state throughout the period.
Number of cases
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Figure SA1. Percent change in incidence of human salmonellosis in countries with 
available data and where salmonellosis is notiﬁable. Reported number of cases in 
2004 compared to a ﬁve-year mean (1999-2003)
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Table SA2. Number of reported domestic and imported human cases of salmonellosis 
by serovar, 2004
Domestic Imported
S. Ent1 S. Typ2 S. spp.3 S. Ent1 S. Typ2 S. spp.3
Czech Republic 29,595 448 433 167 9 72
Estonia 87 18 26 4 0 0
Finland 78 125 118 738 177 873
Germany 31,641 10,007 7,314 2,328 326 1,071
Ireland 135 115 92 38 9 21
Latvia 420 23 54 3 - 3
Malta 44 10 23 1 0 1
Norway 80 83 182 693 101 340
Slovakia 11,192 152 1,278 29 1 13
Sweden 75 193 229 1,209 180 1,320
The Netherlands 665 449 319 103 14 176
United Kingdom 486 319 - 211 37 -
1. S. Enteritidis.
2. S. Typhimurium.
3.  S. spp. includes cases with unknown serovar as well as all serovars other than S. Enteritidis and 
S. Typhimurium.
Some MS made a distinction between cases acquired within the country and cases 
acquired abroad (Table SA2). Of the MS reporting this data, most cases were acquired 
within the country and S. Enteritidis was the most common serotype. Finland, Sweden 
and Norway, however, reported a large proportion of cases as acquired outside the 
country. Sweden deﬁnes an imported case if the person has been abroad during the 
incubation period for salmonellosis.
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Human Salmonella serovars
Data on Salmonella serovars was provided by 23 MS (Italy and Poland did not provide 
data) and Norway. (Table SAS1 in Section 3.1.5. provides detail.) S. Enteritidis is identiﬁed 
in 76% of Salmonella isolates that are serotyped. In general, MS report S. Enteritidis as 
their most prevalent serovar, ranging from 32% in France to 100% in Cyprus. This serovar 
is commonly associated the consumption of under-cooked eggs and poultry meat. 
Salmonella Typhimurium was identiﬁed in 14% of all serotyped isolates. S. Typhimurium 
infections are associated with the consumption of contaminated animal products 
particularly pig, poultry and bovine meat. S. Typhimurium was the most common cause 
of domestic human cases in Sweden and Finland. 
Age distribution
The greatest incidence of reported salmonellosis was in children aged 0-4 years 
(Figure SA2). This age group represented 26% of all cases of salmonellosis reported 
in the EU. A secondary peak occurs in adults aged 25-44 years. Data on age distribution 
in humans is summarised in Level 3, Table SA2-SA4.
Figure SA2. Age distribution of cases of salmonellosis in EU and Norway, 2004
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Seasonality
All MS provided data on the monthly distribution of salmonellosis. A peak in the incidence 
of salmonellosis is seen in late summer/autumn (Figure SA3). Data on seasonal distribution 
in humans is summarised in Level 3, Table SA5-SA7.
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Figure SA3. Distribution of salmonellosis by month in EU and Norway, 2004
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3.1.2. Salmonella in food
At this time no common scheme has been agreed upon for monitoring the occurrence 
of Salmonella in foodstuffs. As a consequence the sampling schemes and diagnostic 
methods, as well as the type of foodstuffs selected for analyses, vary between MS. As 
such, results are not directly comparable between MS and comparison between years 
within the same country should be done with caution. Only results based on more than 
25 samples tested are addressed in the following. Details on the monitoring schemes 
applied in the MS are summarised in Appendix Tables SA9, SA12, SA18 and SA21.
Poultry meat and products thereof
A number of MS have applied monitoring schemes for Salmonella in poultry, these are 
described in Appendix Table SA7 and SA8. Data on the occurrence of Salmonella in 
broiler meat at different levels of the production line, in MS that have applied such 
programmes and that have reported consistently from 2000-2004 are presented in Table 
SA3 (slaughter and processing) and Figure SA4 (retail). 
Poultry meat is a known source of human Salmonella infections. Denmark, Finland, Ireland, 
Sweden and Norway have had programmes for the control of Salmonella in broilers for 
a number of years and have reported data on Salmonella in broiler meat consistently. 
Sweden, Finland and Norway have consistently reported very low levels of Salmonella 
over the last 5 years. In Ireland there has been a decreasing trend for Salmonella ﬁndings 
in broiler meat at processing, from 9.3% in 2000 to 2.7% in 2004, see Table SA3.
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Table SA3. Salmonella in poultry meat in countries with a monitoring/control 
programme1, 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
At slaughter
Belgium2 - - 189 17.5 171 9.4 222 12.2 170 8.8
Belgium3 - - 57 24.6 72 23.6 120 25.8 116 31.9
Denmark 1,472 1.6 1,5523 5.0 1,6673 5.5 1,6953 4.1 4,543 2.9
Norway4 7,2392 1.0 7,1832 0 6,9592 0 7,1352 0 3,882 0
Greece 897 5.5 878 8.4 940 5.6 747 12.7 325 14.2
Italy 43 0 334 3.3 349 6.9 651 4.8 166 3.6
Spain 151 8.6 30 6.7 241 3.7 242 6.6 - -
Sweden 3,730 0.1 4,2092 0 4,4662 0.1 4,2432 0 7,467 0
At processing/cutting plant
Belgium 1832 8.7 1485 14.2 1383 16.7 1503 20.0 171 13.5
Finland 777 0.1 1,034 0.1 946 0.2 637 0.2 340 0
Ireland 6,955 2.7 1,8696 4.3 3,222 4.9 3,287 7.5 6,422 9.3
Italy 202 3.5 3556 2.3 1,100 2.0 243 1.2 399 2.0
Spain 141 2.1 168 18.5 288 5.6 93 8.6 - -
Sweden 1,025 0 1,130 0 1,146 0 1,121 0
1. Data are only presented for sample size >25 with positive ﬁndings.
2. Chicken carcasses (presence in 1g).
3. Layer carcasses (presence in 0.1g).
4. In Norway, neck-skin samples (presence in 5g).
5. Chicken breast (presence in 25g).
6. Ofﬁcial food control.
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Figure SA4. Salmonella in poultry meat at the retail level, from MS with monitoring 
and or control programmes and that have reported for most years in 2000-2004.
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Note: Data from Ireland have not been included due to sample sizes of less than 25, 2002-2004. Data from 
Sweden 2002 have not been shown since they these included samples of imported poultry meat (12%).
In 2000, Salmonella was detected in 7.7–21.0% of the samples collected at retail in the 
selected MS compared with 2004, where the observed ranges were lower: 4.1-13.5%. 
In The Netherlands a clear decrease in the proportion of Salmonella positive samples 
collected at retail was observed, from 21.0% in 2000 to 7.4% in 2004; a clear decreasing 
trend was also observed in Austria. In broiler carcasses sampled in Belgium, Salmonella 
was found in less than 15% of samples throughout the ﬁve-year period.
In 2004, approximately 27,000 samples of broiler meat were collected in 22 MS. Sample 
sizes and the type of product sampled varied among MS. Data for MS collecting 25 
samples or more in 2004 with positive ﬁndings have been summarised in Table SA4. 
Eight MS provided data for broiler samples at slaughter and detected Salmonella in 
0.1-26.8%, with the lowest level observed in Sweden and the highest in Malta. 
At processing, sample-based Salmonella contamination levels ranged from 0.1% in 
Finland to 26.3% in cuts of broiler meat in Belgium (Table SA4). Although not directly 
comparable, the batch-based sampling in Cyprus, yielding 36.6% positive batches is 
indicative of a higher level of Salmonella contamination at processing in Cyprus than in 
the other reporting MS. 
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Table SA4. Salmonella in fresh broiler meat, sample based1, unless otherwise 
stated, 2004
 S. spp. S. Enteritidis S. Typhimurium
N Pos % Pos Pos % Pos Pos % Pos Pos % Pos
At slaughter
Denmark2 1,472 24 1.6 - - - - - -
Greece 897 49 5.5 - - 1 0.1 6 0.7
Latvia2 70 5 7.1 - - 5 7.1 - -
Malta 418 112 26.8 - - 4 1.0 18 4.3
Poland 753 59 7.8 47 6.2 10 1.3 2 0.3
Slovenia 79 1 1.3 - - 1 1.3 - -
Spain 151 13 8.6 - - 8 5.3 - -
Sweden 3,730 2 0.1 - - - - 2 0
At processing/cutting plant
Belgium3 156 41 26.3 - - 16 10.3 4 2.6
Belgium4 183 16 8.7 - - - - - -
Cyprus2 134 49 36.6 4 3 3 2.2 1 0.8
Estonia 42 2 4.8 - - 2 4.8 - -
Finland 777 1 0.1 - - - - - -
Germany 46 3 6.5 - - - - - -
Ireland 6,955 190 2.7 - - 20 0.3 49 0.7
Italy 202 7 3.5 - - - - 1 0.5
Norway6 7,239 1 <0.1 - - 0 0 0 0
Slovenia5 30 1 3.3 - - 1 3.3 - -
Spain 141 3 2.1 - - - - - -
At retail
Austria7 1,042 89 8.5 - - 32 3.1 12 1.2
Belgium3 126 17 13.5 - - 1 0.8 1 0.8
Belgium8 335 62 18.5 - - 12 3.6 10 0
Czech Republic 48 7 14.6 - - 7 14.6 - -
Germany 838 108 12.9 - - 7 0.8 11 1.3
Italy 269 11 4.1 - - 1 0.4 - -
Latvia2 345 25 7.2 - - 25 7.2 - -
Norway6 2,243 22 1.0 0 0 2 <0.1
Slovenia 95 7 7.4 - - 5 5.3 - -
Spain 495 48 9.7 - - 16 3.2 - -
Sweden 197 4 2.0 - - - - - -
The Netherlands 1,483 110 7.4 - - 6 0.4 2 0.1
United Kingdom 1,033 40 3.9 10 1 0 0 4 0.4
1. Data are only presented for sample size >25 with positive ﬁndings.
2. In Cyprus, Denmark and Latvia, batch based sampling.
3. In Belgium, cuts.
4. In Belgium, carcasses.
5. In Slovenia, mechanically separated meat.
6. In Norway, imported poultry.
7. Sampled at retail and processing plant.
8. In Belgium, minced meat.
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At retail level Salmonella was found in 2.0-18.5% of the collected samples. Throughout 
the production line the lowest levels of Salmonella were reported by Sweden. Sweden 
also tested 1,025 samples at processing without any positive ﬁndings. Czech Republic 
reported no positive ﬁnding at slaughter (N=240) nor did Italy (N=43).
In samples of broiler meat products Salmonella positive samples ranged from 0.1-6.9%, 
Table SA5. Italy reported 12.1% positive samples in non-ready to eat products and 10.8% 
in ready-to-eat products at retail (data not presented in the table). These samples were 
HACCP samples collected by the industry. HACCP samples are collected speciﬁcally 
at critical control point and may result in a larger number of positive ﬁndings than 
randomly collected samples. Therefore these two types should not be compared directly. 
Table SA5. Salmonella in broiler meat product samples1, 2004
S. Enteritidis S. Typhimurium
N Pos % Pos Pos % Pos Pos % Pos
NON-READY-TO-EAT
At processing plant
Germany 29 2 6.9 - - - -
Greece 516 4 0.8 - - - -
Hungary 1,558 56 3.6 - - - -
Ireland 2,176 44 2.0 - - 14 0.6
Spain 75 1 1.3 - - - -
At retail
Germany 221 11 5.0 2 0.9 - -
Greece 511 5 1.0 4 0.8 - -
Italy 153 1 0.7 - - 1 0.7
Spain 233 7 3.0 3 1.3 - -
READY-TO-EAT
At processing plant 
Germany 96 3 3.1 - - - -
Hungary 452 5 1.1 - - - -
Ireland 2,847 13 0.5 1 <0.1 3 0.1
Poland 18,816 17 0.1 - - - -
At retail
Austria2 451 12 2.7 5 1.1 - -
Belgium3 83 5 6.0 - - - -
Germany 436 8 1.8 2 0.5 - -
1. Data are only presented for sample size >25 with positive ﬁndings.
2. Sampled at retail and processing plant.
3. In Belgium, carcasses.
A large number of other broiler meat products tested in Estonia (N=89), Greece (N=325), 
Ireland (N=1,361) and Sweden (N=89) yielded no positive samples.
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Turkey meat and products thereof
A total of 13 MS provided data on Salmonella in turkey meat and turkey meat products. 
In general, sample sizes were small (<25). All MS testing more than 25 samples reported 
positive ﬁndings. These are shown in Table SA6. For those MS with positive ﬁndings in 
fresh turkey meat, the highest levels were found at processing in Germany and the lowest 
levels at slaughter in Poland. Data were not suitable for trend analysis, but from 2000-2003, 
5.7-11.5% of turkey neck-skin and meat samples collected at slaughter and at retail 
were found positive for Salmonella. This is consistent with the levels observed in 2004. 
Table SA6. Salmonella in turkey meat samples1, 2004
S. Enteritidis S. Typhimurium
N Pos % Pos % Pos Pos % Pos
At slaughter
Poland 441 3 0.7 - - - -
At processing plant
Germany 66 8 12.1 - - 1 1.5
Ireland 478 21 4.4 1 0.2 1 0.2
At retail
Austria 124 9 7.3 - - 2 1.6
Germany 707 43 6.1 2 0.3 7 1.0
1. Data are only presented for sample size >25 with positive ﬁndings.
In addition to the data shown in Table SA6, Germany reported 6.3% (N=901) and Italy 
8,7% (N=160) positive samples in turkey meat samples. However the point of sampling 
was not provided.
Other poultry meat: Ireland tested 144 samples of fresh duck meat at processing and 
found 33 (18,6%) positive for salmonella.
Eggs and egg products
Control of Salmonella in the table-egg sector is generally done by monitoring and 
controlling for Salmonella in layer ﬂocks. These programmes are described in Appendix 
Tables SA5 and SA6. Salmonella was found in fresh eggs, raw material at processing 
and at retail level at levels similar to previous years. Proportions of positive samples 
found in eggs, 2000-2004, are shown in Figure SA5, and results from raw materials and 
egg products are presented in Table SA7. 
For the ﬁve MS included in Figure SA5, there was a general increase in the proportion of 
positive ﬁndings from 2000 to 2002. In Italy and Austria, the proportion of positive sample 
increased from 2003 to 2004. Still, the overall trend from 2002 to 2004 for all ﬁve MS has 
been decreasing. 
In raw materials for egg products, Austria, reported less than 3% positive samples for all year 
except 2004, where 62.1% of samples of raw materials at processing were found positive, 
most of which were S. Enteritidis. No explanation for this marked increase was given, 
but the sample size for 2004 was considerable smaller compared to previous years.
In egg products, very few ﬁnding have been reported in ﬁve out of the six MS included 
in Table SA7. However, Austria has observed a steady increasing trend, from 0.7-7.1% 
positive samples from 2000-2004.
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Figure SA5. Salmonella in table eggs in MS that have reported consistently from 
2000-2004
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Table SA7. Salmonella in eggs and egg products
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Raw materials (at processing plants)
Austria 29 62.1 179 2.8 92 0 200 2.5 147 1.4
Germany - - 51 0 41 0 53 0 12 0
Ireland 94 0 1,752 0 - - 4 0 13 7.6
Italy 26 0 29 0 170 0 31 0 204 0
Spain - - 165 0.6 84 0 - - - -
Egg products (ﬁnal products)
Austria 369 7.1 2,683 5.6 205 1.0 223 2.2 286 0.7
Germany 243 0.8 368 0 228 0 325 0.9 304 1.0
Ireland1 911 0.1 392 0 469 0 581 0 479 0
Italy 649 1.4 2,297 <0.1 70 1.4 152 0 3,478 0
The Netherlands - - - - - - 352 7.4 225 0
Spain 476 1.3 616 0.7 312 1.0 - - - -
1. In Ireland, in the data compiled by CVRL, 2 out of 53 samples taken at processing plants were positive. 
Findings of Salmonella in table egg samples reported in 2004 are presented in Table SA8. 
In all reporting MS less than 3% of the tested samples were positive. 
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Table SA8. Salmonella in table egg samples1, 2004
S. Enteritidis S. Typhimurium
N Pos % Pos Pos % Pos Pos % Pos
At packing centre
Cyprus2 604 2 0.3 2 0.3 - -
Italy 431 11 2.6 9 2.1 - -
Spain 1,686 24 1.4 13 0.8 - -
At retail
Austria 318 4 1.3 3 0.9 1 0.3
Germany 10,179 44 0.4 39 0.4 1 <0.1
Greece 410 1 0.2 1 0.2 - -
Italy 680 16 2.4 10 1.5 2 0.3
Slovakia 486 6 1.2 6 1.2 - -
1. Data are only presented for sample size >25 with positive ﬁndings.
2. In Cyprus, batch-based sampling.
New MS, Estonia, Latvia and Slovenia reported no ﬁndings in samples collected at 
packaging centres and retail.
Data on the serovar distribution are incomplete, but S. Enteritidis was the most common 
serovar reported in eggs. Please refer to Chapter 3.1.5. on serovar and phagetypes 
distribution for further information.
Pig meat and products thereof
Monitoring programmes for Salmonella in pig meat are in place in several MS, and are 
described in the Appendix Table SA18. Many of these monitoring programmes are based 
on sampling at the slaughterhouse and meat cutting plants, and a number of different 
samples are collected, such as surface swabs, caecal samples and meat samples. 
In addition to meat samples, some of the new MS also collected environmental samples 
at all levels of the production as part of their monitoring programmes. In Table SA9, data 
on the occurrence of Salmonella in pig meat have been summarised for those countries 
that have monitoring programmes.
b169_EFSA_int_02_03_06.indd   34 2/03/06   15:16:40
35 The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Table SA9. Salmonella in pig meat in countries, which run a monitoring/surveillance 
programme, 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Pigs (sample based data) – carcass swabs – at slaughterhouse
Belgium 374 12.3 287 14.6 298 15.4 293 20.8 436 17.7
Denmark6 34,038 0.8 34,460 0.9 36,787 0.8 36,559 1.3 17,954 0.8
Finland 6,576 <0.1 6,186 <0.1 6,260 <0.1 6,254 <0.1 6,387 0
Sweden 5,940 0 6,281 0 6,420 <0.1 6,578 <0.1 6,733 <0.1
Norway 2,456 0 2,353 <0.1 2,371 <0.1 2,417 <0.1 2,542 0
Pig meat at slaughterhouse and cutting plants
Belgium1,2 374 12.3 278 6.1 224 11.2 - - - -
Belgium3 - - 118 1.7 116 7.8 - - - -
Finland2 3,092 0 2,826 0.1 1,840 0.1 2,605 0 3,472 0
Sweden2,3,4 4,474 0 4,411 0 4,478 0 4,311 0 4,454 <0.1
Pig meat at retail
Belgium3 166 12.7 181 9.4 184 13.0 - - - -
Denmark - - 183 0.6 7,003 1.3 715 1.7 1,782 1.1
Finland - - - - - - - - 167 0
Germany 1,217 3.9 1,734 3.0 2,193 2.9 1,547 3.8 1,614 3.7
Norway5 51 3.9 - - 221 0 1,039 0.5 4,129 0.3
The  
Netherlands 333 1.2 227 4.9 105 10.5 - -
1. In Belgium, cuts of meat.
2. In Belgium, Finland and Sweden, at cutting plants.
3. In Belgium and Sweden, minced meat.
4. In Sweden, samples from both pig and bovine meat.
5. In Norway, survey regarding imported products.
6.  In Denmark, the majority of samples are tested as pools of 5 carcass swabs. At small slaughterhouses: 
carcass samples are tested individually.
 
No clear increasing or decreasing trend was observed within these MS and Norway; the 
proportion of positive ﬁndings has remained fairly stable within the countries throughout 
the period (Table SA9). In The Netherlands, however, the proportion of positive samples 
at retail has decreased from 10.5% positive samples to 1.2% in 2004. Finland, Sweden 
and Norway have consistently reported very low levels of Salmonella contamination at 
slaughter and meat cutting plants, ranging from no ﬁndings to 0.1% positive samples. 
Norway reported data from a survey of imported pig meat in 2004, yielding a higher 
proportion of positive ﬁnding than in domestically produced pig meat tested in previous years.
In 2004, 21 MS reported data on Salmonella in 85,446 samples of pig meat samples 
collected at different levels of the production (Table SA10). Denmark, Finland, Germany, 
Hungary, Latvia, Poland all reported levels of less than 1.5% positive samples at slaughter. 
The highest proportions of positive samples were reported by Malta, with 32.8% of the 
samples positive. Italy and Latvia reported higher numbers of positive samples among 
samples collected by the industry as part of HACCP based programmes than in the ofﬁcial 
control samples (data not shown in the table). However, it is important to note that samples 
collected in a HACCP context are usually targeted and not randomly collected. 
b169_EFSA_int_02_03_06.indd   35 2/03/06   15:16:41
36The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Positive ﬁndings at processing were reported by six MS and in four of these less than 
3% of the tested samples were positive. Spain and Belgium reported somewhat higher 
levels, 4.9% and 10.4%, respectively. At retail, all eight reporting MS found less than 7% 
of the tested samples positive (Table SA10).
In minced meat, less than 1% of samples in Hungary and Poland were found positive. 
In Belgium, 7.4% of the samples were positive. Data on the serovar distribution in pig 
meat are incomplete, but the data that were reported indicates that S. Typhimurium is 
dominating in pig meat.
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Table SA10. Salmonella in fresh pig meat samples1, 2004
S. Enteritidis S. Typhimurium
N Pos % Pos Pos % Pos Pos % Pos
At slaughter 
Belgium 374 46 12.3 - - 15 4.0
Denmark2 34,038 274 0.8 1 <0.1 96 0.3
Finland2 6,576 2 0 1 0 - -
Germany 4,744 25 0.5 - - 13 0.3
Hungary 8,257 111 1.3 5 0.1 29 0.4
Italy 256 11 4.3 - 3 1.2
Italy2 1,096 40 3.6 - - 10 0.9
Latvia 185 2 1.1 - - - -
Malta 400 131 32.8 - - - -
Poland 895 2 0.2 - - - -
Portugal 256 39 15.2 - - - -
Spain 147 15 10.2 15 10.2 - -
At processing plant
Belgium 241 25 10.4 - - 8 3.3
Estonia 225 1 0.4 - - - -
Germany 201 6 3.0 - - 3 1.5
Ireland 4,485 104 2.3 - - 52 1.2
Italy 393 8 2.0 1 0.3 3 0.8
Spain 81 4 4.9 - - - -
At retail
Austria3 42 2 4.8 1 2.4 - -
Germany 1,217 47 3.9 - - 21 1.7
Ireland 29 2 6.9 - - 2 6.9
Italy 231 2 0.9 - - - -
Lithuania 46 1 2.2 - - 1 2.2
Norway 51 2 3.9 0 0 2 3.9
Spain 215 8 3.7 6 2.8 - -
The  
Netherlands 333 4 1.2 - - 2 0.6
Minced meat, at processing plant
Belgium 271 20 7.4 - - 8 3.0
Hungary 1,712 16 0.9 1 0.1 4 0.2
Poland 9,172 39 0.4 - -  -
Minced meat, at retail
Belgium 166 21 0.1 4 2.4 15 9.0
Italy 241 2 0.8 - - - -
Italy4 101 8 0.1 - - 1 1.0
1. Data are only presented for sample size >25 with positive ﬁndings.
2. In Denmark, Finland and Italy, carcasses at slaughter.
3. In Austria, sampled at retail and processing plant.
4. In Italy, ofﬁcial food or feed controls.
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In pig meat products Salmonella was found in less than 10% of the samples, ranging 
from 1.0-9.8% in non-ready-to-eat products, with the highest proportions reported by 
Hungary and Italy (Table SA11). In ready-to-eat products, positive ﬁndings were reported 
by Hungary, Italy and Portugal, in ranges 1.2-3.7%. Belgium, Estonia and Latvia reported 
no Salmonella in pig meat products tested.
Table SA11. Salmonella in pig meat products1, 2004
S. Enteritidis S. Typhimurium
N Pos % Pos Pos % Pos Pos % Pos
NON READY-TO-EAT 
At processing plant
Hungary 111 9 8.1 0 0 0 0
Ireland 3,427 55 1.6 - - 22 0.6
Italy 1,200 13 1.1 1 0.1 4 0.3
Luxembourg 98 1 1.0 - - - -
Spain 483 15 3.1 1 0.2 1 0.2
At retail
Austria2 275 3 1.1 - - - -
Ireland 46 2 4.3 - - 1 2.2
Italy 899 88 9.8 1 0.1 26 2.9
Spain 411 15 3.6 1 0.2 - -
Ofﬁcial food or feed controls
Italy 228 9 3.9 - - 2 0.9
READY-TO-EAT 
At processing plant
Hungary 17,256 312 1.8 14 0.1 70 0.4
Italy 257 3 1.2 - - - -
At retail
Italy 330 10 3.0 - - 4 1.2
Portugal 54 2 3.7 - - 1 1.9
1. Data are only presented for sample size >25 with positive ﬁndings.
2. Sampled at retail and processing plant.
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Bovine meat and products thereof
Monitoring programmes similar to the ones in place for pig meat also exist for bovine 
meat (Appendix Table SA21). Data have been summarised for MS with monitoring and 
surveillance programmes that have reported data for the past years, Table SA12. 
Table SA12. Salmonella in bovine meat in countries with a monitoring/surveillance 
programme, 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Bovine meat sampled at slaughterhouse (sample based) – carcass swabs
Belgium - - - - 191 0 294 2.7 - -
Denmark5 11,540 0.3 12,570 0.2 12,700 0.2 10,890 0.1 2,079 0.5
Finland 3,251 0 3,406 <0.1 3,146 <0.1 3,536 0.3 3,154 0.1
Sweden 3,475 0 3,220 <0.1 3,121 0 3,243 <0.1 3,400 <0.1
Norway 2,136 0 2,353 0.04 2,371 0.04 2,417 0 2,542 0
Bovine meat sampled at slaughterhouse and cutting plants
Belgium2,3 - - 100 2.0 223 0.9 - - - -
Finland3 2,458 <0.1 2,404 0.1 1,948 0.4 2,050 0.2 2,600 0.1
Sweden3, 4 4,474 0 4,411 0 4,478 0 4,311 0 - -
Bovine meat sampled at retail
Belgium1 98 0 207 0.5 2,041 2.9 - - - -
Denmark - - 642 2.0 1,400 1.0 642 2.0 1,599 1.2
Germany 363 0.8 494 1.0 590 0.9 438 0.5 - -
Sweden 1,262 0 1,217 0.4 1,125 1.0 2,490 0.5 - -
The 
Netherlands 956 1.1 678 0.6 532 3.0 - - - -
Norway 12,295 0.2 3,550 0.2 2,453 <0.1 14,570 <0.1 1,181 0.3
1. In Belgium, minced meat samples.
2. In Belgium, cuts of meat.
3. In Belgium, Finland and Sweden, at cutting plants.
4.  In Sweden, samples collected from both pig and bovine meat. Approximately 40% is estimated to be 
scrapings collected from beef.
5.  In Denmark, the majority of samples are tested as pools of 5 carcass swabs. At small slaughterhouses: 
carcass samples are tested individually.
Finland, Sweden and Norway reported less than 0.2% positive ﬁndings in bovine meat 
from 2000-2004. For the remaining MS included in Table SA12, proportions of 3% or lower 
were reported. Data for 2004 are summarised in Table SA13. The proportion of positive 
samples were low in most reporting MS not exceeding 2% in fresh meat at slaughter 
and 1% in fresh meat at retail. However at slaughter, higher levels were reported from 
Estonia (3.9%) and Spain (9.9%). Finland, Luxembourg, Poland and Norway reported no 
positive samples at slaughter in sample sizes of 156 to 3,251. Similar proportions were 
also reported at the processing level, except in Spain where 7.1% of the collected samples 
were positive. However, the number of samples collected was considerably smaller than 
those collected by the other MS in this foodstuff category.
 
b169_EFSA_int_02_03_06.indd   39 2/03/06   15:16:42
40The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
In minced meat the proportions of positive samples ranged from, 0.6-7.2% at the processing 
level and 0.1-2.7% at retail. The highest proportions of positive samples were reported by 
Germany and Spain, at processing level. Of the 339 positive samples from MS providing 
information on serovar distribution (Table SA13), 43 were S. Enteritidis and 53 were 
S. Typhimurium. The proportions of S. Enteritidis and S. Typhimurium varied between MS. 
Table SA13. Salmonella in bovine meat samples1, 2004
S. Enteritidis S. Typhimurium
N Pos % Pos Pos % Pos Pos % Pos
At slaughter
Austria 3,940 2 0.1 1 0 - -
Czech 
Republic 1,328 26 2.0 20 1.5 6 0.5
Denmark 11,579 35 0.3 - - 4 0
Estonia 310 12 3.9 - - - -
Germany 4,435 33 0.7 - - 2 0
Hungary 857 8 0.9 0 0 5 0.6
Italy 1,131 5 0.4 4 0.4 - -
Spain 71 7 9.9 0 0 0 0
At processing and cutting plant
Finland2 2,485 1 0 - - 1 0
Ireland 13,364 24 0.2 - - 4 0
Italy 338 1 0.3 1 0.3 - -
Spain 28 2 7.1 - - - -
At retail
Germany 363 3 0.8 - - - -
Italy 422 3 0.7 - - - -
Norway3 12,295 22 0.2 0 0 0 0
The  
Netherlands 956 10 1.0 - - 2 0.2
Italy4 701 3 0.4 - - 1 0.1
Minced meat, at processing plant
Belgium 230 7 3.0 1 0.4 1 0.4
Germany 83 6 7.2 - - 4 4.8
Hungary 113 1 0.9 0 0 0 0
Italy 164 1 0.6 - - - -
Spain 1,361 84 6.2 12 0.9 - -
Minced meat, at retail
Czech 
Republic 326 1 0.3 - - - -
Germany 1,763 47 2.7 1 0.1 22 1.2
Italy 409 3 0.7 - - 1 0.2
Italy4 902 1 0.1 - - - -
Italy5 585 9 1.5 2 0.3 - -
1. Data are only presented for sample size >25 with positive ﬁndings.
2. In Finland, at cutting plant.
3. In Norway, imported meat.
4. In Italy, fresh meat, ofﬁcial food or feed controls.
5. In Italy, minced meat, ofﬁcial food or feed controls.
b169_EFSA_int_02_03_06.indd   40 2/03/06   15:16:42
41 The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Table SA14. Salmonella in bovine meat products1, 2004
Salmonella spp. S. Enteritidis S. Typhimurium
N Pos % Pos Pos % Pos Pos % Pos Pos % Pos
NON-READY-TO-EAT
At processing plant
Ireland 4,016 7 0.2 - - 6 0.2 - -
Italy 105 1 1.0 - - - - - -
Spain 63 1 1.6 - - - - - -
Czech 
Republic2 5,818 9 0.2 - - - - - -
At retail
Germany 252 3 1.2 - - - - - -
Italy 274 1 0.4 - - - - 1 0.4
READY-TO-EAT
At processing plant
Germany 308 7 2.3   5 1.6   
At retail
Belgium 111 2 1.8 - - - - - -
Germany 5,455 90 1.6 2 <0.1 39 0.7 - -
Italy 51 1 2.0 - - - - - -
1. Data are only presented for sample size >25 with positive ﬁndings.
2. In Czech Republic, batch samples.
In bovine meat products, few Salmonella positive ﬁndings were reported, ranging from 
0.2-1.6% in non-ready-to-eat products and from 1.6-2.3% in ready to eat products 
(Table SA14). No positive ﬁndings were reported in samples tested in Austria, Luxembourg 
and Sweden.
Other food
Milk and dairy products
Very few positive ﬁnding of Salmonella in cow milk were reported in 2004. Data was 
reported by 11 MS with sample sizes ranging from 25 to 2,067. Only three MS reported 
positive ﬁndings; Austria, Cyprus and Italy (0.8-2.6%). These results are consistent 
with the levels reported in previous years. Large numbers of dairy products were also 
investigated in 18 MS, generally yielding no positive ﬁndings. Salmonella was found by 
some MS in ice cream, milk powder and other ready-to-eat dairy products ranging from 
0.01-1.7%. The majority of these isolates were S. Enteritidis. No positive ﬁndings were 
reported from samples of soft and semi soft cheeses. Neither did United Kingdom report 
any positive ﬁndings from a survey comprising 1,842 samples of cheeses made from 
raw or thermised milk.
Spices and herbs
Six MS reported data on spices. Among these were results from a large survey of imported 
dried herbs and spices in the United Kingdom, where 1.1% of tested samples were 
positive. Austria found 7% of the tested samples positive for Salmonella, mainly serovars 
other than S. Typhimurium and S. Enteritidis. Ireland found Salmonella in 0.9% of the 
tested samples, where all ﬁnding were serovars other than S. Enteritidis and S. Typhimurium.
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Fishery products
Findings of Salmonella in ﬁshery products were reported by Estonia, Germany, Greece, 
Hungary, Italy, Spain and Sweden (ﬁsh and shellﬁsh), ranging from 0.09% in Germany to 
1.4% in Greece. These ﬁnding are similar to reports from 2003, where 0.08%-2.0% of 
the tested samples were found contaminated, with the highest proportions reported by 
Greece. 
Other foodstuffs
Ireland tested 2,462 sheep meat samples for Salmonella ﬁnding 4 (0.16%) positive. 
Bakery products and cereals were tested by 6 countries, and Greece and Hungary found 
positive samples ranging from 0.06-2.1%. Belgium and Greece reported investigations 
of live bivalve molluscs, and Greece found 1.36% positive. Greece also reported 2 out 
of 6 examined frog legs Salmonella positive.
3.1.3. Salmonella in animals
Laying hen production line
No elite-breeding ﬂocks were found Salmonella positive by the 3 Member States who 
reported information. A total of 9 MS reported on grand-parent-breeding ﬂocks, and Italy 
found Salmonella positive ﬂocks.
In parent-breeding ﬂocks for the laying hen production, the level of Salmonella in 2004 
varied considerably between the MS with monitoring programmes (Table SA15). No 
infected ﬂocks were detected in France, Slovenia, Sweden and Norway. In contrast to 
2003, infected breeding ﬂocks were found in Denmark, Germany and Italy during 2004. 
A total of 6.3% of the ﬂocks were infected during 2004 in the EU-25 MS that conduct 
Salmonella monitoring and control programmes. The new MS had a higher occurrence 
of Salmonella among layer breeders than the old MS (10.7% vs. 4.2%). The highest 
occurrence was recorded in the Czech Republic where 33.3% of the layer breeding 
ﬂocks tested positive for Salmonella.
Salmonella Enteritidis was the predominating serovar among layer breeding ﬂocks in 
most of the MS reporting data. During 2004, S. Typhimurium was only reported from 
layer breeders in Finland, Germany and The Netherlands.
 
b169_EFSA_int_02_03_06.indd   42 2/03/06   15:16:43
43 The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Table SA15. Salmonella in layer breeders (only parent breeders, all age groups1, 
ﬂock based data), 2003-2004 in countries that run monitoring and control 
programmes in accordance to Council directive 92/117/EEC in 2004
2004 2003
N % Pos % S. Ent % S. Typ N % Pos % S. Ent % S. Typ
Austria 20 5.0 5.0 0 - - - -
Belgium 95 4.2 - - - - - -
Czech Republic 42 33.3 33.3 0 - - - -
Denmark 18 11.1 0 0 39 0 - -
Finland 67 0.5 0 0.5 - - - -
France 140 0 - - 133 2.2 0.7 1.5
Germany2 89 1.1 0 1.1 29 0 - -
Greece 118 7.6 5.9 0 - - - -
Hungary 199 1.0 1.0 0 - - - -
Ireland - - - - 51 0 0 0
Italy 144 11.1 - - 31 0 - -
Latvia 22 9.1 9.1 0 - - - -
Norway3 27 0 0 0 - - - -
Poland 518 14.3 7.5 0 - - - -
Slovenia 52 0 - - - - - -
Spain 192 2.6 - - 143 11 4 0
Sweden4 20 0 - - 30 1 3 0
The Netherlands 282 0.7 0.4 0.4 55 9 7 0
United Kingdom 87 14.9 - - - - - -
Note: In Belgium and Hungary, a monitoring programme using a sampling scheme based on the directive 
has been implemented.
1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point of the lifespan of a ﬂock).
2. In Germany, production period only.
3. In Norway, rearing and production period only, data relates to farms not ﬂocks.
4. In Sweden, rearing and production period only.
As the reporting has been inconsistent for many MS, a community trend for Salmonella 
in layer-breeding ﬂocks could not be estimated. However, among the MS that operated 
control programmes for breeding ﬂocks according to the Zoonoses Directive, and reported 
consistently during the period 2001 to 2004, the occurrence of Salmonella varied 
considerably. In Italy and Spain between 0% and 15% of the tested ﬂocks were positive 
in 2001 to 2004. In Greece the proportion of infected ﬂocks increased rapidly from 2002 
to 2004. Also Denmark reported an increase in 2004 following three years with no positive 
ﬁndings. In contrast, data from The Netherlands indicated a decrease from 2003 to 
2004. The level of positive ﬂocks remained low during the four-year period in Germany, 
Ireland, Norway and Sweden (Figure SA6). 
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Figure SA6. Proportion of Salmonella positive layer breeding ﬂocks (only parent 
ﬂocks1, all age groups) in MS running a monitoring and control programme during 
the period 2001-2004
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Note: In Sweden infected breeding ﬂocks were only detected in 2003 (1%), In Ireland, no infected ﬂocks 
were detected in 2001 to 2003 (no data from 2004) and in Norway no infected ﬂocks were detected 
2001-2004. No data from Greece 2002, Ireland 2004, Italy 2001 and The Netherlands 2001 and 2002.
1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point in the lifespan of a ﬂock.
In laying hens, no Salmonella infected ﬂocks were detected in Finland and Luxembourg. 
Several MS reported a low occurrence, whereas Belgium, Greece and Spain reported a 
high proportion of positive layer ﬂocks (ranging from 27 – 32%) (Table SA16). Among the 
MS reporting data from both breeding and production ﬂocks, most MS that reported few 
infected breeder ﬂocks (Austria, Denmark, Finland, France, Germany, Ireland, Sweden 
and The Netherlands) also reported relatively low Salmonella occurrence (less than 4%) 
in rearing and production ﬂocks.
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Table SA16. Salmonella in laying hen ﬂocks (all age groups1, ﬂock based data), 
2003-2004
 
2004 2003
Country N % Pos % S. Ent % S. Typ N % Pos % S. Ent % S. Typ
Austria 2,649 1.5 0.8 0 - - - -
Belgium 265 27.2 - - - - - -
Cyprus 75 12 4.0 0 - - - -
Czech Republic 270 6.7 6.7 0 - - - -
Denmark 1,009 0.6 0.3 0.1 2,934 0.6 0.5 0
Finland 2,111 <0.1 - <0.1 2,347 0 0 0
France 5,935 2.0 1.6 0.4 5,421 2.3 1.9 0.4
Germany 4,916 2.3 1.1 0.4 3,623 2.6 0.9 1.0
Greece 90 32.2 14.4 2.2 258 0.8 0.4 0
Ireland 355 0.8 0.8 0 - - - -
Lithuania 1,392 0.4 0.2 - - - - -
Luxembourg 44 0 - - - - - -
Norway 1,090 0 - - 844 0 - -
Spain 50 28.0 20.0 0 991 18.1 9.5 1.7
Sweden 909 0.2 - - 1,178 0.2 0.1 0
The Netherlands2 3,148 3.7 - - 2,328 3.7 3.5 0.4
1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point of the lifespan of a ﬂock.
2. In The Netherlands, prevalence data is based on serology.
Among the MS that had a monitoring and control programme, and reported consistently 
from 2001 to 2004 (Figure SA7), the proportion of Salmonella positive layer ﬂocks decreased 
in Denmark (from 5.8% to 0.6%), France (from 5.2% to 1.7%) and the Netherlands 
(5.1% to 3.7%), and remained at a low level in Germany (2.3%) during this period. 
The highest levels were reported from Spain and Greece. In Spain, a substantial 
increase in the proportion of Salmonella positive laying hen ﬂocks has occurred since 
2002 (9.6% to 28%). In Greece the decrease observed from 2001 to 2003 (16.7% to 
0.8%), was followed by a signiﬁcant increase in 2004 (32.3%), which may be explained 
by the increase seen in layer breeders. 
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Figure SA7. Proportion of Salmonella positive layer ﬂocks (all age groups1) in MS 
conducting a monitoring and control programme, 2001-2004
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Note: No data from France 2001.
1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point in the lifespan of a ﬂock.
As in 2002 and 2003 no Salmonella positive breeding, rearing or production ﬂocks of 
laying hens were detected in Norway during 2004. An overview of the reported data is 
presented in Level 3, Table SA10-11.
Meat production line (Broilers)
No elite breeding ﬂocks were found Salmonella positive. Hungary reported 1 positive 
grandparent ﬂock.
In parent breeding ﬂocks, no infected ﬂocks were detected in Latvia, Lithuania, Norway, 
Sweden and The Netherlands (Table SA17). Overall 3.3% of ﬂocks were infected in 2004 
in the EU-25 MS that conduct monitoring and control programmes. In the new MS with 
Salmonella programmes, the estimated overall occurrence of Salmonella among broiler 
breeding ﬂocks were lower than in the old MS (0.2% vs. 4.2%). A large number of 
Salmonella isolates other than S. Enteritidis or S. Typhimurium, (mainly S. Senftenberg 
and S. Livingstone) were reported from the UK from monitoring of environmental samples 
taken in the hatcheries. The salmonella isolates may indicate persistent infection in the 
hatchery environment or a few infected supply ﬂocks.
Salmonella Enteritidis was the most common serovar isolated from broiler breeding 
ﬂocks in most of the MS reporting data. In contrast to the layer breeders, S. Typhimurium 
was also detected in broiler breeders in several MS (Table SA17). 
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Table SA17. Salmonella in broiler breeders (only parent breeders, all age groups1, 
ﬂock based data), 2003-2004. Including countries that run a programme in accordance 
to Council Directive 92/117/EEC in 2004
2004 2003
N  % Pos % S. Ent % S. Typ N % Pos % S. Ent % S. Typ
Austria 57 3.5 - - - - - -
Belgium 1,010 3.5 0.1 0.4 - - - -
Czech Republic 325 2.5 2.5 0 - - - -
Denmark 438 1.4 - - 408 1.7 0.2 1.5
Finland 255 0.4 - - - - - -
France 2,186 0.2 0.1 <0.1 2,250 0.7 0.5 0.2
Germany2 2,271 0.4 - - 207 0.5 0 0
Greece 660 5.3 1.8 0.9 148 9.5 6.1 0.7
Hungary 1,834 4.8 1.8 0.8 - - - -
Ireland 548 7.3 - - - - - -
Italy 352 13.6 0.4 0.6 266 5.3 0.4 0
Latvia 28 0 - - - - - -
Lithuania 172 0 - - - - - -
Norway3 182 0 - - 78 0 - -
Poland 2,297 5.1 3.3 0.1 - - - -
Slovenia 35 5.7 5.7 0 - - - -
Spain 1,000 10.4 2.4 0 - - - -
Sweden 288 0 - - 258 0 - -
The Netherlands 2,589 0 0 0 389 0 0 0
United Kingdom4 533 37.1 0 0 - - - -
Note: In Belgium and Hungary, a monitoring programme using a sampling scheme based on the directive 
has been implemented.
1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point of the lifespan of a ﬂock.
2. In Germany, production and rearing phase only.
3.  In Norway, rearing and production period only, include grandparent ﬂocks. Data from 2003 relates 
to holdings not ﬂocks.
4.  In the UK, 198 positive ﬁndings, mainly from environmental sampling at hatchery and not possible to 
relate to a speciﬁc number of ﬂocks.
A community trend for Salmonella in broiler breeding ﬂocks could not be estimated on the 
basis of available data. However, among the MS that operated control programmes for 
breeding ﬂocks according to the Zoonoses Directive, and reported consistently during the 
period 2001 to 2004, the occurrence of Salmonella in Denmark, Germany, France and 
The Netherlands remained at a low level during the four-year period, the proportion of 
infected ﬂocks decreased in Spain and Greece (from 2002) but increased in Italy (Figure SA8).
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Figure SA8. Proportion of Salmonella positive broiler breeding ﬂocks (only parent 
breeding ﬂocks, all age groups1) in MS conducting a surveillance programme, 
2001-2004
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Note: In Sweden and Norway infected breeding ﬂocks were not detected from 2001 to 2004.
1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point in the lifespan of a ﬂock.
In the broiler production, Salmonella infected ﬂocks were detected during 2004 in all the 
reporting MS, and the proportion of positive broiler ﬂocks ranged from less than 1% in 
Finland and Sweden to 23.4% in Cyprus (Table SA18). Among the MS reporting data 
from both breeding and production ﬂocks, most of the MS reporting low Salmonella 
occurrence in the broiler breeder ﬂocks also reported relatively few (less than 4%) 
infected rearing and production ﬂocks (Austria, Denmark, Finland, Slovenia and Sweden). 
In Spain, the high level of infection among the breeding ﬂocks (10.4%) was also reﬂected 
in a high proportion of infected broiler ﬂocks (15.2%). 
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Table SA18. Salmonella in broiler ﬂocks (all age groups1, ﬂock based data), 2004 
and 2003
2004 2003
N % Pos % S. Ent % S. Typ N % Pos % S. Ent % S. Typ
Austria 3,619 3.3 2 0.1 - - - -
Belgium 5,381 7.2 - - - - - -
Cyprus 218 23.4 0.1 0 - - - -
Denmark 4,313 1.5 0.1 0.3 13,155 0.6 0 0.2
Finland 3,132 0.2 - - 3,447 0.1 0 0
France - - - - - - - -
Germany 1,546 7.1 0.2 0.6 227 4 2.6 0
Greece 582 14.6 0.5 0.9 2,016 6.7 4.6 0
Ireland - - - - - - - -
Italy - - - - - - - -
Lithuania 1,737 1 0.8 - - - - -
Norway 3,772 0 - - - - - -
Poland 22,552 7.8 3.4 0.3 - - - -
Portugal 32 6.3 6.3 - - - - -
Slovakia 1,944 3.2 2.7 0.1 - - - -
Slovenia 1,146 1 0.3 - - - - -
Spain 415 15.2 9.9 0.7 2,020 24.3 17.7 0.2
Sweden 3,000 0.1 - - 2,815 0 0 0
The Netherlands 28,279 3.9 - - - - - -
1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point in the lifespan of a ﬂock.
Among the MS that operated monitoring programmes for broiler ﬂocks and reported 
consistently during the period 2001 to 2004 (Figure SA9), the proportion of Salmonella 
positive broiler ﬂocks remained at the same level in Denmark (2%), Germany (7%) and 
Sweden (<0.1%), but increased in Greece from 2003 to 2004 (6.7% to 14.6%). The highest 
levels were reported from Spain, where the proportion of Salmonella positive broiler 
ﬂocks in 2003 (24%) exceeded the levels in 2002 (17%) and 2004 (15%).
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Figure SA9. Proportion of Salmonella positive broiler ﬂocks (all age groups1) in MS 
running a monitoring and control programme, 2001-2004
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1.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point in the lifespan of a ﬂock.
As in 2002 and 2003 no Salmonella positive broiler breeding or production ﬂocks were 
detected in Norway. An overview of the reported data is presented in Level 3, Table SA10-11.
 
Ducks and geese
Only Poland tested a substantial number of duck-breeding ﬂocks in 2004 and found that 
7.9% were infected. Within the MS reporting data from at least 25 production ﬂocks, the 
proportion of infected ﬂocks ranged from 4.8 to 57.2% (Table SA19). As in 2003, very high 
levels were found in Danish duck ﬂocks (57.2%), and medium levels in Germany (10.7%). 
Salmonella was not detected at the tested farms in Norway during 2003 and 2004. 
An overview of the reported data is presented in Level 3, Table SA11.
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Table SA19. Salmonella in production ﬂocks1 of ducks (all age groups2, ﬂock based 
data), 2004
 
Production ﬂocks
N % Pos % S. Ent % S. Typ
Austria 38 5.3 5.3 0
Denmark 201 57.2 - -
Germany 122 10.7 0 0.8
Italy 21 4.8 - -
Norway3 48 0 - -
Poland 442 15.6 2.5 1.8
1. Include MS reporting data from at least 25 ﬂocks.
2.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point of the lifespan of a ﬂock.
3. In Norway, data are related to farms, not ﬂocks.
Similarly, only Poland tested a substantial number of geese breeding ﬂocks, and found 
that 1.4% was infected. Within the three MS reporting data from at least 25 production 
ﬂocks, the proportion of infected ﬂocks ranged from 6.8 to 14.6% (Table SA20). 
Salmonella in ducks was also reported by Belgium, Ireland, Portugal and Sweden and 
in geese by Greece, Italy, Slovakia, Sweden and United Kingdom. An overview of the 
reported data is presented in Level 3, Table SA11.
Table SA20. Salmonella in production ﬂocks1 of geese (all age groups2, ﬂock based 
data), 2004
 
Production ﬂocks
N % Pos % S. Ent % S. Typ
Austria 48 14.6 0 0
Germany 88 6.8 0 2.3
Poland 2,708 7.4 1.8 1.7
1. Include MS reporting data from at least 25 ﬂocks.
2.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point of the lifespan of a ﬂock.
Turkeys
Poland and Finland were the only MS that tested a substantial number of turkey breeding 
ﬂocks in 2004, and found that 3.3% and 0% infected, respectively. Within the MS 
reporting data from at least 25 production ﬂocks, the proportion of infected ﬂocks ranged 
from 0 to 35.8% (Table SA21). As in previous years, the proportion of infected ﬂocks was 
low in Finland, Norway and Sweden. In Austria and Germany the proportion of positive 
ﬂocks were lower than in 2003. 
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Table SA21. Salmonella in production ﬂocks1 of turkeys (all age groups2, ﬂock based 
data), 2004
Production ﬂocks
N % Pos % S. Ent % S. Typ
Austria 185 7 0 1.1
Finland 989 0.1 0 0.1
Germany 1,627 4.5 0.3 0.7
Italy 57 14 - -
Norway 347 0 - -
Poland 4,424 8.6 0.5 0.9
Slovakia 53 35.8 0 1.9
Sweden 131 0 - -
1. Include MS reporting data from at least 25 ﬂocks. 
2.  Combined data (day-old chicks, rearing and production) have been used to estimate the percentage of 
positive ﬂocks. This percentage represents ﬂocks found positive at any point of the lifespan of a ﬂock.
Salmonella in turkeys were also reported by Greece, Ireland, Slovakia and Spain. 
An overview of the reported data is presented in Level 3, Table SA11.
Pigs
Five MS (Estonia Finland, Italy, Sweden and The Netherlands), and Norway reported data 
from active monitoring of pigs in breeding and fattening herds (Table SA22). In Finland, 
Norway and Sweden, the situation was comparable to previous years as no or very few 
Salmonella infected herds/animals were detected in 2004. 
Only The Netherlands reported data from fattening pigs. A total of 29.4% of the fattening 
herds tested in The Netherlands, and 25.4% of the batches of fattening pigs tested prior 
to slaughter in Italy, were Salmonella positive. A similar high proportion of positive herds 
(29%) were also reported by The Netherlands in 2001 and 2002 (no data from 2003).
Most of the other reported pig data were from diagnostic samples and S. Typhimurium 
was the dominant serovar. An overview of the reported data is presented in Level 3, 
Table SA13.
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Table SA22. Salmonella in pigs from MS that run a monitoring programme, 2004
Unit N % Pos % S. Ent % S. Typ
Faecal samples, collected at farm
Estonia Animal (unspeciﬁed) 532 0.4 - -
Finland Animal (boars, AI station) 216 0 - -
Finland Herd (breeding) 144 0 - -
The Netherlands Herd (fattening) 221 29.4 - -
Norway Herd (breeding) 164 0 - -
Faecal samples, collected prior to slaughter
Italy1 Slaughter batches (fattening) 173 25.4 0.6 5.8
Italy1 Slaughter batches (unspeciﬁed) 18 5.6 - -
Lymph nodes, collected at slaughter 
Finland Animal (breeding) 3,304 0.2 - 0.1
Finland Animal (fattening) 3,336 0 - -
Norway Animal (breeding) 893 0.1 - -
Norway Animal (fattening) 1,769 0
Sweden Animal (fattening) 3,191 0 - -
Sweden Animal (breeding) 2,782 0 - -
Carcass swabs, collected at slaughter
Sweden Animal (fattening) 3,190 0 - -
Sweden Animal (breeding) 2,750 0 - -
 
1. In Italy, only the Veneto Region has a monitoring programme.
Cattle
Data from active monitoring of cattle herds was reported in four MS (Estonia Finland, Italy 
and Sweden), and Norway (Table SA23). In Finland, Norway and Sweden, the situation was 
comparable to previous years, as no or very few Salmonella infected herds/animals were 
identiﬁed in 2004. In Italy the proportion of infected herds was slightly higher (1.5%).
Most of reported cattle data were from diagnostic samples, where S. Dublin, S. Enteritidis 
and S. Typhimurium were the dominant serovars. An overview of the reported data is 
presented in Level 3, Table SA13.
 
Table SA23. Salmonella in cattle from MS that run a monitoring programme, 2004
Unit N % Pos % S. Ent % S. Typ
Faecal samples, collected at farm 
Estonia Animal 983 0.1 - -
Finland Herd (bulls at AI station) 214 0 - -
Faecal samples, collected prior to slaughter
Italy Herd 524 1.5 0 1.0
Lymph nodes, collected at slaughter
Finland Animal 3,058 0.2 0 0.2
Norway Animal 2,302 0.1 0 0.1
Sweden Animal 3,470 0 - -
Carcass swabs, collected at slaughter
Sweden Animal 3,475 0 - -
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Other animals 
Other poultry species, such as guinea fowl, ostriches, partridges, quails, and pheasants, 
as well as wild birds, were tested for Salmonella in some MS. Results show that all types 
of poultry can be infected with Salmonella and both S. Enteritidis and S. Typhimurium 
are present. An overview of the reported data is presented in Level 3, Table SA12.
The reported data on Salmonella in sheep, goats and solipeds were primarily results 
from diagnostic submissions. In several countries, Salmonella was detected in sheep 
(Germany, Ireland, Norway, Portugal and Spain), goats (Greece and Norway) and solipeds 
(Austria, Germany, Ireland, Poland, Spain and The Netherlands). In Norway, only the 
speciﬁc serotype S. enterica subsp. diarizonae 61:(k):1,5,(7) was isolated from sheep 
and goats. In Italy, control programmes and surveys found no infected sheep, goats or 
solipeds during 2004, whereas several water buffaloes tested positive. In pets, Salmonella 
was detected in cats and dogs, and at a relatively high rate in reptiles. An overview of 
the reported data is presented in Level 3, Table SA13.
3.1.4. Salmonella in feedingstuffs
Information regarding Salmonella in feedingstuff was reported by most MS (no data from 
Malta). Data could not be separated into MS with comparable surveillance programmes 
and those reporting random sampling of domestic and imported feedingstuffs (Appendix, 
Table SA1). Presentation of sample and batch based data from the different monitoring 
systems were therefore summarised, and may include both domestic and imported 
feedstuffs. Data were excluded when either the number of tested units or number of 
positive units were not reported. Due to signiﬁcant differences in monitoring and reporting 
strategy data are not comparable between MS, and cannot be considered as national 
prevalences. All reported data are presented in Level 3, Table SA14-SA16.
Compared to previous years, the occurrence of Salmonella in ﬁshmeal in 2004 decreased 
in most MS reporting data for 25 samples or more (Table SA24). In these MS, 0-7.5% 
of the tested units were positive, the highest reported by Latvia. In Greece, Spain and 
Sweden, the occurrence of Salmonella in ﬁshmeal increased in 2004, where 3.4-5.6% 
of the tested units were contaminated (Table SA24). Overall, Salmonella contamination 
of meat and bone meal was comparable to previous years, with a contamination rate 
between 0-3.1% for MS reporting data for 25 samples or more.
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Table SA24. Salmonella in animal derived feed material, 2000-2004
 
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Fishmeal
Austria1 44 0 59 6.8 63 9.5 14 21.4 39 7.7
Belgium 29 3.4 8 12.5 - - - - - -
Cyprus 42 0 128 0.8 - - - - - -
Denmark - - 339 0 406 0.2 403 1.7 234 0.9
France1 41 0 57 1.8 12 0 - - - -
Germany2 1,628 1.3 97 7.2 14 0 40 2.5 18 22.2
Greece1 43 4.7 13 0 57 0 132 1.5 70 0
Italy 110 0 183 1.1 371 1.1 203 3.9 209 2.9
Latvia 576 7.5 247 9.7 - - - - - -
Lithuania 130 0.8 108 1.9 - - - - - -
Norway2 49 0 5,187 0.1 8,989 0.1 6,466 0.1 6,784 0.6
Poland 1,720 0 - - - - - - - -
Slovenia 77 0 - - - - - - - -
Spain1,2 89 5.6 83 2.4 265 0.8 51 0 37 2.7
Sweden 669 3.4 228 0 332 0.3 321 0 260 0
The 
Netherlands 821 0.9 493 1.2 799 3.8 109 6.4 883 4.9
United 
Kingdom2 - - 27 7.4 - - - - 126 21.4
Meat and bone meal 
Czech 
Republic 60 0 - - - - - - - -
Denmark 7,979 2.1 5,365 0.3 269 2.2 269 0 73 1.4
Finland2 117 0 97 0 98 0 203 0 418 0
Germany 974 1.7 1,360 1.5 827 4.4 252 3.2 1,213 0.6
Italy 1,983 0.1 197 2.0 247 2.8 467 0.9 1,333 1.5
Lithuania - - 9 0 - - - - - -
Norway 611 0.2 584 0.9 684 0.1 820 0.0 1,867 0
Poland 1,239 1.3 0 - - - - - - -
Spain2 41 2.4 88 0 366 1.9 382 2.6 8,693 0
Sweden2 716 1.8 932 0.3 155 1.3 1,364 0.1 3,529 0.1
The 
Netherlands 64 3.1 25 4.0 71 0 143 3.5 962 3.3
United 
Kingdom2 - - 30 20.0 21 0 14 14.3 32 6.3
1.  Data include other ﬁsh products in the ﬁshmeal category from Austria (2001, 2002), France (2001), 
Greece (2000, 2001, 2002) and Spain (1999, 2002).
2.  Import data excluded from Finland (1999, 2000, 2003), Germany (2004), Norway (2000, 2001, 2002), 
Spain (1999, 2000, 2001, 2002), Sweden (2002) and United Kingdom: 2000, 2001, 2002.
The level of Salmonella contamination in feed material of vegetable origin varied 
considerable between countries in 2004, especially for oil seeds and products thereof. 
No general trend was apparent (Table SA25). Overall, Salmonella contamination of cereals 
ranged between 0-3.2%, and 0-7.6% for oil seeds and products, respectively, for MS 
reporting data for 25 samples or more in at least one reporting year. 
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Table SA25. Salmonella in vegetable derived feed material, 2000-2004
 
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Cereals
Austria 410 3.2 444 1.4 70 2.9 17 0 649 0.9
Belgium 81 0 38 0 - - 7 0 19 0
Finland1 44 0 61 1.6 79 1.3 98 1.0 - -
France 76 2.6 70 5.7 16 0 29 0 267 0
Germany 892 0.6 871 0.9 829 1.0 394 1.3 304 1.3
Greece 25 0 5 0 35 0 37 0 5 0
Ireland 44 0 37 0 33 0 18 0 12 0
Italy 116 1.7 57 0 762 2.5 129 2.3 216 0.5
Latvia 38 0 51 5.9 - - - - - -
Lithuania 58 0 - - - - - -
Norway1 1,083 0.0 - - - - - - 1 0
Poland 466 0.6 - - - - - - - -
Spain1 77 0 105 2.9 148 3.4 15 6.7 29 0
Sweden1 225 2.7 - - 192 0 158 0 132 0
The 
Netherlands 2,994 0.3 2,232 0.6 2,425 0.8 207 0 805 0.4
Oil seeds and products 
Austria 21 0 469 3.0 273 6.2 258 5.0 234 24.4
Belgium 156 0.6 29 0 - - 5 0 39 5.1
Cyprus 46 0 154 1.9 - - - - - -
Czech 
Republic 42 0 - - - - - - -
Denmark 1,101 4.5 104 1.9 - - - - - -
Finland1 444 4.7 264 1.5 322 6.8 275 0.7 - -
France 312 4.8 338 4.4 526 3.4 875 4.1 1,248 6.6
Germany 1,544 7.6 1,345 7.5 1,201 8.1 693 1.9 773 3.4
Greece 56 1.8 2 50.0 49 4.1 12 0 9 22.2
Ireland 62 6.5 36 0 39 7.7 13 7.7 27 0
Italy 119 2.5 28 7.1 44 0.0 9 22.2 17 5.9
Latvia1 36 2.8 - - - - - - - -
Lithuania 173 2.9 - - - - - - - -
Norway 3,927 0.4 25 4.0 6 0 1 0 16 0
Poland1 1,261 2.6 - - - - - - - -
Portugal1 1 0.0 44 11.4 20 25.0 2 100 2 100
Spain 48 0.0 95 15.8 61 3.3 - - 33 9.1
Sweden 2,431 2.2 1,252 0.5 1,993 0.3 1,692 0 1,711 0.2
The  
Netherlands 12,675 6.8 10,421 5.1 9,305 6.0 525 6.3 2,835 4.3
United 
Kingdom - - 12,475 3.0 6,035 4.3 14,842 2.2 19,638 1.9
1.  Import data excluded from Finland (1999, 2000, 2001, 2002, 2003), Norway (2000, 2001, 2002, 2003), 
Spain (1999, 2000, 2001, 2002) and Sweden (2000, 2001, 2002).
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In compound feedingstuffs, the Salmonella contamination rates were comparable to 
previous years, and ranged from 0-1.1% in cattle feed, 0–1.9% in pig feed and 0–6.3% 
in poultry feed (Table SA26). In poultry feed, a relatively high Salmonella occurrence was 
found in Greece (6.3%), Ireland (5.1%), Italy (3.9%) and Latvia (2.7%) in 2004. As for all 
feedingstuff results, the relevance of these high contamination rates depend on whether 
the data are representative of the feedingstuff available in the country, or it reﬂects intensive 
sampling of high risk products. The national reports from 2004 do not include this information.
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Table SA26. Salmonella in compound feedingstuffs (ﬁnal products), 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Cattle feed
Belgium - - 112 0.9 42 0 29 0 4 0
Denmark - - 378 0.3 754 0.3 741 0.4 721 0.6
Finland1 453 0 513 0 439 0 370 0 360 0
Germany 261 0 - - - - - - - -
Greece - - 60 0 17 0 20 0 3 0
Ireland 56 0 44 0 39 5.1 3 0
Italy 206 1.0 168 0 44 2.3 76 0.0 243 1.2
Latvia 6 0 117 1.7 - - - - - -
Poland 477 0.4 - - - - - - - -
Slovenia - - 26 7.7 - - - - - -
Spain 177 1.1 384 2.3 470 4.5 336 1.2 18 0
The 
Netherlands - - 1,409 0.9 1,671 0.8 3,394 0 2,739 1.1
Pig feed
Austria 15 0 72 0 77 2.6 5 0 7 28.6
Belgium - - 180 1.1 7 0 21 4.8 22 4.5
Czech 
Republic 5 0 - - - - - - - -
Denmark - - 796 0.1 1,498 0 1,552 0.1 1,436 0.3
Finland1 299 0 241 0 235 0 157 0 201 0
Germany 569 0.2 - - - - - - - -
Italy 116 0.9 - - - - - - - -
Latvia 67 0 152 2.6 - - - - - -
Norway 44 0 69 0 104 0 67 0 61 0
Poland 1,827 1.2 - - - - - - - -
Slovenia 53 1.9 43 4.7 - - - - - -
Spain 97 1.0 89 0 120 8.3 64 1.6 10 0
The 
Netherlands 3,048 0.6 2,904 0.6 3,146 0.6 3,213 0.3 2,459 0.4
Poultry feed
Austria 321 0.6 683 0.9 377 1.6 656 5.2 160 14.4
Belgium - - 106 1.9 33 0 43 0 12 8.3
Denmark - - 164 0 350 0 262 0 249 0
Finland1 175 0 243 0 180 0 146 0 196 0
France - - 50 4.0 24 0 - - 102 2.0
Germany 408 0.5 - - - - - - - -
Greece 176 6.3 344 3.2 68 0 36 0 35 0
Ireland 570 5.1 14 0 325 0 3,392 4.0 59 0
Italy 356 3.9 - - - - - - - -
Latvia 150 2.7 120 2.5 - - - - - -
Norway 28 0 61 0 78 0 78 0 71 0
Poland 2,682 0.9 - - - - - - - -
1. Import data excluded from Finland (1999, 2000, 2001, 2003).
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The reported occurrences of S. Enteritidis and S. Typhimurium in feedingstuffs were low. 
S. Enteritidis was detected in ﬁnal products of compound feedingstuff for farm animals 
in Italy, Poland, Slovenia, Spain and The Netherlands. S. Typhimurium was detected in 
Belgium, Germany, Ireland, Italy, Poland and The Netherlands. In feed of vegetable origin, 
Austria, France, Germany, Italy, Poland, Sweden and United Kingdom reported ﬁndings 
of S. Enteritidis or S. Typhimurium. Denmark, Germany, Hungary, Italy, Poland, Slovakia, 
Spa in and United Kingdom detected one or both of these serovars in feed material of 
animal origin. More detailed descriptions of the serotype distribution in feedstuff are 
presented in section 3.1.5.
Except for Malta, all new MS reported information on Salmonella in feedingstuffs. 
Compared to the old MS, the level of Salmonella contamination was high in the tested 
feedingstuffs of animal origin in Latvia, due to a high prevalence in ﬁshmeal (7.3%). 
In Poland, Salmonella was not detected in ﬁshmeal, but 1.2% of the tested samples of 
meat and bone meal was positive (Table SA27).
The level of Salmonella contamination in feedingstuffs tested in the non-MS, Norway, 
was low and within the ranges as in the MS.
Table SA27. Salmonella monitoring of feedingstuffs in new MS, 2004
Animal origin Vegetable origin Compound feedstuffs All feedstuffs
N Pos % Pos N Pos % Pos N Pos % Pos N Pos % Pos
Feedstuffs
Cyprus1 81 0 0 50 0 0 51 3 5.9 - - -
Czech  
Republic2 88 0 0 47 0 0 217 0 0 - - -
Estonia1 4 0 0 6 0 0 26 0 26 - - -
Hungary1 - - - - - - - - - 8,667 89 1.0
Lithuania1 130 1 0.8 231 5 2.2 55 1 1.8 - - -
Latvia1 614 45 7.3 261 5 1.9 76 1 1.3 - - -
Poland3 3,468 41 1.2 1,727 36 2.1 8,343 108 1.3 - - -
Slovakia1 1,705 10 0.6 955 15 1.6 1,925 4 0.2 - - -
Slovenia4 77 0 0  36 0 0 183  4 2.2 - -  -
Note: Results were not reported from Malta.
1. Sample based data.
2. In Czech Republic, batch based data.
3. In Poland, sample and batch based data.
4. In Slovenia, feedstuffs of vegetable origin is sample based data, otherwise batch based data.
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3.1.5. Salmonella serovars and phage types
The level of details available on Salmonella serovars and phage types along the food chain 
varies between countries. Serotyping of Salmonella isolates is done in all MS on the basis 
of the Kaufmann-White Scheme, and the Colindale scheme is primarily used for phage 
typing of S. Enteritidis and S. Typhimurium. The Netherlands classiﬁed S. Typhimurium with 
another set of phages, so with the exception of S. Typhimurium DT104 the distributions 
are not comparable. Hungary also classiﬁes S. Enteritidis and S. Typhimurium with 
another set of phages that are not comparable with the Colindale scheme. Therefore, 
these data are not presented here.
The ten most common Salmonella serovars and the ten most common phage types of 
S. Enteritidis and S. Typhimurium are presented for humans, foodstuffs (pig meat, broiler 
meat, eggs), animals (cattle, pigs, Gallus gallus) and feedingstuffs (total for all categories). 
Ranking was based on data from all included MS by calculating the total number of each 
serovar and the percentage of isolates belonging to a particular phage type within 
S. Enteritidis and S. Typhimurium. For humans, the Community serovar distribution was 
estimated, assuming that the serovar distribution in non-serotyped isolates was the 
same as among the serotyped isolates in each MS. For foodstuffs and animals, only 
MS reporting results for at least 25 isolates per food type or animal species (monitoring 
isolates only) were included. The serovar and phage type distributions for each MS were 
based on the number of typed isolates, including non-typeable isolates. 
Most MS reported a group called “other serotypes”. For some MS this may include 
isolates belonging to the ten most common serovars in the Community. However, these 
have not been reported individually by the MS. The relative Community occurrence of 
some serovars may therefore be underestimated. 
Most MS reported some data on Salmonella serovar distributions in foodstuffs (no data 
from France, Luxembourg, Malta and Portugal), animals (no data from Cyprus, Latvia, 
Lithuania, Luxembourg, Malta and Portugal) and feedingstuffs (no data from Czech 
Republic, Luxembourg and Malta).
Data on serovars in humans, foodstuffs, animals and feedingstuff from each MS is 
summarised in Level 3, Table SA17-SA41. Data on phage types in humans is summarised 
in Level 3, Table SA42 and SA43.
Serovars in humans 
Most MS and Norway reported serotyping results for all the human cases recorded. Italy, 
Luxembourg and Poland did not provide serovar information and Greece reported serovars 
for only 25% of cases. Overall, 86% of the isolates from human cases in the Community 
were serotyped. The ten most common serovars among isolates from human cases are 
presented in Table SAS1. 
As in previous years, S. Enteritidis and S. Typhimurium were the most commonly reported 
serovars from human infections in all of the reporting MS, and in Norway. Based on the 
data available, it is estimated that S. Enteritidis caused 76% and S. Typhimurium caused 
14% of human salmonellosis in the EU-25 MS. Other serovars caused each 1% or less 
of the total number of cases in the EU-25.
Inclusion of the new MS increased the relative proportion of S. Enteritidis. In MS, the percent 
of S. Enteritidis cases ranged from 32% in France to 100% in Cyprus. For S. Typhimurium, 
the percent of cases ranged from 1.5% in Czech Republic to 32% in The Netherlands. 
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Section 3.1.1 includes a more detailed presentation of S. Enteritidis and S. Typhimurium 
in humans.
Table SAS1. Distribution of the ten most common Salmonella serovars in humans during 
2004. The serovar distribution for each MS was based on the number of serotyped 
isolates. Ranking was based on the sum of all reported serovars (% isolates).
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Austria1 7,298 83.3 9.6 1.1 0.4 - 0.2 - - 0.4 - 5.1 100.2
Belgium 8,535 71.2 28.8 - - - - - - - - - 89.4
Cyprus 89 100 - - - - - - - - - - 100
Czech 
Republic1
30,724 96.9 1.5 0.3 <1 - <1 <1 - <1 - 1.2 100
Denmark1 1,538 35.5 30.4 2.1 - 2.3 2.3 1.0 - 1.0 - 25.4 100
Estonia 133 68.4 13.5 - - - - 0.8 3.8 - 2.3 11.3 98.5
Finland1 2,248 38.7 14.5 1.6 3.6 5.1 2.7 - - 1.2 - 32.4 100
France 6,352 32.5 26.2 - - - - - - - - 41.3 100
Germany1 48,204 67.0 23.0 - - - - - - - - - 91
Greece1 372 83.1 5.4 0.3 - - - - - - - 11.3 24.9
Hungary 7,557 72.8 7.6 5.9 0.4 - - 0.5 - 0.4 - 12.5 100
Italy1 - - - - - - - - - - - - 0
Ireland1 403 42.9 30.8 0.2 2.5 0.7 1.5 0.5 - 1.0 - 19.9 98.3
Latvia 503 84.1 4.6 0.8 1.4 - - 8.0 - - - 1.2 96.7
Lithuania 1,777 92.8 4.8 1.2 0.1 - - 0.1 - 0.1 - 1.0 95.8
Malta 79 57 12.7 1.3 3.8 - - 2.5 - 2.5 - 20.3 100
Norway1 1,567 51.5 12.8 5.6 2.6 3.8 - - - - - 23.7 100
Poland - - - - - - - - - - - - 0
Portugal1 691 80.3 13 - - - - - - - - 6.7 100
Slovakia 12,667 88.6 1.2 - - - - - - - - 10.2 100
Slovenia1 3,158 98.3 1.0 - - - - 0.1 - - - <1 97.3
Spain 5,613 69 14.6 - - - - - 6.4 0.2 5.7 4.0 79.0
Sweden1 3,562 40.7 11.5 - 4.4 5.4 2.0 - - - - 36 100
The  
Netherlands 1,440 53.3 32.2 1.6 0.9 - 0.9 0.7 - 1.1 - 9.3 94.7
United 
Kingdom 14,476 61.7 11.4 0.7 2.2 1.0 5.3 - - 0.9 - 16.8 100
EU-15 100,477 68 20.4 <1 0.6 <1 1 <1 <1 <1 <1 10 96.3
EU-25 157,164 76.5 13.9 0.5 <1 <1 0.6 <1 <1 <1 <1 8.4 85.5
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serovars may 
be included in the group of “other serovars” for some MS. Thus, empty cells do not necessarily signify 
that no isolates were present. Luxembourg, Italy and Poland did not include data on human serovars. 
No MS reported nontypeable isolates.
1. Salmonellosis notiﬁable in humans.
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Serovars in foodstuffs
As in 2003, S. Typhimurium was the predominating serovar isolated from pig meat during 
monitoring (24–98%) followed by S. Derby (1–22%) (Table SAS2). The relative occurrence 
of the other common serovars varied between the reporting MS. S. Infantis was 
frequently reported from pig meat in Denmark (6%) and Hungary (12%) and S. Ohio in 
pig meat from Belgium (12%). The relative occurrence of serotypes not included in Table 
SAS2 was less than 4%. Apart from an increasing occurrence of S. Infantis, the serotype 
distribution in pig meat in 2004 was largely comparable to the distribution in 2003.
Table SAS2. Distribution of the ten most common Salmonella serovars in pig meat 
in MS that have serotyped at least 25 monitoring isolates. The serovar distribution 
for each MS was based on the number of serotyped isolates, including nontypeable 
isolates. Ranking was based on the sum of all reported serovars (% isolates).
Ranked serovars
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Belguim2,3 117 241 18 1 12 31 - 2 - - - 40
Denmark 280 341 22 6 - - - - - - - 21
Germany 54 521 18 4 2 - 2 4 4 - 2 12
Hungary 113 261 21 12 - 41 1 - - - 3 33
Ireland 79 981 1 - - - - - 1 - - 0
Italy2 144 55 17 2 1 3 6 1 1 6 1 9
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serotypes may 
be included in the group of “other serotypes” for some MS. Thus, empty cells do not necessarily signify 
that no isolates were present.
1.  This serovar was a common cause of human infections in the MS, representing at least 10% of the 
human cases reported.
2.  In Belgium and Italy, serovar data from the monitoring programmes was not speciﬁcally reported, 
so the serotypes distribution from the general Salmonella tables was included.
3. In Belgium, Salmonella notiﬁable in food.
Overall, S. Enteritidis was the most commonly occurring serovar isolated from the 
monitoring of broiler meat in 2004, followed by S. Infantis and S. Typhimurium (Table SAS3). 
However, the predominance of speciﬁc serovars in broiler meat varied greatly between 
the MS. S. Enteritidis dominated in broiler meat in Austria, Belgium and Latvia; S. Infantis in 
Germany and Hungary; S. Hadar in Cyprus and Italy; S. Blockley in Greece; S. Typhimurium 
in Ireland and S. Kentucky in the United Kingdom. Other serovars not included in the list, 
which were common in some MS, are presented in the footnotes for Table SAS3. 
The relative occurrences of all other reported serovars were less than 4%.
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Table SAS3. Distribution of the ten most common Salmonella serovars in broiler meat 
in MS that have serotyped at least 25 monitoring isolates. The serovar distribution 
for each MS was based on the number of serotyped isolates, including nontypeable 
isolates. Ranking was based on the sum of all reported serovars (% isolates).
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Austria2 117 321 15 111 2 2 5 2 1 1 - 30
Belgium2 105 281 7 16 - - 8 - 7 17 - 18
Cyprus2 42 71 - 2 19 21 - - - - 19 31
Germany 88 101 25 14 4 2 2 - 10 - - 33
Greece 52 21 - 12 40 8 6 - 10 - - 23
Hungary 712 51 91 11 - <1 - - - - - 3
Ireland 174 131 1 381 - 1 - 14 1 - - 33
Italy2 70 3 1 9 11 33 - - 1 - - 41
Latvia2 32 971 - - - - - - - - - 3
United Kingdom 46 - - 91 - 2 11 15 - 4 - 59
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serotypes may 
be included in the group of “other serovars” for some MS. Thus, empty cells do not necessarily signify 
that no isolates were present.
1.  This serovar was a common cause of human infections in the MS, representing usually at least 10% 
of the human cases reported.
2.  Serovar data from the monitoring programmes was not speciﬁcally reported, so the serotypes distribution 
from the general Salmonella tables was included.
3.  Other common serotypes from broiler meat in Austria: S. Kottbus (11%), S. Thompson (5%); Belgium: 
S. Paratyphi B (9%), S. Bredeney (8%); Cyprus: S. group C2 (11%), S. Braenderup (7%), S. Kaapstad 
(5%); Germany: S. Paratyphi B var. Java (17%); Greece: S. Livingstone (7%), S. Meleagridis (6%); 
Hungary: S. Saintpaul (6%); Ireland: S. Mbandaka (12%), S. Goldcoast (10%), S. Bredeney (6%); Italy: 
S. Derby (6%), S. Glostrup (6%); United Kingdom: S. Derby (9%), S. Ohio (9%), S. Thompson (7%).
Generally, table eggs are not monitored using bacteriological methods. The data 
available from Germany and Italy showed that S. Enteritidis, as in 2003 and 2002, was 
the predominating serovar in table eggs (Table SAS4).
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Table SAS 4. Distribution of the seven most common Salmonella serovars in table eggs 
in MS that have serotyped at least 25 monitoring isolates. The serovar distribution 
for each MS was based on the number of serotyped isolates, including nontypeable 
isolates. Ranking was based on the sum of all reported serovars (% isolates).
Ranked serovars
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Germany 43 931 21 2 - - - 2 0
Italy2 26 73 8 4 4 4 4 - 4
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serotypes may 
be included in the group of “other serovar” for some MS. Thus, empty cells do not necessarily signify that 
no isolates were present.
1.  In Germany, this serotype was a common cause of human infections in the MS, representing at least 
10% of the human cases reported.
2.  In Italy, serovar data from the monitoring programmes was not speciﬁcally reported, so the serotypes 
distribution from the general Salmonella tables was included.
Several MS provided serovar information for bovine meat in 2004, but the monitoring 
data was too sparse for a Community evaluation of the serovar distribution.
Serovars in animals
In cattle, S. Typhimurium and S. Dublin were the most frequently detected serovars during 
monitoring in 2004 (Table SAS5). The frequent occurrence of S. Mbandaka in German 
cattle in 2003 was not observed in 2004. Apart from that, the distribution in 2003 was 
comparable to this year’s distribution.
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Table SAS5. Distribution of the ten most common Salmonella serovars in cattle, in 
MS that have serotyped at least 25 monitoring isolates. The serovar distribution for 
each MS was based on the number of serotyped isolates, including nontypeable 
isolates. Ranking was based on the sum of all reported serovars (% isolates).
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Czech  
Republic2,3 26 69 - 15
1 4 - 4 - - - - 8
Denmark 65 371 55 - - - - - - - - 8
Finland3 199 911 - - - 8 - - - - - 1
Germany3 274 411 48 31 2 - 1 - - <1 - 5
The  
Netherlands3 184 15
1 46 - 8 - 2 7 6 32 3 10
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serotypes may 
be included in the group of “other serovar” for some MS. Thus, empty cells do not necessarily signify that 
no isolates were present.
1.  This serotype was a common cause of human infections in the MS, representing at least 10% of the 
human cases reported.
2.  Serovar data from the monitoring programmes was not speciﬁcally reported, so the serotypes 
distribution from the general Salmonella tables was included.
3. Salmonella notiﬁable in animals.
In pigs, as in pig meat, S. Typhimurium was the predominant serotype detected during 
monitoring in 2004 (ranging from 19-82%) followed by S. Derby (ranging from 6-19%) 
(Table SAS6). 
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Table SAS6. Distribution of the ten most common Salmonella serotypes in pigs, in 
MS that have serotyped at least 25 monitoring isolates. The serovar distribution for 
each MS was based on the number of serotyped isolates, including nontypeable 
isolates. Ranking was based on the sum of all reported serovars (% isolates).
Ranked serovars
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Czech 
Republic3 47 62 13 17
1 4 - - - - - - 4
Denmark 922 701 18 <11 3 - <1 <1 <1 1 <1 5
Germany3 109 821 6 11 4 - 1 - - - - 7
Hungary 53 19 19 91 6 - 2 6 - - - 40
Italy3 45 22 13 - 2 20 7 - 2 4 2 29
The  
Netherlands3 356 52
1 15 - 1 8 - 12 5 2 4 16
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serovars may 
be included in the group of “other serovars” for some MS. Thus, empty cells do not necessarily signify 
that no isolates were present.
1.  This serovar was a common cause of human infections in the MS, representing at least 10% of the 
human cases reported. 
2.  Serovar data from the monitoring programmes was not speciﬁcally reported, so the serotypes 
distribution from the general Salmonella tables was included.
3. Salmonella notiﬁable in animals.
The dominant serovars isolated from Gallus gallus were S. Enteritidis (Ranging from 2-93%), 
S. Infantis (0-54%) and S. Typhimurium (2-20%). S. Enteritidis was the most common 
serotype in several MS, but S. Infantis dominated in Denmark and Hungary, S. Blockley 
in Greece, S. Paratyphi B var. Java in The Netherlands and S. Livingstone in the United 
Kingdom (Table SAS7). The distribution of serovars in monitoring isolates from layers 
and broiler were reported together.
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Table SAS7. Distribution of the ten most common Salmonella serovars in Gallus gallus, 
in MS that have serotyped at least 25 monitoring isolates. The serotype distribution 
for each MS was based on the number of serotyped isolates, including nontypeable 
isolates. Ranking was based on the sum of serovars (% isolates) for the included MS.
Ranked serovars
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Czech 
Republic3 101 89
1 1 1 - - - - - - - 9
Denmark 66 61 27 201 - - - - - - - 47
France2,3 105 931 - 71 - - - - - - - 0
Germany 197 241 17 131 6 13 - 1 - - 8 18
Greece3 92 91 - 51 12 - - 1 23 4 - 46
Hungary 185 311 54 51 - 1 - - 1 - - 8
Poland 173 61 13 2 - 3 - 6 - - 5 8
Spain2 247 701 2 21 - 41 - 17 - - - 5
The  
Netherlands3 459 11
1 8 41 1 6 27 22 3 10 42 24
United 
Kingdom3 675 2
1 3 21 22 4 - - - 12 3 54
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serovars may 
be included in the group of “other serovars” for some MS. Thus, empty cells do not necessarily signify 
that no isolates were present.
1.  This serovar was a common cause of human infections in the MS, representing at least 10% of the 
human cases reported. 
2.  Serovar data from the monitoring programmes was not speciﬁcally reported, so the serotypes 
distribution from the general Salmonella tables was included.
3. Salmonella notiﬁable in animals.
Serovars in feedingstuffs
The serovars most commonly reported from feedingstuffs varied greatly between MS, 
and to a wide extent depended on the sampling strategy and type of product tested. 
So the ranking of serovars in Table SAS8 must be interpreted with caution. Of the ten 
most common serovars in feedingstuffs, S. Typhimurium, S. Enteritidis and S. Infantis 
are also among the ten most common serovars in humans. With the exception of 
S. Worthington, the ten most common serovars found in feedingstuffs in 2004 were also 
among the most common serotypes found in feed during 2003.
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Table SAS8. Distribution of the ten most common Salmonella serovars in MS that 
have serotyped at least 25 isolates (summed for all reported feedingstuff types, 
excluding environmental and cleaning samples).The serovar distribution for each 
MS was based on the number of serotyped isolates, including nontypeable isolates. 
Ranking was based on the sum of all reported serovars (% isolates).
Ranked serovars
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Austria 83 40 81 - 8 2 7 13 - 4 - 17
Denmark 184 49 11 - 1 2 4 1 4 16 - 23
Finland 42 - 101 - 21 - 5 24 - - - 40
Italy 43 5 7 26 5 - 2 - 2 2 - 51
Poland 30 - 60 40 - - - - - - - -
Slovakia 31 10 - 31 - - 10 - 16 3 26 32
Sweden 119 3 21 11 17 3 12 7 18 2 - 36
United 
Kingdom 415 1 2
1 - 16 44 8 1 4 1 - 23
Note: Most MS reported a group called “other serovars”. Isolates belonging to the top ten serovars may 
be included in the group of “other serovars” for some MS. Thus, empty cells do not necessarily signify 
that no isolates were present.
1.  This serovar was a common cause of human infections in the MS, representing usually at least 10% 
of the human cases reported.
Phage types of S. Enteritidis and S. Typhimurium
Information on distributions of S. Enteritidis and S. Typhimurium phage types in humans 
were provided by eight MS (Austria, Belgium, Denmark, Finland, Hungary, Ireland, The 
Netherlands and United Kingdom), in foodstuff by eight MS (Austria, Czech Republic, 
Denmark, Germany, Hungary, Ireland, Italy and Slovakia) and in animals by ten MS (Austria, 
Czech Republic, Denmark, Finland, Germany, Hungary, Italy, The Netherlands, Slovakia 
and United Kingdom). The Netherlands classiﬁes S. Typhimurium using another set of 
phages, and with the exception of DT104 (the Dutch FT401 and FT506) the phage type 
distribution in The Netherlands is not comparable to that of other MS. Hungary also 
classiﬁes S. Enteritidis and S. Typhimurium with another set of phages that are not 
comparable with the Colindale system; therefore data are not presented here.
The occurrence of some of the less frequently observed phage types may be underestimated, 
as some MS may have included them in the composite group of “other phage types”.
As in 2003, the most common S. Enteritidis phage type in humans was PT4 (22–44%), 
followed by PT1, PT6, PT8 and PT21. These phage types were also among those found 
frequently in broiler meat and Gallus gallus in the MS reporting results from at least 25 
isolates during 2003 and 2004 (Table SAS9). Hungary did not report any human cases of 
PT4, but this type may be included in the relatively large group of “other phage types”.
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Table SAS9. Distribution of the ten most common S. Enteritidis phage types in 
humans, broiler meat and Gallus gallus (only MS that have typed at least 25 
monitoring isolates). The phage type distribution for each MS was based on the 
number of typed isolates, including nontypeable and RDNC isolates. Ranking was 
based on the sum of all reported serovars (% isolates).
Ranked phage types
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Austria 6,076 41 4 12 31 3 2 <1 <1 <1 <1 6
Belgium 479 44 2 25 8 1 9 1 - 2 - 8
Denmark 546 23 14 11 21 6 - <1 - - <1 24
Finland 731 27 24 13 9 5 5 - - 3 - 8
Ireland 171 25 28 11 6 6 6 - 1 6 1 9
The  
Netherlands 766 29 11 19 13 8 2 - - 4 - 14
United 
Kingdom 11,007 22 36 5 3 4 12 <1 - 3 - 13
Broiler meat P
T 
4
P
T 
21
P
T 
7
P
T 
6
P
T 
8
P
T 
14
b
P
T 
1
P
T 
1b
P
T 
4b
P
T 
6a
Austria 51 37 37 2 2 6 2 4 - - 2 8
Germany 32 56 25 - - 3 3 - 3 3 - 0
Gallus gallus P
T 
4
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T 
7
P
T 
6
P
T 
21
 P
T 
8
P
T 
1
P
T 
36
P
T 
23
P
T 
14
b
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T 
1b
Austria 338 33 9 2 14 27 3 5 5 <1 - 2
Germany 54 72 - 4 9 4 7 - - - - 0
The  
Netherlands 50 40 14 10 18 4 2 - - 4 4 12
The dominating S. Typhimurium phage types among isolates from human infections 
were DT104 and DT120. Austria, Denmark and The Netherlands have provided data on 
the prevalence of S. Typhimurium DT104 over the last ﬁve years. All three MS report a 
decrease in the proportion of S. Typhimurium DT104 isolates, relative to all S. Typhimurium 
isolates (Figure SAS1).
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Figure SAS1. Proportion of human S. Typhimurium isolates that are phage type 
DT104 in Austria, Denmark and The Netherlands 
2000 20011999 2002 2003 2004
Austria
Denmark
The Netherlands
Years
0%
5%
10%
15%
30%
25%
20%
40%
35%
50%
45%
Note: Data include phage types: DT104b, DT104c, DT104h, DT104l and the Dutch phage types FT401 
and FT506.
The monitoring data from foodstuffs and animals on S. Typhimurium phage types was 
too limited for a Community evaluation of the phage type distribution. Only Austria, Denmark 
and Germany reported this data for at least 25 monitoring isolates, and the distribution 
pattern varied between these MS. In Germany, DT104 comprised a relative large proportion 
of the S. Typhimurium isolates from red meat (42%), cattle (86%), Gallus gallus (37%) 
and pigs (48%). In The Netherlands, 33% of the S. Typhimurium isolates from pigs 
belonged to the types corresponding to DT104 (phage types FT506 and FT401). DT12 
was predominant among S. Typhimurium isolates from Danish pig meat, cattle and pigs. 
DT120 was also commonly isolated in Danish pigs (Table SAS10).
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Table SAS10. Distribution of the ten most common S. Typhimurium phage types 
in humans, broiler meat, pig meat, red meat (pig meat and bovine meat), cattle, 
Gallus gallus and pigs (only MS that have typed at least 25 monitoring isolates). 
The phage type distribution for each MS was based on the number of typed isolates, 
including nontypeable and RDNC isolates. Ranking was based on the sum of all 
reported serovars (% isolates).
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Austria1 697 - 7 1 31 - <1 3 2 16 1 28
Belgium1 308 24 21 - - - 6 - 11 - 5 38
Denmark 467 10 16 - - 1 18 - - - 4 56
Finland1 298 16 - - - 4 - 19 - - - 42
Ireland1 115 41 3 2 - 20 <1 3 2 - 2 29
United 
Kingdom 1,615 40 2 0 <1 4 1 2 4 - 3 44
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Gallus gallus D
T 
10
4
D
T 
10
D
T 
12
D
T 
99
D
T 
8
D
T 
46
D
T 
12
0
D
T 
2
D
T 
10
4l
D
T 
9
Austria 50 - 18 - 16 6 10 - 2 6 - 10
Germany 49 37 - 16 - 6 - 6 4 - 4 6
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Pigs P
ha
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D
T 
10
4
D
T 
12
0
D
T 
12
D
T 
17
0
D
T 
19
3
D
T 
17
U
 3
02
D
T 
15
a
U
 2
88
D
T 
66
 O
th
er
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ha
ge
 t
yp
es
Denmark 829 6 22 21 10 4 6 4 2 3 3 14
Germany 299 48 9 2 - 4 <1 <1 1 - - 305
Pigs FT
 5
07
2
FT
 5
06
3
FT
 9
0
FT
 4
01
3
FT
 5
08
4
FT
 3
50
8
FT
 5
10
5
FT
 6
07
FT
 2
9
FT
 2
06
The  
Netherlands 138 35 25 12 8 7 4 4 2 <1 <1 1.4
Cattle D
T 
10
4
D
T 
12
D
T 
17
D
T 
15
a
D
T 
12
0
D
T 
17
0
D
T 
9
D
T 
19
3
D
T 
1
D
T 
12
a
 
Denmark 28 14 18 14 7 7 7 - 4 - - <1
Germany 188 86 <1 - - - - 6 1 2 <1 0
Note: The Netherlands uses a different set of phages, where only some types correspond with the 
Colindale scheme.
1.  Other common human phagetypes in Austria: DT 104l (7%), DT U (7%); Belgium: U 302 (5%); Finland: 
DT 40 (7%), DT 85 (5%), DT 41 (5%).
2. FT 507 corresponds mainly to ARS and DT 208a.
3. FT 506 and FT 401 corresponds to DT 104.
4. FT 508 corresponds mainly DT 193 and DT 195.
5. FT 510 corresponds mainly DT 208 and ARS also DT 193 and DT 195.
6. FT 20 corresponds to DT 124.
7. FT 60 corresponds mainly DT 12.
8. FT 350 corresponds mainly to DT 193.
9. FT 2 corresponds to DT 2 and ORS.
See Level 3, Tables SA42-43 for MS detailed information on S. Enteritidis and 
S. Typhimurium phage type distributions in humans.
Sources of human Salmonella infections
Salmonella continues to be one of the leading causes of human gastroenteritis in the EU. 
Several countries have implemented Salmonella surveillance programs to improve food 
safety for meat and eggs. There exists only limited data that provide evidence for the 
success of such programmes in terms of reducing human salmonellosis. However, by 
comparing Salmonella serovars and phage types isolated from humans with serovars 
and phage types isolated from animals and foodstuffs, it may be possible to make some 
inferences about the major sources of human infections.
Ranked phage types (cntd)
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It is generally accepted, that infections caused by S. Enteritidis are related to poultry 
(Gallus gallus) products and especially table eggs. In several MS, this serovar comprised 
more than 70% of reported cases in 2004, indicating that products of Gallus gallus origin 
are major sources of human salmonellosis in these countries. This is supported by the 
serovar and phage type distribution found in Gallus gallus and broiler meat. For instance, 
in Hungary, those phage types dominating among human cases (PT6, PT6b and PT7) 
are also the most common ones found in Gallus gallus and related products. Similar patterns 
can be seen in other MS, where phage type data from both humans, Gallus gallus and/or 
broiler meat has been reported. The phage type reporting for Gallus gallus does not 
distinguish between the table-egg and broiler production, however, since a comparison 
of phage types found in humans with broiler meat suggests that the majority of 
S. Enteritidis infections in most MS are not caused by broiler meat, the major source of 
these infections is assessed to be table eggs.
It is notable that those MS having the lowest proportion of S. Enteritidis cases (i.e. 33-41%) 
have implemented national control programmes that go further than the Zoonoses 
Directive (92/117/EEC) with regard to sampling and control of Salmonella in breeder ﬂocks. 
In addition, some of these MS have surveillance programmes in the table egg producing 
ﬂocks, where restrictions such as heat treatment are enforced in egg production as 
soon as a ﬂock is suspected of being infected. For more information on surveillance 
programmes and control measures see Appendix, Table SA2-6).
S. Typhimurium was the second most frequently reported serovar in humans comprising 
14% of the total number of cases in 2004. S. Typhimurium was also reported from all 
of major food-producing animals and foodstuffs i.e. Gallus gallus and broiler meat, pigs 
and pig meat, and cattle, indicating that these reservoirs are important sources of human 
S. Typhimurium infections. Overall further distinction between broiler meat, pig meat and 
bovine meat as sources of human infections is difﬁcult because phage typing results for 
both humans and animal sources only are reported by a few MS. For Denmark and The 
Netherlands, however, results indicate that the greater part of the human S. Typhimurium 
infections are attributable to pig meat. 
Human infections caused by S. Derby also appear to be related to pig meat, as this 
serovar was commonly found in the porcine reservoir and only infrequently reported 
from other sources in 2004. S. Derby comprised less than 1% of the total number of 
Salmonella cases in EU-25.
Other serovars on the human ten most reported include S. Infantis, S. Virchow, S. Newport 
and S. Hadar, which were also commonly found in broiler meat. With the exception of 
S. Infantis, these serovars were only rarely reported in other sources suggesting that the 
dominant source is broiler meat. 
Serovar and phage type results from bovine meat were very sparse in 2004. In cattle, the 
dominating serovar next to S. Typhimurium was S. Dublin, which is known to be particularly 
associated with the bovine reservoir. Bovine meat is therefore considered to be the single 
most important source of these infections and occurrence in other animals or foodstuffs 
is also very rare. Compared to the relatively frequent occurrence of S. Dublin in cattle, 
only few infections were reported in humans in 2004.
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3.1.6. Antimicrobial resistance in Salmonella
Humans
Data on the occurrence of antimicrobial resistance in Salmonella (S. Enteritidis and S. 
Typhimurium) in humans were provided by Austria, Belgium, Denmark, Estonia, Hungary, 
Lithuania, The Netherlands, and Norway (Table AB SA1 and AB SA2). The prevalence 
of resistant isolates reported from Estonia was based on a relatively small number of 
isolates and therefore comparison to other countries should be made with caution. 
In general, the MS reported higher proportions of resistant isolates among S. Typhimurium 
than among S. Enteritidis. For S. Typhimurium in general, a relatively high level of resistance 
was observed for ampicillin, sulfonamide, streptomycin and tetracycline (Table AB SA1), 
whereas for S. Enteritidis the prevalence of resistant isolates was generally low for all of 
antimicrobials tested (Table AB SA2).
For S. Typhimurium (Table AB SA1), a considerable variation in the prevalence of resistant 
isolates reported from different MS was observed, especially for ampicillin (ranging 
from 17.9-66%) and tetracycline (ranging from 9.6-57.8%). Belgium, Denmark, Hungary 
and The Netherlands reported a relatively high prevalence of resistance to these two 
antimicrobials (40-66% for ampicillin and 46-57% for tetracycline). In contrast, Norway 
and Austria reported lower prevalence of resistant isolates for ampicillin (17.9% and 
22.5% respectively) and tetracycline (20.5% and 20.8% respectively). For ciproﬂoxacin, 
a low prevalence of resistant isolates (0-0.2%) was reported by all MS, while Denmark 
reported 3% prevalence. For quinolones, 2-4% prevalence of resistant isolates was 
reported by all of 6 MS, while Hungary reported 15.9% prevalence. Resistance to 
quinolones (nalidixic acid), may be regarded as an indicator of emerging resistance to 
ﬂuoroquinolones. Lithuania and Norway generally reported low levels of resistance to 
the antimicrobials tested, with the exception of ampicillin for Lithuania (43.5%). Austria, 
Norway and Lithuania reported high proportions of fully sensitive isolates (72.2-79.5%). 
Only for ciproﬂoxacin, ampicillin and tetracycline, results were provided by all of the 
eight reporting MS, whereas for several other antimicrobials, data were provided only by 
few MS. This limited the possibility for comparison between countries, as even within 
the same antimicrobial groups (classes), resistance reported for different antimicrobials 
may not be directly comparable.
For S. Enteritidis (Table AB SA2), the prevalence of resistant isolates was generally low 
for all antimicrobials tested. Little variation was observed between MS, except for resistance 
to nalidixic acid (range from 0-26.4%). Norway and Denmark reported relatively high 
prevalence of isolates resistant to nalidixic acid (26.4% and 16% respectively). Norway 
reported that a considerable proportion of Salmonella infections in humans were travel 
associated. This may have contributed to ﬁndings of resistant strains. For ciproﬂoxacin, 
seven MS reported low prevalence (0-0.3%), whereas Denmark reported 16% prevalence. 
Estonia reported a relatively high prevalence of resistance to sulfonamide (26.3%), 
however, the reporting was based on a relatively small number of isolates and results 
should be interpreted with caution. All six MS providing data on the number of resistance 
determinants for each isolate of S. Enteritidis, reported high proportions of fully sensitive 
isolates (69.7-93.8%).
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Table AB SA1. Antimicrobial resistance in S. Typhimurium from humans, 2004
Country A B DK EST H LT N NL
Monitoring 
program no yes yes yes no no yes yes
No of isolates 
available  697 308 425 8 1,598 133 78 334
Antimicrobial 
Group
Antimicrobials
Aminoglycosides Gentamicin N 697 308 425 8 - 115 - 334
%R 1.7 0 1 25 - 0.9 - 0
Streptomycin N 697 308 425 8 - - - -
%R 20.8 51.9 40 62.5 - - - -
Amphenicols Chloramphenicol N 697 308 - - - - 78 334
%R 10.3 36 - - - - 7.7 28
Cephalosporins Cefotaxim N 697 308 - - 227 - - -
%R 0.3 0 - - 0 - - -
Fluoroquinolones Ciproﬂoxacin N 697 308 425 8 430 115 78 334
%R 0 0 3 0 0.2 0 0 0
Penicillins Ampicillin N 697 308 425 8 632 115 78 334
%R 22.5 61 40 62.5 66 43.5 17.9 49
Quinolones Nalidixic acid N 697 308 425 8 44 - 78 334
%R 3.7 3.6 2 0 15.9 - 2.6 4
Sulfonamides Sulfonamide N 697 308 425 8 - - - 334
%R 22.2 58.1 40 87.5 - - - 49
Tetracyclines Tetracycline N 697 308 425 8 545 115 78 334
%R 20.8 57.1 46 50 57.8 9.6 20.5 54
Trimethoprim Trimethoprim N 697 308 425 8 - - - 334
%R 3.9 21.8 8 50 - - - 12
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfamethoxazol N - - - - 633 - - -
%R - - - - 18.2 - - -
Trimethoprim + 
Sulfonamides N - - - 8 - 115 78 -
%R - - - 50 - 4.4 6.4 -
Multiresistant 
isolates
fully sensitives % 73.5 - - 12.5 24.2 72.2 79.5 55
resistant to 1 
antimicrobial % 3.9 - - 0 17.5 20.0 2.6 10
resistant to 2 
antimicrobials % 0.9 - - 25 33.0 7.8 3.9 3
resistant to 3 
antimicrobials % 2 - - 0 19.8 - 11.5 9
resistant to 4 
antimicrobials % 6.6 - - 12.5 3.0 - 2.6 3
resistant to >4 
antimicrobials % 13.2 - - 50 0.6 - 0 21
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB SA2. Antimicrobial resistance in S. Enteritidis from humans, 2004
Country A B DK EST H LT N1 NL
Monitoring 
program no yes yes yes no no yes yes
No of isolates 
available 6,076 58 262 19 11,791 1,994 750 588
Antimicrobial 
Group
Antimicrobials
Aminoglycosides Gentamicin N 6,076 58 262 19 - 1,743 - 588
%R 0.1 0 0 0 - 0.6 - 0
Streptomycin N 6,076 58 262 19 - - - -
%R 0.5 0 1 0 - - - -
Amphenicols Chloramphenicol N 6,076 58 262 19 514 1743 750 588
%R 0.1 0 1 0 0.2 1.8 0.3 0.2
Cephalosporins Cefotaxim N 6,076 58 - - 2,364 - - -
%R 0 0 - - 0.2 - - -
Fluoroquinolones Ciproﬂoxacin N 6,076 58 262 19 3,591 1,743 750 588
%R 0 0 16 0 0.3 0.1 0.1 0
Penicillins Ampicillin N 6,076 58 262 19 5,281 1,743 750 588
%R 1.8 3.4 2 0 5 6.4 5.6 2.7
Quinolones Nalidixic acid N 6,076 58 262 19 480 - 750 588
%R 4 3.4 16 0 7.9 - 26.4 12.8
Sulfonamides Sulfonamide N 6,076 58 262 19 - - - 588
%R 0.7 0 1 26.3 - - - 0.7
Tetracyclines Tetracyclin N 6,076 58 262 19 4,344 1,743 750 588
%R 0.7 0 2 0 4.1 5.6 2.8 0.4
Trimethoprim Trimethoprim N 6,076 58 262 19 - 1,743 - 588
%R 0.4 0 1 0 - 0.6 - 0.3
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfamethoxazol N - - - - 5,273 - - -
%R - - - - 6.8 - - -
Trimethoprim + 
Sulfonamides N - - - 19 - 1743 750 -
%R - - - 0 - 1.6 2 -
Multiresistant 
isolates
fully sensitives % 93.8 - - 73.7 77.8 84.9 69.7 85
resistant to 1 
antimicrobial % 5.3 - - 26.3 10.2 11.9 25.2 13
resistant to 2 
antimicrobials % 0.1 - - 0 4.3 2.5 3.3 1
resistant to 3 
antimicrobials % 0.4 - - 0 1.5 0.3 1.6 1
resistant to 4 
antimicrobials % 0.2 - - 0 0.1 0.3 0.1 0
resistant to >4 
antimicrobials
% 0.1 - - 0 0.1 0.1 0 0
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
1. In Norway, 54 isolates were domestically acquired.
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Food
Data on the occurrence of antimicrobial resistance in Salmonella (S. Enteritidis and 
S. Typhimurium) in food (bovine meat, pig meat, broiler meat and other poultry meat) 
were provided by Austria, Belgium, Cyprus, Estonia, France, Germany, Italy, Latvia, 
Lithuania, Slovakia, Slovenia, Spain, The Netherlands and United Kingdom (Table AB 
SA3-SA6). Most MS reported data on antimicrobial resistance in Salmonella enterica 
ssp. enterica without dividing them into serotypes. For this reason combined reporting 
of data were selected for this summary. 
Bovine meat
Seven MS provided data on antimicrobial resistance in Salmonella from bovine meat 
(Table AB SA3). Except for data provided by France, Germany and Italy, the reporting 
from four MS was based on a low number of isolates (<7), which hampered valid 
comparison of prevalence between MS. In general, the highest prevalence of resistant 
isolates was observed for streptomycin, ampicillin, tetracycline and trimethoprim. The 
prevalence of resistance to ampicillin and sulfonamide in isolates reported for France 
(4.4% and 15.9% respectively) was low compared to the prevalence reported for Germany 
(46.9% and 58.8%) and Italy (36.7% and 43.3%). Italy also reported higher prevalence of 
resistance to streptomycin and nalidixic acid than France and Germany. Resistance to 
ﬂuoroquinolones was generally low, and for tetracycline only minor variation between the 
three MS was observed. In general, low proportions of fully sensitive isolates were reported. 
Pig meat
Eleven MS provided data on antimicrobial resistance in Salmonella from pig meat (Table 
AB SA4). Except for data provided by Belgium, France and Italy, the reporting from eight 
MS was based on a low number of isolates (<7), which hampered valid comparison 
of prevalence between MS. In general, the highest prevalence of resistant isolates 
was observed for ampicillin, streptomycin, sulfonamide and tetracycline. Compared to 
France and Italy, Belgium reported lower prevalence of resistance to streptomycin and 
tetracycline, whereas Italy reported higher prevalence of resistance to sulfonamide and 
ampicillin compared to France and Belgium. 
Broiler meat
Fourteen MS provided data on antimicrobial resistance in Salmonella from broiler meat 
(Table AB SA5). For ﬁve MS (Greece, Lithuania, Slovakia, Slovenia and Spain) reporting 
was based on a relatively low number of isolates (<25), which hampered the comparison 
between MS. In general, the highest prevalence of resistant isolates was reported for 
tetracycline and sulfonamide, while the prevalence resistance to ampicillin, streptomycin 
and nalidixic was slightly lower. High level resistance to ﬂuoroquinolones was near absent 
among the reporting MS.
 
b169_EFSA_int_02_03_06.indd   77 2/03/06   15:16:58
78The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Table AB SA3. Antimicrobial resistance in Salmonella from bovine meat, 2004
Country A B EST F D I NL
Monitoring 
program yes yes yes yes no no yes
No of isolates 
available 1 7 4 69 303 95 4
Antimicrobial 
group
Antimicrobial
Aminoglycosides Gentamicin N 1 - 4 69 303 60 4
%R 0 - 0 1.5 2.6 0 0
Streptomycin N 1 7 4 69 303 60 -
%R 0 43 0 34.8 45.6 58.3 -
Amphenicols Chloramphenicol N 1 7 4 69 303 60 4
%R 0 0 0 5.8 21.1 15 25
Cephalosporin Cefotaxim N 1 - 4 69 - 60 -
%R 0 - 0 0 - 0 -
Fluoroquinolones Ciproﬂoxacin N 1 7 4 - 303 60 4
%R 0 0 0 - 0.3 0 0
Enroﬂoxacin N - - 3 69 - 60 -
%R - - 0 0 - 0 -
Penicillins Ampicillin N 1 7 4 69 303 60 4
%R 0 29 0 4.4 46.9 36.7 75
Quinolones Nalidixic acid N 1 7 4 69 303 60 4
%R 0 14 0 0 2.6 21.7 0
Sulfonamides Sulfonamide N 1 7 4 69 303 60 -
%R 0 57 0 15.9 58.8 43.3 -
Tetracyclines Tetracyclin N 1 7 4 69 303 60 4
%R 0 43 0 44.9 49.2 55 50
Trimethoprim Trimethoprim N 1 7 4 - 303 57 4
%R 0 29 0 - 13.2 10.5 25
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 7 4 69 303 - 4
%R - 29 0 2.9 13.2 - 25
Multiresistant  
isolates
fully sensitives % 100 29 75 5.8 32.3 19.2 -
resistant to 1 
antimicrobial % - 14 25 34.8 17.5 17.3 -
resistant to 2 
antimicrobials % - 29 0 7.3 1.7 3.9 -
resistant to 3 
antimicrobials % - 0 0 8.7 5.6 5.8 -
resistant to 4 
antimicrobials % - 0 0 2.9 11.9 19.2 -
resistant to >4 
antimicrobials % - 29 0 4.4 31.0 34.6 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB SA4. Antimicrobial resistance in Salmonella from pig meat, 2004
Country  A B CY EST F I LV LT SK ES NL
Monitoring 
program yes yes yes yes yes no no yes yes yes
No of isolates 
available 2 128 1 2 166 772 4 1 1 1 7
Antimicrobial 
Group
Antimicrobials
Aminoglycosides Gentamicin N 2 - 1 2 166 415 4 1 1 1 7
%R 0 - 0 0 0.6 1.5 25 0 0 0 0
Streptomycin N 2 128 1 2 166 416 2 1 1 1 -
%R 0 34 0 100 57.2 46.4 100 0 100 0 -
Amphenicols Chloramphenicol N 2 128 1 2 166 415 2 1 1 1 7
%R 0 10 0 100 24.1 15.7 0 0 0 0 0
Cephalosporins Cefotaxim N 2 - - 2 166 416 3 - 1 - -
%R 0 - - 0 0 0.5 0 - 0 - -
Fluoroquinolones Ciproﬂoxacin N 2 128 1 2 - 416 2 1 1 1 7
%R 0 0 0 0 - 0.2 0 0 0 0 0
Enroﬂoxacin N - - - 2 166 416 - - - - -
%R - - - 0 0 0.7 - - - - -
Penicillins Ampicillin N 2 128 1 2 166 416 4 1 1 1 7
%R 0 27 0 100 27.1 36.8 75 0 0 0 0
Quinolones Nalidixic acid N 2 128 1 2 166 416 3 1 1 1 7
%R 50 4 0 0 3.1 6.01 0 0 0 0 0
Sulfonamides Sulfonamide N 2 128 - 2 166 416 - - 1 1 -
%R 0 50 - 100 49.4 63.9 - - 0 0 -
Tetracyclines Tetracyclin N 2 128 1 2 166 415 0 1 1 1 7
%R 0 33 0 100 78.9 56.9 - 0 0 100 29
Trimethoprim Trimethoprim N 2 128 - 2 - 409 2 1 1 - 7
%R 0 22 - 0 - 17.6 50 0 0 - 0
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 128 1 2 166 - 2 1 1 - 7
%R - 21 0 0 12.7 - 50 2 0 - 0
Multiresistant 
isolates
fully sensitives % 50 36 100 0 0 21.2 25 100 - - -
resistant to 1 
antimicrobial % 50 25 0 0 21 19.1 - - 100 100 -
resistant to 2 
antimicrobials % - 6 - 0 11.4 6.3 50 - - - -
resistant to 3 
antimicrobials % - 9 - 0 22.2 13.9 - - - - -
resistant to 4 
antimicrobials % - 12 - 0 7.2 14.4 - - - - -
 resistant to >4 
antimicrobials % - 12 - 100 21.6 25.1 25 - - - -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB SA5. Antimicrobial resistance in Salmonella from broiler meat, 2004
Country A B CY EST F D GR I LT SK SLO ES NL UK
Monitoring 
program yes yes yes yes yes no no no no yes no no yes yes
No of isolates 
available 148 172 41 25 62 202 14 421 9 4 19 7 112 40
Antimicrobial 
Group
Antimicrobials                
Aminoglycosides Gentamicin N 148 - 11 25 62 202 14 366 9 4 19 7 112 40
%R 0 - 0 0 0 0 0 0.6 0 0 0 0 0 0
Streptomycin N 148 172 12 25 62 202 14 367 9 4 19 7 - 40
%R 15.5 46 0 16 33.918.8 35.7 21.8 0 0 0 0 - 13.6
Amphenicols Chloramphenicol N 148 172 35 25 62 202 14 367 9 4 19 7 112 40
%R 2.7 12 2.8 4 8.1 1 28.6 2.2 0 0 0 43 2 4.5
Cephalosporins 3rd generation 
cephalosporins N - - - - - - - - - - 19 4 112 -
%R - - - - - - - - - - 0 0 11 -
Cefotaxim N 148 - - 25 62 - 10 367 - 4 - - - -
%R 1.4 - - 0 3.2 - 0 3 - 0 - - - -
Fluoroquinolones Ciproﬂoxacin N 148 172 38 25 - 202 14 367 9 4 19 7 112 -
%R 0 0 0 0 - 0 0 0 0 0 0 0 0 -
Enroﬂoxacin N - - - 25 62 - - 366 - - 19 3 - -
%R - - - 0 0 - - 5.2 - - 0 0 - -
Penicillins Ampicillin N 148 172 35 25 62 202 14 367 9 4 19 7 112 40
%R 8.8 41 11.4 8 12.9 22.3 7.14 24.5 0 0 10.5 14 54 9.1
Quinolones Nalidixic acid N 148 172 35 25 62 202 14 367 9 4 19 7 112 40
%R 18.9 27 5.7 36 9.7 16.3 35.7 31.6 11 25 5.3 57 46 0
Sulfonamides Sulfonamide N 148 172 35 25 62 202 14 366 - 4 19 4 - 40
%R 14.2 55 17 36 12.9 31.2 7.14 34.4 - 0 0 0 - 13.6
Tetracyclines Tetracyclin N 148 172 35 25 62 202 14 365 9 4 19 7 112 40
%R 17.6 20 45.7 40 51.6 24.3 35.7 29.3 11 0 0 14 11 6.8
Multiresistant 
isolates
fully sensitives % 74.3 31 45.7 24 9.7 56.4 50 44.3 88 75 84.2 29 - 50
resistant to 1 
antimicrobial % 5.4 18 20 32 33.9 11.9 14.3 19.9 22 25 15.8 43 - 9.1
resistant to 2 
antimicrobials % 0.7 6 34.2 4 9.7 4 0 7.8 - - 0 14 - 20.5
resistant to 3 
antimicrobials % 2.7 10 0 4 1.6 2.5 14.3 5.5 - - 0 - - 4.5
resistant to 4 
antimicrobials % 14.2 16 0 16 6.5 5 0 7.8 - - 0 14 - 4.5
 resistant to >4 
antimicrobials % 2.7 20 0 20 12.9 20.2 21.4 14.7 - - 0 - - 6.8
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Some MS reported relatively high levels of resistance to more antimicrobials, Belgium 
(streptomycin 46%, ampicillin 41%, sulfonamide 55%), The Netherlands (ampicillin 54%, 
nalidixic acid 46%) and France (tetracycline 51.6%, streptomycin 33.9). In contrast, 
Austria reported a high proportion of fully sensitive isolates (74.3%) and a low proportion 
of isolates resistant to more than four antimicrobials (2.7%). Some MS that reported a 
high prevalence of fully sensitive isolates, also reported a relative high proportion of 
isolates resistant to more than four antimicrobials e.g. Germany (56.4% fully sensitive 
isolates and 20.2% resistant to >4 antimicrobials) and Italy (44.3% fully sensitive isolates 
and 14.7% resistant to >4 antimicrobials).
Other poultry meat
Eight MS provided data on antimicrobial resistance in Salmonella from other poultry meat 
(Table AB SA6). Four MS (Estonia, Italy, Slovakia and Spain), reported on a relatively low 
number of isolates (<12). A relatively high level of resistance to streptomycin (32.8-60.9%) 
and tetracycline (35.9-60.9%) was reported by Austria, France and Germany. A lower 
level of resistance to gentamicin (7.8-25%) was reported by Austria, Germany and Italy. 
This is in contrast to the near absence of gentamicin resistance reported for broiler 
meat. Resistance to quinolones was common, whereas resistance to ﬂuoroquinolones 
was low. Austria and Latvia reported high proportions of fully sensitive isolates (45.3% 
and 81% respectively) and low proportions of isolates resistant to >4 antimicrobials 
(14.1% and 0% respectively), whereas Germany reported 14.3% fully sensitive isolates 
and 36.7% of isolates resistant to >4 antimicrobials.
Animals
Data on the occurrence of antimicrobial resistance in Salmonella (S. Enteritidis and S. 
Typhimurium) in animals (cattle, pigs, Gallus gallus and turkeys) were provided by Austria, 
Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, 
Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Slovakia, Slovenia, Spain, 
Sweden, The Netherlands and United Kingdom (Table AB SA7-SA10 and Level 3, Table 
AB SA7-SA14). For animals, most MS reported data on antimicrobial resistance in 
different Salmonella serotypes separately. For this summary, data on S. Enteritidis and 
S. Typhimurium were selected.
Cattle
Sixteen MS and Norway provided data on antimicrobial resistance in S. Enteritidis and 
S. Typhimurium from cattle (Table AB SA7 and Level 3, Table AB SA7).The reporting for 
S. Typhimurium from eleven of 17 reporting MS was based on a low number of isolates 
(<13). For S. Enteritidis from cattle, all reports were based on less than 14 isolates. In 
general, antimicrobial resistance was widespread in S. Typhimurium isolates from cattle. 
The highest prevalence of resistant isolates was observed for ampicillin (up to 89%), 
sulfonamide (up to 96.3%), tetracycline (up to 91.5%) and streptomycin (up to 89.9%). 
This high level of resistance was reﬂected in the proportions of isolates resistant to >4 
antimicrobials, where high proportions were reported by several MS, e.g. Germany (87.8%), 
Italy (76.9%), United Kingdom (61%) and France (59.3%). Resistance to cephalosporins 
and ﬂuoroquinolones was near absent, except for a 3.7% prevalence of resistance to 
enroﬂoxacin reported by France. For quinolones some variation in prevalence between 
countries was observed ranging from 0 to 14.8% (France) and 19.4% (Belgium). 
The level of resistance in isolates of S. Enteritidis was generally low, and high proportions 
of fully susceptible isolates were reported.
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Table AB SA6. Antimicrobial resistance in Salmonella from other poultry meat, 2004
Country A EST F D I LV1 SK ES
Monitoring 
program yes yes yes no no yes yes yes
No of isolates 
available 64 8 23 49 12 221 1 10
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N 64 8 23 49 12 5 1 -
%R 7.8 0 0 18.4 25 0 0 -
Streptomycin N 64 8 23 49 12 18 1 -
%R 32.8 12.5 60.9 44.9 50 6 100 -
Amphenicols Chloramphenicol N 64 8 23 49 12 20 1 10
%R 10.9 0 4.4 32.7 58.3 5 100 50
Cephalosporins Cefotaxim N 64 8 23 - 12 20 1 -
%R 0 0 0 - 0 0 0 -
Fluoroquinolones Ciproﬂoxacin N 64 8 - 49 12 17 1 10
%R 0 0 - 2 0 0 0 0
Enroﬂoxacin N - 6 23 - 12 - - 10
%R - 0 4.4 - 8.3 - - 0
Penicillins Ampicillin N 64 8 23 49 12 19 1 10
%R 21.9 62.5 21.7 53.1 58.3 0 100 20
Quinolones Nalidixic acid N 64 8 23 49 12 6 1 -
%R 32.8 0 13 38.8 66.7 0 100 -
Sulfonamides Sulfonamide N 64 8 23 49 12 - 1 -
%R 23.4 37.5 17.4 61.2 75 - 100 -
Tetracyclines Tetracyclin N 64 8 23 49 12 17 1 10
%R 35.9 50 60.9 46.9 50 0 100 50
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 8 23 49 - 6 1 -
%R - 25 8.7 10.2 - 17 100 -
- - - - - - - -
Multiresistant 
isolates
fully sensitives % 45.3 12.5 13 14.3 9.1 81 - -
resistant to 1 
antimicrobial % 15.6 37.5 21.7 8.2 9.1 5 - -
resistant to 2 
antimicrobials % 7.8 25 26.1 6.1 9.1 14 - -
resistant to 3 
antimicrobials % 7.8 0 4.4 12.2 0 0 - -
resistant to 4 
antimicrobials % 9.4 0 4.4 22.5 9.1 0 - -
 resistant to >4 
antimicrobials % 14.1 25 17.4 36.7 63.6 0 100 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
1. In Latvia, isolates from poultry meat.
 
b169_EFSA_int_02_03_06.indd   82 2/03/06   15:17:01
83 The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Table AB SA7. Antimicrobial resistance in S.Typhimurium from cattle, 2004
Country A B CZ DK EST FIN F D GR
Monitoring 
program no no yes yes yes yes yes no no
No of isolates 
available 4 31 1 28 4 12 27 188 1
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N 4 31 1 28 2 12 27 188 1
%R 0 0 0 0 0 0 0 1.6 0
Streptomycin N 4 31 1 28 2 12 27 188 -
%R 75 77.4 0 39 50 0 74.1 89.9 -
Amphenicols Chloramphenicol N 4 31 1 28 2 12 27 188 1
%R 75 64.5 0 14 0 0 59.3 72.9 0
Cephalosporin 3rd generation 
cephalosporins N - - - - - 12 - - -
%R - - - - - 0 - - -
Cefotaxim N 4 - - - 2 - 27 - 1
%R 0 - - - 0 - 0 - 0
Ceftiofur N - 31 - 28 - - - 188 -
%R - 0 - 0 - - - 0 -
Fluoroquinolones Ciproﬂoxacin N 4 - - 28 2 - - 188 1
%R 0 - - 0 0 - - 0.5 0
Enroﬂoxacin N - 31 1 - 2 12 27 - -
%R - 0 0 - 0 0 3.7 - -
Penicillins Ampicillin N 4 31 1 28 2 12 27 188 1
%R 75 83.9 0 32 0 0 66.7 88.3 0
Quinolones Nalidixic acid N 4 31 - 28 2 12 27 188 1
%R 0 19.4 - 0 0 0 14.8 0.5 0
Sulfonamides Sulfonamide N 4 31 - 28 2 12 27 188 1
%R 75 90.3 - 32 50 0 66.7 96.3 0
Tetracyclines Tetracyclin N 4 31 1 28 2 - 27 188 1
%R 100 71 0 21 50 - 85.2 88.8 100
Trimethoprims Trimethoprim N 4 - - 28 1 12 - 188 1
%R 0 - - 4 0 0 - 16 0
Trimethoprims + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 2 1 - 2 - 27 188 1
%R - 6.5 0 - 0 - 7.4 16 0
Multiresistant 
isolates
fully sensitives % - 9.7 100 - 50 100 0 3.7 -
resistant to 1 
antimicrobial % 25 - - - 0 0 11.1 6.4 100
resistant to 2 
antimicrobials % - - - - 0 0 11.1 0 -
resistant to 3 
antimicrobials % - - - - 50 0 3.7 1.1 -
resistant to 4 
antimicrobials % - - - - 0 0 3.7 1.1 -
 resistant to >4 
antimicrobials % 75 - - - 0 0 59.3 87.8 -
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Table AB SA7. Antimicrobial resistance in S.Typhimurium from cattle, 2004 (cntd.)
Country H IRL I N SK S NL UK
Monitoring 
program no no no yes no yes no yes
No of isolates 
available 4 5 113 2 10 6 13 90
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N 4 - 82 2 8 6 13 90
%R 0 - 1.2 0 0 0 0 0
Streptomycin N 4 - 82 2 8 6 - 90
%R 50 - 89.0 0 87 66.6 - 68
Amphenicols Chloramphenicol N 4 - 82 2 8 6 13 90
%R 75 - 69.5 0 87 66.6 38 62
Cephalosporin 3rd generation 
cephalosporins N - - - - - - 13 -
%R - - - - - - 0 -
Cefotaxim N - - 82 - 8 - - 90
%R - - 0 - 0 - - 0
Ceftiofur N 4 - - 2 - 6 - -
%R 0 - - 0 - 0 - -
Fluoroquinolones Ciproﬂoxacin N 0 - 81 - 8 - 13 90
%R - - 0 - 0 - 0 0
Enroﬂoxacin N 4 5 82 2 - 6 - -
%R 0 0 0 0 - 0 - -
Penicillins Ampicillin N 4 - 82 2 8 6 13 90
%R 75 - 89.0 0 87 66.6 54 69
Quinolones Nalidixic acid N 4 - 82 2 8 6 13 90
%R 0 - 6.1 0 87 0 0 1
Sulfonamides Sulfonamide N 4 - 81 2 8 6 13 90
%R 75 - 90.1 0 87 66.6 69 76
Tetracyclines Tetracyclin N 4 4 82 2 8 6 13 90
%R 75 50 91.5 0 87 66.6 62 84
Trimethoprims Trimethoprim N 0 2 82 2 8 6 13 90
%R - 0 11.0 0 0 0 15 30
Trimethoprims + 
Sulfonamides
Trimethoprim + 
Sulfonamide N 4 4 - - 8 - - -
%R 25 0 - - 0 - - -
Multiresistant 
isolates
fully sensitives % 25 - 6.4 100 13 33.3 31 11
resistant to 1 
antimicrobial % - - 0 - - - 8 12
resistant to 2 
antimicrobials % - - 0 - - - 0 4
resistant to 3 
antimicrobials % - - 1.3 - - - 15 3
resistant to 4 
antimicrobials % - - 15.4 - - - 8 8
 resistant to >4 
antimicrobials % 75 - 76.9 - 87 66.6 38
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Pigs
Sixteen MS and Norway provided data on antimicrobial resistance in S. Enteritidis and 
S. Typhimurium from pigs (Table AB SA8 and Level 3, Table AB SA9). For twelve of 19 
MS providing data for S. Typhimurium, the reporting was based on a small number of 
isolates(<11 isolates). For S. Enteritidis from pigs, all reports were based on one to four 
isolates. In general, the highest level of resistance in S. Typhimurium from pigs was 
observed for ampicillin (up to 78.6%), sulfonamide (up to 90%), tetracycline (up to 96.7%) 
and streptomycin (up to 82.6%). In contrast, among countries testing for susceptibility 
to ﬂuoroquinolones and cephalosporins, resistance to these groups of antimicrobials 
were near absent, and with few exceptions, the level or resistance to for quinolones was 
generally very low (0-3.3%). For antimicrobials frequently used for pigs i.e. ampicillin, 
sulfonamide, tetracycline and streptomycin, a considerable variation in prevalence of 
resistant isolates was observed among the reporting MS. Germany, Italy, Spain and 
United Kingdom reported high levels of resistance to ampicillin, sulfonamide, tetracycline 
and streptomycin (ranging from 60 to 97% prevalence). Slightly lower prevalences (ranging 
from 50 to 73%) were reported by Belgium and the Netherlands, while the lowest level 
of resistance to these antimicrobials was reported by Denmark (ranging from 22-40%). 
The high level of resistance observed for S. Typhimurium from pigs was reﬂected in the 
proportions of isolates resistant to >4 antimicrobials, where relatively high proportions 
were reported by several MS, e.g. Germany (58.5%), Italy (44.4%), United Kingdom 
(71%) and Spain (39.9%). In contrast, the level of resistance in isolates of S. Enteritidis 
in pigs was generally low (Level 3, Table AB SA9), although this should be interpreted 
with care as none of the reports were based on more than 5 isolates.
Gallus gallus
Twenty MS provided data on antimicrobial resistance in S. Enteritidis and S. Typhimurium 
from Gallus gallus (Table AB SA9-10). For nine of the14 MS providing data for S. Typhimurium, 
the reporting was based on a small number of isolates(<12 isolates). Data on S. Enteritidis 
from Gallus gallus were provided by 18 MS, and only four MS reported on small numbers 
of isolates (<14). Thus, especially for S. Typhimurium, MS reported on very few isolates 
for Gallus gallus, which limited the possibility of making valid comparisons of prevalence 
between MS. Reporting of data for S. Enteritidis was more frequent for Gallus gallus 
among MS, than in other animal species. In general, lower levels of antimicrobial resistance 
were reported for isolates of S. Enteritidis than for S. Typhimurium. In general, the highest 
level of resistance was reported for ampicillin (up to 63.3%), sulfonamide (up to 81.6%), 
tetracycline (up to 59.2%) and streptomycin (up to 63.3%) in S. Typhimurium, whereas 
for S. Enteritidis only the reported prevalence for quinolones were high (up to 96.2%). 
High proportion of fully sensitive isolates was reported by Austria (86%) in S. Typhimurium 
and for Austria (92.9%), Belgium (95.8), Greece (76.9%), and Slovakia (98%) in S. Enteritidis.
Turkeys
Nine MS provided data on antimicrobial resistance in S. Typhimurium from turkeys (Level 3, 
Table AB SA10). For ﬁve MS, the reporting was based on a small number of isolates (<3 
isolates). In general, the prevalence of resistance to several antimicrobials in isolates 
from turkeys was high compared to isolates from other animal species. The highest 
level of resistance was observed for ampicillin (up to 94.1%), nalidixic acid (up to 81.8%), 
sulfonamide (up to 100%), streptomycin (up to 91.2%) and tetracycline (up to 96.4%). 
High prevalence of resistance to several antimicrobials was reported by Germany and 
Italy followed by United Kingdom and France. Germany also reported a high proportion 
(91.2%) of isolates resistant to >4 antimicrobials. Italy and United Kingdom reported 
high prevalence of resistance to nalidixic acid (81.8% and 60% respectively), whereas 
resistance to ﬂuoroquinolones was low.
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Table AB SA8. Antimicrobial resistance in S. Typhimurium from pigs 2004
Country A B CZ DK FIN F D H IRL I
Monitoring 
program no no yes yes yes yes no no no no
No of isolates 
available 2 175 5 814 3 6 299 3 2 430
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N 2 175 5 814 3 6 299 3 - 216
% R 0 0 0 1 0 0 6 0 - 1.4
Streptomycin N 2 175 5 814 3 6 299 3 - 216
% R 100 50.3 100 37 33.3 50 82.6 66.7 - 70.8
Amphenicols Chloramphenicol N 2 175 5 814 3 6 299 3 - 215
% R 100 42.9 100 9 33.3 33.3 46.2 66.7 - 32.6
Cephalosporins 3rd generation 
cephalosporins N - - - - 3 - - - - -
% R - - - - 0 - - - - -
Ceftiofur N - 175 - 814 - - 299 3 - -
% R - 1.1 - 0 - - 0 0 - -
Cephalothin N - - - 814 - - - 3 - 210
% R - - - 1 - - - 0 - 3.3
Fluoroquinolones Ciproﬂoxacin N 2 - - 814 - - 299 0 - 216
% R 0 - - 1 - - 0 - - 0.5
Enroﬂoxacin N - 175 5 - 3 6 - 3 2 216
% R - 0 0 - 0 0 - 0 0 0.9
Penicillins Ampicillin N 2 175 5 814 3 6 235 3 - 216
% R 100 58.9 100 22 33.3 33.3 78.6 66.7 - 66.2
Quinolones Nalidixic acid N 2 175 - 814 3 6 5 3 - 216
% R 0 2.3 - 1 0 0 1.7 0 - 10.2
Sulfonamides Sulfonamide N 2 175 - 814 3 6 269 3 - 216
% R 100 64 - 38 33.3 50 90 66.7 - 81.9
Tetracyclines Tetracyclin N 2 175 5 814 - 6 233 3 1 216
% R 100 64.6 100 40 - 83.3 77.9 66.7 100 80.6
Trimethoprims Trimethoprim N 2 - - 814 3 - 80 0 0 207
% R 0 - - 6 0 - 26.8 - 0 20.3
Trimethoprims + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 49 5 - - 6 80 3 2 -
% R - 28 100 - - 16.7 26.8 0 50 -
Multiresistant 
isolates
fully sensitives % - 25 - - 66.7 0 7 33.3 - 6.4
resistant to 1 
antimicrobial % - - - - 0 50 7.4 - - 10.1
resistant to 2 
antimicrobials % - - - - 0 0 2.7 - - 3.7
resistant to 3 
antimicrobials % - - - - 0 16.7 7 - - 12.2
resistant to 4 
antimicrobials % - - 100 - 0 0 17.4 - - 23.3
 resistant to >4 
antimicrobials % 100 - - - 33.3 33.3 58.5 66.7 - 44.4
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Table AB SA8. Antimicrobial resistance in S. Typhimurium from pigs 2004 (cntd.)
Country L N PL SK SLO ES S NL UK
Monitoring 
program yes no no no no yes yes yes
No of isolates 
available 3 11 1 1 30 6 77 147
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N - 3 10 1 1 30 6 77 147
% R 0 0 0 0 100 0 0 0 0
Streptomycin N - 3 10 1 1 30 6 - 21
% R 0 0 40 - 100 60 0 - 80
Amphenicols Chloramphenicol N - 3 10 1 1 30 6 77 147
% R 50 0 30 0 100 46.7 0 32 71
Cephalosporins 3rd generation 
cephalosporins N - - - - 1 30 - 77 147
% R 0 - - - 100 0 - 0 0
Ceftiofur N - 3 10 - - - 6 - -
% R - 0 0 - - - 0 - -
Cephalothin N - - 10 1 - - - - -
% R - - 0 0 - - - - -
Fluoroquinolones Ciproﬂoxacin N - - 10 1 1 30 - 77 147
% R 0 - 10 0 0 0 - 0 0
Enroﬂoxacin N - 3 - - 1 - 6 - -
% R - 0 - - 0 - 0 - -
Penicillins Ampicillin N - 3 10 1 1 30 6 77 147
% R 100 0 40 0 100 66.7 0 52 71.4
Quinolones Nalidixic acid N - 3 10 1 1 30 6 77 147
% R - 0 20 0 100 3.3 0 1 0
Sulfonamides Sulfonamide N - 3 10 1 1 30 6 77 147
% R 100 0 40 0 100 66.7 0 68 71.4
Tetracyclines Tetracyclin N - 3 10 - 1 30 6 77 147
% R 100 0 40 - 100 96.7 0 73 93
Trimethoprims Trimethoprim N - 3 10 1 1 30 6 77 21
% R - 0 0 0 0 3.3 0 30 19.1
Trimethoprims + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - - - 1 1 - - - 147
% R - - - 0 0 - - - -
Multiresistant 
isolates
fully sensitives % - 100 30 100 0 0 100 37 23.8
resistant to 1 
antimicrobial % - - - - 0 33.3 - 13 4.7
resistant to 2 
antimicrobials % - - - - 0 0 - 4 0
resistant to 3 
antimicrobials % 33 - 10 - 0 0 - 12 6
resistant to 4 
antimicrobials % - - - - 0 26.7 - 4 19
 resistant to >4 
antimicrobials % - - 40 - 100 39.9 - 29 71
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB SA9. Antimicrobial resistance in S. Typhimurium from Gallus gallus, 2004
 
Country A B CZ DK FIN F D GR H PL SK S NL UK
Monitoring 
program no no yes yes yes yes no no no yes yes yes yes yes
No of isolates 
available 50 43 1 18 2 43 49 10 7 4 4 2 9 11
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N 50 43 1 18 2 43 49 7 7 4 4 2 9 11
%R 6 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptomycin N 50 43 1 18 2 43 49 7 7 4 4 2 - 11
%R 12 25.6 0 17 0 55.8 63.3 0 28.6 25 50 0 - 64
Amphenicols Chloramphenicol N 50 43 1 18 2 43 49 7 7 4 4 2 9 11
%R 6 25.6 0 6 0 16.3 53.1 0 28.6 25 25 0 22 45
Cephalosporins 3rd generation 
cephalosporins N - - - - 2 - - - - - - - 9 -
%R - - - - 0 - - - - - - - 0 -
Ceftiofur N - 43 - 18 - - 49 - 7 4 - 2 - -
%R - 0 - 0 - - 0 - 0 0 - 0 - -
Fluoroquinolones Ciproﬂoxacin N 50 - - 18 - - 49 7 0 4 4 - 9 11
%R 0 - - 0 - - 0 0 - 0 0 - 0 0
Enroﬂoxacin N - 43 1 - 2 43 - - 7 - - 2 - -
%R - 0 0 - 0 2.3 - - 0 - - 0 - -
Penicillins Ampicillin N 50 43 1 18 2 43 49 7 7 4 4 2 9 11
%R 8 41.9 0 17 0 30.2 63.3 0 28.6 50 50 0 44 45
Quinolones Nalidixic acid N 50 43 - 18 2 43 49 7 7 4 4 2 9 11
%R 0 7 - 0 0 16.3 2 0 0 50 0 0 0 9
Sulfonamides Sulfonamide N 50 43 - 18 2 43 49 7 7 4 4 2 9 11
%R 14 41.9 - 11 0 32.6 81.6 0 71.4 50 50 0 44 64
Tetracyclines Tetracyclin N 50 43 1 18 - 43 49 7 7 4 4 2 9 11
%R 14 39.5 0 17 - 44.2 59.2 0 28.6 25 25 0 33 55
Trimethoprims Trimethoprim N 50 - - 18 2 - 49 4 - 4 4 2 9 -
%R 2 - - 0 0 - 2 0 - 0 25 0 22 -
Trimethoprims + 
Sulfonamides
Trimethoprim + 
Sulfaonamide N - 43 1 - - 43 49 7 7 - 4 - - 11
%R - 25.6 0 - - 7 0 0 0 - 25 - - 0
- - - - - - - - - - - - - -
Multiresistant 
isolates
fully sensitives % 86 53.5 100 - 100 0 14.3 0 28.6 50 50 0 40 27
resistant to 1 
antimicrobial % - - - - 0 21 18.4 - 42.9 - - - 10 0
resistant to 2 
antimicrobials % - - - - 0 14 8.2 - - - - - 0 18
resistant to 3 
antimicrobials % - - - - 0 0 0 0 - - - - 20 0
resistant to 4 
antimicrobials % 2 - - - 0 2.3 6.1 - - 25 25 - 0 0
 resistant to >4 
antimicrobials % 12 - - - 0 27.9 53.1 - 28.6 25 25 - 30 45
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB SA10. Antimicrobial resistance in S. Enteritidis from Gallus gallus, 2004
Country A B CZ EST F D GR H I
Monitoring 
program no no yes yes yes no no no no
 No of isolates 
available 338 144 21 3 73 54 38 63 1441
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N 338 144 - 2 73 54 26 63 101
%R 0.9 0 - 0 4.1 0 0 0 0
Streptomycin N 338 144 - 2 73 54 25 63 101
%R 0.9 0 - 0 5.3 1.9 0 1.6 14.9
Amphenicols Chloramphenicol N 338 144 21 2 73 54 26 63 101
%R 0 0 0 0 0 0 0 0 0
Cephalosporins 3rd generation 
cephalosporins N - - - - - - - - -
%R - - - - - - - - -
Cefotaxim N 338 - - 2 73 - 18 - 101
%R 0 - - 0 0 - 0 - 0
Fluoroquinolones Ciproﬂoxacin N 338 - - 2 - 54 26 0 101
%R 0 - - 0 - 0 0 - 0
Enroﬂoxacin N - 144 - 2 73 - - 63 101
%R - 0 - 0 0 - - 0 1
Penicillins Ampicillin N 338 144 21 2 73 54 26 63 101
%R 0 2.1 0 0 8.2 1.9 0 6.3 5
Quinolones Nalidixic acid N 338 144 - 2 73 54 26 63 101
%R 2.4 2.1 - 50 17.8 31.5 23.1 9.5 20.8
Sulfonamides Sulfonamide N 338 144 - 2 73 54 26 63 101
%R 0.9 0 - 0 12.3 0 0 18.9 29.7
Tetracyclines Tetracyclin N 338 144 21 2 73 54 26 63 101
%R 0.9 0 4.8 0 26 0 0 1.6 5
Trimethoprim Trimethoprim N 338 - - 2 - 54 12 0 99
%R 0 - - 0 - 0 0 - 8.1
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfamethoxazol N - 144 - 2 73 54 26 63 -
%R - 0 - 0 8.2 0 0 0 -
Multiresistant 
isolates
fully sensitives % 92.9 95.8 - 50 23.3 66.7 76.9 68.3 49.5
resistant to 1 
antimicrobial % 6.2 - - 0 31.5 31.5 23.1 28.6 -
resistant to 2 
antimicrobials % - - - 50 1.4 1.8 - 3.2 29.7
resistant to 3 
antimicrobials % - - - 0 0 0 - - 1.1
resistant to 4 
antimicrobials % 0.9 - - 0 6.9 0 - - 1.1
 resistant to >4 
antimicrobials % - - - 0 4.1 0 - - 0
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Table AB SA10. Antimicrobial resistance in S. Enteritidis from Gallus gallus, 2004 (cntd.)
Country LV LT PL P SK SLO ES NL1 UK
Monitoring 
program yes yes yes  yes no no yes yes
 No of isolates available 4 17 106 5 78 27 26 271 13
Antimicrobial 
Group
Antimicrobial
Aminoglycosides Gentamicin N 4 1 105 4 48 27 26 27 13
%R 0 100 1 0 0 0 15.4 0 0
Streptomycin N 2 1 105 4 48 27 26 - 13
%R 0 0 4.8 0 0 0 0 - 8
Amphenicols Chloramphenicol N 3 1 105 5 48 27 26 27 13
%R 0 0 1 0 0 0 0 0 8
Cephalosporins 3rd generation 
cephalosporins N - - - - - 27 26 27 -
%R - - - - - 0 0 0 -
Cefotaxim N 4 - - 5 48 - - - 13
%R 0 - - 0 0 - - - 0
Fluoroquinolones Ciproﬂoxacin N 1 1 105 5 48 27 26 27 13
%R 0 0 0 0 0 0 0 0 0
Enroﬂoxacin N - - - - - 27 - - -
%R - - - - - 7.4 - - -
Penicillins Ampicillin N 3 1 105 - 48 27 26 27 13
%R 0 0 1 - 0 7.4 15.4 11 0
Quinolones Nalidixic acid N 1 1 105 5 48 27 26 27 13
%R 0 0 22.9 80 2 63.0 96.2 0 0
Sulfonamides Sulfonamide N - - 105 - 48 27 26 27 13
%R - - 2.9 - 0 0 3.8 3.7 8
Tetracyclines Tetracyclin N 3 1 105 4 48 27 26 - 13
%R 33 0 1 0 0 0 3.8 - 8
Trimethoprim Trimethoprim N 2 1 105 - 48 27 26 - -
%R 0 0 1 - 0 0 0 - -
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfamethoxazol N 2 1 - 3 48 27 - - 13
%R 0 0 - 0 0 0 - - 0
Multiresistant 
isolates
fully sensitives % 75 - 68.6 - 98 37.0 3.8 85 85
resistant to 1 
antimicrobial % 25 100 22.7 - 2 48.2 76.9 15 8
resistant to 2 
antimicrobials % - - 3.8 - - 7.4 15.4 0 0
resistant to 3 
antimicrobials % - - 1.9 - - 7.4 3.8 0 8
resistant to 4 
antimicrobials % - - 1.9 - - 0 0 0 0
 resistant to >4 antimicrobials % - - 1.0 - - 0 0 0 0
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
1. In The Netherlands isolates from poultry.
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3.1.7. Summary on Salmonella
Humans
The incidence of salmonellosis in EU-25 in 2004 was 42.2 per 100,000 population. This 
represents an increase of 22% when compared with 2003. This is due mainly to the addition 
of the ten new MS reporting for the ﬁrst time. In the old MS, a general decreasing trend 
of salmonellosis has been observed in recent years. This decrease is most likely due to 
Salmonella control programmes in these countries. A quarter of all reported cases in 
EU-25 are from children aged 0-4 years, and there is a seasonal peak during the late 
summer/autumn. Salmonella Enteritidis comprised 76% of all the reported cases in 2004. 
Food
Data on Salmonella were reported for a wide range of foodstuffs. The majority of samples 
were collected from various types of meat and meat products and the number of samples 
collected and the types of food selected differed between MS.
The lowest levels of contamination in eggs, poultry, pig, and bovine meat during the 
last ﬁve-year period has been reported from Finland, Sweden and Norway. Salmonella 
was detected at all levels of the poultry meat production, with the highest rates of 
contamination observed at the slaughterhouse and processing plants. Proportions of 
positive samples in poultry meat were generally lower than 10%, with the lowest proportions 
reported in countries with control programmes in the poultry production.
In table eggs, a general decrease was observed in those countries that have reported 
consistently since 2000. Contamination rates reported did not exceed 2,4% in 2004. 
In pig meat, no clear trend was discernable in the MS that have provided data for ﬁve years, 
except for The Netherlands where a clear reduction was observed. Salmonella levels in 
fresh pig meat ranged from 0 to 32.8%, however, most countries reported levels below 10%. 
Levels of Salmonella contamination in bovine meat were generally lower than 2%. 
The same rates of contamination were reported at all levels of the production. Some 
MS reported the same levels of contamination in fresh meat and ready-to-eat-meat 
products. Salmonella contamination in ready-to eat meat products constitutes a 
particular risk to human health.
With a few exceptions, New MS generally reported similar levels of Salmonella in food 
as the old MS. 
Animals
The mandatory control program for Salmonella in breeding ﬂocks of Gallus gallus ensures 
relatively comparable data within the Community. Overall, 6.3% of the layer breeding 
ﬂocks and 3.3% of the broiler breeding ﬂocks were infected with Salmonella in the EU-25 
MS in 2004. The levels of Salmonella infection in ﬂocks of layer breeders ranged from 
0 to 33%, and in ﬂocks of broiler breeders from 0 to 37% in the MS with Salmonella 
control programmes. 
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In ﬂocks of laying hens the levels of infection in the different MS ranged from 0 to 32.2% 
and in ﬂocks of broilers the ranges were from 0 to 23.4%.
The proportion of infected ﬂocks ranged between 4.8 – 57% in ducks, 6.8 – 14.6% in geese 
and 0-35.8% in turkeys within the MS reporting data from at least 25 production ﬂocks.
Few MS have active monitoring of Salmonella in pigs and cattle. As in previous years, 
the level of Salmonella in pig and cattle herds in Finland, Norway and Sweden remained 
low In Italy the proportion of infected cattle herds was slightly higher (1.5%), and in the 
Netherlands, a relatively high proportion of the pig fattening herds were infected (29.4%).
Feedingstuffs 
The occurrence of Salmonella in ﬁshmeal decreased in most MS in 2004 compared to 
previous years, whereas the overall levels of Salmonella in meat and bone meal and in 
compound feedingstuffs were comparable to previous years. The level of Salmonella 
contamination in feed of vegetable origin varied considerably between MS in 2004. 
This was especially true for oil seeds and products thereof (0-7.5% positive units). 
No general trend was discernable. S. Enteritidis and S. Typhimurium were detected in 
several types of feedingstuffs, however the levels were low.
Salmonella serovars
Overall, 86% of the isolates from human cases in the Community were serotyped. 
S. Enteritidis and S. Typhimurium were the most commonly reported serovars from human 
infections, comprising 76% and 14% of human cases respectively. Other serovars 
caused 1% or less of the total number of cases in the EU-25. Inclusion of the new MS 
increased the relative proportion of S. Enteritidis. 
S. Enteritidis was the most commonly occurring serovar isolated from the monitoring 
of broiler meat in 2004, followed by S. Infantis and S. Typhimurium. However, the 
predominance of speciﬁc serovars in broiler meat varied greatly between the MS.
Generally, table eggs are not monitored. The data available from two MS showed that 
S. Enteritidis was the predominating serovar in table-eggs. The dominant serovars isolated 
from laying hens and broilers (Gallus gallus) were S. Enteritidis (ranging from 2 to 93%), 
S. Infantis (0-54%) and S. Typhimurium (2-20%). 
S. Typhimurium was the predominating serovar isolated from pigs and pig meat followed 
by S. Derby. The serotype distribution in pig meat in 2004 was largely comparable to the 
distribution in 2003, with the exception of an increasing occurrence of S. Infantis.
Several MS provided serovar information for bovine meat in 2004, but the monitoring 
data was too sparse for a Community evaluation of the serovar distribution. In cattle, 
S. Typhimurium and S. Dublin were the most frequently detected serovars during 
monitoring in 2004.
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Antimicrobial resistance
Twenty-four MS and Norway provided data on antimicrobial resistance in Salmonella 
isolates from humans, various animal species and food of animal origin. Resistance to 
ampicillin, streptomycin, tetracycline and sulphonamide was common in Salmonella isolates 
from humans. Most MS reported resistance to nalidixic acid, which is an indicator of 
emerging resistance to ﬂuoroquinolones. Among isolates from food (bovine-, pig-, and 
poultry-meat) resistance to ampicillin, nalidixic acid streptomycin, tetracycline was common. 
Resistance to nalidixic acid occurred especially in broiler and poultry meat, whereas 
resistance to ﬂuoroquinolones was uncommon. Several MS reported high levels of 
resistance to ampicillin, streptomycin, tetracycline and sulphonamide in Salmonella from 
animals (cattle, pigs an poultry). With some exceptions resistance to nalidixic acid, as 
well as ﬂuoroquinolones was low. Large variations in the resistance levels between MS 
were evident. The levels of antimicrobial resistance in Salmonella reported by new MS 
were similar to or lower than levels reported by the old MS. However, in many cases, 
reporting was based on a relatively small number of isolates, making direct comparison 
of prevalence between MS less valid.
The reporting of antimicrobial resistance in Salmonella from the MS clearly demonstrates 
the presence of a reservoir of antimicrobial resistance in food animals and food of animal 
origin that likely reﬂects antimicrobial consumption in food animals in the MS. Emergence 
of infections in humans, caused by resistant bacteria originating from the animal reservoir 
is a concern, as effective treatment may be compromised.
3.1.8. Sources of Salmonella data
Humans
Salmonellosis is a notiﬁable disease in humans in all MS, with the exception of The 
Netherlands and the United Kingdom (Appendix Table SA23). In the United Kingdom, 
reporting of food poisoning is mandatory, however, isolation and speciﬁcation of the 
organism is voluntary. Luxembourg did not provide any data in 2004.
Food
Data on Salmonella in foodstuffs were reported by most MS and Norway in 2004. However, 
the sampling schemes, place of sampling, sampling frequency, and diagnostic methods 
applied varied between MS and in the different types of food sampled. For a full description 
of the monitoring schemes implemented in the individual MS and the diagnostic methods 
used, please refer to Appendix Tables SA9, SA12, SA18 and SA21. The monitoring 
schemes are based on a variety of different samples such as neck skin samples, carcass 
swabs, caecal contents and meat cuttings, collected at slaughter, processing, meat 
cutting plants and at retail. A few MS reported data collected as part of HACCP 
programmes, based on sampling at critical control points. These samples are targeted 
samples, speciﬁcally sampled at certain point of the production and may not be 
compared directly with samples collected randomly for monitoring purposes and have 
therefore not been included in the tables. 
Information on serotype distribution was not provided consistently from all MS, but 
has been included in the tables presented for 2004 data, wherever available. All data 
reported by the MS have been summarised in Level 3, Table SA8 and SA9.
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Animals
Salmonella in poultry (Gallus gallus) and other animals is notiﬁable in most MS (Appendix, 
Table SA23), except for Hungary. No information was received from the Czech Republic, 
France, Ireland, Luxembourg, Malta and Poland. In Denmark clinical cases are notiﬁable. 
Monitoring of Salmonella in animals is mainly conducted as passive laboratory based 
surveillance of clinical samples, active routine monitoring of ﬂocks of breeding and 
production animals in different age groups, and testing during meat inspection (organs). 
Directive 92/117/EEC prescribed a sample plan for the control of S. Enteritidis and 
S. Typhimurium in breeding ﬂocks of Gallus gallus. This should ensure comparability of 
data from MS, however, in Belgium and Estonia, the monitoring scheme applied differs 
from that described in Directive 92/117/EEC. In Appendix, Table SA2-4 the monitoring 
programmes and control strategies applied in the different MS are shown.
The directive does not include requirements of monitoring and control of other commercial 
poultry production systems, but most MS have national programmes for laying hens 
(Appendix, Table SA5 and SA6), broilers (Appendix, Table SA7 and SA8), ducks (Appendix, 
Table SA13 and SA15), geese (Appendix, Table SA14 and SA15) and turkeys (Appendix, 
Table SA10 and SA11). Some MS also monitor Salmonella in pigs (Appendix, Table SA16 
and SA17), cattle (Appendix, Table SA19 and SA20) and other animals.
All data reported by the MS have been summarised in Level 3, Table SA10-SA13.
Feedingstuffs
There is no common sampling scheme for feed materials in the EU. Results from 
compulsory and voluntary monitoring programmes, follow-up investigations, industry 
quality assurance programmes, as well as surveys, are reported (Appendix, Table SA1). 
The MS monitoring programmes often include both random sampling, as well as targeted 
sampling, of feedstuffs that are considered risk products. Samples of raw material, 
materials during processing and ﬁnal products are collected from batches of feedstuffs 
of domestic and imported origin. The reported epidemiological units are either “batch” 
(usually based on pooled samples) or “sample” (often several samples from the same batch). 
In 2004, most MS did separate data from the different types of monitoring programmes 
or data from domestic and imported feed. Therefore, it must be emphasised that the 
data related to Salmonella in feedstuffs cannot be considered national prevalence data, 
and due to the lack of a harmonised surveillance approach data are not comparable 
between the countries. Nevertheless, data are presented in the same tables. 
Information was requested on feed materials of animal and vegetable origin and of 
compound feedstuffs (mixture of feed materials intended for feeding of speciﬁc animal 
groups). Detection of Salmonella in ﬁshmeal, meat and bone meal, cereals, oil seeds and 
products and compound feed for cattle, pigs and poultry in 1999 to 2004 are presented. 
Sample and batch based data from the different monitoring systems were summarised. 
Data were excluded when either the number of tested units or number of positive units 
were missing or if directly labelled as imported. The tables only include MS reporting 
results for at least 25 samples or batches in 2003 or 2004. All feedstuff data from the 
new Member Stats are summarised in a table.
All data reported by the MS have been summarised in Level 3, Table SA14-SA16.
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An overview of countries providing data on serovars and phage types are presented 
in Appendix, Table SA22. For a summary of the serovar data reported by each MS 
and Norway see Level 3, Table SA17-SA41 and for a summary of the S. Enteritidis and 
S. Typhimurium phage type data reported by the MS see Level 3, Table SA42 and SA43.
Antimicrobial resistance
Data on the occurrence of antimicrobial resistance in Salmonella were provided by 24 MS 
and Norway. Malta did not provide data. The countries reported results of antimicrobial 
susceptibility testing of Salmonella isolates from humans, various animal species and 
from various foods and feedstuffs. Results were requested for the Community Report as 
percentage of resistant isolates out of the total number of isolates tested against each 
antimicrobial for each bacterial species, in each speciﬁc sample category. In contrast to 
previous years countries were not conﬁned to reporting on a deﬁned panel of antimicrobials, 
speciﬁc serovars or speciﬁc sample categories. This has caused large heterogeneity 
of data on antimicrobial resistance in Salmonella reported for 2004. In order to preserve 
comparability of data between countries, categories in which several countries reported were 
primarily selected for this summary. Furthermore, categories were selected based on their 
relative public health importance. Direct comparison of proportions of resistant isolates 
between countries was avoided if the reporting was based on small numbers of isolates.
MS’ generate data on antimicrobial susceptibility in Salmonella in different ways. Most 
often the reported isolates constitute a subsample of isolates available at the National 
Reference Laboratory. Isolates may be obtained by different laboratory based monitoring 
approaches; either by active and systematic monitoring of healthy animals, foods, a.o. 
sources, or by passive monitoring based on diagnostic submissions of samples from 
cases of clinical salmonellosis in animals and by testing of foods only on suspicion. 
In some MS, Salmonella prevalence in animals and food is very low and only a limited 
number of isolates, or none, were available for susceptibility testing. 
In most MS standard methods and breakpoints published by the National Committee 
for Clinical Laboratory Standards, USA (NCCLS)1,2, are used for susceptibility testing 
of Salmonella isolates, but for some substances national standards are used. For a few 
antimicrobials, no NCCLS standard breakpoints are established. Most reporting MS 
provided data on Salmonella serovars S. Enteritidis or S. Typhimurium. In order to facilitate 
comparison of data, this summary is based only on reporting of antimicrobial resistance 
in these two serovars. When comparing results of antimicrobial susceptibility testing of 
Salmonella isolates, special attention should be given to variation in break points used by 
different countries. This applies especially to streptomycin and ciproﬂoxacin. Please refer 
to Level 3, Table AB SA15 for information on breakpoints and ranges used by different countries.
1  Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from 
Animals; Approved Standard [ISBN 1-56238-377-9] M31-A.
2  NCCLS. Performance Standards for Antimicrobial Susceptibility Testing: Eleventh Informational 
Supplement. NCCLS document M100-S11 [ISBN 1-56238-426-0]. NCCLS, 940 West Valley Road, Suite 
1400, Wayne, Pennsylvania 19087-1898 USA, 2001. (NCCLS changed name to Clinical and Laboratory 
Standards Institute by January 1st, 2005 (www.clsi.org).
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3.2. Campylobacter
Campylobacteriosis in humans is caused by thermophilic Campylobacter spp. Most 
of the cases are due to thermophilic species C. jejuni and C, coli, but also C. lari, C, fetus 
and C, upsaliensis are known to cause infections in humans. In developed countries, 
C. jejuni is most commonly isolated from human infections. 
Patients may have mild to severe symptoms. The infective dose is low, and infection 
is generally manifested by an acute attack of diarrhoea, abdominal pain and cramps. 
Infections are usually self-limiting and last only a few days. Extra-intestinal infections 
and chronic sequelae do occur and C. jejuni has recently become the most recognised 
antecedent cause of Guillain-Barré syndrome (GBS), which is an acute temporal paralysis 
of the peripheral nervous system. 
Thermophilic Campylobacter spp. are widespread in nature and the principal reservoirs 
are the alimentary tracts of wild and domesticated birds and mammals. Consequently, 
thermophilic Campylobacter spp., especially C. jejuni and C. coli, are commonly isolated 
from water sources, farm animals such as poultry, cattle, pigs and sheep, as well as from 
cats and dogs. Animals rarely succumb to disease by these organisms. The bacteria can 
readily contaminate various foodstuffs, including meat, raw milk and dairy products, 
and, less frequently, ﬁsh and ﬁshery products, mussels and fresh vegetables.
Among sporadic cases, contact with live poultry, consumption of poultry meat and 
contact with pets and other animals has been identiﬁed as major sources of infection. 
Raw milk and contaminated drinking water have also been causes of major outbreaks.
3.2.1. Campylobacteriosis in humans
A total of 183,961 cases of laboratory conﬁrmed campylobacteriosis were recorded in 
the EU-25 in 2004. The overall incidence of campylobacteriosis was 47.6 per 100,000 
population, which is slightly higher than for Salmonella (42.2). This makes Campylobacter 
the most commonly reported gastrointestinal bacterial pathogen in humans in the EU 
(Table CA1).
With the exception of Spain and Sweden, all EU-15 MS reported an increase in the 
number of human cases of campylobacteriosis in 2004 compared to 2003. The reported 
incidences of human campylobacteriosis in the new MS ranged from 0.1-89.8 cases per 
100,000 population. However, the Czech Republic, where diagnosing of human cases 
has only recently begun, reported a remarkably high number of cases and the highest 
incidence within the Community, with 249.6 cases per 100,000 population. The overall 
incidence in 2004, including all reporting EU MS represents an increase of approximately 
32% compared to 2003. If the cases from the Czech Republic are excluded from the 
EU-total, the overall incidence was 42.1 per 100,000 population corresponding to a 
12% increase compared to 2003. A notable increase in number of human cases reported 
from Austria in 2004 was observed following improvements in the notiﬁcation system.
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Table CA1. Number of reported human cases of campylobacteriosis from 1999-2004, 
and incidences in 20041
2004 2004 2003 2002 2001 2000 1999
Cases/
100,000 
population
Number 
of cases 
Austria 76.4 6,222 3,926 4,446 3,919 3,458 3,253
Belgium 64.6 6,716 6,556 7,354 7,357 6,682 -
Cyprus 0 0 - - - - -
Czech 
Republic 249.6 25,492 (253) - - - - -
Denmark 69 3,724 3,537 4,385 4,620 4,386 4,164
Estonia 9.2 124 (4) - - - - -
Finland 68.6 3,583 3,190 3,738 3,969 3,527 3,305
France 3.6 2,127 (77) 1,997 1,353 203 378
Germany 67.5 55,745 (4426) 47,876 56,350 54,410 30,876 28,882
Greece 3.6 392 1 - 386 3 15
Hungary 89.8 9,087 - - - - -
Ireland 42.5 1,711 1,568 1,336 1,286 1,613 2,085
Italy - - 1 - - -
Latvia 0 0 1 - - - -
Lithuania 23.1 797 617 - - - -
Luxembourg - - - - 287 - 171
Malta - - - - - - -
Poland 0.1 24 - - - - -
Portugal - - - - - - -
Slovakia 31.4 1,691 (9) - - - - -
Slovenia 53.2 1,063 890 - - - -
Spain2 14.1 5,958 6,048 5,051 6,149 6,113 5,101
Sweden 68.7 6,169 (3372) 7,149 7,137 7,845 7,646 7,137
The  
Netherlands 20.1 3,273 (300) 2,805 3,421 3,682 3,474 3,175
United 
Kingdom 83.9 50,063 49,055 52,519 62,118 63,371 63,174
EU-Total 47.6 183,961 135,217 147,095 156,231 131,527 120,462
Norway 49.7 2,275 (1111) 2,270 2,192 2,889 2,326 2,027
Note: Figures in brackets are reported imported cases, values are included in the total number of cases.
1. EU-Total incidence is based on population in reporting countries.
2. In Spain, only hospitalised cases are notiﬁable.
For those MS that have consistently reported the number of human cases since 1999, 
a gradual decrease was observed from 2001 to 2003, however, in 2004 the number of 
cases increased once again (Figure CA1).
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Figure CA1. The total number of human cases of campylobacteriosis and the trend 
for countries reporting consistently from 1999-2004 (9 MS)
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Trend data from: Austria, Denmark, Finland, Germany, Ireland, Spain, Sweden, The Netherlands, and 
United Kingdom.
In 2004, there was a deﬁnite predominance of human campylobacteriosis cases amongst 
the age categories 1-4 years and 25-55 years. Furthermore, there was also a clear 
seasonal distribution with an increase of cases during the summer months from June to 
September. These trends are similar to what has been observed in previous years. 
All reported data on Campylobacter in humans are presented in Level 3, Table CA1-CA7.
3.2.2. Campylobacter in food
Results from several different food categories were reported by the MS. The number of 
samples collected ranged from a few samples to several thousands. The sampling and 
testing methods varied between the countries and as such the results are not directly 
comparable between the countries. Also, it should be taken into consideration, that 
Campylobacter are known to be more prevalent during the summer than during the winter. 
Thus, the proportion of positive samples observed, may be inﬂuenced by the time of 
year at which the samples are taken.
Poultry meat and products thereof
Data on the occurrence of Campylobacter in fresh poultry meat at different stages of 
production from 2000-2004 are summarised in Table CA2. The data reported from 2000 to 
2004, provide no clear increasing or decreasing trend for the occurrence of Campylobacter 
in fresh poultry meat, in the reporting countries. As same procedures of sampling 
and testing have not always been used consistently, ﬁgures are not necessarily directly 
comparable even within one country.
In Table CA3, ﬁndings of Campylobacter in fresh poultry meat (broiler, turkey and duck 
meat) sampled at different stages of the production line are summarised. At slaughter 
the prevalence ranged from 1.8% to 83%. At the processing level, ranges of 26.0-53.0% 
were reported, and at the retail level, proportions of positive samples were within the 
same the magnitude, ranging from 2.2-62.2% positive samples. 
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Samples of poultry meat products at the retail level were collected in Austria, Belgium, 
Estonia, Finland, Germany, Ireland, Italy, Lithuania, Spain and Sweden. Only Belgium, 
Finland, Germany and Spain reported positive ﬁndings, ranging from 10.9% in Germany 
to 60.4% in Belgium, (see Level 3, Table CA8 for further details). A large number of broiler 
meat products (non-ready to eat and ready–to-eat) were tested in Ireland. In non-ready-to 
eat products, sampled at processing, 38.7% were found positive. Very few positive 
samples (0.2%) were found in ready-to-eat products. (see Level 3, Table CA8). 
The United Kingdom conducted a survey of Campylobacter in fresh wild game bird 
meat. A total of 33 samples were tested and 14 samples (42.4%) were found positive.
Table CA2. Campylobacter in fresh poultry meat sampled1 at slaughter, processing 
and retail in MS that reported data from 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
At slaughterhouse or processing plants (sample based data)
Belgium 197 4.1 142 16.2 138 19.6 147 22.5 171 28.7
Ireland 2,6202 54.7 1,8683 58.1 3,222 53.0 3,213 54.3 3,422 53.9
At retail 
Austria5 525 45.3 231 47.2 74 9.5 172 32.6 200 20.0
Belgium 77 6.5 99 20.2 92 16.3 82 2.4 83 7.2
Denmark 584 23.5 4073 32.9 712 41.7 1,8964 29.5 708 41.1
Finland 130 20.0 - - 244 19.7 101 22.8 161 10.6
France - - - - 406 88.7 - - - -
Germany 2,000 34.5 1,396 19.6 1,510 25.0 1,058 14.5 958 19.5
Ireland 992 77 - - - - 151 12.6 391 38.9
Norway 1,067 5.1 1,093 5.0 1,069 8.1 - - - -
Sweden 27 55.6 425 13.2 - - 79 11.4 858 9.3
The 
Netherlands 1,477 29.3 1,510 26.0 1,600 31.3 1,578 32.5 1,454 30.5
United 
Kingdom 1,533
2 62.2 734 73.0 - - - -  
 
Note: Data from 2000-2003 are all broiler samples.
1. Data are only presented for sample size >25 with positive ﬁndings.
2. In Ireland and United Kingdom, broilers.
3. In Ireland and Denmark, domestic broiler meat.
4. In Denmark, data includes turkey meat.
5. In Austria, sampling at retail and processing plants.
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Table CA3. Campylobacter in fresh poultry meat1 at slaughter, processing and 
retail in 2004
Slaughter Processing Retail Point of sampling
not speciﬁed
N % Pos N % Pos N % Pos N % Pos
Austria4 - - - - 525 45.3 412 52.7
Belgium 197 27.9 131 26.0 77 35.1 336 3.3
Cyprus 47 83.0 47 46.8 - - - -
Czech Republic2 - - - - 31 41.9 48 27.1
Denmark - - - - 584 23.5 - -
Estonia 27 37.0 12 33.3 - - - -
Finland,  
broiler meat 182 18.7 - - 104 20.2 - -
Finland,  
turkey meat3 37 29.7 - - 26 19.2 - -
France2 142 81.7 - - - - - -
Germany - - 151 53.0 2,000 34.5 - -
Ireland,  
broiler meat - - 2,620 54.7 99 77 - -
Ireland,  
turkey meat - - 384 33.1 - - - -
Ireland,  
duck meat - - 60 21.7 - - - -
Italy, other 
poultry meat - - - - - - 120 0.0
Latvia2 110 1.8 - - 365 2.2 - -
Malta 29 24.1 - - - - - -
Norway - - - - 1,067 5.1 - -
Portugal - - 33 0.0 47 8.5 - -
Slovakia - - - - 270 8.1 - -
Slovenia,  
broiler meat 81 19.8 - - 95 40.0 30 20.0
Spain 146 39.7 151 28.5 321 16.5 - -
Sweden - - - - 27 55.6 - -
The Netherlands - - - - 1,477 29.3 - -
United Kingdom, 
poultry meat - - - - 1,533 62.2 - -
United Kingdom, 
turkey meat - - - - 152 34.2 - -
United Kingdom,  
duck meat - - - - 33 30.3 - -
1. Data are only presented for sample size >25 with positive ﬁndings.
2. Batch based sampling.
3. In Finland, ﬂock-based samples, neckskin samples.
4. In Austria, sampling at retail and processing plants.
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Pig meat and products thereof
Compared to data on poultry meat, much less data are available for pig meat. Data 
reported on the occurrence of Campylobacter in pig meat from 2002-2004 have been 
summarised in Table CA4. For those MS reporting positive ﬁndings in pig meat in 2004, 
the proportion of positive samples ranged from 1.1% at the retail level in The Netherlands 
to 11.9% observed at the slaughter level in France. The proportion of positive samples 
in samples tested at retail was generally low (5% or lower) when compared to the levels 
in pigs before slaughter (Table CA5).
Table CA4. Campylobacter in fresh pig meat, at retail, sample based data, 2002-2004
2004 2003 2002
N % Pos N % Pos N % Pos
Belgium 161 5.0 - - - -
Denmark - - 50 0 2413 0.2
Germany 454 2.0 188 2.7 254 1.2
Italy 51 2.0 41 9.8 43 4.7
The Netherlands 287 1.11 227 0 97 2.1
Spain 46 - 132 54.6 84 0
1. In The Netherlands, C. coli only.
Campylobacter were not isolated from meat product samples in Austria (N=89) or Ireland 
(N=454). In Italy, 103 meat product samples, tested at processing were found negative, 
while two out of 362 samples collected at retail were found positive.
Table CA5. Campylobacter in fresh pig meat at slaughter, processing and retail, 2004
 
Slaughter Processing Retail
N % Pos N % Pos N % Pos
Belgium 344 4.9 266 1.5 161 5.0
France 226 11.9 - - - -
Germany - - 15 0 454 2.0
Ireland - - 41 0 - -
Italy - - 83 1.2 51 2.0
Slovakia - - - - 1,278 0
Spain 60 0 31 0 46 0
The Netherlands - - - - 287 1.1
Bovine meat and products thereof
In samples of fresh bovine meat and meat products, the proportion of samples found 
positive for Campylobacter was generally very low. From 2002-2004, 1.1% or less of the 
tested samples of bovine meat from Denmark, Italy and The Netherlands were found 
positive (Table CA6). In 2004, the prevalence ranged from 0.8% at retail in The Netherlands 
to 11.9% at slaughter in the Czech Republic (Table CA7). 
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Table CA6. Campylobacter in fresh bovine meat, at retail, sample based data, in the 
years 2002-2004
2004 2003 2002
Country N % Pos N % Pos N % Pos
Denmark 96 0 45 0 3,046 0.1
Italy 196 - 161 0.6 90 1.1
The Netherlands 847 0.8 678 0.2 489 0.2
 
Table CA7. Campylobacter in fresh bovine at slaughter, processing and retail, 2004
Slaughter Processing Retail
Country N % Pos N % Pos N % Pos
Austria - - - - 34 2.9
Czech republic 42 11.9 - - - -
Denmark - - - - 96 0
Ireland - - 40 0 - -
Italy 55 3.6 40 0 196 0
Spain 46 0 21 0 30 0
The Netherlands - - 40 0 847 0.8
Samples of bovine meat products, collected at processing and at the retail level in 
Germany, Italy, Spain and Lithuania were all found negative, see Level 3, Table CA8 for 
details. Two out of 34 non-ready-to-eat products were found positive in Ireland.
Other foodstuffs
Other types of food, not included in the tables above, were also tested for Campylobacter. 
More than 6,000 samples of dairy products were tested in 2004. Among these were 
2,138 samples of soft and semi-soft cheeses made from raw or thermised milk, tested 
in Belgium, Czech Republic, Finland, Estonia, Slovenia and United Kingdom. Positive 
ﬁndings were reported by Belgium, where two out of 147 samples were positive, and by the 
United Kingdom where one out of 1,842 cheese samples was positive. In the remaining dairy 
products, only one positive sample was reported from raw cow milk in Hungary (N=78).
Furthermore, out of 241 tested samples of ﬁshery products, none were found positive. 
However, Belgium found 15 (16.7%) out of 90 tested live bivalve molluscs samples 
positive for Campylobacter. Sweden tested 209 fruit and vegetable samples ﬁnding two 
samples positive. Please refer to Table CA1 in Level 3 of the report for further details.
3.2.3. Campylobacter in animals
While poultry may be a major reservoir for Campylobacter, other animal species also 
constitute reservoirs for the organism. However, the majority of investigations have been 
carried out within the poultry production.
Data on prevalence in broiler ﬂocks has been reported over several years by 6 MS, 
(in Italy the Veneto region) and Norway. Sweden, Finland and Norway have consistently 
reported low ﬂock prevalences. Denmark observed somewhat higher ﬂock prevalences, 
but with a clear decreasing trend. In the Veneto region of Italy the prevalence varied 
around 70-90%, and in Austria around 60% (Table CA8 and Figure CA2).
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Table CA8. Campylobacter in broiler ﬂocks, 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Broilers (ﬂock based data if nothing else stated) 
Austria1 - - 427 52.0 - - - -
Austria2 648 64.5 549 58.7 210 57.6 - - - -
Denmark1 520 19.4 349 32.4 294 38.8 - - - -
Denmark2 5,159 27.0 5,150 35.0 6,255 42.6 6,054 41.9 6,160 37.7
Finland2 1,315 6.2 77 6.5 - - 1,069 4.0 1,094 5.8
Germany2, 3 - - 180 63.9 - - - -
Italy2  
(Veneto region) 212 91.0 154 71.4 23 87.0 - - - -
Norway 3,8422,4 3.1 3,550 4.9 3,627 6.3 2,270 7.7
Sweden 3,0192 14.2 3,2241 17.6 3,842 19.8 4,220 16.2 3,969 9.9
The Netherlands 6,208 10.0 - - 166 27.1 123 16.3 128 24.2
1. In Austria and Denmark, at farm.
2. At slaughterhouse.
3. In Germany, survey from Berlin.
4. In Norway, batch based data.
Figure CA2. Campylobacter in broiler ﬂocks 2000-2004 in selected countries
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Germany and Italy (Region of Veneto) reported positive ﬁndings of Campylobacter in 
22.4% and 93.5% of turkeys, respectively. Italy also investigated wild birds, ﬁnding positive 
proportions ranging from 0.5% (N=202) to 14.4% (N=381).
 
In contrast to the low proportions of positive samples found in bovine and pig meat, 
the levels of Campylobacter in pig and cattle herds were generally high. Table CA9 and 
CA10 summarise herd-level data reported from 2000-2004. The reported prevalence in 
pig herds ranged from 24.8% to 79.6% in 2004 Similar levels were reported in cattle 
herds, with positive ﬁndings ranging from 14.0% to 64.2% in 2004. 
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Table CA9. Campylobacter in pigs and pig herds, 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Pigs (herd based data)
Austria1 741 57.5 262 53.8 276 54.4 - - - -
Denmark 191 79.6 259 93.4 240 80.4 238 76.9 310 64.2
France1 176 70.5 - - - - - - - -
Germany 375 24.8 - - - - - - - -
Italy 37 67.6 46 52.2 29 44.8 - - - -
Ireland1 273 0.4 - - - - - - - -
United Kingdom - - 528 69.3 - - - - 860 94.5
1. Animal based sampling.
Table CA10. Campylobacter in cattle and cattle herds, 2000-2004
2004 2003 2002 2001 2000
N % Pos N % Pos N % Pos N % Pos N % Pos
Cattle (herd based data)
Austria3 898 18.6 346 35.0 350 40.0 - - - -
Denmark1 67 64.2 88 63.6 87 65.5 76 72.4 90 61.0
Germany 394 14.0 - - - - - - - -
Germany2 127 1.6 - - - - - - - -
Italy 150 28.0 119 35.3 229 35.4 - - - -
Italy3 1,444 0.7 - - - - - - - -
Ireland3 4,375 0.8 - - - - - - - -
Lithuania2,3 1,424 0.1 - - - - - - - -
Norway4 - - - - - - 1222 18.0 - -
United Kingdom - - 667 54.6 - - - - - -
1. In Denmark, caecal samples taken at slaughterhouse.
2. In Germany and Lithuania, dairy cows.
3. Animal based data.
4. Survey in calves.
A substantial number of sheep were investigated in Italy at both the herd and animal level. 
At the animal level, less than 0.3% of the 842 tested samples were positive. However, at the 
herd level, 22.0% were found positive (N=182). Findings in animal-based samples from sheep 
in Ireland were consistent with the Italian data, yielding 0.3% positive animals (N=717). 
Italy also investigated 190 water buffalos and found only one animal positive for 
Campylobacter spp.
In 2004, a large number of pets was also tested for Campylobacter. The proportion of 
positive samples observed in dogs in Germany, Ireland, Italy, Slovakia and The Netherlands 
ranged from 0% in Slovakia to 36.8% in The Netherlands. The observed prevalence in 
cats within these MS was much lower and ranged from 1.7% in The Netherlands to 
5.1% in Italy, see Table CA11. 
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Table CA11. Campylobacter in pets1, 2004
Pets N % Pos
The Netherlands Birds 32 0
Germany Cats 246 2.4
Italy Cats 79 5.1
The Netherlands Cats 239 1.7
Germany Dogs 917 2.7
Ireland Dogs 331 0.9
Italy Dogs 242 5.4
Slovakia Dogs 39 0
The Netherlands Dogs 133 36.8
1. Data are only presented for sample size >25 with positive ﬁndings.
Monitoring and control of Campylobacter in broilers 
Monitoring programmes for Campylobacter in broilers have been implemented  
in Austria, Denmark, Finland, Italy (Veneto region), Norway, The Netherlands and 
Sweden. The majority of samples for these programmes are collected at slaughter 
and investigated bacteriologically. Samples collected in this context are taken either 
at the slaughterhouse or at the farm, or in both locations.
While the programmes in Denmark and Sweden are voluntary, the programmes  
in Finland and Norway are mandatory. In Denmark, the programme is ﬁnanced by  
the poultry industry and in Sweden the programme is ﬁnanced by the poultry industry, 
the Swedish Board of Agriculture and the European Commission. In Norway, an  
ofﬁcial action plan against Campylobacter spp. was established in 2001 and Finland  
implemented their control programme in 2004.
The programmes share common traits and generally focus on 
• High level of biosecurity at the farm level to prevent ﬂocks from being infected. 
•  Logistic slaughter i.e. slaughtering positive ﬂocks at the end of the day to prevent 
cross contamination at the slaughterhouse.
Furthermore, carcasses from positive ﬂocks may be frozen or subjected to heat treatment.
Denmark, Norway and Sweden have all experienced a decrease in the number of 
Campylobacter positive broiler ﬂocks over the past three years. This may, in part, be 
explained by the implemented control strategies.
3.2.4. Campylobacter spp. distribution
A total of 12 MS and Norway provided information on the Campylobacter species 
distribution among human cases in 2004 (Table CA12). Not all human cases were 
speciated, but for those MS, where the majority of human isolates were speciated, 
C. jejuni was by far the predominant species isolated.
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Table CA12. Campylobacter species distribution among human cases, 2004
Cases Speciated C. jejuni C. coli C. lari C. 
upsaliensis
C. fetus
N N % % % % %
Austria 6,222 2,005 93.6 6.4 0 0 0
Czech Republic 25,492 25,492 99.5 0.5 0 0 0
Estonia 124 124 98.4 1.6 0 0 0
France 2,127 2,127 81.6 18.4 0 0 0
Germany 55,745 48,083 90.8 9.2 0 0.1 0
Greece 392 392 100 0 0 0 0
Hungary 9,087 9,087 83.9 12.0 4.1 0 0
Ireland 1,711 708 92.5 7.5 0 0 0
Lithuania 797 797 92.0 8.0 0 0 0
Norway 2,275 2,275 94.8 4.8 0 0.4 0
Slovenia 1,063 1,037 100 0 0 0 0
Spain 5,958 5,958 97.3 2.7 0 0 0
The Netherlands 3,273 3,273 94.4 4.5 0.6 0.3 0.2
No cases reported in Cyprus, Italy, Latvia, Luxembourg and Malta in 2004.
As regards isolates from animals and food, the majority of speciated isolates were 
obtained from poultry and food of poultry origin. In poultry ﬂocks, C. jejuni was most 
commonly isolated at rates ranging from 60.3-95.0% of the positive samples. France 
and Italy reported almost equal distributions of C. jejuni and C. coli among isolates 
obtained from broiler ﬂocks. In poultry products, C. jejuni was also the predominant species 
isolated, however high proportions of C. coli were observed in the Czech Republic and 
Malta. The predominant species found in positive samples from cattle was C. jejuni; 
found in 50.0-100% of the obtained positive samples in Austria, Denmark, Germany, 
Ireland and Italy. In contrast, C. coli was the predominant species found in pig herds. 
In Austria, Denmark, Germany France and Italy 56.0-98.0% of the positive samples 
obtained from pig herds were identiﬁed as C. jejuni. The fact that C. jejuni is the 
predominant species in both humans and poultry, supports the general belief that poultry 
is one of the major sources of human campylobacteriosis. However, C. jejuni is prevalent 
in other animal species and cattle and pigs, and products thereof are also potential 
sources of human infections.
3.2.4. Antimicrobial resistance in Campylobacter
Humans
Data on antimicrobial resistance to Campylobacter in humans were provided by the 
following countries: Belgium, Denmark, France, Hungary, Lithuania, Norway and The 
Netherlands. (Table AB CA1). Isolates reported from Denmark, The Netherlands and Norway 
were C. jejuni only, whereas all other countries reported on more species collectively. 
Comparison of prevalence of resistance between countries should be made with caution, 
as the proportion of different Campylobacter species may affect the prevalence of 
resistance. With the exception of Hungary, the countries only reported results for few 
antimicrobials (3-5). In general, high levels of resistance were reported for tetracyclines 
and quinolones, whereas resistance to macrolides was generally at a low level. For 
Lithuania the occurrence of resistance to erythromycin and tetracycline was very low.
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For further results on antimicrobial resistance to Campylobacter in animals, please refer 
to Level 3, Table AB CA1.
Food
Data on antimicrobial resistance in Campylobacter from broiler meat were provided by 
the following countries: Belgium, Denmark, Norway, The Netherlands and United Kingdom 
(Table AB CA2). Belgium further provided data on antimicrobial resistance in pig meat (Level 3, 
Table AB CA4) and United Kingdom provided further data on antimicrobial resistance in 
other poultry meat (Level 3, Table AB CA3). Isolates reported from Denmark and Norway 
were C. jejuni only, whereas all other countries reported on more species collectively.
For isolates from broiler meat (Table AB CA2) the highest level of resistance was reported 
for quinolones, ﬂuoroquinolones and tetracyclines, whereas the level of resistance to 
macrolides and aminoglycosides was generally low.
However, a considerable variation between countries in prevalence of resistance was 
evident for quinolones (0-50%), ﬂuoroquinolones (0-56%) and tetracyclines (0-51%), as 
well as for the proportion of fully sensitive isolates. Denmark and Norway reported a 
markedly lower prevalence of resistance to these antimicrobials compared to the other 
countries, and the proportion of fully sensitive isolates was >90% for Norway. Care 
should be taken when comparing countries reporting resistance for more Campylobacter 
species collectively, with countries reporting for one species only.
For resistance in Campylobacter from other poultry meat (Level 3, Table AB CA3), a 
high level of resistance to several antimicrobials was reported by United Kingdom; 
especially resistance to ampicillin (67%) and tetracycline (57%) was high. For resistance 
in Campylobacter from pig meat (Level 3, Table AB CA4) provided only by Belgium, a 
high level of resistance to tetracycline (86%) was reported.
Animals
Data on the occurrence of antimicrobial resistance in Campylobacter from animals (cattle, 
pigs, poultry and sheep) were provided by the following countries; Austria, Denmark, 
Finland, France, Hungary, Italy, Norway, Spain, Sweden, The Netherlands and United 
Kingdom (Table AB CA3 to AB Cas, as well as Level 3, Table AB CA12).
For further results on antimicrobial resistance in animals, please refer to Level 3, Table 
AB CA2, AB CA5 to AB CA11.
In general, a large variation in the prevalence of resistance in Campylobacter isolates from 
animals was observed among the reporting countries. Similar to what was observed for 
food, this variation was especially large for quinolones, ﬂuoroquinolones and tetracyclines, 
whereas the prevalence of resistance to macrolides and aminoglycosides in isolates 
from animals was lower and showed less variation. For Campylobacter spp. in general, 
the prevalence of resistance to some antimicrobials (e.g. ﬂuoroquinolones, quinolones and 
tetracycline) in isolates reported from the Nordic countries (Denmark, Finland, Norway 
and Sweden), seems to be low especially when compared to resistance in isolates 
reported from southern European countries (e.g. Spain), however comparison between 
prevalences in different Campylobacter species should be interpreted with caution. 
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Poultry
Antimicrobial resistance in Campylobacter isolates from poultry was reported by 10 
countries (Tables AB CA3 and AB CA4, and and Level 3, Table AB CA11). For C. coli 
isolates from poultry (Table AB CA3) a high level of resistance was seen for quinolones, 
ﬂuoroquinolones, tetracyclines and trimethroprim/sulfonamide. Some variation between 
countries was seen for macrolide and ﬂuoroquinolone resistance. A generally high level 
of resistance was reported from Spain. For C. jejuni isolates from poultry (Table AB CA4) 
considerable variation between countries was seen for quinolones, penicillins, and 
macrolides. In general the prevalence of resistance in isolates reported from the Nordic 
countries (Denmark, Finland, Norway and Sweden) was low when compared to resistance 
in isolates reported from other countries. The proportion of fully sensitive isolates reported 
from the Nordic countries was high (80-95%).
Pigs
Antimicrobial resistance in Campylobacter isolates from pigs was reported by Austria, 
France, Hungary, Italy, Spain and The Netherlands (Table AB CA5 and Level 3, Table AB 
CA10). Among C. coli from pigs, high prevalence of resistance to tetracyclines (up to 96%) 
and ﬂuoroquinolones (up to 83%) was reported and large variation between countries 
was observed for ﬂuoroquinolones, macrolides, penicillins and tetracycline. Resistance 
in isolates reported from Spain and Ireland was generally high.
Cattle
Antimicrobial resistance in Campylobacter isolates from cattle was reported by Austria, 
Denmark, Hungary, Italy and United Kingdom. Among C. coli isolates from cattle (Level 3, 
Table AB CA5) reported by Austria and Italy, relatively high prevalence of resistance to 
quinolones, ﬂuoroquinolones and tetracyclines was observed. However, due to small 
sample sizes this should be interpreted with care. Among C. coli isolates from cattle 
(Table AB CA6) large variation between countries was seen for tetracyclines (0-40%) and 
ﬂuoroquinolones (2-42%). In contrast, very little variation was seen for resistance to 
macrolides (0.8-6%) and ampicillin (7.1-14%). Austria and Italy reported relatively high 
levels of resistance to ﬂuoroquinolones and tetracycline compared to Denmark and 
United Kingdom. Hungary also reported relatively high prevalence of resistance to these 
antimicrobials, however direct comparison should be made with caution when more 
than one Campylobacter spp. is included.
Sheep
Data on antimicrobial resistance in Campylobacter isolates from sheep were provided 
by Italy (Level 3, Table AB CA8 and CA12). As for other animal species the prevalence of 
antimicrobial resistance was higher for quinolones, ﬂuoroquinolones and tetracyclines 
than for other antimicrobials.
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Table AB CA1. Antimicrobial resistance in Campylobacter from humans, 2004
Country B DK F H LT N NL
Monitoring 
program no yes yes no no yes yes
No of isolates 
available 121 107
1 5,088 13,045 957 104 3,273
Antimicrobial 
Group
Antimicrobial 
Aminoglycosides Gentamicin N - - 5,088 - - 104 -
%R - - 0.2 - - 2.9 -
Fluoroquinolones Ciproﬂoxacin N 121 107 - 7,140 646 104 2,092
%R 33 29 - 49.5 15.9 8.7 33
Macrolides Erythromycin N 121 107 5,088 9,818 646 104 1,848
%R 7 5 3.4 1.3 0.9 3.8 2
Penicillins Amoxicillin N - - - 195 - - -
%R - - - 15.4 - - -
Ampicillin N - - 5,088 9,139 646 - -
%R - - 39.3 24 13.1 - -
Quinolones Nalidixic acid N - 107 5,088 7,730 - 104 -
%R - 31 28.1 50 - 9.6 -
Tetracyclines Doxycyclin N - - - - - 104 -
%R - - - - - 5.8 -
Tetracycline N - 107 5,088 6,430 646 - 1,665
%R - 24 31.9 21.7 0.6 - 24.2
Multiresistant 
isolates
fully sensitives % - - - 21.7 54.5 88.5 -
resistant to 1 
antimicrobial % - - - 25.4 13.3 1.9 -
resistant to 2 
antimicrobials % - - - 22.7 17.8 2.9 -
resistant to 3 
antimicrobials % - - - 14.5 9.4 4.8 -
resistant to 4 
antimicrobials % - - - 6.24 5.1 1 -
 resistant to >4 antimicrobials % - - - 2.9 0 1 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
1. In Denmark C. jejuni isolates only.
 
b169_EFSA_int_02_03_06.indd   109 2/03/06   15:17:14
110The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Table AB CA2. Antimicrobial resistance in Campylobacter from broiler meat, 2004
 
Country B DK N NL UK
Monitoring 
program yes yes yes no no
No of isolates 
available 197 103
1 331 157 788
Antimicrobial 
group
Antimicrobial 
Aminoglycosides Gentamicin N 197 103 33 157 788
%R 0 0 0 1 0
Streptomycin N - 103 - - -
%R - 0 - - -
Fluoroquinolones Ciproﬂoxacin N 197 103 - 157 788
%R 38 3 - 56 27
Enroﬂoxacin N - - 33 - -
%R - - 0 - -
Macrolides Erythromycin N 197 103 33 157 788
%R 3 0 0 3 8
Penicillins Ampicillin N 197 - 33 157 788
%R 26 - 9.1 20 74
Quinolones Nalidixic acid N 197 103 33 157 788
%R 39 3 0 50 29
Tetracyclines Tetracycline N 197 103 33 157 788
%R 40 1 0 40 51
Multiresistant 
isolates
fully sensitives % 36 - 90.9 10 14
resistant to 1 
antimicrobial % 21 - 9.1 34 28
resistant to 2 
antimicrobials % 15 - 0 24 15
resistant to 3 
antimicrobials % 16 - 0 18 19
resistant to 4 
antimicrobials % 12 - 0 10 7
 resistant to >4 antimicrobials % 0 - 0 5 16
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
1. In Denmark C. jejuni isolates only.
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Table AB CA3. Antimicrobial resistance in C. coli from poultry, 2004
Country  A F H I ES NL
Monitoring 
program yes yes yes yes no yes
 No of isolates 
available  135 63 75
1 32 31 21
Antimicrobials 
Group
Antimicrobials 
Aminoglycosides Gentamicin N 135 46 - 32 28 21
%R 0.7 0 - 0 7 0
Amphenicols Chloramphenicol N 135 - - - - -
%R 0 - - - - -
Fluoroquinolones Ciproﬂoxacin N 135 45 - 32 28 21
%R 60.7 13 - 56.3 96 52
Enroﬂoxacin N - - 75 - - -
%R - - 62.7 - - -
Macrolides Erythromycin N 135 46 75 32 31 21
%R 9.6 4 3.9 40.6 19 5
Penicillins Ampicillin N 135 46 75 32 28 21
%R 8.9 35 18.7 34.4 32 5
Polymyxins Colistin N 135 - - - - -
%R 0.7 - - - - -
Quinolones Nalidixic acid N 135 46 - 32 28 21
%R 52.6 28 - 50 96 52
Tetracyclines Tetracyclin N 135 46 75 32 28 21
%R 39.3 61 40 56.3 86 57
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N 135 - - - - -
%R 16.3 - - - - -
Multiresistant 
isolates
fully sensitives % 30.4 - 23.4 28.1 - -
resistant to 1 
antimicrobial % 14.1 - 32 15.6 - -
resistant to 2 
antimicrobials % 24.4 - 37.3 9.4 - -
resistant to 3 
antimicrobials % 20 - 5.3 12.5 - -
resistant to 4 
antimicrobials % 5.9 - 1.3 15.6 - -
resistant to >4 
antimicrobials % 5.2 - - 18.8 - -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB CA4. Antimicrobial resistance in C. jejuni from poultry, 2004
 
Country  A DK FIN F I N ES S NL
 Monitoring 
program  yes yes yes yes yes yes yes yes yes
 No of isolates 
available  211 77 74 62 50 75 18 94 57
Antimicrobial 
Group
Antimicrobials
Aminoglycosides Gentamicin N 211 77 69 46 50 75 5 94 57
%R 0 0 0 0 2 0 0 0 0
Amphenicols Chloramphenicol N 211 77 - - - - - - -
%R 0 0 - - - - - - -
Fluoroquinolones Ciproﬂoxacin N 211 - - 45 50 - 5 - 57
%R 37 - - 13 76 - 100 - 40
Enroﬂoxacin N - - 69 - - 75 - 94 -
%R - - 0 - - 0 - 5.3 -
Macrolides Erythromycin N 211 77 69 46 50 75 18 94 57
%R 0.9 1 0 4 18 0 28 0 0
Penicillins Ampicillin N 211 - 69 46 50 75 5 94 57
%R 13.7 - 5.8 35 44 4 40 5.3 50
Polymyxins Colistin N 211 - - - - - - - -
%R 0 - - - - - - - -
Quinolones Nalidixic acid N 211 77 69 46 50 75 5 94 57
%R 36 5 4.3 28 58 0 100 5.3 40
Tetracyclines Tetracyclin N 211 77 69 46 50 - 5 94 57
%R 26.5 5 10.1 61 80 - 20 0 46
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N 211 - - - - - - - -
%R 5.7 - - - - - - - -
Multiresistant 
isolates
fully sensitives % 56.4 - 79.7 - 12 94.7 - 89.4 -
resistant to 1 
antimicrobial % 7.6 - 20.3 - 8 5.3 - 5.3 -
resistant to 2 
antimicrobials % 15.2 - 0 - 12 0 - 5.3 -
resistant to 3 
antimicrobials % 15.2 - 0 - 32 0 - 0 -
resistant to 4 
antimicrobials % 4.3 - 0 - 30 0 - 0 -
 resistant to >4 
antimicrobials % 1.4 - 0 - 6 0 - 0 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB CA5. Antimicrobial resistance in C. coli from pigs, 2004
Country  A F H I ES NL
Monitoring 
program yes yes yes yes no yes
No of isolates 
available 346 105 77
1 60 113 199
Antimicrobial 
Group
Antimicrobials
Aminoglycosides Gentamicin N 346 97 - 60 88 199
%R 1.7 0 - 13.3 15.9 0
Amphenicols Chloramphenicol N 346 - - - - -
%R 0.9 - - - - -
Fluoroquinolones Ciproﬂoxacin N 346 97 - 60 90 199
%R 35.3 24 - 68.3 83.3 7
Enroﬂoxacin N - - 77 - - -
%R - - 33.8 - - -
Macrolides Erythromycin N 346 97 77 60 113 199
%R 15.9 78 19.5 71.7 66.4 18
Penicillins Ampicillin N 346 96 77 60 88 199
%R 18.2 13 5.2 60 59.1 22
Polymyxins Colistin N 346 - - - - -
%R 0.9 - - - - -
Quinolones Nalidixic acid N 346 97 - 60 89 199
%R 32.4 38 77 58.3 86.5 8
Tetracyclines Tetracycline N 346 97 63.6 60 90 199
%R 72.8 96 - 98.3 95.6 75
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N 346 - - - - -
%R 45.1 - - - - -
Multiresistant 
isolates
fully sensitives % 48.8 - 25.3 0 - -
resistant to 1 
antimicrobial % 13.9 - 40.3 5 - -
resistant to 2 
antimicrobials % 6.1 - 27.3 13.33 - -
resistant to 3 
antimicrobials % 3.8 - 9.1 25 - -
resistant to 4 
antimicrobials % 7.5 - - 21.6 - -
resistant to >4 
antimicrobials % 19.9 - - 35 - -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
1. In Hungary including a few C. jejuni isolates.
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Table AB CA6. Antimicrobial resistance in C. jejuni from cattle, 2004
Country  A DK H I UK
Monitoring 
program  yes yes yes yes yes
No of isolates 
available  126 42 52
1 50 284
Antimicrobial 
Group
Antimicrobials
Aminoglycosides Gentamicin N 126 42 - 50 -
%R 0 0 - 2 -
Streptomycin N 126 42 - - -
%R 7.1 0 - - -
Amphenicols Chloramphenicol N 126 42 - - -
%R 0.8 0 - - -
Fluoroquinolones Ciproﬂoxacin N 126 42 - 50 284
%R 25.4 2 - 42 3
Enroﬂoxacin N - - 52 - -
%R - - 28.8 - -
Macrolides Erythromycin N 126 42 52 50 284
%R 0.8 0 5.8 6 3
Penicillins Ampicillin N 126 - 52 50 284
%R 7.1 - 7.7 14 14
Ampicillin/
Sulbactam N 126 - - - -
%R 0.8 - - - -
Polymyxins Colistin N 126 - - - -
%R 0 - - - -
Quinolones Nalidixic acid N 126 42 - 50 284
%R 27 2 - 26 8
Tetracyclines Tetracycline N 126 42 52 50 284
%R 38.1 0 32.1 40 6
Trimethopri m + 
Sulfonamides
Trimethoprim + 
Sulfonamide N 126 - - - -
%R 5.6 - - - -
Multiresistant 
isolates
fully sensitives % 65.9 - 53.8 44 74
resistant to 1 
antimicrobial % 9.5 - 28.8 18 18
resistant to 2 
antimicrobials % 7.1 - 17.3 12 5
resistant to 3 
antimicrobials % 11.1 - - 18 1
resistant to 4 
antimicrobials % 4.8 - - 6 1
resistant to >4 
antimicrobials % 1.6 - - 2 1
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
1. In Hungary including 9 C. coli isolates.
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3.2.5. Summary on Campylobacter
For human campylobacteriosis cases, the most comparable data are from countries 
in which notiﬁcation of all diagnosed human cases occur. Using only these data, the 
number of human cases in EU-15 MS appeared to have increase by 19.6% from 2003 
to 2004. The same trend is also seen in several individual MS. Seven of the new MS 
reported the number of human cases for 2004. With the exception of Czech Republic, 
who reported the highest incidence of human campylobacteriosis in the EU, the new MS 
reported incidences within ranges previously reported by EU-15 MS.
The majority of data on the prevalence of Campylobacter in food and animals originates 
from poultry and poultry products. Poultry is assumed to be one of the main sources of 
human campylobacteriosis and monitoring focus is therefore aimed at this sector of the 
food production. In meat, the highest prevalences were reported in poultry meat, whereas 
the prevalences in pig and bovine meat were considerably lower. Campylobacter were 
also isolated from a variety of other foodstuffs such as ﬁshery products (bivalve molluscs), 
cheeses and vegetables. 
Comparison between MS, or from year to year within the same MS, is difﬁcult due to 
the variability of the monitoring systems. However, in recent years the MS has reported 
increasing amounts of data on the prevalence for this pathogen in animals and food.
The reporting of antimicrobial resistance in Campylobacter from the MS and Norway, 
demonstrates the presence of a reservoir of resistant bacteria in food animals, which 
implies a potential risk for foodborne transmission to humans. Subsequent emergence 
of infections in humans, caused by resistant bacteria originating from the animal reservoir, 
is of great concern as effective treatment may be compromised.
Campylobacter isolates resistant to ﬂuoroquinolones and macrolides were detected 
from animals and meat from some MS, and this resistance is especially undesirable, 
as these drugs are used frequently to treat human campylobacteriosis. In some MS, 
the use of ﬂuoroquinolones in food animals is restricted in order to minimise emergence 
and spread of resistance. The large differences between countries in the occurrence of 
resistance to quinolones, ﬂuoroquinolones and tetracyclines in Campylobacter may 
likely be attributed to differences in antimicrobial consumption in food animals in the 
countries, and to differences in policies of antimicrobial use.
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3.2.6. Sources of Campylobacter data
With the exception of France, Germany, The Netherlands and the United Kingdom, 
human campylobacteriosis is notiﬁable in all MS and Norway (see Appendix Table CA2). 
Luxembourg, Malta, Poland and Portugal provided no information. Most MS have had 
notiﬁcations systems in place for many years. However Cyprus and Ireland have 
implemented their notiﬁcation systems within recent years (2003-2005). It should be 
noted, that Italy, despite a notiﬁcation system, reports no or very few cases annually. 
Diagnosis of human infections is generally done by culture from human stool samples 
(see Appendix Table CA1). In some countries isolation of the organism is followed by 
biochemical tests for speciation.
Campylobacter is notiﬁable in Gallus gallus in Finland and Norway, and in all animals in 
Belgium, Estonia, Latvia, Lithuania, Slovenia, Spain and The Netherlands. 
Testing for the presence of Campylobacter was predominantly carried out on fresh 
meat using the bacteriological methods ISO 10272:1995, as well as NMKL 119:1990 
(see Appendix Table CA1 for further details). For poultry sampled prior to slaughter, 
faecal material was collected either as cloacal swabs or sock samples (faecal material 
collected from the ﬂoor of poultry houses by pulling gauze over footwear and walking 
through the poultry house). At slaughter, several types of samples were collected including 
cloacal swabs, caecal contents, whole intestines and/or neck skin. 
Foodstuff samples are collected in several different contexts, i.e. continuous monitoring or 
control programmes, screenings, surveys and as part of HACCP programmes implemented 
within the food industry (see Appendix Table CA1 for further details).
Data on the occurrence of antimicrobial resistance in Campylobacter were provided 
by the following countries: Austria, Belgium, Denmark, Finland, France, Hungary, Italy, 
Lithuania, Norway, Spain, Sweden, The Netherlands and United Kingdom. These 13 
countries reported results of antimicrobial susceptibility testing of Campylobacter 
isolates from humans, various animal species and from various foods. Results were 
requested for the Community Zoonoses Report as percentage of resistant isolates out 
of the total number of isolates tested against each antimicrobial for each bacterial species 
in each speciﬁc sample category. In contrast to previous years, countries were not 
conﬁned to reporting on a deﬁned panel of antimicrobials or speciﬁc sample categories. 
This has implied large heterogeneity of data on antimicrobial resistance reported for 
2004. In order to preserve comparability of data between countries, categories in which 
several countries reported was selected for this summary. Furthermore, categories were 
selected based on their relative importance.
With the exception of a few sample categories, all countries providing antimicrobial 
susceptibility data on Campylobacter in 2004 generated the data through monitoring 
programmes. Except for Austria, Belgium and Lithuania, using disc diffusion method for 
testing of isolates from humans, all countries used dilution (MIC) methods for antimicrobial 
susceptibility testing of Campylobacter isolates. Breakpoints, concentrations and range 
of dilutions applied in individual countries for antimicrobial susceptibility testing are 
presented in Level 3, Table AB CA13.
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3.3. Listeria
The genus Listeriae comprises six species, but human cases are almost exclusively 
caused by the species Listeria monocytogenes. Listeriae are ubiquitous organisms, 
which are widely distributed in the environment, especially in plant matter and soil. 
In humans, infections most often affect the pregnant uterus, the central nervous system 
or the bloodstream. Symptoms vary; ranging from mild ﬂu-like symptoms and diarrhoea 
to life threatening infections characterised by septicaemia and meningoencephalitis. In 
pregnant women, the infection spreads to the foetus, which will either be born severely 
ill or die in the uterus resulting in abortion. Illness is often severe and mortality is high. 
Human infections are rare, but are important because of the high mortality rate associated 
with them. These organisms are amongst the most important causes of death from 
foodborne infections in industrialised countries. 
 
The main route of transmission to both humans and animals is believed to be through 
consumption of contaminated food or feed, however infection can also be transmitted 
directly from infected animals to humans as well as between humans. Cooking kills Listeria, 
but the bacteria are known to multiply at chilling temperatures up to 2-4°C, which makes 
its occurrence in ready-to-eat foods with a relatively long shelf life, particularly important. 
In domestic animals (especially sheep and goats) clinical listeriosis is usually presents 
as encephalitis, abortion, mastitis or septicaemia. 
3.3.1. Listeriosis in humans
In 2004, all MS and Norway except Cyprus, Luxembourg and Malta reported cases 
of listeriosis. Data reported here include all MS and Norway. There were 1,267 cases of 
listeriosis in the EU, which represents an incidence of 0.3 cases per 100,000 population. 
This is the same incidence as 2003. Incidences by country are reported in Table LI1, 
and ranged from 0.03 in Greece, Lithuania and Poland to 0.8 in Denmark.
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Table LI1. Reported cases of listeriosis in humans, 1999-2004, and incidence in 20041
2004 2004 2003 2002 2001 2000 1999
Cases/ 
100,000 
population
Number  
of cases
Austria 0.2 19 8 16 9 14 13
Belgium 0.7 70 76 44 57 48 64
Cyprus - - - - - - -
Czech 
Republic 0.2 16 - - - - -
Denmark 0.8 41 29 28 38 39 44
Estonia 0.2 2 - - - - 1
Finland 0.7 35 41 20 28 18 46
France 0.4 236 220 218 187 261 275
Germany2 0.4 295 255 237 216 33 31
Greece <0.1 3 0 5 3 2 1
Hungary 0.2 16 - - - - -
Ireland 0.3 11 6 6 7 7
Italy <0.1 25 0 - 31 13 17
Latvia 0.2 5 8 - - 36 -
Lithuania <0.1 1 2 - - - -
Luxembourg - - - - - - -
Malta - - - - - - -
Poland <0.1 10 - - - - -
Portugal 0.4 38 - - - - -
Slovakia 0.2 8 - - - - -
Slovenia <0.1 1 6 - - - -
Spain3 0.2 100 52 49 57 35 32
Sweden 0.5 44 48 39 67 46 27
The  
Netherlands 0.3 55 52 32 16
United 
Kingdom 0.4 236 243 150 156 115 116
EU-Total 0.3 1,267 1,046 844 872 586 667
Norway 0.5 21 18 17 18 - -
1. EU-Total incidence is based on population in reporting countries.
2. In Germany, cases were reported through a revised reporting system from 2001.
3. In Spain, only hospitalised cases are notiﬁable.
For those MS where data was available for the last ﬁve years, the reported incidence 
in 2004 was compared to the mean of the previous ﬁve years (Figure LI1). All MS, with 
the exception of Sweden, reported an increase in the incidence of listeriosis. The most 
notable increase was reported from Spain (Figure LI1).
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Figure LI1. Percent change in reported incidence of human listeriosis in 2004 
compared to the previous ﬁve-year mean (1999-2003)
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Fifty-one per cent of the reported listeriosis cases were in people aged 65 years or older 
(Figure LI2). Males and females are represented equally among the cases. There were 
55 cases associated with pregnancy, mothers and babies, reported by nine countries. 
A total of 107 (8.3%) deaths were reported. Mortality from listeriosis is usually higher, 
but under-reporting of deaths may occur in MS.
Figure LI2. Number of human cases of listeriosis by age and sex, 2004
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All reported data on listeriosis in humans are presented in Level 3, Table LI1 and LI2.
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3.3.2. Listeria in food
Findings of Listeria monocytogenes are important in three main scenarios: presence 
of L. monocytogenes on surfaces that come in direct contact with food, presence of 
L. monocytogenes in foods that are ready-to-eat (RTE) and can sustain growth of the 
bacterium and ﬁndings of L. monocytogenes in concentrations greater than 100 colony 
forming units per gram (cfu/g) in RTE. Findings of L. monocytogenes in concentrations 
less than 100 cfu/g in RTE are usually not considered signiﬁcant for human disease, 
except in vulnerable population groups.
Testing for the presence of L. monocytogenes in food was reported by 21 MS and Norway. 
Most results come from ofﬁcial food controls and own controls by the food industry, 
where high numbers of foodstuffs have been tested for L. monocytogenes. 
Findings of L. monocytogenes in the processing environment, on food contact surface 
areas, may be a source of contamination and be an indication of inadequate hygiene. 
Usually L. monocytogenes was detected very seldom, in less than 1% of the environmental 
samples, but up to 27.6% positive samples were reported by one country. Data from 
environmental results will not be presented here but is available in the Level 3, Table LI3.
Data presented here focuses on ready-to-eat foods with any ﬁndings of L. monocytogenes 
for qualitative data, and ﬁndings of L. monocytogenes with more than 100 cfu/g for 
quantitative data. 
Table LI2 summarises the range of results for qualitative Listeria ﬁndings in food. Data 
may not be directly comparable between years.
Table LI2. L. monocytogenes in food in 2003 and 2004 based on all positive ﬁndings 
of the bacterium in the 21 MS and Norway reporting data
Food item Positive ﬁndings (range) 
2004
Positive ﬁndings (range) 
2003
Bovine meat products, ready-to-eat 0-48.6% 0-10.7%
Pig meat products, ready-to-eat 0-27.6% 0-6.1%
Other meat, ready-to-eat 0-29.1% 0-21.5%
Poultry meat products, ready-to-eat 0-40% 0-32.3%
Cheeses 0-12.5% 0-4.8%
Raw milk 0-100% 0-0.3%
Dairy products, ready-to-eat 0-0.6% -
Fishery products 0-29.8% 0-13.2%
Fruits and vegetables 0-33.3% 0-1.3%
Data presented in tables LI3a-d is qualitative data where over 500 samples were tested 
and quantitative data where more than 25 samples were tested (including the use of a 
sample weight of 0.01g, which is considered to be equivalent to testing for >100 cfu/g). 
All other data is available in detail in Level 3, Table LI3.
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Ready-to-eat products of meat origin
Data on testing for L. monocytogenes in RTE products from red meat and poultry meat 
was available from 15 MS. Testing results are categorised to sampling at the retail level 
and at the processing plant.
Belgium carried out a survey for L. monocytogenes in 2004. More than 100 meat-cutting 
plants and 200 retail facilities representative of the Belgian production of carcasses 
and meat were sampled. Samples were taken from seven products: minced bovine 
meat, minced pig meat, chicken meat preparation, cooked ham, paté, salami and 
smoked salmon. L. monocytogenes was detected in 5% of samples across all foods. 
For detailed results see Table LI3a-d and Level 3, Table LI3.
Qualitative data results ranged considerably. The highest reported were from Portugal, 
where 48.6% (17 out of 35) of 25g samples of RTE bovine meat were positive. Large 
numbers of RTE bovine meat samples were tested in Germany (2,825) with a prevalence 
of 13.3% reported (Table LI3a).
Quantitative data was reported from ten countries in RTE meat products: Austria, Czech 
Republic, Denmark, Germany, Italy, Ireland, Poland, Portugal, Slovakia and Spain. Belgium 
used a semi-quantitative method able to identify samples over >100 cfu/g. (Table LI3a-d) 
L. monocytogenes in concentrations greater than 100 cfu/g was usually reported in 
small numbers. The highest reported was in Poland who reported 8.7% (2 out of 23) of 
tested pig meat products had concentrations more than 100cfu/g (data not shown). 
Spain tested 676 RTE pig meat products with 36 (5.4%) results greater than 100 cfu/g. 
Table LI3a. L. monocytogenes in ready-to-eat products of bovine meat1, 2004
N Positive % Pos >100 cfu (%)
Austria Meat products, ready-to-eat,  
at retail, (sample weight: 25g) 25 1 4.0 1 (4.0) 
Belgium Meat products (carpaccio at retail) 
(sample weight: 0.01 g) 95 0 - 0
Meat preparation, ready-to-eat,  
at retail (sample weight: 0.01 g) 110 0 - 0
Meat products, ready-to-eat,  
at retail, (sample weight: 0.01 g) 98 2 2.0 2 (2,0)
Germany Meat products, ready-to-eat,  
at processing, (sample weight: 25g) 711 42 5.9 -
Meat products, ready-to-eat,  
at retail, (sample weight: 25g) 2,825 375 13.3 -
Italy Meat products, ready-to-eat, at 
processing, (sample weight: 25g) 804 26 3.2 -
Ireland Meat products, ready-to-eat, at 
retail, qualitative/quantitative method 615/640 17 2.8 3 (0.47)
1.  Only qualitative data where over 500 samples were tested and quantitative data where more than 25 
samples were tested are presented (including the use of a sample weight of 0.01g, which is considered 
to be equivalent to testing for >100 cfu/g).
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Table LI3b. L. monocytogenes in ready-to-eat products of pig meat1, 2004
N Positive % Pos >100 cfu (%)
Belgium Cooked ham, at retail  
(sample weight: 0.01 g) 350 1 0.3 1 (0.3)
Fermented sausage, at retail 
(sample weight: 0.01g) 78 1 1.3 1 (1.3)
Minced meat, ready-to-eat,  
at retail (sample weight: 0.01 g) 152 8 5.3 8 (5.3)
Meat preparation, ready-to-eat,  
at retail, (sample weight: 0.01 g) 326 3 0.9 3 (0.9)
Czech 
Republic
Meat products, ready-to-eat,  
at retail, (sample weight: 25g), 
salami, sausages
204 8 3.9 1 (0.5)
Italy Meat products, ready-to-eat, at 
processing, (sample weight: 25g) 1,551 43 2.8 -
Meat products, ready-to-eat,  
at retail, (sample weight: 25g) 2,700 100 3.7 -
Meat products, ready-to-eat,  
at processing, HACCP (sample 
weight: 25g
2,006 12 0.6 -
Ireland Meat products, ready-to-eat,  
at processing 7,659 0 -
Meat products, ready-to-eat, at 
retail, qualitative/quantitative method 1,567/1,587 64 4.1 4 (0.3)
Portugal Meat products, ready-to-eat,  
at processing plant,  
(sample weight: 25g)
25 - - 2 (8.0)
Spain Meat products, ready-to-eat,  
at processing plant,  
(sample weight: 25g)
676 - - 36 (5.3)
1.  Only qualitative data where over 500 samples were tested and quantitative data where more than 25 
samples were tested are presented (including the use of a sample weight of 0.01g, which is considered 
to be equivalent to testing for >100 cfu/g). 
Table LI3c. L. monocytogenes in ready-to-eat products of poultry meat1, 2004
 
N Positive % Pos >100 cfu (%)
Czech 
Republic
Meat products, ready to eat,  
at retail, (sample weight: 25g), 
salami, sausages
36 1 2.8 1 (2.8)
Italy Meat products, ready-to-eat, at 
processing, (sample weight: 25g) 718 8 1.1 -
Ireland Meat products, ready-to-eat,  
at processing 3,720 1 0.0 -
Meat products, ready-to-eat, at 
retail, qualitative/quantitative method 1,601/1,667 27 1.7 2 (0.1)
1.  Only qualitative data where over 500 samples were tested and quantitative data where more than 25 
samples were tested are presented (including the use of a sample weight of 0.01g, which is considered 
to be equivalent to testing for >100 cfu/g). 
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Table LI 3d. L. monocytogenes in ready-to-eat products of other meat1, 2004
N Positive % Pos >100 cfu (%)
MEAT FROM SHEEP
Ireland Meat products, ready-to-eat, at 
retail, qualitative/quantitative method 46/49 1 2.2 2 (4.1)
RED MEAT
Germany Meat products, heat-treated, 
(sample weight: 25g) 2,382 44 1.9 2 (0.1)
Meat products, stabilised,  
(sample weight: 25g) 3,161 224 7.1 6 (0.2)
MIXED MEAT
Ireland Meat products, ready-to-eat, at 
retail, qualitative/quantitative method 102/104 5 4.9 3 (2.9)
1.  Only qualitative data where over 500 samples were tested and quantitative data where more than 25 
samples were tested are presented (including the use of a sample weight of 0.01g, which is considered 
to be equivalent to testing for >100 cfu/g). 
Milk and dairy products
Qualitative data on L. monocytogenes in raw milk intended for direct human consumption 
was provided by 11 MS. All countries, except Estonia, reported proportions of positive 
samples of less than 7%. Estonia reported 2 of 2 samples positive for Listeria. Poland 
tested 2,474 samples and found only one positive sample (0.04%). Hungary also 
reported large numbers of samples with low prevalence detected (38 positive out of 2,285). 
See text box for results from two dairy product surveys from the United Kingdom.
The United Kingdom conducted two surveys in 2004. A study of butter from production, 
retail and catering premises was carried out over two months in 2004. Thirteen of 
3,229 (0.4%) of the butter samples were positive for L. monocytogenes; all of these 
were below 10 cfu/g. The second survey tested cheeses made of raw or thermised 
milk. L. monocytogenes was detected in 0.97% (18/1,842) samples. Two samples 
contained L. monocytogenes above 100 cfu/g.
Austria was the only MS to provide quantitative data for raw milk intended for direct human 
consumption. They found no positive results from 66 samples tested.
In 2004, sixteen MS reported large numbers of other RTE dairy products, including 
cheese (Table LI4), tested for L. monocytogenes. Council Directive 92/46/EEC sets down 
a criterion of absence of L. monocytogenes in 25g for cheeses and other RTE dairy 
products. Finland reported that 5 of 90 samples of soft and semisoft cheeses made from 
raw or thermised milk tested at processing had levels greater than 100 cfu/g. Detailed 
data are provided in Level 3, Table LI1.
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Table LI4. L. monocytogenes in cheeses, 2004
Cheeses N Positive % Pos >100 cfu (%)
MADE FROM RAW OR THERMISED MILK
Belgium At retail, (sample weight 0.01g) 147 0 - -
Germany At process, (sample weight 25 g) 36 0 0 -
At retail, (sample weight 25 g) 149 1 0.7 -
Finland Soft and semisoft, at process, 
(sample weight 25 g) 90 5 5.6 5(5.6)
Soft and semisoft, at retail, 
(sample weight 25 g) 60 0 - -
United 
Kingdom
At process, (sample weight 25 g) 25 1 4.0 1 (4.0)
At retail, (sample weight 25 g) 1,817 17 0.9 1 (0.1)
MADE FROM PASTEURISED MILK
Finland Soft and semisoft, at process, 
(sample weight 25 g) 42 0 - -
Soft and semisoft, at retail, 
(sample weight 25 g) 90 0 - -
UNSPECIFIED
Austria At retail, (sample 25g) 1,666 16 1.0 4 (0.3)
Hard, at process,  
(sample weight 1 g) 653 11 1.7 3 (0.5)
Hungary At process, (sample weight 25 g) 2,744 15 0.6 -
Italy At process, (sample weight 25 g) 3,652 33 2.0 3 (0.8)
At retail, (sample weight 25 g) 2,258 18 0.8 -
Ireland At process 1,513 13 0.9 -
At retail, qualitative method 894 34 3.8 -
At retail, quantitative method 901 - - 2 (0.2)
Malta At process, (sample weight 25 g) 249 2 0.8 -
Norway At process, (sample weight 25 g) 1,875 3 0.2 -
At retail, (sample weight 25 g) 
imported data 1,856 6 0.4 -
Slovakia At retail, (sample weight 25 g) 3,196 10 0.3 -
Fishery products
Fishery products, in particular lightly preserved ﬁsh products and products cooked 
before packaging, have been identiﬁed as products at risk of contamination with 
L. monocytogenes. As a result, a number of MS have conducted special surveys in ﬁshery 
products (see text box for an example from Denmark).
In 2004, sixteen MS reported on L. monocytogenes ﬁndings in ﬁshery products (Table LI5). 
Products tested were mainly cold-smoked ﬁsh products. Some MS also tested ﬁsh, 
crabs and prepared meals. Estonia reported the highest rate of contamination with 
22.9% (25/109) of positive samples (data in Level 3, Table LI3).
Six MS provided quantitative data. Sweden reported 20.0% (13 out of 65) smoked ﬁsh 
samples tested at retail were positive at concentrations above 100 cfu/g. Finland also reported 
signiﬁcant positive ﬁndings in cold smoked ﬁsh samples (3.2% of samples >100 cfu/g).
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In 2004, Denmark conducted a study on smoked and marinated ﬁsh products. A total 
of 1,339 samples were analysed. Listeria monocytogenes was detected in 10.3% of 
samples. A total of 0.2% of samples had greater than 100 cfu/g detected.
Table LI5. L. monocytogenes in ﬁshery products, 2004
Ready-to-eat ﬁshery products N Positive % Pos >100 cfu (%)
FISH
Austria Smoked, at retail,  
(sample weight: 25g) 382 35 9.2 3 (0.8)
Belgium Smoked salmon at the end  
of shelﬂife, at retail,  
(sample weight: 0.01g)
59 2 3.4 2 (3.4)
Finland Cold smoked, at retail, survey, 
(sample weight 25g): 279 48 17.2 9 (3.2)
Gravad/slight salted, at retail, 
survey, (sample weight 25g): 285 41 14.4 5 (1.7)
Roe, at retail, survey,  
(sample weight 25g): 29 0 - -
Italy Smoked, at retail,  
(sample weight: 25g) 79 9 11.4 -
Ireland Smoked, at process,  
qualitative method 44 1 2.3 -
Smoked, at retail,  
qualitative method 29 2 6.9 -
Sweden Smoked, at retail 65 - - 13 (20.0)
OTHER FISHERY PRODUCTS 
Austria At retail, (sample weight: 25g) 772 25 3.2 1 (0.1)
Belgium At retail, (sample weight: 0.01g) 121 2 1.7 2 (1.7)
Germany1 Sample weight 25g 3,781 235 6.2 20 (1.0)
Italy At process, (sample weight 25g): 729 7 1.0 -
Ireland At retail, qualitative/quantitative 
method 439/460 18  4.1 0 
1. In Germany, the quantitative results are based on 2,060 samples only.
Other ready-to-eat products
MS reported a variety of other RTE products tested for L. monocytogenes (Table LI6). 
For complete data see Level 3, Table LI3. Rates of detection of L. monocytogenes were 
low. However, of special interest is that Ireland found in fruits and vegetables 0.9% of 
the samples harbouring L. monocytogenes over 100 cfu/g.
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Table LI6. L. monocytogenes in other ready-to-eat products, 2004
Other ready-to-eat products N Positive % Pos >100 cfu (%)
Ireland Cereals and bakery products, at 
retail, qualitative/quantitative method 429/529 11 2.6 0
Fruits and vegetables, at retail, 
qualitative/quantitative method 279/320 13 4.7 3 (0.9)
Czech Republic Salads with dressing,  
qualitative method 24 4 16.7 -
Ireland Egg products at retail,  
qualitative/quantitative method 460/472 13 2.8 0
Ices and deserts at retail, 
qualitative/quantitative method 181/251 3 1.7 0
Prepared food, at retail,  
qualitative/quantitative method 2,627/2,871 112 4.3 1 (0.03)
Soups, at retail,  
qualitative/quantitative method 354/372 1 0.3 0
Sweden Prepared food,  
quantitative method 30 - - 2 (5.8)
Italy Other RTE product, (sample 
weight: 25g), qualitative method 976 11 1.1  -
3.3.3. Listeriosis in animals
Cases of listeriosis in animals were reported in Sweden, mainly in sheep.
3.3.4. Summary on Listeria
Listeriosis is an important disease in Europe due to high morbidity and mortality in 
vulnerable populations, although it remains a relatively rare disease in the EU. The reported 
incidence of human listeriosis in 2004 was the same as in 2003. However, in countries 
with several years of data the incidence of human listeriosis reported has increased in 
2004 when compared with the mean of the previous ﬁve years.
The lower than expected reported mortality rate (8.3%) might be due to a lack of data 
on patient outcomes after the initial notiﬁcation. To assess the burden of listeriosis in the 
EU community better harmonisation of data collection systems is required. 
All new MS, except Cyprus and Malta, reported listeriosis for the ﬁrst time in 2004. Listeriosis 
reported by new MS represented only 6.7% of all cases reported. It is likely that the number 
of cases reported would increase as surveillance systems in these countries improve.
Testing for the presence of L. monocytogenes in food was performed in 21 MS and 
Norway. Qualitative results range from 0-100%. Foodstuffs that are contaminated with 
more than 100 L. monocytogenes bacteria per gram, and that are to be consumed without 
further heat-treatment are considered to form a direct risk to human health. In this 
aspect, most signiﬁcant ﬁndings are reported from ﬁshery products with up to 20% 
of samples positive for L. monocytogenes at concentrations greater than 100 cfu/g. 
Results higher that 100 cfu/g were also reported from cheeses, some meat products 
and other foodstuffs. These food categories have been typically identiﬁed as risk products 
for contamination with Listeria. 
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MS conduct and report food-testing data variably. Some MS conduct large surveys 
with numerous samples whilst others report very small numbers. Data on sample sizes 
and testing protocols was not always provided and so comparison between MS is 
difﬁcult. The majority of MS report qualitative data only i.e. the presence or absence 
of L. monocytogenes in food. It is generally considered that concentrations of L. 
monocytogenes greater than 100 cfu/g are required to cause human disease in healthy 
populations, therefore qualitative results alone are not necessarily an indicator of risk.
3.3.5. Sources of Listeria data
Listeriosis is a notiﬁable disease in humans in all MS and Norway, with the exception of 
Cyprus, The Netherlands and the United Kingdom. Luxembourg did not provide any 
data in 2004. See the Appendix, Table LI2.
Listeria in animals is notiﬁable in 11 MS: Belgium, Estonia, Finland, Greece, Latvia, 
Lithuania, Slovakia, Slovenia, Spain, Sweden and The Netherlands, and Norway.
Testing for the presence of Listeria in food is reported in all MS and Norway. Details 
of testing and surveillance programmes are found in Appendix, Table LI1. Surveillance 
in ready-to-eat foods is performed in most MS. Data reported here focus on Listeria 
ﬁndings in foods considered to be a risk to human health.
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3.4. Verotoxigenic Escherichia coli 
Verotoxigenic Escherichia coli (VTEC) are strains of the bacterium E. coli capable of 
producing certain cytotoxins. Enterohemorrhagic E. coli, commonly referred to as EHEC, 
are a subset of the VTEC harbouring additional pathogenic factors. Over 150 different 
serotypes of VTEC have been associated with human illness. The majority of reported 
outbreaks and sporadic cases of VTEC infections have been associated with serotype O157. 
The spectrum of symptoms associated with VTEC infections ranges from mild to 
bloody diarrhoea, often accompanied by severe abdominal cramps but usually without 
fever. VTEC infection can also result in haemolytic uraemic syndrome (HUS). HUS is 
characterised by acute renal failure, anaemia and lowered platelet counts. HUS develops 
in up to 10% of patients infected with VTEC O157 and is the leading cause of acute 
renal failure in young children.
Infection may be acquired through consumption of contaminated food (predominantly 
bovine meat and raw milk) or water, or by direct transmission from person to person or 
from infected animals to humans.
Animals may be infected without displaying symptoms. Cattle and calves are usually 
asymptomatic carriers and are probably the main reservoir of strains associated with 
human disease. However, VTEC strains have also been found in other animals such as 
sheep, goats, pigs and wild game.
3.4.1. VTEC in humans
Human cases of VTEC infections were reported by 18 countries (17 MS and Norway). 
In 2004, a total of 4,143 laboratory-conﬁrmed VTEC cases was reported, yielding a 
community incidence of 1.3 cases per 100,000 population. The highest incidence, 17.1 
cases per 100,000 population, was reported by the Czech Republic. The remaining MS 
reported incidences ranging from 0.1 to 3.0.
For 10 MS reporting cases of VTEC infections both in 2004 and 2003, there were 2,294 
laboratory conﬁrmed VTEC cases reported in 2004 compared to 2,377 cases in 2003. 
In 2004, 50% of the cases were caused by VTEC O157 and 25% by other VTEC serotypes. 
This distribution is similar to what was reported for 2003. For the remaining cases, no 
information on the serotype distribution was available (Table VT1). The laboratory-diagnostic 
methods used by the MS to detect VTEC are usually speciﬁc for VTEC O157. Therefore, 
VTEC serotypes other than O157 may well be underreported.
In Austria, the number of human VTEC non-O157 cases in 2004 almost tripled compared 
to 2003 (10 to 32 cases), while the number of O157 cases remained at approximately the 
same level (18 to 13). This increase could possibly be attributed to two outbreaks involving 
environmental transmission and animal contact. 
In Denmark, incidence of this disease has been steadily increasing since 1997, in part 
due to improvements in diagnostic methods and reporting systems. The number of 
reported VTEC cases increased by 27% in 2004 compared to 2003. This increase was 
mainly attributed to an outbreak caused by contaminated pasteurised milk. 
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Table VT1. Reported cases of laboratory conﬁrmed VTEC infections, except HUS, 
in humans, 2003 and 2004, and incidences1 in 2004
2004 2004 2003
Cases/ 
100,000 
population
No. of 
laboratory 
conﬁrmed 
cases
% O157 % Other 
VTEC
No. of 
cases
% O157 % Other 
VTEC
Austria 0.6 45 29 71 28 64 36
Belgium 0.3 36 56 44 39 36 64
Cyprus - - - - - - -
Czech 
Republic 17.1 1,743 18 0 - - -
Denmark 3.0 163 27 73 128 21 79
Estonia 0 0 0 0 0 0 0
Finland 0.2 10 40 60 14 43 57
France - - - - - - -
Germany 1.1 903 10 42 1,100 11 39
Greece - - - - - - -
Hungary <0.1 7 71 29 - - -
Ireland 1.4 57 88 12 90 93 7
Italy 0 3 100 0 5 40 60
Latvia - - - - - -
Lithuania - - - - - - -
Luxembourg - - - - - - -
Malta - - - - - - -
Poland 0.2 81 99 1 - - -
Portugal - - 3 cases 22 cases 9 0 100
Slovakia 0.3 16 0 100 - - -
Slovenia 0.1 2 - - - - -
Spain - - - - - - -
Sweden2 1.7 149 - - 52 - -
The  
Netherlands 0.2 30 100 0 51 98 -
United 
Kingdom 1.5 898 99 1 870 93 1
EU-Total 1.3 4,143 - - 2,401 - -
Norway 0.3 12 7 5 15 80 20
1. EU-Total incidence is based on population in reporting countries.
2. Prior to 2004, only VTEC 0157 was notiﬁable in Sweden.
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Table VT2. Reported cases of HUS caused by VTEC infections in humans, 2003 and 
2004, and incidences1 in 2004
2004 2004 2003
Cases/ 
100,000 
population
No. of 
cases
% O157 % Other 
VTEC
No. of 
cases
% O157 % Other 
VTEC
Austria 0.12 10 90 10 11 91 9
Belgium <0.1 9 100 0 8 88 13
Cyprus - - - - - - -
Czech Republic - - - - - - -
Denmark <0.1 5 60 40 3 100 0
Estonia 0 0 0 0 0 0 0
Finland - - - - 1 0 100
France 0.10 61 82 18 51 82 35
Germany <0.1 42 67 10 61 72 10
Greece 0.76 84 - - - - -
Hungary <0.1 2 0 100 - - -
Ireland 0.10 4 50 50 5 80 20
Italy <0.1 17 24 76 13 8 92
Latvia - - - - - - -
Lithuania - - - - - - -
Luxembourg - - - - - - -
Malta - - - - - - -
Poland - - - - - - -
Portugal - - 1 case 1 case 3 0 100
Slovakia - - - - - - -
Slovenia - - - - - - -
Spain - - - - - - -
Sweden <0.1 5 100 0 6 100 -
The  
Netherlands <0.1 5 100 0 7 100 -
United 
Kingdom <0.1 37 95 5 32 84 3
EU-Total <0.1 281 203
Norway <0.1 1 100 2 50 50
1. EU-Total incidence is based on population in reporting countries.
A total of 281 laboratory-conﬁrmed HUS cases were reported in 13 MS, of which 
VTEC O157 caused 53% of the cases, and 13% were caused by other VTEC serotypes. 
The overall incidence of HUS caused by VTEC in 2004 was 0.1. In the 10 MS reporting 
cases of HUS in 2004 and 2003, the number of cases remained at the same level in the 
two years, 195 and 199, respectively (Table VT2). 
Of the new MS, this disease became notiﬁable in Lithuania in 2004. In Hungary, since 
2000, half of the public health laboratories routinely screen primary faecal cultures for 
verotoxin. Slovakia performs targeted investigations based on clinical suspicion.
The non-MS, Norway, reported 13 cases of VTEC, one of which was a HUS case.
For additional information on data provided on VTEC in humans, please, refer to Level 3, 
Table VT1 and VT2.
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3.4.2. VTEC in food
Testing for the presence of VTEC in food was performed in 18 MS and Norway. In total, 
there were 41,929 foodstuff samples tested, and 1% of these were positive for VTEC. 
Cyprus, Estonia, Norway, Slovenia and Sweden did not detect any VTEC in food from 
the samples tested, which varied by types of food sampled and number of samples 
collected. The Czech Republic, France, Latvia, Lithuania, Luxembourg, Malta and the 
United Kingdom did not report data for VTEC in food. All data results for food are 
summarised in Level 3, Table VT3. Only results deriving from more than 25 samples 
tested are addressed below.
The sampling and testing procedures varied between the countries, and therefore the 
results from the different MS are not directly comparable.
Nine MS provided data on VTEC in bovine meat and products thereof (Table VT3). 
In fresh bovine meat, proportions of positive samples varied usually between 0.2-4%, 
although Poland and Italy reported higher ﬁgures, 8.3% and 38.2% respectively. 
VTEC was also detected in ready-to-eat meat preparations and meat products.
Germany reported 2.4% of raw cow milk samples were positive for VTEC. This represents 
a higher proportion than what was observed 2003, where 0.1% of 818 tested samples 
were positive (Table VT3).
Table VT3. VTEC in fresh bovine meat and cow milk, 2004. Data are only presented 
for sample sizes >25 with positive ﬁndings
Bovine meat Cow Milk 
Description N % Pos Description N % Po
Belgium Fresh, at slaughter 1,319 1.4 - - -
Fresh, at processing 244 0.8 -
Minced meat, at retail 98 1.0 - - -
Meat preparation, 
steak tartare, at retail 109 0.9 - - -
Germany Fresh, at processing 28 0 -
Fresh, at retail 102 2.9 Raw at farm 205 2.4
Ireland Fresh, at processing 6,715 0.2 - - -
Meat products,  
non ready-to-eat,  
at processing
309 0.3 - - -
Italy Fresh, at processing 34 38.2 - - -
Poland Fresh, at slaughter 144 8.3 - - -
Portugal - - - - 25 0.0
Slovakia Fresh, at processing 54 0 Heat treated 203 0.0
- - - Raw 83 0.0
Spain Meat products,  
at processing 25 4.0 - - -
Findings of VTEC were also reported in cheeses, ﬁshery products and different types of 
meat. (Table VT4).
Four countries reported positive ﬁndings of VTEC in pig meat. In fresh meat the proportion 
of positives varied between 0.7-16%, being lower at the retail level.
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In poultry meat, Spain reported 17.4% of samples (4 from 23 samples) were positive at 
processing. Ireland tested 28 turkey meat and meat product samples at processing and 
retail levels, without ﬁnding any VTEC.
Germany reported 12.6% of the 349 red meat samples positive for VTEC, while none of 
the 100 tested samples in Slovenia were positive. Ireland found one positive sample 
when testing 120 fresh sheep meat samples, while Norway found no positive among 
243 samples tested. Norway also tested 33 fresh goat meat samples at slaughter, but 
found no positives.
VTEC positive ﬁndings in dairy products were reported by ﬁve MS. Slovakia detected 
one sample positive out of the 626 sheep milk cheeses analysed. Germany reported 
0.3% positive samples in dairy products made from raw milk. Neither Belgium nor 
Sweden found VTEC from 147 and 109 samples of cheeses made from raw or thermised 
milk tested, respectively.
Two countries, Italy and Spain, reported VTEC ﬁndings in ﬁshery products without 
specifying the products tested. Ireland and Slovakia tested 333 and 100 fruit and 
vegetable samples, respectively, without positive ﬁndings. 
Table VT4. VTEC ﬁndings in other food, 2004. Data are only presented for sample 
sizes >25 with positive ﬁndings
Country Description Place of sampling N
VTEC VTEC, O157
Pos % Pos Pos % Pos
DAIRY PRODUCTS
Germany Made from raw milk 303 1 0.3 - -
Greece 359 11 3.1 - -
Italy 1,765 9 0.5 4 0.2
Portugal 49 1 2 - -
Slovakia Sheep milk cheeses 626 1 0.16 - -
FISHERY PRODUCTS
Italy 423 13 3.1 - -
Spain 319 22 6.9 - -
PIG MEAT
Ireland Meat products At processing plant 110 2 1.8 2 1.8
Italy Fresh At retail 121 1 0.8 1 0.8
Spain Fresh At retail 142 1 0.7 1 0.7
Fresh At slaughter 97 1 1 - -
Meat products At processing plant 90 1 1.1 - -
Portugal Fresh At processing plant 25 4 16 - -
Fresh At retail 74 4 5.4 - -
POULTRY MEAT
Spain Fresh At retail 188 2 1.1 - -
Fresh At slaughter 58 1 1.7 - -
SHEEP MEAT
Ireland Fresh At processing plant 120 1 0.8 1 0.8
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3.4.3. VTEC in animals 
Eleven MS (Austria, Belgium, Denmark, Finland, Germany, Greece, Latvia, Portugal, Poland, 
Sweden and The Netherlands) and Norway reported on VTEC in a number of animal species.
Several MS conducted testing for VTEC in cattle (Table VT5). For the most part, the 
purpose of monitoring was to detect the presence of E. coli O157. Samples were either 
collected at the slaughterhouse or at the farm. In Belgium, Finland, Norway and Sweden, 
targeted sampling was carried out as a follow-up of E. coli O157 infections in humans or 
ﬁndings in animals.
VTEC O157 in cattle and bovine meat in Finland
In Finland, a compulsory control programme for all bovine slaughterhouses started in 
January 2004. Faecal samples were collected by industry at a frequency based on 
the expectancy rate of 1%, accuracy of 0.5% (CI 95%). The number of samples to be 
collected at the different slaughterhouses was calculated based on slaughter capacity, 
and sampling was distributed throughout the year. VTEC O157 was detected in 20 
animals from 15 farms. However, VTEC O157 could not be isolated from samples  
collected from six of these 15 farms. 
A second project to detect the herd point-prevalence of VTEC O157 was conducted 
in Finland in 2004. A total of 72 conventional farms, selected as they sent animals for 
slaughter during a prevalence study carried out in 2003, as well as 57 organic farms, 
participated in this project. VTEC O157 was found in 5.7% of these farms.
The highest proportion of positive animals was observed in Germany where 24.1% of 29 
dairy cows were found positive. In total, 13.6% of cattle were found positive for VTEC, 
two of which were positive for VTEC O177. Slightly lower proportions were reported from 
meat production animals in Denmark and Finland. Denmark reported 8.4% of animals 
tested positive for VTEC O157. Finland reported 10% of meat production herds positive 
from survey results. 
Table VT 5. VTEC in cattle, 2004
Remark N VTEC % Pos O157 Non-O157
Austria Cattle at slaughter 287 7 2.4 - -
Belgium Animals 59 2 3.4 - -
Denmark Meat production, 
animals 251 21 8.4 - -
Finland At slaughter, animals 1,603 20 1.2 20 0
Dairy cows, herds 67 1 1.5 1 0
Meat production 
animals, herds 50 5 10 5 0
Germany Animals 273 37 13.6 - 2
Dairy cows, animals 29 7 24.1 - -
Calves, animals 97 0 0 - -
Italy Survey, animals 154 0 0 - -
Calves, animals 308 3 1 0 3
Portugal Animals 241 0 0 - -
Slovakia Calves, animals 100 0 0 - -
The Netherlands Dairy cows, herds 153 13 8.5 - -
Veal calves, herds 171 23 13.5 - - 
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VTEC was also found in animals other than cattle. Three out of 5 reporting countries 
reported positive ﬁnding of VTEC in pigs (see Table VT6 and in Level 3, Table VT4). Few 
ﬁndings of VTEC in goats and sheep were reported, however Italy detected VTEC O157 
in three out of 32 goats tested.
Only four MS reported data on poultry and VTEC was not detected by three of them. 
However, in Italy, 11 out of 58 samples of poultry tested were VTEC positive. A monitoring 
programme in turkeys was also conducted Italy, and none of the 115 animals tested 
were found positive. Finally, Italy also tested 168 wild deer without isolating any VTEC.
Table VT 6. VTEC in other animals, 2004
Remark N VTEC % Pos O157
PIGS
Germany - 209 18 8.6 -
Italy Survey 97 0 0 -
Latvia - 81 4 4.9 1
Portugal - 397 22 5.5 -
Slovakia - 135 0 0 -
POULTRY
Italy - 58 11 19 -
Turkey ﬂocks 115 0 0 -
Greece - 58 0 0 -
Latvia - 121 0 0 -
Portugal - 205 0 0 -
GOATS AND SHEEP
Austria Goats and sheep 89 1 1.1 0
Greece Goats and sheep 74 0 0 -
Italy Goats 32 3 9.4 3
Italy Goats and sheep, survey 585 0 0 -
Portugal Goats and sheep 158 2 1.3 -
OTHER
Italy Deer 168 0 0 -
Small numbers of samples from pets were investigated (sample sizes ranged from 1-45) 
and reported by six MS. The majority of these samples were collected from dogs and 
the vast majority of the samples were negative. 
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3.4.4. Summary
The overall number of human cases reported in the EU increased in 2004 compared to 
2003. The majority of the increase was reported by the Czech Republic, who contributed 
with 42% of the total number of cases. By comparing only those MS who reported 
data for both years, the total number actually decreased by 3% from 2003 to 2004. 
The number of cases of HUS caused by VTEC remained similar to that reported in 2003.
A total of 18 MS and Norway reported data on the occurrence of VTEC in foodstuffs. 
Fresh meat, milk and dairy products were the food categories most often tested, and 
positive ﬁndings occurred from all of them. VTEC was reported from bovine, pig, sheep 
and poultry meat. Two MS reported relatively high proportions of positive samples in ﬁshery 
products, and the relevance of these ﬁndings to human health deserves further study.
The occurrence of VTEC in animals was mainly monitored through collection of faecal 
samples at slaughter. Positive ﬁnding were detected in several farm animal species: cattle, 
goats, sheep, and pigs. The reported prevalences varied and the data received does 
not permit the evaluation of differences between animal species or MS. Information on 
pathogenicity factors of the isolated VTEC strains was not provided.
3.4.5. Sources of VTEC data 
In humans, VTEC infections are notiﬁable in 14 MS: Austria, Czech Republic, Denmark, 
Estonia, Finland, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Poland, Slovenia, 
and The Netherlands (see Appendix, Table VT2). In Norway, notiﬁcation of VTEC in 
humans has been mandatory since 1995. In Sweden, as of 1 July 2004, all serotype of 
VTEC are notiﬁable in humans. EHEC is notiﬁable in Greece. In Cyprus, EHEC will be a 
notiﬁable disease as of January 2005.
Food samples were collected in a variety of settings such as ofﬁcial control and monitoring 
programmes, random national surveys and as part of HACCP or own check programmes. 
The number of samples collected and types of food sampled varied among individual MS.
 
In animals, VTEC is notiﬁable in Estonia, Finland, Lithuania and Slovenia. In Sweden, 
VTEC O157 became notiﬁable in cattle in 1996, however, since 1996, ﬁndings are notiﬁable 
only when associated with human infections. In Belgium, VTEC ﬁndings will become 
notiﬁable in animals as of 2005. Samples were, for the most part, collected as faecal 
samples or carcass swabs at slaughter.
For further details on surveillance and monitoring, please refer to Appendix, Table VT1.
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3.5. Tuberculosis due to Mycobacterium bovis
Tuberculosis is a chronic disease caused by granulomatous infections with either 
Mycobacterium tuberculosis or M. bovis. M. avium is also able to cause diseases 
in humans, especially in immunocompromised persons. Man is the natural host for 
M. tuberculosis and birds for M. avium. M. bovis causes tuberculosis in cattle, but is also 
highly infectious in humans, which poses a serious zoonotic risk. Tuberculosis in 
humans caused by M. bovis is clinically indistinguishable from infections caused by 
M. tuberculosis. This chapter focuses on zoonotic tuberculosis caused by M. bovis.
Transmission of tuberculosis from animals to humans occurs mainly through consumption 
of raw milk from infected cattle. It may be prevented by heat-treatment such as 
pasteurisation of milk and milk products. The introduction of pasteurisation and eradication 
programmes implemented in cattle in combination with vaccination of humans has 
signiﬁcantly reduced human infections caused by M. bovis.
3.5.1. M. bovis in humans
In many MS, the notiﬁcation systems do not distinguish between the different species 
of mycobacteria, or only a subset of the Mycobacteria isolates is speciated. Thus, even 
though tuberculosis in humans is notiﬁable, the reported number of human cases due to 
M. bovis can be much higher than reported here. Due to this, a Community incidence for 
human M. bovis infections was not estimated.
In 2004, the 17 MS that included data on human M. bovis cases reported a total of 86 
cases (Table TB1). This number is much higher than reported 2001-2003, where approx. 
60 cases occurred annually, mainly because German data were included in 2004. 
The risk of contracting tuberculosis from domestic animals in MS that are ofﬁcially free 
of bovine tuberculosis (OTF) is assumed to be extremely low, and none of the MS 
reported suspicions of contact with animals as source of infection for human cases of 
M. bovis in 2004. This was also the case in 2003. 
Six MS included information on whether the tuberculosis infection was acquired 
domestically or abroad, and three MS reported imported cases for M. bovis, speciﬁcally 
(Table TB1). In MS where bovine tuberculosis has been eradicated, domestic cases are 
usually considered to be reactivations of pre-existing infections in elderly persons or 
immigrants, such as the single domestic case reported from Denmark in 2004. 
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Table TB1. Total number of human tuberculosis cases reported infected with 
M. bovis, 1999-2004. OTF status in 2004 is indicated, and numbers of imported 
cases are noted in brackets
2004 2004 2003 2002 2001 2000 1999
Cases/ 
100,000 
population
No. of cases: Total (Imported)
Austria1 (OTF) <0.1 4 4 4 5 0 0
Belgium (OTF) <0.1 5 5 2 2 0 0
Cyprus 0.14 1 (1) - - - - -
Czech Republic 
(OTF) - - - - - - -
Denmark (OTF) <0.1 2 (1) 1 2 4 12 2
Estonia 0 0 - - - - -
Finland (OTF) 0 0 0 0 0 0 0
France (OTF) - - - - - - 22
Germany (OTF) <0.1 51 - - - - 64
Greece 0 0 0 0 0 93 -
Hungary 0 0 - - - - -
Ireland <0.1 2 6 7 3 1 8
Italy2 <0.1 5 1 4 0 0 -
Latvia 0 0 - - - - -
Lithuania 0 0 0 - - - -
Luxembourg 
(OTF) - - - - - - -
Malta - - - - - - -
Poland - - - - - - -
Portugal - - - - 0 - -
Slovakia - - - - - - -
Slovenia 0 0 - - - - -
Spain3 <0.1 4 6 2 3 5
Sweden (OTF) <0.1 4 (2) 5 7 5 5 2
The Netherlands 
(OTF) - - - 8 10 13 19
United 
Kingdom <0.1 8 30 20 30 21 40
EU-Total 86 58 56 62 150 159
Norway (OTF) 0 0 0 1 (1) 1 (1) 2 (2) 1 (1)
Note: Not all MS report M. bovis separately, or only type a subset of the isolates. Therefore even when 
tuberculosis is notiﬁable, the reported number of M. bovis can be much higher. 
1.  In Austria, M. bovis spp. caprae was isolated in 3 out of 4 cases in 2004 and 2003, in 1 out of 4 cases 
in 2002 and in 1 out of 5 cases in 2001.
2.  In Italy, the following six provinces were OTF: Bergamo, Lecco, Sondrio, Ascoli Piceno, Bolzano and Trento.
3. In Spain, only hospitalised cases are notiﬁable.
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3.5.2. Tuberculosis due to M. bovis in animals
Cattle
The status of bovine tuberculosis in the European Union and Norway in 2004 is 
presented in Figure TB1. Austria, Belgium, Czech Republic, Denmark, Finland, France, 
Germany, Luxembourg, The Netherlands, Sweden and Norway were ofﬁcially bovine 
tuberculosis-free in accordance with the Community legislation. Six provinces of Italy 
had this status, as well. All reported data are presented in Level 3, Table TB3 and TB4.
Figure TB1. Status of bovine tuberculosis in the EU and Norway, 2004
Ofﬁcially Tuberculosis Free Member States (OTF)
Bovine tuberculosis was detected in cattle herds during the year in two of the 10 OTF MS, 
Belgium and France (Table TB2). In these two countries, together 51 herds were tuberculin 
test positive in 2004. In the non-MS, Norway, no infected herds or animals were reported.
Non-OTF Member States
During 2004, tuberculin test positive cattle herds were detected in eight of the 15 non-OTF 
MS (Table TB2). In these 15 MS, between 30-100% of the cattle herds were under 
ofﬁcial control during 2004. In total, 1.11% of the herds tested in the non-OTF MS were 
detected tuberculin positive in 2004 (12,625 positive out of 1,139,427 herds tested).
In Cyprus, Estonia, Latvia, Lithuania, Malta, Slovakia and Slovenia no herds tested positive 
during the year. These are all new MS that not yet have acquired OTF status according 
to EU legislation. Overall, in the new non-OTF MS, only 0.02% of the tested herds (126 
out of 618,098) were tuberculin positive during the year 2004 (Table TB2). Poland and 
Hungary accounted for the positive herds.
Overall, a decrease in the proportion of infected herds in most non-OTF EU-15 MS has 
occurred since 2001(Figures TB2 and TB3). In the non-OTF EU-15 MS, a total of 1.72% herds 
(12,526 out of 521,329 herds tested) were tested positive for bovine tuberculosis in 2004. 
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Table TB2. Notiﬁcation of bovine tuberculosis and routine tuberculin testing in cattle 
herds in MS and Norway, 2004
Herds Routine testing At year end
Under 
control
% Under 
control
Tested Herds 
positive
% positive 
herds
Infected 
herds
% OTF 
herds
Cyprus 341 92 81 0 0 0 -
Estonia 6,548 70 6,548 0 0 0 -
Greece1 31,097 83 11,273 136 1.21 136 69
Hungary 26,218 - 26,218 1 0 1 100
Ireland 124,414 - 120,290 3,595 2.99 3,852 96
Italy2 187,098 101 100,508 1,110 1.10 674 62
Latvia 71,799 100 71,799 0 0 0 -
Lithuania1 195,226 100 195,226 0 0 0 100
Malta1 154 37 78 0 0 0 100
Poland 260,907 30 260,907 125 0.05 34 100
Portugal1 90,292 100 67,468 178 0.26 82 95
Slovakia1 11,355 62 10,188 0 0 0 97
Slovenia1 46,041 99 47,053 0 0 0 103
Spain1 154,610 63 151,723 2,735 1.80 2,742 96
United 
Kingdom 120,931 109 70,067 4,772 6.81 1,491 96
EU-10, Total 
non-OTF 640,434 51 618,098 126 0.02 35
EU-15, Total 
non-OTF 708,442 87 521,329 12,526 1.72 8,977
EU-25, Total 
non-OTF 1,348,876 64 1,139,427 12,652 1.11 9,012
Ofﬁcially tuberculosis free (OTF)
Austria 86,034 - - - 0 100
Belgium 42,553 3,371 8 0.24 4 100
Czech 
Republic 27,806 12,829 0 0 0 100
Denmark - - - - 0 100
Finland 22,882 - - - 0 100
France 283,124 118,563 43 0.04 65 88.2
Germany 32,412 - - - - -
Luxembourg 2,000 0 - - 0 100
Sweden - 0 - - 0 100
The  
Netherlands 59,524 - - - 0 100
EU-25 total 12,703
Norway 22,500 0 - 0 100
1.  The % herds under control are based on the reported number of holdings, so the proportions can be 
overestimated. All others are based on number of reported herds.
2. In Italy, six provinces are ofﬁcially tuberculosis free.
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Figure TB2. Proportion of cattle herds tested tuberculin positive in routine testing 
during the years 2000 to 2004 in selected non-OTF Member States
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Compared to 2003, the proportion of cattle herds tested positive for bovine tuberculosis 
during the year decreased in Spain, Greece and Ireland, remained at the same level in 
Portugal and slightly increased in Italy and United Kingdom (Figure TB2). However, the 
proportion of cattle herds infected at the year end decreased both in Italy and the United 
Kingdom when compared to 2003 (Figure TB3). All the non-OTF EU-15 MS perform 
national eradication programmes for bovine tuberculosis, most of which are co-ﬁnanced 
by the Community. 
Figure TB3. Proportion of cattle herds infected with M. bovis at the end of year 
1999 to 2004 in selected non-OTF Member States. 
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Note: For the United Kingdom, year 2000 and 2004 only include data from Great Britain.
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Tuberculosis due to M. bovis in other animals
Surveillance of tuberculosis in sheep and goats is performed mostly by post mortem meat 
inspection. In addition, results from other bacteriological investigations are sometimes 
reported. Findings of M. bovis are notiﬁable in Finland, Ireland, Sweden and Norway. 
In 2004, M. bovis was detected in sheep in United Kingdom, and in goats in Portugal 
and Spain. Previously M. bovis in sheep or goats was also reported from France 2002, 
Ireland (1999 and 2000), Portugal (1999, 2002, 2003), Spain (2000 and 2001) and United 
Kingdom (2001 and 2002).
Surveillance of tuberculosis in pigs is performed mostly by post mortem meat inspection. 
Findings of M. bovis in pigs are notiﬁable in Denmark, Finland, Sweden and Norway. 
In 2004, M. bovis in pigs was only detected in United Kingdom, which was also the case 
in 2002 and 2003. 
Surveillance of tuberculosis in farmed deer is also performed mostly by post mortem 
meat inspection, but in some MS also by intradermal tuberculin tests in herds. M. bovis 
is notiﬁable in farmed deer in Denmark, Finland, Ireland, Sweden, Norway and Great 
Britain. As in the previous years, no positive ﬁndings were reported from farmed deer 
(herds/animals) during 2004. 
 
With the exception of Finland, Sweden and Norway, tuberculosis in wildlife is not notiﬁable 
in the MS. In wildlife populations, M. bovis was reported in deer (Spain and United Kingdom), 
in wild boars (Spain) and badgers (United Kingdom) in 2004. This occurrence is comparable 
to numbers reported for previous years.
All reported data from farmed deer are presented in Level 3, Table TB5, and from other 
animals in Level 3, Table TB6 and TB7.
3.5.3. Summary on M. bovis
In 2004, the total number of human cases (86) was much higher than in 2001-2003 
(approx. 60 cases annually). This increase was mainly due to the inclusion of German 
data in 2004. The notiﬁcation systems in most MS do not distinguish between the different 
types of Mycobacteria, or only a subset of the isolates are speciated, so a Community 
incidence for human M. bovis infections and an overall trend cannot be estimated.
The risk of humans contracting tuberculosis from domestic animals in the OTF MS 
and the new MS is assumed to be extremely low. In these MS, domestic cases in 
humans are usually considered to be reactivation of pre-existing infections in elderly or 
immunosuppressed persons or infections in immigrants. 
The occurrence of bovine tuberculosis among cattle herds in the non-OTF EU-25 MS 
generally decreased or showed an insigniﬁcant increase. Most of the new MS do not yet 
have OTF status according to the EU legislation, but the proportion of cattle herds that 
tested positive in tuberculin test, was relatively low in these MS compared to the old 
non-OTF MS. 
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3.5.4. Sources of tuberculosis data 
Tuberculosis in humans is notiﬁable in 22 MS and Norway. Luxembourg, Malta and 
Poland provided no information on their notiﬁcation systems. In several of the reporting 
MS, the notiﬁcation system for human tuberculosis does not distinguish the tuberculosis 
cases caused by different species of Mycobacterium (Appendix Table TB1).
Rules for intra-Community trade on bovine animals including requirements for cattle 
herds and countries qualiﬁcation as ofﬁcially free from tuberculosis are laid down in 
Council Directive 64/432/EEC as last, amended by Regulation (EC) 1226/2002. 
Community co-ﬁnancing of programmes for eradication of bovine tuberculosis in 2004 
were approved for Greece, Spain, Ireland, Italy, Lithuania, Poland, Portugal, Slovenia 
and United Kingdom (Commission Decision 2003/849/EC).
The non-MS, Norway, is Ofﬁcially Tuberculosis Free, and monitors M. bovis according to 
the EU directives. An overview of the OTF status is presented in Appendix Table TB-BR1.
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3.6. Brucella
Brucellosis is an infectious disease caused by some bacterial species of the genus Brucella. 
There are four species known to cause human disease and each of these has a speciﬁc 
animal reservoir: B. abortus in cattle, B. canis in dogs, B. melitensis in goats and sheep 
and B. suis in pigs. Transmission occurs through contact with animals, or animal tissue 
contaminated with the organisms, or through ingestion of contaminated products. 
In humans, brucellosis is characterised by ﬂu-like symptoms such as fever, headache, and 
weakness of variable duration. However, severe infections of the central nervous systems 
or endocarditis may occur. Brucellosis can also cause long-lasting or chronic symptoms 
that include recurrent fever, joint pain and fatigue. Of the four species known to cause 
disease in humans, B. melitensis is the most virulent and causes the most severe illness.
In animals, the organisms are localised in the reproductive organs causing sterility and 
abortions, and are shed in large numbers in the animal’s urine, milk and placental ﬂuid.
3.6.1. Brucellosis in humans
In 2004, a total of 1,337 cases of human brucellosis were reported from 21 MS (Table BR1), 
resulting in a Community incidence (EU-25) of 0.4 cases per 100,000 population. 
No data were provided from Luxembourg, Malta and Slovakia. 
Overall, the human incidence of brucellosis in the old MS has decreased since 1999 
(Figure BR1). From 1999 to 2004 the incidence among non-OBF (non-Ofﬁcially Brucellosis 
Free) EU-15 MS decreased from 1.6 in 1999 to 0.5 in 2004. The level of reported human 
brucellosis in the new non-OBF MS was relatively low (>0.1) in 2004 compared to the 
level in the old non-OBF MS. 
The risk of contracting brucellosis from animals in the OBF MS is assumed to be 
extremely low, and none of these MS reported occupational cases in 2004. The risk was 
also low in non-OBF MS where few occupational cases were reported in Cyprus (1), 
France (1), Poland (6), Portugal (1) and Northern Ireland (5). Six MS and Norway reported 
a number of cases to be acquired abroad (Table BR1).
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Table BR1. Reported cases of brucellosis in humans, 1999-2004, and incidences in 
20041. OBF and ObmF2 status in 2004 is indicated.
2004 2004 2003 2002 2001 2000 1999
Cases/ 
100,000 
population
No. of cases: Total (imported)
Austria  
(OBF/ObmF) <0.1 2 (1) 5 (5) 4 2 (2) 2 (2) 2
Belgium  
(OBF/ObmF) <0.1 8 (2) 0 1 1 0 -
Cyprus 0.3 2 - - - - -
Czech Republic 
(OBF/ObmF) 0 0 - - - - -
Denmark  
(OBF/ObmF)3 <0.1 4 14 16 18 1 1
Estonia 0 0 - - - - -
Finland  
(OBF/ObmF) <0.1 1 (1) 1 (1) 0 1 (1) 0 0
France4 <0.1 19 (16) 21 37 - 44 31
Germany  
(OBF/ObmF) - - 27 (8) 35 (16) 25 (12) 27 (15) 21 (15)
Greece 2.0 223 255 (3) 327 (2) 379 334 451
Hungary 
(ObmF) 0 0 - - - - -
Ireland (ObmF) <0.1 29 5 4 14 15 19
Italy5 0.7 398 - 820 343 801 1129
Latvia 0 0 - - - - -
Lithuania <0.1 1 0 - - - -
Poland <0.1 7 - - - - -
Portugal6 0.4 39 139 206 40 507 686
Slovenia 0 0 1 - - - -
Spain7 1.4 589 596 886 924 1.104 1.519
Sweden  
(OBF/ObmF)   <0.1 3 (3) 3 (3) 5 (5) 2 (2) 1 (1) 0
The Netherlands 
(OBF/ObmF) <0.1 8 4 5 (4) 1 (1) 3 (3) 1
United 
Kingdom 
(ObmF)8
<0.1 31 (19) 21 (1) 37 27 19(5) 15
EU-Total 0.4 1,337 (42) 1,092 (21) 2,386 (27) 1,777 (18) 2,858 (26) 3,900 (15)
Norway  
(OBF/ObmF) <0.1 2 (1) 3 (2) 3 (3) 2 (2) 1 (1) 1 (1) 
Note: No data from Luxembourg (OBF/ObmF), Malta and Slovakia (ObmF).
1. EU-Total incidence is based on population in reporting countries.
2. ObmF: Ofﬁcially B. melitensis Free.
3. In Denmark, the disease not notiﬁable in humans.
4. In France, 64 départements are ObmF.
5. In Italy, 22 provinces are OBF and 20 provinces are ObmF.
6. In Portugal, Azores are OBF/ObmF.
7. In Spain, Canaries are ObmF. Only hospitalised cases notiﬁable.
8.  In United Kingdom, Great Britain is OBF, Great Britain and Northern Ireland are ObmF. All domestic 
cases in 2004 were reported from Northern Ireland.
9. Only conﬁrmed cases. In 2004, Ireland reported additionally 1 unspeciﬁed and 57 probable cases.
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The highest incidences of human brucellosis in 2004 were recorded in Greece, Italy, 
Portugal and Spain (Table BR1), primarily caused by B. melitensis. The incidence of 
human brucellosis has reduced in these MS during the last ﬁve years, where brucellosis 
eradication programmes among cattle, sheep and goat populations have been ongoing 
(Figure BR1). Similarly, a reduction in the human incidence from 1999 to 2004 in France 
(from 0.1 to 0.03) and Ireland (from 0.5 to 0.05) occurred parallel with implementation of 
speciﬁc eradication programmes in France (caprine and ovine brucellosis) and Ireland 
(bovine brucellosis).
Figure BR1. Incidence of human brucellosis in selected MS that were non-OBF in 
2004. Estimated EU-15 incidence in non-OBF MS and in all EU-15 MS was based 
on data from MS reporting the actual years (see Table BR1)
H
um
an
 b
cr
ce
llo
si
s 
ca
se
s 
pe
r 
10
0,
00
0 
po
pu
la
tio
n
20001999 2001 2002 2003 2004
0
1
2
3
4
5
6
7
Years
Spain
EU-15, non-OBF
EU-154, All
France
Greece
Italy
Portugal
All reported data on brucellosis in humans (2004) are presented in Level 3, Table BR1 
and BR2.
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3.6.2. Brucella in food
Milk, cheese and dairy products were tested for the presence of Brucella in a few MS 
(Table BR2). Most samples were of raw milk, and Brucella was only detected in Italy.
Since 2000, Brucella in raw cow milk has only been reported by Greece, Italy and Portugal. 
In Greece and Portugal the occurrence has decreased since 2002, whereas a slight 
increase in proportion of positive samples occurred in Italy in 2004 (Figure BR2). 
See Level 3, Table BR3 for more information.
Table BR2. Number of food samples tested for Brucella in 2004. The number of 
Brucella positive samples in brackets
Belgium Germany Greece Italy Portugal Poland
Cow milk For manufacture - - - 167 (0) - -
Raw 14,270 (0) 24 (0) 231 (0) 586 (7)1 10 (0) 36,159 (0)
Heat-treated - - - 35 (0) - -
Other Soft and semi soft cheeses - - - 5 (0) -
 Dairy products - - - 409 (0) - -
1. In Italy, B. melitensis: 6 samples and B. abortus: 1 sample.
Figure BR2. Proportion of Brucella-positive raw milk samples, 2000 to 2004
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3.6.3. Brucella in animals 
Cattle
The status of bovine brucellosis in the EU and Norway in 2004 is presented in Figure 
BR3. Austria, Belgium, Czech Republic, Denmark, Finland, Germany, Luxembourg, The 
Netherlands, Sweden and Norway were ofﬁcially bovine brucellosis-free in accordance 
with the Community legislation. Several provinces of Italy, region of Azores of Portugal and 
Great Britain had this status, as well. See Level 3, Table BR4 and BR5 for more information.
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Figure BR3. Status of bovine brucellosis in the EU and Norway, 2004
OBF Member States
During 2004, bovine brucellosis was not detected in the nine OBF MS or Norway, but 
only in the OBF region of Great Britain where one infected herd was detected. No OBF-MS 
had infected herds at the end of the year.
Non-OBF Member States
In the 16 non-OBF MS, 25-100% of the cattle herds were controlled during 2004. 
Brucellosis in cattle was detected in eight of these MS during 2004. Italy tested cattle 
herds in 22 provinces. In nine provinces no bovine brucellosis was detected and one 
other province 11 herds were found positive in routine testing, but all herds were OBF at 
the end of the year. In total, 0.51% of the herds tested in the non-OBF MS were detected 
bovine brucellosis positive in 2004 (5,551 positive out of 1,083,250 herds tested).
No herds were tested positive during the year in the non-OBF MS Estonia, France, Hungary, 
Latvia, Malta, Slovakia and Slovenia (Table BR3). Lithuania did not provide information 
on testing. Of these, the seven new MS do not have the OBF status according to the EU 
legislation, but are either free according to OIE standards or report that no herds have 
been found infected since the 1960s. Overall, in the new non-OBF MS, only 0.01% of 
the tested herds (19 out of 341,133 herds) were found infected with bovine brucellosis 
during the year 2004. These herds were detected in Cyprus and Poland.
In the non-OBF EU-15 MS, a total of 0.75% herds (5,532 out of 742,117 herds tested) 
were positive for bovine brucellosis in 2004. Overall, there is no clear trend in the proportion 
of infected herds in these non-OBF EU-15 MS for the last 3 years. The proportion of 
herds tested positive for brucellosis decreased in 2004, compared to 2003, in Northern 
Ireland, but increased slightly or remained at the same level in Spain, Greece, Ireland, 
Italy and Portugal. However, the proportion of infected herds at the year end decreased 
clearly in Portugal, and slightly in Ireland and Greece (Figures BR4 and BR5). 
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All the non-OBF EU-15 MS implement eradication programmes to control and eventually 
eradicate bovine brucellosis in their country. In Greece, Italy and Spain vaccination was 
implemented in high-risk areas.
Table BR3. Notiﬁcation of bovine brucellosis and results of routine testing of cattle 
herds in MS and Norway, 2004
Herds Routine Testing At year end
Under 
control
% Under 
control
Tested Herds 
positive
%  
Positive
Herds 
Infected
% OBF 
herds
Cyprus 345 93 345 7 2.03 6 48
Estonia 2,343 25 2,343 0 0 0 0
France 283,124 100 271,645 0 0 1 99
Greece 27,224 73 10,503 440 4.19 277 82
Hungary 26,218 100 4,447 0 0 0 100
Ireland 124,583 - 124,583 283 0.23 102 100
Italy1 163,089 88 91,392 1,630 1.78 1,630 51
Latvia 18,643 26 18,643 0 0 0 0
Lithuania 195,226 100 - - - 0 100
Malta 420 100 284 0 0 0 100
Poland 283,823 32 258,937 12 0 3 100
Portugal2 90,292 100 71,594 701 0.98 617 79
Slovakia 11,355 62 10,188 0 0 0 97
Slovenia 46,041 99 45,946 0 0 0 103
Spain 154,248 62 151,409 2,330 1.54 2,330 92
UK-Northern 
Ireland 27,766 100 20,991 148 0.71 68 100
EU-10, Total 
non-OBF 584,414 100 341,133 19 0.01 9
EU-15, Total 
non-OBF 870,326 71 742,117 5,532 0.75 5,025
EU-25, Total 
non-OBF 1,454,740 83 1,083,250 5,551 0.51 5,034
Ofﬁcially brucellosis free (OBF)
Austria 86,034 17,015 0 0 0 100
Belgium 42,553 22,762 0 0 0 100
Czech Republic 27,806 25,636 0 0 0 100
Denmark 848 - - - 0 100
Finland 22,882 3,036 0 0 0 100
Germany - 10,546 0 0 -
Luxemburg 2,000 977 0 0 0 100
Sweden 27,905 1,915 0 0 0 100
The  
Netherlands 59,524 7,729 0 0 0 100
UK-Great Britain 114,766 55,327 0 0 0 100
EU-25 total 5,551
Norway (OBF) 22,500 3,138 0 0 0 100
 
1. In Italy, 22 provinces are OBF.
2. In Portugal, the Azores are OBF.
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Figure BR4. Proportion of cattle herds tested positive for Brucella in years 2002 to 
2004 in selected non-OBF EU-15 MS
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Figure BR5. Proportion of cattle herds infected with Brucella at the end of year 
2000 to 2004 in selected non-OBF EU-15 MS
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Sheep and goats
The status of ovine and caprine brucellosis (B. melitensis) in the EU and Norway in 2004 
is presented in Figure BR6. Austria, Belgium, Czech Republic, Denmark, Germany, 
Luxembourg, The Netherlands, Slovakia, Finland, Ireland, Hungary, Sweden, the United 
Kingdom and Norway are ofﬁcially ovine and caprine brucellosis-free in accordance with 
the Community legislation. Several provinces of Italy and France, the Canaries of Spain 
as well as region of Azores of Portugal have this status, as well. See Level 3, Table BR6 
and BR7 for more information.
Figure BR6. Status of ovine and caprine brucellosis (B. melitensis) in the European 
Union and Norway, 2004
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Table BR4. Notiﬁcation of ovine and caprine brucellosis and results of routine testing 
of sheep and goat herds in MS and Norway, 2004
Herds Routine testing At year end
Under 
control
% Under 
control1
Tested Positive 
Herds
% Positive 
Herds
Herds 
infected
% OBF 
herds
Cyprus 4,059 97 4,059 30 0.74 21 41
Estonia 58 3 66 0 0 0 -
France4 93,233 76 - 0 - 0 76
Greece 126,160 145 657 37 5.63 40 4
Italy1 82,998 69 69,955 2,411 3.45 2,411 78
Latvia - - - - - - -
Lithuania 6,850 109 750 0 - 0 100
Malta 2,109 57 1,636 0 0 0 100
Poland 3,406 25 1,739 0 0 0 74
Portugal2 70,977 100 65,907 1,767 2.68 1,034 78
Slovenia 5,281 57 529 0 0 0 -
Spain3 127,150 56 120,422 6,171 5.12 4,220 49
EU-10, Total 
non-ObmF 21,763 55 8,779 30 0.34 21
EU-15, Total 
non-ObmF 500,518 80 256,941 10,386 4.04 7,705
EU-25, Total 
non-ObmF 522,281 78 265,720 10,416 3.92 7,726
Ofﬁcially brucellosis free (ObmF)
Austria 77,809 1,625 0 0 100
Belgium 45,141 - - - 100
Czech  
Republic 4,559 2,243 0 0 100
Denmark 650 - - 0 100
Finland 2,766 - - 0 100
Germany 1,268 - - 0 100
Hungary 18,613 2,719 0 0 100
Ireland 43,000 1,400 0 0 100
Luxembourg - - - - -
Slovakia 2,553 1,455 0 0 100
Sweden 7,639 - 0 0 100
The  
Netherlands 18,007 1,700 0 0 100
United 
Kingdom 288,869 7,271 0 0 100
EU-25 total 10,416  
Norway (ObmF) 1,655 0  
1. In Italy, 22 provinces are OBF.
2. In Portugal, the Azores are OBF.
3. In Spain, the Canaries are ObmF.
4. In France 64 départements are ObmF.
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Ofﬁcially B. melitensis Free (ObmF) Member States 
In 2004, B. melitensis was not detected in sheep and goat herds in the 13 MS, French 
départements or Norway with ObmF status. Infection was detected in ObmF regions in 
Italy, Portugal (Azores) and Spain (Canaries).
Non-ObmF Member States
Brucellosis in sheep and goat herds was detected in 5 of the 12 non-ObmF MS during 
2004 (Cyprus, Greece, Italy, Portugal and Spain) (Table BR4). In Estonia, France, Lithuania, 
Malta, Poland and Slovenia no infected herds were reported during year 2004. Latvia did 
not provide information on testing. In most MS, at least half of the herds were under 
control, but in Estonia and Poland only 3% and 25%, respectively, were controlled during 
2004. In total, 3.92% of the herds tested in the non-ObmF MS were detected positive 
for B. melitensis in 2004 (10,416 positive out of 265,720 herds tested).
Of the new MS that have not ObmF status according to the EU legislation, B. melitensis 
has never been detected in Latvia and Lithuania. Slovenia is free according to OIE standards 
and Estonia report that no herds have been found infected since the 1960s. Of the new 
MS, B melitensis was only detected in sheep and goats in Cyprus during 2004. 
Figure BR7. Proportion of sheep and goat herds tested positive for Brucella 
melitensis during the years 2002 to 2004 in selected non-ObmF EU-15 MS
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In the non-ObmF EU-15 MS, a total of 4.04% herds (10,386 out of 256,941 herds tested) 
were positive for B. melitensis in 2004. Overall, the proportion of infected herds at year 
end has decreased in most of the countries since 2000. However, the proportion of 
herds tested positive in 2004 increased in Greece, Italy and Portugal when compared to 
2003. In Spain the proportion of the herds tested positive decreased during the same 
period (Figures BR7 and BR8). 
All the non-ObmF EU-15 MS implement eradication programmes to control and eradicate 
ovine and caprine brucellosis in their country. In Greece, Italy, Portugal and Spain 
vaccination was implemented in high-risk areas.
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Figure BR8. Proportion of sheep and goat herds infected with Brucella at the end 
of year 1999 to 2004 in selected non-ObmF EU-15 MS1
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1.  Less than 0.1% of the herds under control in France and Greece were infected at the end of the year 
from 2000 to 2004.
Pigs and other animals
Porcine brucellosis is a relatively rare disease in the EU Community. Seventeen MS and 
Norway reported testing of pigs, and B. suis was bacteriologically veriﬁed in Austria and 
Hungary. In previous years, B. suis was detected in pigs in Austria (2002, 2003), Denmark 
(1999), France (2002), Portugal (1999-2003) and Spain (2000-2003).
Wildlife was tested for Brucella in Belgium, Italy, Latvia, Spain and Sweden. In Belgium, 
B. suis was detected in a wild boar. In Italy, a research project found Brucella (primarily 
B. suis) in 5% of the tested wildlife, and surveillance of 3661 game animals in Spain 
found Brucella (primarily B. abortus and B. melitensis) in 5% of game animals (primarily 
in deer and wild boars). Brucella was not detected in the wildlife tested in the other MS. 
See Level 3, Table BR8 for more information.
3.6.4. Summary on Brucella
The Community incidence of human brucellosis (EU-25) in 2004 was 0.4 cases per 
100,000 population. Overall, human incidence of brucellosis in the EU-15 MS decreased 
from 1999 to 2003, and remained at the same level in 2004. During recent years, the 
highest incidences of human brucellosis have been recorded in Greece, Italy, Portugal 
and Spain; cases have primarily been caused by B. melitensis. Over the last ﬁve years, 
implementation of brucellosis eradication programmes took place resulting in a reduction 
of human brucellosis in the majority of these MS. 
No clear general trends were detectable in bovine or caprine and ovine brucellosis in the 
non-free Member States. The overall occurrence of brucellosis among cattle, sheep and 
goat herds in the EU-15 MS remained approximately at the same level as in 2003. 
Most of the new MS had not yet obtained the OBF/ObmF status according to the EU 
legislation in 2004, however brucellosis has been eradicated or has never been observed 
in many of these MS. 
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3.6.5. Sources of Brucella data
Brucellosis in humans is notiﬁable in most MS except Denmark and Norway (Appendix 
Table BR1). Information on notiﬁcation was not provided by Luxembourg and Malta.
Legislation on intra-community trade on bovine animals and swine (including qualiﬁcation 
of herds) is laid down in Council Directive 64/432/EEC as last amended by Commission 
Regulation 2002/1226 and for sheep and goats in Council Directive 91/68/EEC as last 
amended by 2003/708/EC.
By the end of 2004, 9 MS: Austria, Belgium, Czech Republic, Denmark, Finland, Germany, 
Luxembourg, Sweden and The Netherlands as well as 22 provinces in Italy, the Azores 
in Portugal and Great Britain in the United Kingdom were ofﬁcially free of brucellosis in 
cattle (OBF), sheep and goat (ObmF). Hungary, Ireland, Slovakia and the rest of the 
United Kingdom as well as 64 départements in France and the Canaries in Spain were 
only ObmF in 2004. Two provinces in Italy were only OBF. (Appendix Table TB-BR1).
In March 2004, the Czech Republic obtained OBF and ObmF status, and Hungary and 
Slovakia obtained ObmF status (Commission Decision 2004/320/EC). 
Community co-ﬁnancing of programmes for eradication of bovine, ovine and caprine 
brucellosis were approved for Cyprus, Greece, Italy, Lithuania, Portugal, Slovenia and 
Spain. Eradication programmes were approved for ovine and caprine brucellosis in 
France, and bovine brucellosis in Ireland, Poland and United Kingdom (Commission 
Decision 2003/849/EC).
The non-MS, Norway, has been declared OBF and ObmF, and monitor brucellosis in 
cattle, sheep and goat according to the EU directives.
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3.7. Yersinia
The genus Yersinia comprises three main species causing human infections: Yersinia 
enterocolitica, Yersinia pseudotuberculosis and Yersinia pestis (plague). The last major 
human outbreak of plague in Europe was in 1720. The following description deals only 
with Yersinia enterocolitica and Yersinia pseudotuberculosis infections.
Yersiniosis affects mainly young children, and symptoms are dominated by diarrhoea, 
which is often bloody. Symptoms typically develop four to seven days after exposure 
and may last one to three weeks or longer. In older children and adults, right-sided 
abdominal pain and fever may be the predominant symptoms, and may be confused 
with appendicitis. In a small proportion of cases, complications such as skin rash, joint 
pains, or spread of bacteria to the bloodstream can occur.
Infection is most often acquired by eating contaminated food, particularly raw or undercooked 
pig meat. The ability of this organism to grow at 4oC makes refrigerated food with a relatively 
long shelf life an important source of infections. Drinking contaminated unpasteurised 
milk or untreated water can also transmit the infection. On rare occasions, transmission 
may also occur by direct contact with infected animals or humans.
Clinical disease is uncommon in animals. However, dogs and farm animals, in particular 
pigs and cattle are known reservoirs of Yersinia.
3.7.1. Yersiniosis in humans
Twenty MS reported a total of 10,381 cases of human yersiniosis in 2004 compared to 
10,086 cases reported from 18 MS in 2003 (Table YE1). In 2004, two thirds of cases were 
reported from Germany. The overall EU-25 incidence (cases per 100,000 population) for the 
20 MS reporting cases in 2004 was 2.7, covering large variations between MS (Table YE1). 
The highest incidences were observed in the Northern part of Europe (Lithuania, Finland, 
Sweden, Germany, Czech Republic, Belgium and Denmark). The incidence was higher 
in MS with a notiﬁcation system (4.9) than in MS without a notiﬁcation system (0.3). 
A smaller difference was observed between the incidences in the old MS (EU-15: 3.0) 
and the new MS (EU-10: 1.7).
Of the 10,288 speciated Yersinia isolates, Y. enterocolitica was cultured from 98.5% 
of human cases samples and 1.3% of the cases were Y. pseudotuberculosis. Ten MS 
provided information on Y. enterocolitica serotype distribution. Serotype O:3 was by far 
the most predominant serotype in 2004 comprising 93.5% of the isolates (ranging from 
70-100%). The remaining Y. enterocolitica isolates from 6 MS were serotype O:9.
Y. pseudotuberculosis
In 2004, 136 cases of Y. pseudotuberculosis were reported from four MS. Of these 
131 were reported from Finland, four from Lithuania and one from Austria. Since 
1998, Finland has experienced large outbreaks of Y. pseudotuberculosis on an almost 
annual basis and three of these have been traced back to domestic fresh products, 
iceberg lettuce and carrots. 
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Table YE1. Reported cases if yersiniosis in humans, 2000-2004, and incidence in 20041
2004 2004 2003 2002 2001 2000
 Cases/ 
100, 000 
population
No. of 
cases
No. of 
cases2
No. of cases
Austria 1.4 110 109 58 58 116 119
Belgium 4.8 494 494 338 330 375 485
Cyprus - - - - - - -
Czech  
Republic 4.9 498 498 372 403 301 231
Denmark 4.2 227 227 243 240 286 265
Estonia 1.1 15 15 31 20 50 59
Finland 13.1 686 550 646 695 728 641
France <0.1 249 249 218 - 391 -
Germany 7.5 6,182 6,182 6,571 7,515 7,186 4,778
Greece 0.4 39 37 1 - 48 -
Hungary 0.7 68 63 - - - -
Ireland 0.1 6 0 6 12 3 14
Italy 0 0 0 0 2 - -
Latvia 1.1 25 22 28 63 91 64
Lithuania 13.6 470 466 273 214 209 168
Luxembourg - - - - - 11 -
Malta - - - - - - -
Poland 0.2 84 0 - - - -
Portugal <0.1 3 3 6 - 1 -
Slovakia 1.4 78 78 - - - -
Slovenia 1.9 38 38 69 74 52 49
Spain3 0.5 231 231 417 528 526 463
Sweden 9.0 804 804 714 610 519 554
The  
Netherlands - - - - - - -
United 
Kingdom 0.1 74 68 95 43 48 59
EU-total 2.4 10,381 10,134 10,086 10,807 10,941 7,949
Norway 2.2 101 96 86 107 123 140
1. EU-Total incidence is based on population in reporting countries.
2. Veriﬁed as Y. enterocolitica by speciation.
3. In Spain, only hospitalised cases are notiﬁable.
There has been no clear trend in the total number of cases reported within EU (14-20 
reporting MS per year) from 2000 to 2004. But an increasing trend (24%) was observed 
in the number of cases from the 9 MS (including both old and new MS) that reported and 
had notiﬁcation throughout this period (Figure YE1).
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Figure YE1. Total number of reported cases and EU trend of human yersiniosis, 
2000-2004
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Note: EU trend was based on data from nine MS: Austria, Belgium, Czech Republic, Denmark, Finland, Latvia, 
Lithuania, Slovenia and Sweden, with notiﬁcation and reporting of yersiniosis throughout the entire period.
Sixteen MS reported the age distribution for at least 10 cases of yersiniosis in 2004. 
Approximately 25% of the Y. enterocolitica cases were children 1-4 years of age and 
another 25% of the cases were children aged 5-14 years. This overall distribution covers 
a heterogeneous age distribution between countries with the more important differences 
being an excess of infants among Spanish cases and an excess of elderly among cases 
from Finland and Great Britain. 
Thirteen countries reported that the majority of yersiniosis cases are known or assumed to 
be domestically acquired. No countries consider travel activity to contribute signiﬁcantly 
to the burden of human yersiniosis except for Sweden and Norway. In Sweden the recent 
increase in number of cases was largely due to an increase in travel-related cases. 
In general, the cases of yersiniosis are sporadic but outbreaks have been reported from 
Austria, Denmark, Finland and Hungary. 
For additional information on data provided on Yersinia in humans, please, refer to Level 3, 
Table YE1-YE3.
3.7.2. Yersinia enterocolitica in food
Seven MS provided data on Y. enterocolitica in pig meat and products thereof. The 
following description presents the result from six MS and 12 investigations, in which at 
least 25 samples were tested. The proportion of positive samples in fresh pig meat at 
retail ranged from 0-10.4%. The highest positive proportion was reported from Sweden, 
where a PCR method was used for detection (see textbox). Belgium, Czech Republic 
and Germany did not detect Y. enterocolitica in fresh pig meat. For samples of meat 
products, the proportion of positive samples ranged from 0% to 8.8%, the highest from 
Italy in samples taken at retail using greater sample weights (Table YE2). 
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Table YE2. Y. enterocolitica in pig meat and products thereof1, 2004
N Positive % Positive Product Sampling 
location
Sample 
weight
Fresh, minced
Belgium 198 0 0 meat Processing 1g
Fresh, minced
103 0 0 meat Retail 1g
Czech Republic 93 0 0 Fresh - -
Germany 36 0 0 Fresh Retail -
Italy 62 1 1.6 Fresh Retail 25g
85 3 3.5 Fresh Slaughter 25g
33 1 3 Meat products Processing 25g
148 13 8.8 Meat products Retail 25g
Spain 135 7 5.2 Fresh - -
137 0 0 Meat products - -
Sweden 933 97 10.4 Fresh Retail 10g
522 35 6.7 Meat products Retail 10g
1. Data are only presented for sample size >25.
Four MS reported adequate data on Y. enterocolitica in bovine meat, cow milk and dairy 
products to be included in Table YE3. For samples of fresh bovine meat, the proportion 
of positive samples ranged from 0-7% with the highest found in bovine meat from 
Italy sampled at retail with a greater sample weight. In contrast, Italy did not detect 
Y. enterocolitica in any samples taken at slaughter. Czech Republic examined 135 samples 
of raw milk without detection of Y. enterocolitica. All dairy products tested by Czech 
Republic, Italy and Slovenia were negative. 
Table YE3. Y. enterocolitica in bovine meat, and milk and dairy products, 2004
N Positive % Positive Product Sampling 
location
Sample  
weight
Bovine meat and products thereof
Italy 57 4 7 Fresh Retail 25g
50 0 0 Fresh Slaughter 25g
Spain 31 1 3.2 Fresh - -
Milk and dairy products
Czech Republic 135 0 0 Raw milk - 250ml
751 0 0 Unspeciﬁed product
- -
Italy 35 0 0 Unspeciﬁed product
Dairy 25g
Slovenia 1881 0 0 Ready-to-eat products
Processing -
1. In Slovenia, number of batches.
Five 5 MS provided data on Y. enterocolitica in poultry meat (Table YE4). Of these, three 
reported results from investigations including more than 25 samples, and only Germany 
detected positive samples. 
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Table YE4. Y. enterocolitica in poultry meat and products thereof1, 2004
N Positive % Positive Product Sampling 
location
Sample  
weight
Germany 58 3 5.2 Meat products Processing -
Italy 25 0 0 Fresh Processing 25g
Spain 127 0 0 Fresh - -
1. Data are only presented for sample size >25.
Several other types of foodstuffs were tested for Yersinia, but generally the number of 
samples was low. Two MS, however, tested a substantial number of samples of red meat 
(animal species not speciﬁed). Of 57 examined samples, Germany found 1.8% positive 
samples. In Slovenia, the ﬁndings were 2.0% positives of 100 samples. Of particular 
interest, Slovenia, also tested 240 samples from products sold as delicatessen and 150 
samples of sweets and found a prevalence of 3.3% and 1.3%, respectively.
For additional information on data provided on Yersinia in food, please, refer to Level 3, 
Table YE4.
Increased prevalence of Yersinia in food using PCR for detection
An investigation of fresh pig meat in Norway (1997-98) indicated presence of pathogenic 
Y. enterocolitica in 17% of the samples using a PCR method for detection, while  
Y. enterocolitica O:3 was isolated from only 2% of the samples using conventional 
culture methods. Swedish PCR investigations of fresh pig meat and products thereof 
in 2004, found 10.4% and 6.7%, respectively, of the samples Yersinia positive. 
3.7.3. Yersinia enterocolitica in animals 
Seven MS provided data on Y. enterocolitica in farm animals. Results from six MS reporting 
on investigations comprising more than 25 samples or herds are presented in Table YE5. 
The individual proportion of positive pigs varied from 0-10.4% with the highest positive 
proportion in Denmark. Comparing 2004 data with data from previous years, the prevalence 
seems to be relatively stable within individual MS. Thus, in Portugal no pigs were found 
positive in the years 2001 to 2004. In Denmark, the annual proportion of positive animals 
varied from 12.7-17% in the period from 1999 to 2003, which is very similar to the results 
from 2004. Italy was the only country reporting results on herd level. Of 36 examined pig 
herds 5.6% were positive. Similar herd prevalence was found in 2002 and 2003, whereas 
all 73 Italian herds examined in 2001 were negative.
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Table YE5. Y. enterocolitica in farm animals, 2004
Country N Positive % Positive Epidemiological Unit
Pigs Denmark 576 60 10.4 Animal
Germany 6,751 63 0.9 Animal
Ireland 273 0 0 Animal
Italy 36 2 5.6 Herd
Italy 43 0 0 Animal
Portugal 264 0 0 Animal
Cattle Germany 8,483 77 0.9 Animal
Ireland 4,375 0 0 Animal
Italy 444 78 17.6 Animal
Italy 40 0 0 Herd
Portugal 267 1 0.4 Animal
Sheep Germany 894 1 0.1 Animal
Ireland 717 0 0 Animal
Italy 480 1 0.2 Animal
Portugal 127 0 0 Animal
Goats Germany 260 0 0 Animal
Portugal 54 0 0 Animal
Solipeds Germany 1,623 0 0 Animal
Ireland 1,263 0 0 Animal
Poultry Germany 1,890 0 0 Animal
Ireland 300 0 0 Animal
Portugal 205 0 0 Animal
Farmed ﬁsh Lithuania 210 0 0 Animal
In cattle, four MS reported proportions of positive animals ranging between 0-17.6% 
(Table YE5). The highest proportions of positive animals was observed in Italy, where the 
positive proportion appears to have increased rapidly over the last six years, from 1.9% 
in 1999 to 17.6% in 2004.
The occurrence of Y. enterocolitica was very low in the other farm animals examined 
(Table YE5). Lithuania was the only MS to provide data from a study in farmed ﬁsh. 
No positive samples were found.
Y. enterocolitica prevalence in pigs/pig meat and cattle/bovine meat
In general, pigs and pig meat are believed to be the main source of human yersiniosis 
in most EU MS. In 2004, the occurrence of Y. enterocolitica in cattle/bovine meat  
appeared to be very similar to the prevalence in pigs/pig meat. Very few Y. enterocolitica 
strains were serotyped. Additional information on the serotype distribution of Y.  
enterocolitica in non-porcine animals and food sources may provide important  
information to attribute sources to human cases of yersiniosis.
 
Dogs are known carriers of Yersinia. In 2004, three MS provided adequate data from 
studies of dogs (Table YE6). In general, the occurrence in dogs was low (0.3-1.1%). 
Germany also examined 1,063 cats, only 1 (0.1%) was positive for Y. enterocolitica. 
Finally, Italy reported no positive ﬁnding in two local surveys on rabbits (N=75) and 
wild-living hares (N=39), and no positive animals were detected in an investigation of 
zoo animals in Portugal (N=86). 
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Twenty-two animal isolates of Y. enterocolitica were serotyped. Thirteen isolates from 
German cattle were serotype 0:9, the remaining strains from cats (1, Germany), dogs 
(1, Germany), pigs (6, Germany and Slovakia) and unknown animals species (1, Slovakia) 
were serotype O:3.
Table YE6. Y. enterocolitica in dogs, 2004
N Positive % Positive
Germany 1,703 19 1.1
Ireland 331 1 0.3
Portugal 45 0 0
For additional information on data provided on Yersinia in animals, please, refer to Level 3, 
Table YE5.
3.7.4. Summary on Yersinia
Twenty MS reported a total of 10,381 cases of human yersiniosis in 2004, where two 
thirds of the cases were reported from Germany. The overall EU-25 incidence in 2004 
was 2.7 cases per 100,000 population. The incidence was higher in MS with a notiﬁcation 
system than in MS without notiﬁcation. There has been no clear trend in the total number 
of cases reported within the EU from 2000 to 2004. But an increasing trend was 
observed in the number of cases from the nine MS that reported and had notiﬁcation 
throughout the period.
The occurrence of Yersinia in pig meat and bovine meat appears to be quite similar, and 
higher than the occurrence observed for other food sources. The same applies for pigs 
and cattle compared to other farm animals. 
Based on the frequent isolation of the most common human pathogenic Yersinia 
subtypes in pigs and pork, several countries (Belgium, Czech Republic, Denmark, Estonia, 
Finland, Lithuania, Sweden and Norway) consider the porcine reservoir to be the main 
source for human infection. However, the relatively high occurrence of Yersinia in 
cattle and bovine meat in some MS indicate that also other sources may contribute 
signiﬁcantly to human infections. 
There appeared to be no signiﬁcant difference between old and new MS in the overall 
Yersinia situation.
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3.7.5. Sources of Yersinia data 
In 2004, mandatory notiﬁcation of yersiniosis was reported to take place in 16 MS (Austria, 
Belgium, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Ireland, Italy, 
Latvia, Lithuania, Slovakia, Slovenia, Spain and Sweden) and in the non-MS Norway. 
Notiﬁcation in Belgium was restricted to the Flemish community. Registration of human 
yersiniosis through less comprehensive or voluntary reporting systems takes place in 
most other MS with the exception of France, The Netherlands and the United Kingdom. 
Cyprus, Italy, Luxembourg, Malta and The Netherlands did not provide any data. Eight EU-10 
countries and 12 EU-15 countries reported cases of yersiniosis in 2004. In all reporting 
countries, cases were identiﬁed through passive surveillance based on culture-conﬁrmed 
clinical cases reported by laboratories and/or physicians to the authorities.
A notiﬁcation system for Yersinia in foodstuffs exists in Austria, Belgium, Estonia, Italy, 
Slovakia, Slovenia, Spain and The Netherlands. Data on Yersinia in food samples were 
provided from 9 MS in 2004 (Austria, Belgium, Czech Republic, Germany, Italy, Portugal, 
Slovenia, Spain and Sweden). Data from Belgium, Czech Republic, Germany, Italy, Slovenia, 
Spain and Sweden were obtained through monitoring programmes or national surveys, 
and in Italy from the industry HACCP/own control as well. With the exception of Slovenia, 
these MS all provide data from sampling of fresh pig meat. Several MS report data on 
milk/dairy products, bovine meat and poultry meat as well. In Belgium and Sweden only 
samples of pig meat were examined. 
The detection methods for Yersinia in foodstuffs were reported by 4 MS, and comprised 
different versions of ISO 10273 (Austria, Czech Republic and Slovenia) and PCR (Sweden). 
Thus, differences in diagnostic sensitivity should be kept in mind, when interpreting 
differences in prevalence between countries. 
Yersinia infections in animals are notiﬁable in Belgium, Lithuania, Slovenia, Spain, and 
The Netherlands and notiﬁcation of clinical cases take place in Latvia. Only 8 MS: Denmark, 
Germany, Ireland, Italy, Latvia, Lithuania, Portugal and Slovakia reported any sampling 
from animals. Of these, substantial numbers of samples were tested in Denmark (pigs), 
Lithuania (screening of farmed ﬁsh) and from several animal species in Germany, Italy, 
Ireland and Portugal.
Overview of notiﬁcation is presented in Appendix, Table YE1.
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3.8. Trichinella 
Trichinellosis is a zoonotic disease caused by a parasitic nematode of the genus Trichinella. 
These parasites have a wide range of host species, mostly mammals. The Trichinella 
larvae undergoes all stages of the life cycle, from larva to adult, in the body of a single 
host, see Figure TR1.
Figure TR1. Lifecycle of Trichinella
Source: Centers for Disease Control and Prevention – U.S.A. – http://www.dpd.cdc.gov/dpdx/
In Europe, trichinellosis has been described as an emerging and/or re-emerging disease 
during the past decades. Four species are found: T. spiralis, T. nativa, T, britovi and 
T. pseudospiralis. The majority of human infections are caused by T. spiralis, T. nativa 
and T. britovi.
Infection is acquired by eating raw or inadequately cooked meat of an infected animal. 
The most common sources of human infection worldwide are pig meat, wild boar meat, 
and other game meat. However, horse, dog, and many other animal meats have also 
transmitted the infection. 
The clinical signs of acute trichinellosis are characterised by two phases: one phase 
where the parasites are present in the intestine and one phase where the parasites are 
circulating and/or present in the musculature. The ﬁrst symptoms of trichinellosis may 
include nausea, diarrhoea, vomiting, fatigue, fever, and abdominal discomfort. Symptoms 
such as headaches, fevers, chills, cough, eye swelling, aching joints and muscle pains, 
itchy skin, diarrhoea, or constipation may follow. In more severe cases difﬁculties 
coordinating movements, and heart and breathing problems may appear. In most severe 
cases, death can occur.
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3.8.1. Trichinellosis in humans
In 2004, Germany, Latvia, Lithuania, Poland, Slovakia and Spain reported human cases 
of domestic trichinellosis. Denmark, France, Germany and Sweden reported imported 
cases, either because of travel abroad or from privately imported meat.
The total number of human trichinellosis cases reported increased by almost three fold, 
from 97 cases in 2003 to 270 cases in 2004. However, 172 cases alone were reported 
from Poland that reported for the ﬁrst time. Poland had four outbreaks involving 157 
patients in 2004. In the EU-15 countries the annual number of reported cases has varied 
between 48 and 97 cases during last 6 years (Table TR1).
Table TR1. Reported cases of trichinellosis in humans, 1999-2004, and incidence 
in 20041
2004 2004 2003 2002 2001 2000 1999
Cases/ 
100,000 
population
No. of cases: Total (imported)
Austria 0 0 3 1 0 2 (2) 3 (3)
Belgium 0 0 - - - - -
Cyprus 0 0 - - - - -
Czech Republic 0 0 - - - - -
Denmark 0.17 9 (9) 0 0 0 0 0
Estonia 0 0 - - - - -
Finland 0 0 0 0 0 0 0
France 0.01 3 (3) 6 4 (4) 0 - 2
Germany 0.01 5 (4) 3 (3) 10 5 4 22 (9)
Greece 0 0 0 0 0 0
Hungary 0 0 - - - - -
Ireland 0 0 0 0 0 0
Italy 0 0 0 2 0 21 0
Latvia 1.03 24 22 - - - -
Lithuania 0.64 22 19 - - - -
Luxembourg - - - - - - -
Malta - - - - - - -
Poland 0.45 172 - - - - -
Portugal - - 0 1 0 - -
Slovakia 0.02 1 - - - - -
Slovenia 0 0 - - - - -
Spain 0.08 33(1) 39 26 44 38 13
Sweden 0.01 1 (1) 0 0 0 0 0
The Netherlands 0 0 5 (4) 4 (2) 3 2 (2) 7 (6)
United Kingdom 0 0 0 0 1 (1) 0 1 (1)
EU-Total 0.06 270 97 48 53 67 48
Norway 0 0 0 0 0 0 0
Note: Figures in brackets are reported imported cases, values are included in the total number of cases.
1. EU-Total incidence is based on population in reporting countries.
For additional information on data provided on Trichinella in humans, please, refer to 
Level 3, Table TR1 and TR2.
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3.8.2. Trichinella in animals
All MS and Norway reported data for Trichinella in animals. In 2004, Austria, Cyprus, 
Denmark, Greece, Ireland, Italy, Luxembourg, Malta, Norway and UK did not report any 
ﬁndings of Trichinella in animals (Table TR2).
Trichinella was found in domestic pigs in Finland, France, Lithuania, Poland, Slovakia 
and Spain, however, the prevalence was below 0.001%. Trichinella was not detected 
in horsemeat in 2004 and has only been detected in 1999 and 2001 in two horsemeat 
samples from France (Table TR2 and TR3). In Finland, the prevalence in pigs has 
been decreasing during the last couple of years, which may be a result of more 
industrialised management.
In wild boars, Trichinella was found more frequently. Results showed a proportion of 
positive samples of 0.1% in the EU. In total, 70% of the positive wild boars were 
recorded from EU-10 MS, although the number of wild boars examined from these MS 
represented only 43% of the total samples. The highest number of positive wild boars 
(240 cases) was reported by Poland.
In the other wildlife population, the proportion of Trichinella positive samples was higher 
than within the domestic animal population (Table TR2). Positive ﬁndings were reported 
from 9 MS with a total positive proportion of 3%. As in previous years, Finland reported 
more than 50% of these positive samples (mostly foxes, lynx and racoon dogs) with a 
proportion of positive samples of 18.2%. In Slovakia, 12.6% of samples (mainly foxes) 
investigated were positive for Trichinella. Belgium, France, Hungary, Lithuania, Portugal 
and Sweden also reported positive ﬁndings in foxes. For a total list of wild animal species 
where Trichinella has been isolated see Level 3, Table TR3.
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Table TR2. Number of reported Trichinella ﬁndings in animals, 2004
Pigs Horses Wild boar Other wildlife
N Positive N Positive N Positive N Positive
Austria 5,397,670 0 1,033 0 31,947 0 - -
Belgium 10,284,186 0 11,416 0 8,167 1 307 1
Cyprus 357,638 0 - - 0 - - -
Czech  
Republic 4,298,706 0 351 0 73,489 2 28 0
Denmark 24,945,030 0 1,278 0 0 - - -
Estonia 444,084 0 4 0 6,185 10 17 3
Finland 2,368,495 3 725 0 1,006 0 925 168
France 271,100 102 23,619 0 26,287 0 182 1
Germany - - - - 102,726 1 5,653 0
Greece 377,242 0 - - 32 0 - -
Hungary 4,703,371 0 3 0 42,110 0 402 1
Ireland 3,801 0 58 0 0 0 - -
Italy 10,044,378 0 43,139 0 35,006 0 2 0
Latvia 419,105 0 239 0 1,022 12 19 0
Lithuania 867,757 21 - - 9,168 78 159 9
Luxembourg 323 0 21 0 1,482 0 - -
Malta 840 0 249 0 0 - - -
Poland 19,766,359 29 39,145 - 76,698 240 4 0
Portugal 6,162 0 - - 213 0 221 14
Slovakia 1,151,763 2 - - 15,063 2 715 90
Slovenia 443,513 0 857 0 5,472 1 - -
Spain 35,707,576 4 25,836 0 82,536 121 628 0
Sweden 3,337,488 0 5,033 0 6,191 1 382 19
The  
Netherlands 14,340,981 0 2,187 0 945
1 1 - -
United  
Kingdom 867,612 0 832 0 0 - 1,048 0
EU-Total 140,405,180 69 156,0219 0 523,579 470 10,695 306 
Norway 1,469,200 0 2,000 0 0 - 3 -
1.  In The Netherlands, 534 of the collected samples were part of a prevalence survey and 34 positive 
observations were detected using a serological method only (not presented in this table).
2. In France, Corsican pigs farmed outdoor in contact with wildlife.
In the United Kingdom, two surveys from Great Britain and Northern Ireland were carried 
out concerning Trichinella in foxes. In both surveys, Trichinella was not detected.
An overview of the Trichinella ﬁndings in domestic animals and wildlife since 1999 is 
given in Table TR3.
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Table TR3. Trichinella in animals, 1999-2004
2004 2003 2002 2001 2000 1999
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Austria 0 0 0 0 0 + 0 0 + 0 0 + 0 0 + 0 0 0
Belgium 0 0 + 0 0 - 0 0 0 0 0 0 0 0 - 0 0 0
Cyprus 0 - - 0 0 0
Czech  
Republic 0 0 0
Denmark 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Estonia 0 0 +
Finland + 0 + + 0 + + 0 + + 0 + + 0 + + - +
France +3 0 + 0 0 + 0 0 + 0 + 0 0 0 0 0 + +
Germany - - + - - + + - + 0 0 0 - - + 0 0 +
Greece 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - -
Hungary 0 0 +
Ireland 0 0 0 0 0 0 0 + 0 0 - 0 0 - 0 0 0
Italy 0 0 0 0 0 + 0 0 + 0 0 + 0 0 0 0 0 0
Latvia 0 0 + + - +
Lithuania + - + + - +
Luxembourg 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0
Malta 0 0 -
Poland + - +
Portugal 0 - 0 0 - - 0 - 0 - - 0 0 - 0 0 - 0
Slovakia + - + 0 - -
Slovenia 0 0 + 0 0 -
Spain + 0 + + 0 + + 0 + + 0 + + 0 + + 0 +
Sweden 0 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0 +
The  
Netherlands 0 0 +
2 0 0 +2 + 0 +2 0 0 +2 0 0 +1 + 0 +1
United 
Kingdom 0 0 0 - 0 0 0 0 0 0 0 - 0 0 0 0 - -
Norway 0 0 0 0 0 + 0 0 + 0 0 0 0 0 0 0 0 0
+: Trichinella detected.
0: Trichinella not detected.
-: No data reported.
Blank: MS were not EU members at the time and therefore reported no data. Latvia, Lithuania, Slovakia 
and Slovenia reported on a voluntary basis in 2003.
1. In The Netherlands, low grade infections (1 larva in 16 g muscle tissue).
2.  In The Netherlands, positive cases in wildlife refer to serology testing results, only in 2004 was 1 positive 
sample recorded using digestion method.
3. In France, Corsican pigs farmed outdoor in contact with wildlife.
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3.8.3. Summary on Trichinella
Generally, few cases of Trichinella in humans are reported in EU and Norway, and as 
in previous years, some MS have reported all or the majority of human cases as a result 
of private import of meat infected with Trichinella or consumption abroad of meat not 
examined for Trichinella.
A much higher prevalence of Trichinella is observed in the wildlife population compared 
to the domestic animals indicating that the wildlife serves as a reservoir of the parasite. 
Generally, the outbreak investigations point to the fact that humans become ill after 
consuming meat slaughtered without authorised meat inspection. 
MS from the eastern part of EU have the highest prevalence of Trichinella among wildlife 
and domestic animals. Also the highest number of domestic human cases was reported 
by these countries. A number of the new MS were among the countries with highest 
infection rates.
3.8.4. Sources of Trichinella data
All MS and Norway included information about Trichinella in their report for 2004. All pigs 
and horses, wild boars and carnivorous game slaughtered for human consumption must 
be tested for Trichinella at slaughter or alternatively subject to freezing in accordance 
with Council Directive 64/433/EEC, 91/495/EEC and 92/45/EEC. France, Ireland, Malta 
and Portugal provided no information whether or not they comply with the directive. 
The remaining MS and Norway all comply with the directives. See the Appendix, Table 
TR2 for more information.
Trichinella in humans and in animals is notiﬁable in most MS and Norway. In Cyprus, 
Trichinella became notiﬁable in humans as of 2005. In Denmark and United Kingdom, 
Trichinella in humans is not notiﬁable. France (animals), Ireland (animals), Italy (animals), 
Luxembourg and Malta did not report if Trichinella is notiﬁable. Trichinella in foodstuffs 
is notiﬁable in Austria, Belgium, Estonia, Finland, Greece, Hungary, Italy, Norway, Portugal, 
Slovakia, Slovenia, Spain, Sweden and United Kingdom. See the Appendix, Table TR2 
for more information.
In humans, most MS and Norway diagnose Trichinella infections based on clinical 
symptoms, serology (ELISA), histopathology and Western blot. Belgium, Czech Republic, 
Greece, Ireland, Italy, Luxembourg, Malta, Portugal, Slovakia, Slovenia, Spain, The 
Netherlands, United Kingdom provided no information on diagnostic methods used to 
detect this pathogen in humans. 
Generally, for diagnosis of Trichinella in animals, the MS and Norway use the digestion 
and compression methods described in Directive 77/96/EEC. Ireland, Lithuania and Poland 
provided no information concerning diagnostic methods used in animals. See the 
Appendix, Table TR1 for more information.
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3.9. Echinococcus
Human echinococcosis (also known as hydatid disease) is caused by small tapeworms 
of the genus Echinococcus. In Europe, this disease is caused by two of the four 
recognised species, namely E. granulosus or E. multilocularis.
E. granulosus lives in the small intestines of foxes, dogs and other canids. Humans may 
become infected through accidental ingestion of the eggs of the tapeworm, excreted in 
the fae ces of infected animals. The eggs may enter the bloodstream and migrate to the 
liver, lungs and other tissues to develop into cysts, developing unnoticed over many 
years, and may ultimately rupture, see Figure EH1. Clinical symptoms and signs depend 
on the location of the cyst and are similar to those of a slowly growing tumour. Sheep 
and cattle may also be particularly prone to this infection.
Figure EH1. Lifecycle of E. granulosus
Source: Centers for Disease Control and Prevention – U.S.A. – http://www.dpd.cdc.gov/dpdx/
E. multilocularis is the causative agent of highly pathogenic alveolar echinococcosis in man 
and other mammals. The red fox is the most important deﬁnitive host in Europe, although 
dogs, and occasionally cats, may also be infected with the adult parasite. Eggs shed by the 
deﬁnitive host develop into an intermediate stage in rodents, which serve as intermediate 
hosts. In accidental cases, humans may also acquire E. multilocularis infection by egg 
ingestion. Although a rare disease in humans, alveolar echinococcosis is of considerable 
public health importance because it is fatal in up to 100% of untreated patients. 
b169_EFSA_int_02_03_06.indd   169 2/03/06   15:17:42
170The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
3.9.1. Echinococcosis in humans
In 2004, a total of 343 human cases of echinococcosis was registered in 19 MS (Table EH1), 
which represents an incidence of 0.1 per 100,000 population. Incidence ranged from less 
than 0.1 per 100,000 in Belgium, France and Spain to 0.5 per 100,000 population in Portugal. 
Compared to 2003, there was a decrease in the number of cases reported in 2004, for those 
14 MS that reported data in both years. In these MS, a total of 445 cases were reported in 
2003 versus 322 in 2004. Spain, however, reported a marked decrease from 445 cases in 2003 
to 6 in 2004. This decrease is most likely a result of a continued animal hydatiodosis education 
control programme, particularly in endemic regions with extensive animal production.
Table EH1. Reported cases of echinococcosis in humans, 2000-2004, and incidence 
in 20041
2004 2004 2003 2002 2001 2000 1999
Cases/ 
100,000  
population
% Species distribution
 
Echinococcus spp.
E. g.2 E. m.3 E.spp.4 No. of cases
Austria 0.3 84 16 - 25 34 - - - 30
Belgium <0.1 - 100 - 1 - - - - -
Cyprus - - - - 0 2 - - - -
Czech Republic - - - - - - - - -
Denmark 0.2 89 11 - 9 0 0 0 0 0
Estonia - - - - 0 1 0 0 1 0
Finland 0.1 75 - 25 4 2 0 0 0 0
France <0.1 - 100 - 17 6 - - 6 10
Germany 0.1 68 16 15 97 86 - 515 - -
Greece 0.2 - - 100 26 17 24 37 20 105
Hungary 0.1 36 - 64 11 - - - - -
Ireland - - - - - - - - - -
Italy - - - - - 1 - - - -
Latvia 0.1 100 - - 2 4 - - - -
Lithuania 0.4 93 7 - 15 2 - - - -
Luxembourg - - - - - - - - - -
Malta - - - - - - - - - -
Poland 0.1 86 14 - 21 34 40 37 - -
Portugal 0.5 100 - - 57 42 11 19 26 133
Slovakia - - - - - - - - - -
Slovenia 0.1 - - 100 1 1 - - - -
Spain5 <0.1 - 100 - 6 167 175 17 181 228
Sweden 0.1 - - 100 9 4 14 8 3 5
The  
Netherlands 0.2 100 - - 34 36 32 44 52 31
United Kingdom <0.1 100 - - 8 11 10 11 17 13
EU-Total 0.1 57 7 36 343 450 306 688 306 555
Norway - - - - 0 0 0 0 0 0
1. EU-Total incidence is based on population in reporting countries.
2. Echinococcus granoulosus.
3. Echinococcus multilocularis.
4. Echinococcus spp.
5. In Spain, only hospitalised cases are notiﬁable.
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Data on human cases as well as age distribution of human cases of echinococcus are 
presented in Level 3, Tables EH1 and EH2.
3.9.2. Echinococcus in animals 
In general, the prevalence of Echinococcus was low in farm animals. However, in some 
MS the parasite was found in relatively high numbers in cattle, goats and pigs. Guidelines 
for the control of the pathogen through meat inspection of animal carcasses for human 
consumption are provided through Council Directive 64/433/EEC, whereby monitoring 
of all slaughtered animals is carried out by ofﬁcial veterinarians examining organs and 
muscles intended for human consumption. Whole carcasses or organs are destroyed in 
cases where Echinococcus cysts are found. 
For the Mediterranean MS, namely Greece, Italy, Portugal and Spain, E. multilocularis is 
known to have been prevalent in the past. In 2004, the overall detection of Echinococcus 
in these MS decreased compared to previous years, Table EH2. Italy, for example, 
reported a six-fold decrease in prevalence in sheep, and an eight-fold decrease in goats 
compared to 2003. A notable decrease in the detection of this parasite was also 
reported by Spain. This was a continuance of the decreasing trend, which has been 
observed in Spain since 1999. 
Table EH2. Prevalence of Echinococcus in farm animals detected through meat 
inspection in selected Mediterranean MS, 1999-2004
 
2004 2003 2002 2001 2000 1999
% % % % % %
Cattle
Greece 1.19 0.99 1.37 1.89 3.30 2.34
Italy 0.51 1.35 0.85 1.36 0.97 0.41
Spain 0.10 0.60 0.70 0.80 1.00 -
Goats
Greece 0.31 0.52 0.57 0.80 0.80 0.99
Italy 0.19 1.60 2.89 6.29 0.96 2.72
Sheep
Greece 1.89 2.83 3.21 3.21 2.86 3.07
Italy 0.96 6.28 2.04 6.08 6.86 7.25
Pigs
Greece 0 0 0.99 0 0.01 0
Italy 0.01 0.01 0.02 0.03 0.02 0.02
Portugal 3.10 - - - 100.00 -
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Table EH3. Findings of Echinococcus in farm animals in old and new MS, 2004
 
Old MS New MS
Belgium Greece Italy Spain Latvia Poland Slovakia Slovenia
Cattle
N 881,535 115,417 2,171,690 602,247 117,120 1,280,960 115,398 144,884
Pos 48 1,368 11,023 624 0 140 35 1
% Pos 0.01 1.19 0.51 0.10 0 0.01 0.03 <0.01
Goats
N 3,814 474,847 25,220 260,926 - 223 - -
Pos 0 1,469 47 276 - 30 - -
% Pos 0.00 0.31 0.19 0.11 - 13.45 - -
Sheep
N 87,119 1,527,086 910,189 2,116,493 3,696 29,862 83,052 -
Pos 2 28,916 8,727 1,014 0 6,300 26 -
% Pos <0.01 1.89 0.96 0.05 0 21.10 0.03 -
E. granulosus - - - 230 - - - -
% E. 
granulosus - - - 0.01 - - - -
Pigs
N 11,229,149 848,589 9,657,804 14,282,677 419,105 19,766,359 1,151,763 443,513
Pos 0 0 483 0 268 989,760 1,303 234
% Pos 0.00 0 0.01 0.00 0.06 5.01 0.11 0.05
Horses
N - - 51,814 7,284 239 39,145 - 857
Pos - - 18 5 0 - - 0
% Pos - - 0.03 0.07 0 - - 0
Note: Portugal found 44 (3.1%) of 1,438 pigs positive for E. granulosus.
Lithuania found 71 (2.8%) of 2,503 pigs positive for E. granulosus.
Cyprus found 1 of 110,372 pigs positive for E. granulosus.
Greece reported an increase of positive ﬁndings in cattle compared to 2003. This is in 
contrast to the trend observed since 2000, where the prevalence decreased from 3.3% 
in 2000 to 0.99% in 2003. In goats and sheep, the prevalences continue to decrease in 
2004, a trend that has continued since 1999. No ﬁndings of Echinococcus in pigs have 
been reported in Greece in pigs since 2002.
Spain reported a continuing decrease in the detection of this pathogen in cattle. 
The reported ﬁndings in farm animals are presented in table (Table EH3).
Occurrence of Echinococcus in farm animals at slaughter was also reported by the new 
MS Cyprus, Estonia, Latvia, Poland, Slovenia and Slovakia. The highest prevalences 
were detected in Poland, reporting a prevalence of 21.1% in sheep, 13.5% in goats and 
5.0% in pigs (Table EH3). Lithuania found 71(2.8%) of 2,503 pigs positive for E. granulosus, 
but did not report data for any other animal species. Estonia reported 3 pigs (<0.01%) 
positive out of 444,048 pigs investigated.
In general, little information was provided on the species distribution. However, Portugal 
found 44 (3.1%) of 1,438 examined pigs positive for E. granulosus. Spain found a 0.1% 
of the investigated sheep positive for E. granulosus and in Poland E. granulosus was 
detected in two out of ﬁve speciated isolates from sheep. 
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Study of pets in France/Information campaign in Belgium
In 2004, France conducted a study involving cats and dogs to evaluate the rate of 
transmission of this disease to man. None of the 70 cats and 130 dogs investigated 
was found positive. 
In an attempt to prevent human disease, Belgium recently launched an information 
campaign discouraging visitors to parks and woodlands from eating berries.
Data on investigated pets were reported by Cyprus, Germany, Finland, France, Slovakia 
and Spain. Only Germany reported positive ﬁndings of E. multilocularis in two out of 
88 investigated cats.
Over the past ten years, the population of red foxes has increased in Europe and these 
animals are progressing into urban zones. This is of particular importance since the red 
fox is the most important deﬁnitive host of E. multilocularis in Europe. Increased contact 
between foxes and humans in urbans areas is a concern, since it may increase the 
chance of humans becoming infected. 
Five MS reported positive ﬁndings of E. multilocularis in foxes, Table EH4. The largest 
number of foxes was investigated in Germany and 20.2% of the investigated foxes were 
found positive. This represented a decrease in the number of positive ﬁndings compared 
to 2003, and broke the increasing trend that has been observed from 1999-2003. 
The highest proportion of positive foxes was found Slovakia. E. multilocularis was not 
found in 355 foxes investigated in Finland and in 6 foxes investigated in Denmark. 
Sweden investigated 400 foxes in 2004, however, the results of these investigations 
were not available at the time of writing this report.
Table EH4. MS reporting E. multilocularis ﬁndings in foxes, 2001-2004
2004 2003 2002 2001
N % N % N % N %
Austria 86 8.1 807 5.6 592 6.8 - -
Germany 5,398 20.2 4,483 33.4 7,860 28.4 2,412 16.2
France 986 7.6 - - - - - -
Luxembourg 35 14.3 29 27.6 58 37.9 100 20
Slovakia 490 30.2 - - - - - -
In other wildlife species, E. granulosus was reported in two out of 965 moose and two 
out of 21 wolves investigated in Finland. Furthermore, Finland found two carcasses of 
semidomesticated reindeer positive for E. granulosus, out of the 21,129 examined through 
meat inspection at slaughter. France tested two wild boars and isolated E. multilocularis 
from both animals. In Norway, in the archipelago of Svalbard, E. multilocularis was detected 
in three of 22 tested voles. All reported data are presented in Level 3, Table EH3.
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3.9.3. Summary on Echinococcus
In 2004, the total number of human cases caused by Echinococcus spp. decreased by 
approximately 20% in the 17 MS that reported for both years. The majority of the human 
cases were caused by E. granulosus. The reduction may be attributed to a signiﬁcant 
decrease of the number of cases reported from Spain. If Spain is removed from the 
calculation, there was an overall increase in the number of reported human cases. 
The largest increases were observed in Portugal and Lithuania. 
 
In animals the majority of positive ﬁndings were observed in the Mediterranean MS, 
which is consistent with what has been reported in previous years. However, most of 
these MS have reported a decreasing trend in the number of positive ﬁndings in animals 
over the last ﬁve years. The other old MS reported either no ﬁndings or very low 
prevalences. Six new MS reported data on the occurrence of Echinococcus, the highest 
prevalences were reported in sheep and goats from Poland. 
E. multiocularis, the cause of alveolar echinococcosis in humans which may be fatal 
in untreated patients, was detected in foxes in ﬁve MS, and in wild boars in France. 
With the increasing population of foxes in the Community, and the migration of these 
animals into urban areas, there may be an increased risk of humans becoming infected. 
E. granulosus was found in other wildlife such as moose, reindeer and wolves.
As a part of the strategy to control the spread of Echinococcus, Cyprus, Finland and 
Greece reported treating dogs with antiparasitic drugs.
3.9.4. Sources of Echinococcus data 
Echinococcosis is notiﬁable in humans in all MS and Norway, except for Denmark, 
France, The Netherlands and United Kingdom. From 2005, the disease will become 
notiﬁable in Denmark. Cyprus, Luxembourg, Malta and Poland provided no information. 
In animals, Echinococcus detection is notiﬁable in 14 MS: Austria, Belgium, Denmark, 
Estonia, Finland, Greece, Latvia, Lithuania, Portugal, Slovakia, Slovenia, Spain, Sweden 
and The Netherlands, and Norway (Appendix, Table EH2).
For an overview of the monitoring and diagnostic methods, please refer to Appendix, 
Table EH1.
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3.10. Toxoplasma
Toxoplasmosis is a common infection in animals and humans. It is caused by an obligate 
intracellular protozoan parasite, Toxoplasma gondii. Nearly all warm-blooded animals 
can act as intermediate hosts, and seemingly all animals may be carriers of tissue cysts 
of this parasite. However, the parasite only matures in domestic and wild cats, which are 
the deﬁnite hosts. The infection may be acquired by humans through the consumption 
of undercooked contaminated meat or food contaminated with cat faeces or from handling 
contaminated soil or cat litter trays. Assisting sheep during lambing is also a known risk 
factor (Figure TO1).
Figure TO1. Lifecycle of Toxoplasma gondii
Source: Centers for Disease Control and Prevention – U.S.A. – http://www.dpd.cdc.gov/dpdx/
In humans, the majority of infections is asymptomatic or cause mild ﬂu-like symptoms. 
However, toxoplasmosis can be life threatening, especially for immunocompromised 
individuals. If acquired during pregnancy, toxoplasmosis can cause abortion or congenital 
malformation affecting the brain, eyes or other organs. 
In animals, Toxoplasma is an important cause of abortion in sheep, but may be controlled 
by proper management practices and vaccination. In previous years, the detection of 
this parasite was most frequently reported in cats, dogs, sheep and pigs.
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3.10.1. Toxoplasmosis in humans
In 2004, all MS except Belgium, Cyprus, France, Italy, Luxembourg, Malta and The Netherlands 
reported cases of toxoplasmosis. For the MS not reporting cases, toxoplasmosis is only 
notiﬁable in Belgium (French community) and Italy. Thirteen MS speciﬁed the number of 
congenital cases. The vast majority of the cases reported in the EU (approx. 97%) were 
laboratory-conﬁrmed clinical cases. Exceptions were cases from Austria and Slovenia, 
which were mainly asymptomatic cases identiﬁed via monitoring of pregnant women, and 
all cases reported from Denmark, which were identiﬁed via a neonatal screening programme. 
In total, 1,736 human cases of toxoplasmosis were reported from 18 EU MS in 2004 
(Table TO1). Few congenital cases (45 cases) were reported from 10 MS, and should be 
regarded as a minimum, since 8 MS provided no or incomplete information on the type 
of reported clinical cases. 
Table TO1. Reported cases of toxoplasmosis in humans, 2000-2004, and incidence in 20041
2004 2004 2003 2002 2001 2000
Cases/ 
100,000 
population
No. of cases: Total (congenital cases)
Austria (Upper)2 - 29 (0) 39 (1) - - -
Belgium - - - - - -
Cyprus - - - - - -
Czech Republic 3.1 319 455 646 516 670
Denmark3 0.2 9 (9) 13 (13) 12 (12) 19 (19) -
Estonia 1.2 16 (0) 9 4 7 14
Finland 0.8 43 45 34 48 40
France - - - - - -
Germany4 0 16 (16) 19 (19) 18 (18) 39 (39) 19 (19)
Greece4 0 2 (2) - - - -
Hungary 1.1 107 - - - -
Ireland 0.8 33 18 15 6 90
Italy - - 21 15 - -
Latvia 0.3 7 (1) 3 - - -
Lithuania 5 172 (3) 117 - 12 (12) -
Luxembourg - - - - - -
Malta - - - - - -
Poland 1.6 602 617 652 446 -
Portugal 0.4 46 (12) 54 - 40 45
Slovakia 2.9 154 (1) - - - -
Slovenia 1.2 23 (1) 38 - - -
Spain6 0.1 56 96 78 58 53
Sweden 0.1 5 17 10 18 13
The  
Netherlands - - - - - -
United Kingdom 0.2 97 113 137 132 128
EU-Total 0.6 1,736 (45) 1,674 (33) 1,621 (30) 1,329 (70) 1,072 (19)
Norway5 0 0 1 (0) 0 (0) 0 (0) 0 (0)
1. EU-Total incidence is based on population in reporting countries.
2. In Austria, reporting of congenital and screen positive (pregnant women).
3. In Denmark, only reporting of congenital cases from neonatal screening.
4. In Germany and Greece, only reporting of congenital cases.
5. In Norway, only enchephalotis cases are notiﬁable.
6. In Spain, only hospitalised cases are notiﬁable.
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In 2004, the overall incidence (cases per 100,000 population) in reporting MS was 0.6. 
(Table TO1). In MS where human toxoplasmosis is notiﬁable, the incidences ranged from 
0.02 to 5.0 (Germany and Greece compared to Lithuania, respectively).
 
The incidence in new MS was higher than the incidence in old MS; 1.9 in 8 reporting new 
MS versus 0.1 in 10 old MS. Only a minor difference was observed between the nine MS 
with full notiﬁcation system and the other reporting MS (0.4 versus 0.7).
Overall, an increasing number of toxoplasmosis cases were reported, from 1,072 cases 
in 2000 to 1,736 cases in 2004 following a parallel increase in the number of reporting 
MS from 10 to 18.
3.10.2. Toxoplasma in animals
Data on toxoplasmosis in animals were provided from 12 MS and Norway. The majority 
of the data were from diagnostic submissions, and 12,662 out of 23,948 examined units 
(animals/samples) were from sheep. Of these, 9,845 were from Italy, where a regional 
control programme on toxoplasmosis is carried out in Sardinia, as a result of a local 
high prevalence of Toxoplasma infection in sheep and goats and the importance of 
toxoplasmosis in ovine and caprine abortion.
Animal samples examined for Toxoplasma are almost entirely submitted with diagnostic 
purposes, and often with a speciﬁc suspicion of Toxoplasma being the causative agent. 
Thus, the results of the investigations do not reﬂect the general prevalence in the animal 
populations nor the overall risk for human exposure.
In 2004, positive animals or samples were found in all animals species examined: cattle, 
sheep, goats, pigs, solipeds, dogs, cats and pigeons. All reported data are available in 
Level 3, Table TO2.
Previous serological surveys of Toxoplasma in domestic and wild animals indicate 
that toxoplasmosis is endemic in the EU. In general, most animal species have a high 
proportion of seropositive samples including cats, which are deﬁnitive hosts for T. gondii. 
Only solipeds tend to have a lower proportion of seropositives.
Attempts to control toxoplasmosis in animals, was only reported from Italy (Sardinia), 
where measures (not speciﬁed) were applied in positive ﬂocks of sheep and goats to 
control the infection.
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3.10.3. Summary on Toxoplasma
According to the number of human cases of toxoplasmosis reported by 18 MS in 2004, 
the disease is not among the most common zoonotic diseases in the EU (overall 0.6 cases 
per 100,000 population). The vast majority of cases was laboratory-conﬁrmed clinical 
cases, and only few MS have a routine surveillance for toxoplasmosis in pregnant women 
or newborns. Congenital cases were rare (2.8% of all reported cases), but information 
on the syndromes presented in clinical cases was lacking from several countries. 
The reported incidence was considerably higher in the new MS (EU-10) than in the old 
MS (EU-15), which in part can be explained by several EU-15 countries reporting cases 
from a subset of the population or only reporting congenital cases.
Several MS: Belgium, Denmark, Spain and Sweden, and Norway report an effort to avoid 
the potentially disabling or even fatal congenital infections through advice to women on 
how to prevent Toxoplasma infections during pregnancy.
Data from animals in 2004 were mainly results from diagnostics submissions. In general 
the focus of toxoplasmosis in animals is on T. gondii as an important causative agent 
for abortions in sheep and goats rather than the food safety aspect, and information on 
type and method for detection of Toxoplasma in animals is lacking from several MS.
3.10.4. Sources of Toxoplasma data
Human infections with T. gondii were notiﬁable in 14 MS in 2004 (Appendix Table, TO2), 
of which Germany, Greece and Lithuania only notiﬁed congenital cases. In United Kingdom 
T. gondii is only notiﬁable in Scotland. In Cyprus, notiﬁcation began January 2005, and 
in Sweden notiﬁcation was discontinued in July 2004. No information on notiﬁcation 
was provided from Luxembourg, Malta, Poland and Portugal. Norway reported no cases 
in 2004, but has a notiﬁcation system for T. gondii infections associated with encephalitis 
(Appendix, Table TO2).
In 2004, toxoplasmosis in animals was notiﬁable in 8 MS: Belgium, Finland, Germany, 
Latvia, Lithuania, Slovenia, Spain and The Netherlands, and Norway (Appendix Table TO2).
Tables describing monitoring programmes and diagnostic methods are presented in 
Appendix, Table TO1.
b169_EFSA_int_02_03_06.indd   178 2/03/06   15:17:46
179 The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
3.11. Other parasitic zoonoses reported
Belgium was the only MS to report on the following two zoonoses.
3.11.1. Cysticerci
Cysticercus infection in humans is caused by the larval form of the tapeworm Taenia 
saginata. Cattle become infected through the ingestion of contaminated vegetation, 
and the eggs develop into cysterci in the muscle of the animal. Humans may become 
infected through consumption of raw or undercooked contaminated meat. Symptoms 
are mild abdominal discomfort and effective drug treatments exist.
Figure OP1. Lifecycle of Taenia saginata
Source: Centers for Disease Control and Prevention – U.S.A. – http://www.dpd.cdc.gov/dpdx/
Belgium reported data on the presence of cysticercus observed at post-mortem visual 
inspection of bovine carcasses at slaughterhouses. In 2004, of the 881,535 carcasses 
screened, 3,002 tested positive. The majority (2,981) of carcasses were infected with 
low parasitic loads and were treated by freezing at –10°C for 10 days prior to human 
consumption. The remaining 21 carcasses were heavily contaminated. This is a decrease 
from the 3,886 contaminated carcasses (3,859 lightly, 25 heavily) from 2003.
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3.11.2. Sarcocystis
Disease in humans may be caused by several species of Sarcocystis all of which have 
have a life cycle requiring two hosts. Humans become infected through the ingestion of 
infected meat or excreted oocysts and develop symptoms including diarrhoea, headache, 
as well, abortion and congenital disorders can result. 
Belgium reported ﬁndings from post-mortem inspection of bovine carcasses at 
slaughterhouses for the presence of sarcosporidiosis lesions. In 2004, of the 881,535 
carcasses screened, 19 tested positive for Sarcocystis. Infected carcasses were 
destroyed. This incidence of detection of this pathogen increased compared to 2003 
where there were 14 cattle rejections in 2003, and only 5 in 2002.
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3.12. Rabies
Rabies is a virus disease caused by a rhabdovirus of the genus lyssavirus. This virus can 
infect all warm-blooded animals and is transmitted through contact with infected animal 
saliva from animal bites. The disease causes swelling in the central nervous system of 
the host and is usually fatal. Two sub-types of rabies virus (lyssavirus genotypes 5 and 6), 
also known as European bat lyssavirus (EBL), are seen in bats. In rare cases, the infection 
can be transferred to mammals, including humans.
Symptoms in humans include a sense of apprehension, headache and fever and 
eventually leading to death of the affected person. Human cases are extremely rare in 
developed countries including EU, however, those working with bats and other wildlife 
are encouraged to seek advice on immunisation. 
In animals, pathogenicity and infectivity of the disease vary greatly among different species. 
Infected animals may exhibit a wide range of symptoms, including drooling, difﬁculty 
swallowing, irritability, strange behaviour, alternating rage and apathy and increasing 
paralysis of lower jaw and hindparts. Animals may excrete the virus during the incubation 
period, prior to the onset of clinical symptoms.
3.12.1. Rabies in humans
Generally, very few rabies cases in humans are reported in EU. Since 2001, only ﬁve 
cases imported from outside of EU have been registered (Table RA1), and most MS have 
not had any indigenous cases for decades. In 2004, one person died in Austria after being 
bitten by a puppy in Morocco, and one imported human case was reported from Germany.
Table RA1. Human rabies cases in EU, 2001-2004
Year Country Case
2001 UK 1 visitor from Philippines
2002 UK 1 registered bat handler died from EBL1
2003 France 1 visitor from Gabon
2004 Austria 1 case imported from Morocco
 Germany 1 imported case
1. EBL = European Bat Lyssavirus.
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3.12.2. Rabies in animals 
In 2004, rabies was reported in various animal species by 12 MS: Austria, Estonia, France, 
Germany, Hungary, Latvia, Lithuania, Poland, Slovakia, Slovenia, Spain and The Netherlands 
(Table RA2). In Austria the virus isolated from a dead fox was not a wild rabies strain, but 
the vaccination strain. Estonia, Hungary, Latvia, Lithuania, Poland and Slovakia reported 
cases in farm animals, pets and wildlife. France reported European Bat Lyssavirus (EBL) 
in bats and rabies in 3 illegally imported dogs, The Netherlands reported EBL from bats 
and Spain reported rabies in one dog imported from Morocco. In Austria, the vaccination 
strain of the virus was isolated from one fox, not the wild rabies strain.
With the exception of Estonia, France, Spain and The Netherlands, all of these MS have 
implemented rabies eradication programmes in the wildlife population, focusing on foxes. 
Estonia and France will implement eradication programmes from 2005. Austria, Czech 
Republic, Finland (along the south eastern border), Germany, Latvia, Poland, Slovakia 
and Slovenia run programmes approved and co-ﬁnanced by the European Commission 
(2003/849/EC). Furthermore, Hungary, Italy (Region Friuli Venezia Giulia) and Lithuania 
had similar types of eradication programmes in 2004 and Spain consider the mainland 
and islands free from rabies. See the Appendix Table RA1 for more information.
b169_EFSA_int_02_03_06.indd   182 2/03/06   15:17:48
183 The EFSA Journal 2005 – 310
INFORMATION ON SPECIFIC ZOONOSES
Table RA2. Reported rabies cases in animals, 2004
Domestic 
animals1
Pet animals Wildlife
Cats Dogs Bats Foxes Other
N Posi-
tive
N Posi-
tive
N Posi-
tive 
N Posi-
tive
N Posi-
tive
N Posi-
tive
Austria 24 0 126 0 78 0 2 0 9,772 19 1,229 0
Belgium 341 0 10 0 10 0 31 0 211 0 14 0
Cyprus 0 - 0 - 0 - 0 - 0 - 0 0
Czech Republic 20 0 421 0 286 0 21 0 8,186 0 357 0
Denmark - - - - 1 0 18 0 2 0 0 0
Estonia 85 153 158 20 96 24 0 0 169 92 283 163
Finland 5 0 16 0 13 0 4 0 321 0 333 0
France 37 0 1,175 0 1,476 34 223 42 379 0 11 0
Germany - - - - - 1 - 14 - 27 - 6
Greece - - 2 0 1,052 0 - - - - 0 0
Hungary 140 3 643 5 431 6 5 0 4,758 111 168 0
Ireland - - - 0 - 0 - 0 - 0 - 0
Italy 25 0 198 0 432 0 11 0 2,554 0 390 0
Latvia 74 265 198 35 174 33 0 0 409 181 347 168
Lithuania 156 706 271 34 287 41 - 609 197 541 2117
Luxembourg 3 0 8 0 1 0 - 26 0 2 0
Malta - - - 0 - 0 0 - 0 - 0
Poland 233 83 1,153 10 1,022 4 80 10 19,875 86 1,007 0
Portugal - - - - - - - - 40 0 0 0
Slovakia 22 18 276 3 384 1 - - 1,563 47 108 5
Slovenia 38 0 79 0 65 0 0 0 1,324 2 106 0
Spain - - 1,177 0 3,748 110 - - - - 0 0
Sweden - - 13 0 25 0 59 0 - - 19 0
The Netherlands - - 2 0 4 0 91 142 12 0 1 0
United Kingdom - - 11 0 11 0 - - - - 0 0
EU-Total 1,203 123 5,937 107 9,596 114 545 42 50,210 744 4,916 553
Norway - - - - 1 0  - 36 0 3 0
1. Include cattle (75% of the samples), sheep (12%), horses (6%), goats, pigs and other.
2. European Bat Lyssavirus (EBL).
3. Cattle were positive.
4. In France, dogs imported illegally.
5. In Latvia, 25 cattle positive.
6. In Lithuania, 65 cattle and 5 solipeds positive.
7. In Lithuania, 161 raccoon dogs positive.
8. In Slovakia, 1 sheep positive.
9.  In Austria, the vaccination strain of the virus was isolated from one fox, not the wild rabies strain. 
It is known that vaccination of a fox population can cause lethality in very young animals.
10. In Spain, a positive dog imported from Morocco.
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Compulsory vaccination of carnivorous pets has been implemented in Belgium (in some regions), 
Czech Republic, Estonia, Greece, Hungary, Lithuania, Poland, Portugal, Slovakia and Slovenia. 
In Finland vaccination is recommended. See the Appendix, Tab le RA1 for more information.
At least since 1999, six of the EU-15 countries: Belgium, Finland, Greece, Ireland, Italy, 
Portugal and Sweden, and Norway (mainland) had no reports of rabies (Table RA3). 
Malta has been free from rabies since 1911.
Table RA3. Rabies in animals, 1999-2004
2004 2003 2002 2001 2000 1999
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Austria 0 0 +7 + 0 0 0 + + +4 - - 0 0 +4 - - -
Belgium 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cyprus - - - 0 0 0
Czech Republic 0 0 0
Denmark - 0 0 0 0 - +3 0 +3 - - +3 - - +3 - - +3
Estonia + + +
Finland 0 0 0 +4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
France 0 +4 +6 - - - 0 +4 +6 0 +4 +6 0 0 +6 0 0 +2
Germany - + + + - + - + + + + + + + + + + +
Greece - 0 - - 0 0 - - - 0 0 0 - - - - 0 0
Hungary + + +
Ireland - - 0 0 0 0 - - - - - - 0 - - - - -
Italy 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Latvia + + + + + +
Lithuania + + + + + +
Luxembourg 0 0 0 - 0 0 0 0 0 0 0 0 - - - + 0 0
Malta - - -
Norway 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 +5
Poland + + +
Portugal - - 0 - 0 0 - - 0 - - - - - 0 - - 0
Slovakia + + +
Slovenia 0 0 + 0 0 +
Spain - +1 - 0 +1 0 + +1 + 0 +1 0 - +1 + - +1 +
Sweden - 0 0 - 0 0 0 0 0 - 0 0 0 0 0 0 0 0
The Netherlands - 0 +6 0 0 + - 0 + - 0 + - 0 + 0 0 +
United Kingdom - 0 - 0 0 0 0 0 + 0 0 0 0 - - 0 0 0
+: Rabies cases registered.
0: Rabies cases not registered.
Blank:  MS were not EU members at the time and therefore reported no data. Cyprus, Latvia, Lithuania 
and Slovenia reported on a voluntary basis in 2003.
1. In Spain, imported from North Africa.
2. In France, bat imported from Belgium.
3. In Denmark, all cases in bats and sheep were caused by EBL.
4. Imported animals.
5. In Norway, wild fox at the achipilago of Svalbard.
6. In France and The Netherlands, bats infected with EBL.
7.  In Austria, the vaccination strain of the virus was isolated from one fox, not the wild rabies strain. 
It is known that vaccination of a fox population can cause lethality in very young animals.
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Between 2002 and 2003, the number of reported cases of rabies in animals within 
the EU increased remarkably from 85 to 2,130 cases, mainly due to the cases reported 
by two new MS; Latvia and Lithuania. From 2003 to 2004 this number decreased to 
1,683 cases (Figure RA1). The four new MS; Cyprus, Latvia, Lithuania and Slovenia 
reported on voluntary basis in 2003.
In 2004, the majority of the reported rabies cases (95%) were found in the EU-10 countries, 
especially in Estonia, Latvia and Lithuania, and here the cases are primarily observed in 
the wildlife population. Foxes alone represent 44% of the total positive animals (Figure RA1).
Figure RA1. Number of reported rabies cases in animals in EU, 1999-2004
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A 3-year longitudinal study in bats started in England in 2004. Results will be available in 
2007. Another study on bats is in progress in Scotland. In Norway, a survey investigating 
the occurrence of rabies in wildlife on Svalbard is ongoing.
For additional information on data provided on rabies in animals, please, refer to Level 3, 
Table RA1.
3.12.3. Summary on rabies
Very few human rabies cases are reported in the EU annually. Usually persons known or 
suspected to be infected are immediately treated with prophylactic vaccinations, which 
prevent the disease from developing.
In most MS, the reported cases in animals are very rare or have been absent for many years. 
In those countries where the wild carnivore population carries the infection, vaccination 
programmes to control the disease have proven effective. This highlights the importance 
of continuous vaccination of the wildlife population in high risk or endemic areas in order 
to eradicate rabies throughout EU and to avoid reintroduction of rabies from countries 
east of the EU. Furthermore, illegal import of animals into the rabies free zones of EU is 
a threat. Of note, the infected bat population forms a potential risk.
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All MS with positive ﬁndings have eradication programmes in action or will start eradication 
programmes in 2005 (Estonia). In France, rabies in foxes was eradicated in the late 
1980’s after the implementation of eradication programmes and in Germany the number 
of rabies cases in foxes has decreased from 150 from an outbreak in 2000 to 27 in 2004.
The majority of rabies cases in animals were reported by the new MS, where wildlife 
(especially foxes) is frequently infected. These wild animals form a source of infection 
for farm animals, pets and humans. Latvia and Lithuania voluntarily reported number 
of rabies cases in 2003. These countries have an eradication programme for foxes, and 
both countries had a reduction in the relative number of positive cases in foxes in 2004 
compared to 2003.
Eradication programme in Slovenia
Slovenia has had an eradication programme in place since the late 1980’s. In foxes, 
the number rabies cases decreased from 996 in 1989 to 5 in 1999. However, in 2000 
the number of cases increased mainly due to an increase in the number of cases of 
rabies along the south-eastern border and distribution of fewer vaccines. As a result, 
the number of cases had increased to135 in 2001. Therefore, the eradication strategy 
was altered to focus on distribution of vaccine containing baits along the south-eastern 
border of the country. A very encouraging result was obtained with only 15 positive 
cases in 2002, 8 in 2003 and 2 in 2004.
3.12.4. Sources of rabies data 
In 2004, information concerning rabies was submitted from all MS and Norway.
Rabies is notiﬁable in humans in all MS and Norway. No information was provided by 
Luxembourg, Malta, Poland and Portugal. In most MS and Norway, examination of 
human cases is based on blood samples or cerebrospinal ﬂuid. However, in case of post 
mortem examinations the central nervous system is sampled. Identiﬁcation is mostly 
based on antigen detection, isolation of virus and the mouse inoculation test. See 
Appendix, Table RA3 for more information. 
In accordance with Council Directive 64/432/EEC, rabies is notiﬁable in animals in all 
MS and Norway; in The Netherlands only in dogs. No information on notiﬁcation was 
provided by Ireland, Luxembourg and Malta.
Belgium, Finland, France, Ireland, Luxembourg, Norway (mainland) and United Kingdom 
have been appointed ofﬁcially free from rabies (ORF) by the OIE or WHO. Sweden is free 
from rabies, but is not declared ORF. Cyprus, Greece, Malta and Spain (mainland and islands) 
consider themselves free from rabies. See Appendix, Table RA3 for more information.
In animals, most MS and Norway examine clinically suspect animals by testing samples 
of the central nervous system. Identiﬁcation is mostly carried out using the ﬂuorescent 
antibody test (FAT), which is recommended by both WHO1 and OIE2. and the mouse 
inoculation test. However, ELISA, PCR and histology are also used. France, Greece, 
Ireland, Luxembourg, Portugal, Slovenia and The Netherlands provided no information 
on the diagnostics used. See Appendix, Table RA2 for more information.
1 WHO Laboratory techniques in rabies.
2 O.I.E. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.
INFORMATION ON SPECIFIC ZOONOSES
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4.  INFORMATION ON ANTIMICROBIAL RESISTANCE  
IN SPECIFIC INDICATORS
4.1. E. coli indicators
4.1.1. E. coli indicators in food
Data on antimicrobial resistance in E. coli indicators from bovine meat (Table AB EC1), 
from pig meat (Table AB EC2), and from broiler meat (Table AB EC3) was provided by 
Denmark, Latvia and The Netherlands. Norway provided data on antimicrobial resistance 
in pig meat and broiler meat. In general, these four countries reported low levels of 
antimicrobial resistance in food. 
4.1.2. E. coli indicators in animals
Data on the occurrence of antimicrobial resistance in E. coli indicators from animals (cattle, 
pigs, Gallus gallus) was provided by the following countries; Austria, Czech Republic, 
Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Norway, Poland, 
Portugal, Spain, Sweden, The Netherlands and United Kingdom (Table AB EC4-EC6).
In general, a large variation in the prevalence of resistance in E. coli indicator isolates 
was observed among the data providing countries. This variation was especially large 
for penicillins, quinolones and tetracyclines, whereas in general, less variation was seen 
in the prevalence of resistance to the other antimicrobials tested. In general, the highest 
prevalence was reported in isolates from Gallus gallus, followed by pigs and cattle. 
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Table AB EC1. Antimicrobial resistance in E. coli indicators from bovine meat, 2004
Country DK LV NL
Monitoring program yes no yes
No of isolates available 196 3 66
Antimicrobial Group Antimicrobial
Aminoglycosides Gentamicin N 196 2 66
R% 0 0 0
Streptomycin N 196 2 -
R% 9 0 -
Amphenicols Chloramphenicol N 196 2 66
R% 1 0 5
Cephalosporins Cefotaxim N - 3 66
R% - 0 2
Cephalothin N 196 - -
R% 5 - -
Fluoroquinolones Ciproﬂoxacin N 196 3 66
R% 2 0 0
Penicillins Ampicillin N 196 2 66
R% 8 0 15
Quinolones Nalidixic acid N 196 1 66
R% 0 0 2
Sulfonamides Sulfonamide N 196 - -
R% 7 - -
Tetracyclines Tetracycline N 196 2 66
R% 9 0 27
Trimethoprim Trimethoprim N 196 - 66
R% 4 - 12
Trimethoprim + Sulfonamides Trimethoprim + Sulfonamide N - - 66
R% - - 12
Multiresistant isolates fully sensitives % - 100 -
resistant to 1 antimicrobial % - 0 -
resistant to 2 antimicrobials % - 0 -
resistant to 3 antimicrobials % - 0 -
resistant to 4 antimicrobials % - 0 -
 resistant to >4 antimicrobials % - 0 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB EC2. Antimicrobial resistance in E. coli indicators from pig meat, 2004
Country DK LV N NL
Monitoring program yes no yes yes
No of isolates available 178 8 97 24 
Antimicrobial Group Antimicrobial 
Aminoglycosides Gentamicin N 178 2 97 24
%R 0 0 0 0
Streptomycin N 178 9 97 -
%R 28 33 19.6 -
Amphenicols Chloramphenicol N 178 13 97 24
%R 2 15 1 8
Cephalosporins Cefotaxim N - 13 - 24
%R - 0 - 0
Ceftiofur N 178 - 97 -
%R 0 - 0 -
Fluoroquinolones Ciproﬂoxacin N 178 11 - 24
%R 0 9 - 0
Enroﬂoxacin N - - 97 -
%R - - 0 -
Penicillins Ampicillin N 178 11 97 24
%R 15 27 9.3 21
Quinolones Nalidixic acid N 178 3 97 24
%R 2 0 0 0
Sulfonamides Sulfonamide N 178 - 97 24
%R 18 - 11.3 29
Tetracyclines Tetracycline N 178 9 97 24
%R 26 11 8.3 42
Trimethoprim Trimethoprim N 178 3 97 24
%R 10 0 7.2 21
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 3 - 24
%R - 0 - 29
Multiresistant isolates fully sensitives % - 62 77.3 -
resistant to 1 antimicrobial % - 23 9.3 -
resistant to 2 antimicrobials % - - 3.1 -
resistant to 3 antimicrobials % - 8 3.1 -
resistant to 4 antimicrobials % - - 3.1 -
resistant to >4 antimicrobials % - 8 4.1 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB EC3. Antimicrobial resistance in E. coli indicators from poultry meat, 2004
Country DK LV N NL
Monitoring program yes no yes yes
No of isolates available 216 8 87 144
Antimicrobial Group Antimicrobial
Aminoglycosides Gentamicin N 216 5 87 144
%R 0 0 0 3
Streptomycin N 216 4 87 -
%R 6 75 16.1 -
Amphenicols Chloramphenicol N 216 5 87 144
%R 1 40 0 9
Cephalosporins Cefotaxim N - 7 - 144
%R - 14 - 2
Fluoroquinolones Ciproﬂoxacin N 216 7 - 144
%R 6 14 - 4
Enroﬂoxacin N - - 87 -
%R - - 3.4 -
Penicillins Ampicillin N 216 5 87 144
%R 15 100 23.3 58
Quinolones Nalidixic acid N 216 4 87 144
%R 6 50 3.4 22
Sulfonamides Sulfonamide N 216 - 87 -
%R 15 - 12.6 -
Tetracyclines Tetracycline N 216 4 87 144
%R 9 50 6.9 48
Trimethoprim Trimethoprim N 216 4 87 144
%R 3 75 2.3 47
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamides
N - 4 - 144
%R - 75 - 44
Multiresistant isolates fully sensitives % - 13 58.6 -
resistant to 1 antimicrobial % - - 29.9 -
resistant to 2 antimicrobials % - 25 8.1 -
resistant to 3 antimicrobials % - 13 1.2 -
resistant to 4 antimicrobials % - 50 0 -
resistant to >4 antimicrobials % - - 2.3 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB EC4. Antimicrobial resistance in E. coli indicators from cattle, 2004
Country  A CZ DK F GR H
Monitoring 
program yes yes yes yes no yes
No of isolates 
available 212 51 97 308 3 263
Antimicrobial Group Antimicrobial 
Aminoglycosides Gentamicin N 212 50 97 301 3 263
%R 0 6 0 5 0 0.4
Streptomycin N 212 50 97 306 3 263
%R 3.3 60 18 38.6 33.3 3.4
Amphenicols Chloramphenicol N 212 50 97 301 3 263
%R 0 8 0 17.6 33.3 0.4
Cephalosporins Cefotaxim N - - - - - -
%R - - - - - -
Cephalothin N 212 - 97 - - 263
%R 0.9 - 1 - - 5.3
Fluoroquinolones Ciproﬂoxacin N 212 - 97 302 3 -
%R 0 - 0 3.3 0 -
Enroﬂoxacin N - 51 - - 1 263
%R - 15.7 - - 0 0
Penicillins Ampicillin N 212 51 97 298 3 263
%R 1.9 13.7 8 27.5 33.3 5.7
Quinolones Nalidixic acid N 212 - 97 305 3 263
%R 0.9 - 0 9.8 0 0.4
Sulfonamides Sulfonamide N 212 - 97 - 3 263
%R 2,4 - 14.0 - 66.7 5.3
Tetracyclines Tetracycline N 212 50 97 303 3 263
%R 5.2 60 12 41.6 33.3 13.3
Trimethoprim Trimethoprim N 212 - - 296 3 0
%R 0.9 - 3 20.9 66.7 -
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 51 - - 3 263
%R - 15.7 - - 66.7 1.9
Multiresistant 
isolates
fully sensitives
% 91.5 - - 54.9 33.3 82.1
resistant to 1 
antimicrobial % 4.7 - - 5.8 - 10.6
resistant to 2 
antimicrobials % 0.5 - - 8.8 - 2.3
resistant to 3 
antimicrobials % 0.9 - - 3.9 33.3 2.3
resistant to 4 
antimicrobials % 1.9 - - 7.8 - 1.5
 resistant to >4 
antimicrobials % 0.5 - - 18.8 33.3 1.1
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Table AB EC4. Antimicrobial resistance in E. coli indicators from cattle, 2004 (cntd)
Country  IRL I LV PL P UK
Monitoring 
program no yes no yes no
No of isolates 
available 29,603 471 20 234 43 1,303
Antimicrobial Group Antimicrobial 
Aminoglycosides Gentamicin N - 471 18 181 - 1,303
%R - 4.2 6 1.1 - 0.5
Streptomycin N 481 471 14 184 - 1,303
%R 72.1 21.9 36 6.0 - 2
Amphenicols Chloramphenicol N - 471 8 181 1 1,303
%R - 10.8 25 0 0 0.5
Cephalosporins Cefotaxim N - 471 7 - 1 1,015
%R - 0.4 0 - 0 0
Cephalothin N 1,241 - - - - -
%R 49.3 - - - - -
Fluoroquinolones Ciproﬂoxacin N - - 16 183 1 -
%R - - 0 0 0 -
Enroﬂoxacin N 3,075 471 - 184 - 3,576
%R 26.5 6.4 - 0 - 0
Penicillins Ampicillin N 1,777 471 16 184 - -
%R 76.6 18.0 19 7.1 - -
Quinolones Nalidixic acid N - 471 8 184 - 1,303
%R - 13.0 0 1.1 - 0.5
Sulfonamides Sulfonamide N - 157 - 181 - 1,303
%R - 27.4 - 5.0 - 4.0
Tetracyclines Tetracycline N 1,374 471 8 182 1 -
%R 77.4 32.3 38 9.9 100 -
Trimethoprim Trimethoprim N 365 264 4 184 - -
%R 78.9 17.4 50 3.8 - -
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide
N 2,819 157 5 184 - -
%R 60.9 14.6 0 3.8 - -
Multiresistant 
isolates
fully sensitives % - 62.0 65 84.2 - 92
resistant to 1 
antimicrobial % - 5.0 10 7.6 - 3
resistant to 2 
antimicrobials % - 5.5 - 3.3 - 3
resistant to 3 
antimicrobials % - 5.3 15 2.7 - 1
resistant to 4 
antimicrobials % - 4.2 - 1.1 - 1
 resistant to >4 
antimicrobials % - 16.3 10 1.1 - 0
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
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Table AB EC5. Antimicrobial resistance in E. coli indicators from pigs, 2004
Country A CZ DK EST FIN F H IRL
Monitoring 
program yes yes yes yes yes yes yes no
No of isolates 
available
 217 175 208 9 391 101 171 649
Antimicrobial Group Antimicrobial
Aminoglycosides Gentamicin N 217 175 208 9 391 98 171 -
%R 0.9 9.71 3 22.2 0 3.1 0.6 -
Streptomycin N 217 175 208 9 391 100 171 5
%R 54.4 54.3 48 77.8 14.6 67 29.8 100
Amphenicols Chloramphenicol N 217 175 208 9 391 98 171 -
%R 3.7 14.3 9 33.3 1.3 21.4 8.7 -
Cephalosporins Cefotaxim N - - - 9 - - - -
%R - - - 0 - - - -
Cephalothin N 217 - 208 - - - 171 5
%R 0.5 - 5 - - - 8.2 80
Fluoroquinolones Ciproﬂoxacin N 217 - 208 9 - 101 0 -
%R 0.9 - 3 0 - 0 - -
Enroﬂoxacin N - 175 - 9 391 - 171 78
%R - 19.4 - 0 0.8 - 0.6 19.2
Penicillins Ampicillin N 217 175 208 9 391 98 171 61
%R 6 2.9 33 22.2 6.1 26.5 23.4 82
Quinolones Nalidixic acid N 217 - 208 9 391 99 171 -
%R 2.3 - 3 33.3 0.8 7.1 1.2 -
Sulfonamides Sulfonamide N 217 - 208 9 391 - 171 -
%R 30 - 47 66.7 11.5 - 27.5 -
Tetracyclines Tetracycline N 217 175 208 - 391 101 171 11
%R 58.1 63.4 44 55.6 16.4 81.2 74.2 81.8
Trimethoprim Trimethoprim N 217 - 208 9 391 100 0 1
%R 8.8 - 21 55.6 7.7 48 - 100
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N - 175 - 9 - - 171 77
%R - 19.4 - 55.6 - - 9.3 83.1
Multiresistant 
isolates
fully sensitives % 28.1 - - 11 71.4 15.8 18.7 -
resistant to 1 
antimicrobial % 12.9 - - 11 14.8 6.9 38.6 -
resistant to 2 
antimicrobials % 18 - - 0 5.4 23.8 13.5 -
resistant to 3 
antimicrobials % 18.4 - - 11 3.1 22.8 11.1 -
resistant to 4 
antimicrobials % 13.8 - - - 3.1 12.9 5.8 -
 resistant to >4 
antimicrobials % 8.8 - - 67 2.3 17.8 12.3 -
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Table AB EC5. Antimicrobial resistance in E. coli indicators from pigs, 2004 (cntd)
Country I LV N PL P ES NL UK
Monitoring 
program yes no yes yes no yes no
No of isolates 
available
 180 39 125 310 10 183 300 1,037
Antimicrobial Group Antimicrobial
Aminoglycosides Gentamicin N 166 30 125 273 10 183 300 1,037
%R 1.1 10 0 0.4 10 7.7 0 0.5
Streptomycin N 166 28 125 272 10 183 - 1,037
%R 49.4 71 33.6 36 100 66.1 - 28
Amphenicols Chloramphenicol N 166 3 125 278 - 183 300 1,037
%R 29.0 0 0.8 1.8 - 30.6 12 22
Cephalosporins Cefotaxim N 166 11 - - 10 183 300 807
%R 0 18 - - 10 0.5 0 0
Cephalothin N - - - - - - - -
%R - - - - - - - -
Fluoroquinolones Ciproﬂoxacin N - 37 - 277 - 183 300 -
%R - 0 - 0.4 - 3.3 0 -
Enroﬂoxacin N 166 - 125 277 10 - - 313
%R 4.8 - 0 0.4 10 - - 2
Penicillins Ampicillin N 166 35 125 278 10 183 300 -
%R 54.3 74 8.0 10.4 100 69.9 25 -
Quinolones Nalidixic acid N 166 24 125 277 10 183 300 1,037
%R 6.6 13 0 4.0 10 20.8 0 1
Sulfonamides Sulfonamide N 80 - 125 278 - 183 300 1,037
%R 78.8 - 12.0 15.8 - 73.2 53 62
Tetracyclines Tetracycline N 166 25 125 272 10 183 300 -
%R 80.7 72 9.6 34.6 90 95.6 64 -
Trimethoprim Trimethoprim N 86 4 125 276 10 183 300 -
%R 29.7 75 4.0 6.9 90 66.7 43 -
Trimethoprim + 
Sulfonamides
Trimethoprim + 
Sulfonamide N 80 3 - 276 - - - -
%R 67.5 67 - 6.7 - - - -
Multiresistant 
isolates
fully sensitives % 15.1 8 60.0 53.6 - 2.7 10 14
resistant to 1 
antimicrobial % 8.4 18 20.0 17.3 - 3.8 9.3 17
resistant to 2 
antimicrobials % 7.8 15 14.4 18.4 - 7.1 8 14
resistant to 3 
antimicrobials % 12.7 26 3.2 2.5 - 12.6 13 19
resistant to 4 
antimicrobials % 14.5 21 1.6 7.2 - 24 21.7 15
 resistant to >4 
antimicrobials % 41.5 13 0.8 1.1 - 49.7 38 -
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3. 
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Table AB EC6. Antimicrobial resistance in E. coli indicators from Gallus gallus, 2004
Country  A1 DK EST F GR H IRL I
Monitoring 
program
 yes yes yes yes no yes no yes
No of isolates 
available 216 142 1 102 52 147 826 471
Antimicrobial 
Group
Antimicrobial 
Aminoglycosides Gentamicin N 216 142 1 100 52 147 - 156
%R 2.3 0 0 5 1.9 0 - 1.28
Streptomycin N 216 142 1 101 52 147 25 156
%R 30.6 8 0 36.6 59.6 24.5 80 35.9
Amphenicols Chloramphenicol N 216 142 1 101 52 147 - 156
%R 4.6 0 0 6.9 17.3 7.5 - 17.3
Cephalosporins Cephalothin N 216 142 - - - 147 25 -
%R 2.3 2 - - - 18.4 92 -
Fluoroquinolones Ciproﬂoxacin N 216 142 1 100 52 - - -
%R 3.2 12 0 0 11.5 - - -
Enroﬂoxacin N - - 1 - 12 147 81 156
%R - - 0 - 25 24.5 4.9 10.3
Penicillins Ampicillin N 216 142 1 101 51 147 56 156
%R 23.6 18 0 33.7 57.0 42.2 89.3 53.2
Quinolones Nalidixic acid N 216 142 1 102 52 147 - 156
%R 41.2 13 0 22.5 63.5 71.4 - 42.3
Sulfonamides Sulfonamide N 216 142 1 - 52 147 - 82
%R 31.0 18 0 - 71.1 34.7 - 42.7
Tetracyclines Tetracycline N 216 142 1 99 51 147 18 156
%R 35.2 11 0 77.8 90 42.9 38.9 74.3
Trimethoprim Trimethoprim N 216 - 1 99 46 - 3 74.0
%R 14.4 5 0 25.3 56.5 - 100 32.4
Trimethoprim +  
Sulfonamides
Trimethoprim + 
Sulfonamide
N - 1 - 52 147 78 82
%R - 0 - 55.7 21.8 48.7 36.6
Multiresistant 
isolates
fully sensitives % 26.9 - 100 18.6 - 11.6 - 16.0
resistant to 1 
antimicrobial
% 24.1 - 0 25.5 17.3 23.1 - 10.3
resistant to 2 
antimicrobials
% 17.1 - 0 15.7 7.7 18.4 - 12.8
resistant to 3 
antimicrobials
% 8.8 - 0 13.7 5.8 17.7 - 17.3
resistant to 4 
antimicrobials
% 8.8 - 0 14.7 17.3 11.6 - 10.4
 resistant to >4 
antimicrobials
% 14.4 - 0 11.8 51.9 17.7 - 32.1
1. 216 isolates: 211 isolates from Gallus gallus and 5 isolates from turkey.
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Table AB EC6. Antimicrobial resistance in E. coli indicators from Gallus gallus, 2004 (cntd)
Country  LV N PL P ES S NL UK
Monitoring 
program
 no yes yes  no yes yes no
No of isolates 
available 13 86 106 32 152 300 296 177
Antimicrobial 
Group
Antimicrobial 
Aminoglycosides Gentamicin N 13 86 88 6 152 300 296 -
%R 15 0 9.1 16.7 8.6 0 4 -
Streptomycin N 11 86 93 6 152 300 - -
%R 55 9.3 63.4 33.3 57.9 4.9 - -
Amphenicols Chloramphenicol N 4 86 88 6 152 300 296 -
%R 25 0 17.1 100 18.4 0 23 -
Cephalosporins Cephalothin N - - - - - - - -
%R - - - - - - - -
Fluoroquinolones Ciproﬂoxacin N 12 - 93 6 152 - 296 -
%R 33 - 37.6 50 25.7 - 0 -
Enroﬂoxacin N - 86 95 - - 300 - 176
%R - 0 44.7 - - 2.3 - 6
Penicillins Ampicillin N 9 86 93 - 152 300 296 177
%R 89 17.4 71.0 - 57.2 4 63 37
Quinolones Nalidixic acid N 6 86 93 23 152 300 296 -
%R 33 0 81.7 83 78.3 5 46 -
Sulfonamides Sulfonamide N - 86 93 - 152 300 296 -
%R - 14 44.1 - 57.2 9 73 -
Tetracyclines Tetracycline N 2 86 93 6 152 300 296 177
%R 50 7 62.4 83.3 76.3 6 67 65
Trimethoprim Trimethoprim N - 86 94 - 152 300 296 -
%R - 2.3 24.5 - 34.9 0.3 63 -
Trimethoprim +  
Sulfonamides
Trimethoprim + 
Sulfonamide
N 1 - 94 6 - - - 176
%R 0 - 24.5 66.7 - - - 28
Multiresistant 
isolates
fully sensitives % 31 65.1 19.4 - 7.9 85.3 26.7 -
resistant to 1 
antimicrobial
% 15 24.4 1.1 - 9.9 6.7 19.3 -
resistant to 2 
antimicrobials
% 8 8.1 12.9 - 9.2 2.7 13.9 -
resistant to 3 
antimicrobials
% 31 1.2 15.1 - 7.9 1.7 15.5 -
resistant to 4 
antimicrobials
% - 0 22.6 33.3 11.8 1.3 16.6 -
 resistant to >4 
antimicrobials
% 15 1.2 29.0 66.7 53.3 2.3 8.1 14
Note: Only selected antimicrobials are presented in the table. The percentage of multiresistant isolates is based 
on all antimicrobials tested. Tables containing results for all antimicrobials tested can be found in Level 3.
INFORMATION ON ANTIMICROBIAL RESISTANCE IN SPECIFIC INDICATORS
b169_EFSA_int_02_03_06.indd   196 2/03/06   15:17:56
197 The EFSA Journal 2005 – 310
Cattle
For E. coli indicator isolates from cattle reported by Austria, Czech Republic, Denmark, 
France, Greece, Hungary, Ireland, Italy, Latvia, Poland, Portugal and United Kingdom 
(Table AB EC4), the highest level of resistance was reported for tetracyclines (with few 
exceptions), whereas the level of resistance to the other antimicrobials tested was 
generally moderate or low. The reporting from Austria, Greece, Latvia and Portugal was 
based on relatively small numbers of isolates. Ireland reported a high prevalence of 
resistance to several antimicrobials, e.g. ampicillin (77%), macrolides (87%) and tetracycline 
(77%). The other countries reported moderate or low occurrence of resistance to these 
antimicrobials. Austria, Hungary, Poland and United Kingdom reported high proportions 
of fully susceptible E. coli isolates.
Pigs
For E. coli indicator isolates from pigs reported by Austria, Czech Republic, Denmark, 
Estonia, Finland, France, Hungary, Ireland, Italy, Latvia, Norway, Poland, Portugal, Spain, 
The Netherlands and United Kingdom (Table AB EC5), the highest level of resistance was 
reported for tetracyclines, although large variation was observed (ranging from 9.6% for 
Norway up to 95.6% for Spain). For Italy, Spain and United Kingdom high prevalence of 
resistance to sulfonamides (62-79%) was reported. Resistance to quinolones was generally 
at a low level, with the exception of Spain and Estonia reporting 20.8% and 33.3% 
respectively, however the reporting from Estonia was based on a small number of samples.
Gallus gallus
The occurrence of antimicrobial resistance in E. coli indicator isolates from Gallus gallus 
was reported by Austria, Denmark, Estonia, France, Greece, Hungary, Ireland, Italy, 
Latvia, Norway, Poland, Portugal, Spain, Sweden, The Netherlands and United Kingdom 
(Table AB EC6). The reporting from Estonia, Latvia and Portugal was based on a small 
number of isolates. In general, a large variation in the prevalence was seen among the 
reporting countries. A high level of resistance to ampicillin, tetracycline and quinolones 
was observed in several of the reporting countries. Denmark, Norway and Sweden 
reported a generally low prevalence of resistance, with Sweden and Norway reporting 
high proportions of fully susceptible isolates (85% and 65% respectively). With few 
exceptions, low levels of ﬂuoroquinolones resistance were reported.
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4.1.3. Summary on E. coli indicators
The reporting of antimicrobial resistance in E. coli indicators from the MS and Norway, 
clearly demonstrates the presence of a reservoir of resistant bacteria in food animals 
and food of animal origin. Subsequent emergence of infections in humans, caused by 
resistant bacteria originating from the animal reservoir, is of concern as effective treatment 
may be compromised. The large differences between countries in the occurrence of 
resistance to penicillins, quinolones and tetracyclines in E. coli indicators, may likely be 
attributed to differences in antimicrobial consumption in food animals in the countries, 
and to differences in policies of antimicrobial use.
4.1.4. Sources of E. coli indicators data
Data on the occurrence of antimicrobial resistance in E. coli indicators was provided 
by the following countries: Austria, Czech Republic, Denmark, Estonia, Finland, France, 
Greece, Hungary, Ireland, Italy, Latvia, Norway, Poland, Portugal, Spain, Sweden, The 
Netherlands and United Kingdom. The countries reported results of antimicrobial 
susceptibility testing of isolates of E. coli indicators from various animal species and 
from various foods. All countries provided data on the occurrence of antimicrobial resistance 
in isolates from one or more of the following animal species: cattle, pigs and Gallus gallus. 
Denmark, Latvia, Norway and The Netherlands further provided data on the occurrence 
of antimicrobial resistance in isolates from one or more of the following food categories: 
bovine meat, pig meat and poultry meat.
Results were requested for the Community Zoonoses Report as the percentage of 
resistant isolates, out of the total number of isolates tested against each antimicrobial 
for each bacterial species in each speciﬁc sample category. In contrast to previous 
years, countries were not conﬁned to report on a deﬁned panel of antimicrobials or 
speciﬁc sample categories. This has implied large heterogeneity of data on antimicrobial 
resistance reported for 2004. In order to preserve comparability of data between 
countries, categories in which several countries reported were selected for this summary. 
Furthermore, categories were selected based on their relative importance. Direct 
comparison of the prevalence of resistant isolates between countries is not made if the 
reporting is based on small numbers of isolates. 
All countries providing data on antimicrobial resistance in E. coli indicators in 2004 
generated the data through monitoring programmes. The majority of reporting countries 
used dilution (MIC) method for antimicrobial susceptibility testing of E. coli isolates. 
Exceptions were Hungary, Italy, Latvia, Poland and United Kingdom using disc diffusion 
method. Breakpoints applied in individual countries for antimicrobial susceptibility testing 
by dilution methods are presented in Level 3, Table AB EC9.
For additional data on antimicrobial resistance in E. coli indicators in humans, food and 
animals, please refer to Level 3, Tables AB EC1 to EC8.
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5. FOODBORNE OUTBREAKS 
5.1. General outbreak overview
In 2004, 20 MS and Norway reported 6,883 foodborne outbreaks affecting all together 
more than 44,000 people (Table OUT1). In the MS, these outbreaks resulted in 4,361 
hospitalisations and 13 deaths. Outbreaks are reported as either General Outbreaks, 
affecting members of more than one private household, or Family Outbreaks, affecting 
only members of a single household. In 2004, there were 3,798 General Outbreaks and 
3,062 Family Outbreaks. Germany and Sweden do not distinguish between General and 
Family Outbreaks. The United Kingdom and Poland only reported General Outbreaks. 
Poland only reported outbreaks with more than four persons ill.
Czech Republic and Germany reported the largest number of outbreaks, 2,334 and 2,647 
respectively, representing 72.6% of all outbreaks reported for 2004. The EU reporting rate 
was 1.50 per 100,000 population and ranged from 0.09 in the United Kingdom to 22.86 
in Czech Republic. All foodborne outbreak data is presented in Level 3, Table OUT1.
Table OUT1. Number of reported foodborne outbreaks in EU Member States and 
Norway, 2004
Total 
number 
of out- 
breaks
Percent 
of total 
outbreaks 
reported 
in EU
Number 
of general 
out-
breaks
Number 
of family 
out-
breaks
Percent 
of out- 
breaks 
with 
aetiology1
Number 
of people 
affected
Number 
of people 
hospita-
lised
Number 
of deaths
Report-
ing rate 
per 
100,000 
for 2004
Austria 539 8.4 58 481 100 1,777 224 1 6.66
Belgium 55 0.8 33 22 78 530 74 0 0.53
Czech 
Republic 2,334 34.2 94 2,240 100 8,057 1,017 0 22.86
Denmark 53 0.8 31 22 81 147 0 0 0.98
Estonia 1 0.0 1 0 100 10 2 0 0.07
Finland 48 0.7 47 1 52 1,271 24 0 0.92
Germany2 2,647 38.8 2,647 100 10,851 0 0 3.21
Greece 39 0.6 23 16 92 1,737 442 1 0.35
Hungary 29 0.4 29 0 100 746 42 0 0.29
Ireland 13 0.2 7 6 77 71 6 0 0.32
Latvia 65 1.0 10 55 65 363 0 0 2.80
Lithuania 40 0.6 13 27 100 376 198 1 1.16
Poland 345 5.1 345 74 5,812 1,528 1 0.90
Portugal 20 0.3 9 11 100 181 61 0 0.19
Slovakia 42 0.6 30 12 100 1,013 0 0 0.78
Slovenia 64 0.9 51 13 98 1,871 196 0 3.21
Spain 338 4.8 195 143 100 4,593 433 8 0.78
Sweden2 86 1.3 86 0 40 1,318 1 0 0.96
The  
Netherlands 27 0.4 21 6 100 277 11 0 0.17
United 
Kingdom 52 0.8 52 100 1,903 102 1 0.09
EU-Total 6,860 100 3,798 3,062 97 42,904 4,361 13 1.50
Norway 23 0.3 16 7 100 1,573 8 0 0.50
1. Percent of outbreaks where the causative agent has been identiﬁed and reported.
2. No distinction between general outbreaks and family outbreaks.
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Causative agents
The most common agent responsible for foodborne disease outbreaks was Salmonella, 
which was responsible for 73.9% (5,067) of all reported outbreaks (Table OUT2).
In 2004, the causative agent was unknown in 3.2% (217) of outbreaks. This proportion 
was higher for general outbreaks than for family outbreaks. Some MS did not report 
information on outbreaks where the causative agent was unknown.
 
Table OUT2. Causative agents responsible for foodborne outbreaks showing number 
of outbreaks and number of persons affected, 20041
Total number 
of outbreaks
Percent of 
total number 
of outbreaks
Number of 
general 
outbreaks1
Number of 
family 
outbreaks
Number of 
people 
affected
Number of 
people 
hospitalised
Bacillus spp. 6 0.1 5 1 96 0
Brucella spp. 3 <0.1 0 3 35 1
Campylobacter 
spp. 1,243 18.1 600 643 3,749 157
Clostridium 
spp. 18 0.3 11 7 650 17
Diphyllobothrium 
spp. 1 <0.1 0 1 2 0
Food borne 
viruses 86 1.3 86 0 3,010 146
Giardia 1 <0.1 1 0 1,300 0
Histamine 6 0.1 6 0 39 2
Lectin 1 <0.1 1 0 12 1
Leptospira spp. 1 <0.1 0 1 2 0
Marine 
biotoxins 1 <0.1 1 0 12 0
Pathogenic 
Escherichia coli 87 1.3 61 26 799 54
Salmonella 
spp. 5,067 73.9 2,756 2,311 30,638 3,304
Scrombrotoxin 1 <0.1 1 0 8 1
Shigella spp. 20 0.3 8 12 288 50
Staphylococcus 
spp. 35 0.5 28 7 778 14
Trichinella spp. 15 0.2 5 10 196 145
Yersinia spp. 51 0.7 39 12 182 5
Unknown 217 3.2 189 28 2,681 472
EU-Total 6,860 100 3,798 3,062 44,477 4,369
1. Including all outbreaks from Germany and Sweden with no distinction on type (general or family outbreak).
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5.2. Foodborne outbreaks caused by Salmonella spp.
Outbreaks of salmonellosis were reported by 20 MS and Norway. Outbreaks caused 
by Salmonella affected a total of 30,638 persons with 10.8% hospitalised and 12 
deaths reported. 
Salmonella not further speciﬁed (‘Salmonella spp.’) was responsible for 78% (3,971 out 
of 5,067) of these outbreaks. These data likely include a number of different Salmonella 
serovars. In outbreaks where the serovar is known, S. Enteritidis was responsible for 
90% of outbreaks. (Table OUT3).
 
Table OUT3. Salmonella serovars responsible for foodborne outbreaks showing 
number of outbreaks and numbers of persons affected, hospitalised and died, 2004
Salmonella  
serotype
Number of 
outbreaks 
Percent of all 
outbreaks
Number of 
people affected
Number of 
people 
hospitalised
Number of 
people died
Salmonella spp. 3,971 57.89 17,643 1,243 0
S. Agona 1 0.01 19 0 0
S. Brandenburg 2 0.03 3 0 0
S. Bredeney 1 0.01 4 0 0
S. Coeln 1 0.01 2 1 0
S. Derby 1 0.01 43 0 0
S. Dugbe 1 0.01 2 0 0
S. Enteritidis 982 14.30 11,142 1,913 12
S. Give 1 0.01 47 1 0
S. group B 2 0.03 6 1 0
S. group C 1 0.01 30 2 0
S. group C2 2 0.03 4 1 0
S. group D 7 0.10 17 0 0
S. group E 1 0.01 2 0 0
S. Hadar 2 0.03 42 0 0
S. Heidelberg 1 0.01 9 8 0
S. IIIb 48:
lv,z13:1,5,7 1 0.01 2 0 0
S. Infantis 12 0.17 111 12 0
S. Leith 1 0.01 2 0 0
S. Mikawasima 1 0.01 12
S. Newport 4 0.06 299 40 0
S. Poona 1 0.01 2 1 0
S. Thompson 3 0.04 39 0 0
S. Typhimurium 64 0.93 1,101 75 0
S. Uganda 1 0.01 8 0 0
S. Virchow 3 0.04 47 6 0
Total 5,067 73.86 30,638 3,304 12
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Important outbreaks
Greece reported the largest Salmonella outbreak caused by S. Enteritidis. This outbreak 
resulted in 651 ill persons, with 247 hospitalisations and one death. An epidemiological 
investigation identiﬁed dry fruit and nuts as the source. The outbreak occurred following 
a church gathering. 
Austria reported a S. Typhimurium DTU291 outbreak from a restaurant that affected 233 
people. A case series investigation implicated tiramisu – a dessert containing raw eggs 
– and walnut cake, as the food vehicles. 
S. Typhimurium DT104 is an important phage type due to its frequent multiresistance to 
antimicrobials. The United Kingdom reported an outbreak from a fast food outlet affecting 
174 people with ten hospitalisations. S. Typhimurium DT104 was isolated from mayonnaise. 
The United Kingdom also reported an infected foodhandler as the source of a second 
S. Typhimurium DT104 outbreak with 126 cases.
The United Kingdom reported three S. Newport outbreaks with lettuce as the food vehicle 
conﬁrmed by statistical evidence. These outbreaks resulted in 297 ill persons and 40 
people requiring hospitalisation.
A multi-state outbreak of S. Give was investigated in Germany. There were 115 cases 
reported with a proportion hospitalised higher than expected. Consumption of raw minced 
pig meat was identiﬁed as a risk factor for illness in a case control study. 
Norway reported a hospital-based outbreak caused by foodhandler contamination with 
S. Infantis resulting in illness in 68 persons.
Of the new MS, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Slovakia 
and Slovenia reported Salmonella outbreaks. The Czech Republic reported more 
outbreaks (34.2% of all outbreaks) than any other new MS; most were family outbreaks. 
In Lithuania the largest outbreak was caused by S. Enteritidis due to consumption of 
Farsi salmon ﬁlled with raw eggs. Fifty-two persons were ill and 28 hospitalised.
Phage type
Austria, Finland, Norway, Portugal, Slovakia and the United Kingdom provided phage 
type information on S. Enteritidis. From the total number of S. Enteritidis outbreaks 
(n=811) (Table OUT3) these countries reported the phage type in 320 of them. Seventeen 
different phage types were reported. The ﬁve most commonly reported were S. Enteritidis 
PT4 (n=120), PT8 (n=105), PT21 (n=24), PT14b (n=15) and PT1 (n=13).
Austria, Denmark, Finland, Sweden and the United Kingdom provided phage type 
information on S. Typhimurium. From the total number of S. Typhimurium outbreaks 
(n=58) (Table OUT3), these countries reported the phage type in 37 outbreaks. Ten 
different phage types were reported. The most commonly reported were S. Typhimurium 
DT46 (n=15), DT120 (n=6) and DT104 (n=5).
Location of exposure
Speciﬁc information on the location of exposure was available for 8.9% (453 out of 
5,067) of domestic Salmonella outbreaks reported (Table OUT4). Private homes and 
restaurants were most commonly reported as the location of exposure to Salmonella.
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Table OUT4. Categories of exposure locations of people in Salmonella outbreaks 
in EU, 20041
Setting exposed Number of outbreaks Number of people affected
Abroad 38 181
Bakery 3 42
Camp 10 118
Catering 3 181
Community 1 21
Contaminated product 2 10
Fast food outlet 3 186
Hospital 9 152
Institution 49 1,090
Not reported 29 871
Other 5 856
Private home 140 1,226
Restaurant 92 1,362
Takeaway 10 216
Unknown 59 136
Total 453 6,648
1. Only domestic outbreaks with speciﬁc information on source were included.
Sources of infection
Data on sources of infection was provided in 7.9% (400 out of 5,067) of Salmonella 
outbreaks. (Table OUT5). There were 105 outbreaks reported where source was conﬁrmed. 
Level of evidence was stated in 73 outbreaks: microbiological conﬁrmation in 42 outbreaks, 
epidemiological evidence in seven, descriptive epidemiology in six, and both microbio-
logical and epidemological evidence in seven outbreaks. There were 191 outbreaks where 
the source was suspected, and for the remaining 104 outbreaks source was unknown.
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Table OUT5. Sources implicated in Salmonella outbreaks, 2004
Source Number of  
general outbreaks
Number of  
family outbreaks
Number of  
people affected
Number of people 
hospitalised
Bakery products 17 15 392 22
Bovine meat 2 1 23 2
Carrier person 2 2 26 2
Broiler meat 14 19 227 22
Dairy product 6 10 95 14
Duck meat 1 1 8 2
Eggs and egg products 44 38 1,307 56
Foodhandler  
contamination 3 - 90 3
Fruit or vegetables 9 3 1,000 9
Meat unspeciﬁed 10 9 218 11
Pig meat 11 7 204 9
Poultry meat other - 1 7 1
Seafood 6 7 173 10
Other food 1 - 10 -
Unknown 74 70 1,853 118
Water 3 1 690 4
Only meal identiﬁed 12 1 304 10
Total 215 185 6,627 295
Eggs and egg products was the group most frequently associated with outbreaks, in 
82 outbreaks. Bakery products, broiler meat, pig meat, and meat unspeciﬁed were also 
common causes of outbreaks. 
5.3. Foodborne outbreaks caused by Campylobacter spp.
Campylobacter caused 18% (1,243) (Table OUT2) of reported outbreaks with a low percent 
hospitalised (0.04%). Thirteen MS and Norway reported outbreaks of campylobacteriosis. 
C. jejuni was identiﬁed in 82% of outbreaks where typing of the agent was reported 
(in 2.7% outbreaks). C. coli was identiﬁed in two family outbreaks in Austria. The largest 
single outbreak of identiﬁed C. jejuni was reported in Norway, affecting 15 people.
Of the new MS, Czech Republic reported 547 outbreaks (out of which 542 were family 
outbreaks) caused by Campylobacter affecting 1,555 people, with 90 hospitalisations. 
Hungary reported one large waterborne outbreak of campylobacteriosis affecting 203 people. 
Location of exposure
Information on the location of exposure was available for 72 Campylobacter outbreaks. 
The most commonly reported locations were the home (74%) and restaurants (14%).
Source of infection
Source was reported in 30 outbreaks (Table OUT6).
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Table OUT6. Sources implicated in Campylobacter outbreaks, 2004
Source Number of outbreaks Number of people affected
Bovine meat 1 2
Broiler meat 8 63
Eggs and egg products 1 2
Fruit or vegetables 1 8
Meat unspeciﬁed 2 4
Only meal identiﬁed 1 11
Poultry meat other 1 2
Water 6 242
Unknown 9 38
Total 30 372
5.4. Foodborne outbreaks caused by pathogenic E. coli 
There were 87 outbreaks caused by pathogenic E. coli during 2004. These outbreaks 
affected 627 persons, and 52 required hospitalisation. There were no deaths reported.
Austria reported 3 VTEC outbreaks, with 9 people affected. Germany reported 36 VTEC 
outbreaks, affecting 92 people. The United Kingdom reported two E. coli O157 outbreaks. 
The largest outbreak affected 134 people. Cooked meat sandwiches from a single 
shop were identiﬁed as the source. Denmark reported its ﬁrst outbreak of VTEC in 2004. 
See text box below.
E. coli, other than VTEC, outbreaks were reported in three countries: Czech Republic, 
Poland and Portugal. Czech Republic reported 26 outbreaks with 108 persons ill, and 18 
hospitalisations. Poland reported 13 outbreaks with 213 cases, and 23 hospitalisations. 
Denmark experienced its ﬁrst two VTEC outbreaks, of which one was foodborne.  
In this outbreak, there were 25 conﬁrmed cases caused by E. coli O157:H- of phage 
type 8 that encoded virulence genes vtx1, vtx2x and eae. The source was traced 
back to an organic dairy with a small-scale contamination. Milk from this dairy was 
sold in one supermarket chain.
5.5. Foodborne outbreaks caused by Yersinia spp.
In 2004, there were 51 outbreaks (0.8%) (Table OUT2) caused by Yersinia, affecting 
182 people and hospitalising ﬁve. Six member states reported outbreaks: Austria, 
Czech Republic, Denmark, Finland, Germany and Portugal. 
Portugal and Finland (see text box) reported outbreaks with a known source. An outbreak 
in Portugal caused by ingestion of raw hamburger meat caused illness in three family members. 
Finland reported the largest Yersinia outbreak caused by Y. pseudotuberculosis O:1, 
affecting 58 people and hospitalising three people. The source was conﬁrmed to  
be grated carrots that were widely distributed. Carrots were traced back to the farm.  
The exact mechanism of contamination is unknown but it is likely that soil was  
contaminated with animal faeces.
Of the new MS, Czech Republic reported eight outbreaks affecting 22 people. 
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5.6. Foodborne outbreaks caused by other bacterial agents
Brucella 
Spain is the only MS to report Brucella outbreaks. In 2004, they reported three 
foodborne outbreaks of brucellosis causing illness in 35 people, and one hospitalisation. 
Cheese was the identiﬁed source in all three outbreaks. 
Leptospira
Latvia reported two cases of leptospirosis. No further information was available.
Shigella
Shigella outbreaks were reported by three MS: Latvia, Lithuania and Poland. Latvia 
reported 14 outbreaks (13 Shigella sonnei and one Shigella ﬂexneri) affecting 164 people. 
Contaminated milk and dairy products were the identiﬁed as the food vehicle in six 
outbreaks. Meat was identiﬁed as the cause in two outbreaks; in six outbreaks the food 
source was unknown. Lithuania reported three Shigella sonnei outbreaks causing illness 
in 93 people. In the largest outbreak, ﬁfty-six percent (23 out of 41) of cases were 
hospitalised following consumption of unpasteurised curd made on a private farm and 
sold in two markets. Poland reported three shigellosis (S. ﬂexneri) outbreaks, with 31 
cases and 20 hospitalisations. 
Bacterial toxins
Outbreaks caused by bacterial toxins were reported in 11 MS and Norway (Table OUT7).
There were 59 outbreaks (1.2%) (Table OUT2) involving toxins, which included 35 
outbreaks due to Staphylococcal enterotoxins and 18 outbreaks due to Clostridium spp. 
Morbidity and mortality were higher for Staphylococcus aureus and Clostridium perfringens 
than for most other causes of outbreaks. Outbreaks caused by S. aureus resulted in 
777 cases, 14 hospitalisations and one death. Clostridium spp. caused 650 cases, 
17 hospitalisations and two deaths.
Table OUT7. Outbreaks caused by bacterial toxins showing number of outbreaks 
and number of persons affected, 2004
Zoonotic Agent Number of 
general 
outbreaks
Number of 
family  
outbreaks
Number 
affected
Number 
hospitalised
Number of 
deaths
Bacillus cereus 5 1 96 0 0
Clostridium 
botulinum 1 6 21 15 1
Clostridium 
perfringens 10 1 629 2 1
Staphylococcus 
aureus 28 7 777 14 1
Total 44 15 1,523 31 3
The largest single outbreak of Clostridium perfringens was reported by the United Kingdom 
and affected 400 people. A variety of foods consumed in a club were implicated. Both 
microbiological and statistical evidence conﬁrmed the source. 
Belgium reported a large outbreak of Bacillus cereus affecting 50 people. Pasta was the 
identiﬁed meal.
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Finland reported ﬁve toxin outbreaks. The largest was an outbreak of C. perfringens 
from pork causing illness in 58 people.
Norway reported one B. cereus outbreak and two S. aureus outbreaks.
Portugal reported eight outbreaks: ﬁve C. perfringens, three S. aureus. The largest outbreak 
affected 20 people and was caused by contaminated pastry cakes.
Of the new MS, Poland reported 18 outbreaks, 17 were S. aureus. These outbreaks 
resulted in 664 cases, four hospitalisations and one death. A C. botulinum outbreak 
resulted in all nine cases requiring hospitalisation. Latvia reported three S. aureus family 
outbreaks. Lithuania report a C. botulinum outbreak with three cases from mushrooms 
canned at home. Slovenia reported one S. aureus outbreak with seven cases. The identiﬁed 
food was cottage cheese.
Sources of intoxication
Meat was identiﬁed as the source in 25% (15 out of 59) of bacterial toxin outbreaks. 
Bakery products were identiﬁed in four outbreaks, dairy products in three and sauces in two. 
Forty-four percent outbreaks were conﬁrmed with laboratory evidence. Epidemiological 
evidence conﬁrmed the source in two further outbreaks. In 51% (30 out of 59) of the 
outbreaks, no source information was provided.
5.7. Foodborne outbreaks caused by viruses
Foodborne viruses (hepatitis A, rotavirus, and calicivirus, including norovirus) caused 86 (1.7%) 
(Table OUT 2) outbreaks in eight countries, affecting more than 3,010 people (Table OUT 8). 
Table OUT8. Countries reporting outbreaks caused by foodborne viruses, 2004
Country Foodborne 
virus not 
speciﬁed
adenovirus astrovirus calicivirus 
(including 
norovirus)
hepatitis A 
virus
rotavirus Total
Austria - - - - 1 - 1
Belgium - - - 2 2 - 4
Finland - - - 10 - - 10
The 
Netherlands - - - 7 - - 7
Poland - 1 - 3 - 7 11
Slovenia - - 2 12 - 10 24
Sweden - - - 18 - 1 19
United 
Kingdom 3 - - 6 - 1 10
Total 3 1 2 58 3 19 86
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Calicivirus including norovirus
Sixty-seven percent (58) of these outbreaks were caused by caliciviruses, including 
norovirus. Caliciviruses are the most common cause of non-bacterial foodborne outbreaks. 
Illness is usually mild and short-lived, and attack rates are high. Caliciviruses were 
responsible for the majority of cases caused by viruses (2,540) and 43 hospitalisations. 
There were no deaths reported. The largest reported outbreak was reported by Sweden 
with 200 cases. Homemade cakes were identiﬁed as the source.
Poland, Slovenia and Hungary were the only new MS to report viral outbreaks. Poland 
reported 11 outbreaks of adenovirus, calicivirus and rotavirus. Outbreaks occurred 
mainly in institutions and at work places. Slovenia reported 12 outbreaks of calicivirus 
affecting 466 people. A waterborne outbreak was responsible for illness in 80 people. 
The remaining 11 outbreaks were caused through person-to-person transmission. 
Hungary reported a large waterborne outbreak affecting 203 people caused by sewage 
contaminated drinking water.
Location of exposure
Locations were reported in 93% (54) of calicivirus outbreaks. Catering services and 
restaurants were the location in 35% (19) of outbreaks, and hotels in four outbreaks. 
Institutions, including schools and aged care facilities, were the location in 33% (18) outbreaks.
Sources
Sources of infection were reported in 47% (27 out of 58) of calicivirus outbreaks. Sources 
were oysters in four outbreaks, water in four, fruit and vegetables in four, bakery 
products in three, and foodhandler contamination in 11 cases. Exposure to contaminated 
fruits and vegetables caused the largest number of cases. (Table OUT9).
Table OUT9. Number of people affected with calicivirus by source, 2004
Exposure Number of people affected
Bakery products 227
Fruit or vegetables 387
Seafood 60
Only meal identiﬁed 283
Other processed foods, prepared dishes 14
Water 339
Person-to-person 386
Unknown 86
Total 1,782
Given the low infectious dose of caliciviruses, especially norovirus, person-to-person 
transmission is common. Often it is difﬁcult to identify whether the food is contaminated at 
the source, as is common with oysters, or the food is contaminated by a sick foodhandler, 
or further person-to-person transmission occurred. Data reported for calicivirus outbreaks 
includes all sources of contamination. 
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Other viral outbreaks
Poland reported an adenovirus outbreak in a boarding school affecting 14 people. Slovenia 
reported two astrovirus outbreaks, one in a hospital and one in a residence for students.
There were three outbreaks of hepatitis A. One in Austria affecting 13 people, and two in 
Belgium affecting 19 people with two hospitalisations. No further information was provided. 
Rotavirus was responsible for 19 outbreaks, affecting 321 people, of which 83 people 
were hospitalised. Rotavirus is commonly spread person-to-person particularly in children. 
Forty-two percent of outbreaks were reported in children’s institutions. Slovenia reported 
ten outbreaks and Poland reported seven. 
5.8. Foodborne outbreaks caused by parasites
Trichinella
There were 15 outbreaks of trichinellosis affecting 196 people, of which 145 people 
were hospitalised. Lithuania reported four outbreaks with 20 cases caused by eating 
undercooked wild boar meat and pig meat. Poland reported four outbreaks with 157 
cases and 131 hospitalisations. Czech Republic and Latvia also reported outbreaks. 
Pig meat and wild boar meat sausages were foods identiﬁed.
Diphyllobothrium
Latvia was the only MS to report an outbreak of diphyllobothriasis. Two people became 
ill after consuming infected ﬁsh.
5.9. Foodborne outbreaks caused by marine biotoxins  
and other toxins
Four countries reported histamine poisoning, scombrotoxin or marine biotoxin outbreaks: 
Belgium, Finland, Portugal and Sweden. 
There were seven histamine poisoning (including scombrotoxin) outbreaks reported. 
Belgium reported two outbreaks of histamine poisoning from tuna. Five people were ill. 
Finland reported two outbreaks with 6 and 24 people ill, also from tuna. Sweden reported 
two outbreaks from cooked ﬁsh, affecting four people. Portugal reported an outbreak 
with eight people ill from tuna; scombrotoxin was conﬁrmed in the ﬁsh. 
Sweden reported an outbreak with 12 people caused by cooked shellﬁsh containing 
marine biotoxins, not further speciﬁed. 
5.10. Foodborne outbreaks caused by other agents
Lectin
Finland reported a lectin outbreak caused by the consumption of undercooked beans. 
Twelve people were affected and one hospitalised.
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5.11. Waterborne outbreaks
Waterborne outbreaks are frequently large outbreaks especially if a source of drinking 
water is contaminated.
Greece reported two waterborne outbreaks caused by Salmonella affecting 526 and 
125 people. No further information was available.
Hungary reported a waterborne outbreak caused by norovirus and Campylobacter 
affecting 203 people. A waterborne outbreak in Slovenia was responsible for illness in 
80 people. Both outbreaks were caused by contaminated drinking water.
Norway reported an outbreak of giardiasis affecting 1300 people caused by contaminated 
drinking water. Norway also reported an outbreak of waterborne campylobacteriosis 
affecting 15 people. 
5.12. Summary on foodborne outbreaks
This is the ﬁrst year where data on foodborne disease outbreaks has been summarised 
at the Community level. Data was received from 20 MS and Norway. All new MS reported 
outbreaks in 2004.
The most common cause of outbreaks in the EU in 2004 was Salmonella, causing the 
largest number of outbreaks and by far the largest number of human infections. Salmonella 
outbreaks were reported in all 20 MS that provided data on outbreaks, and in Norway. 
S. Enteritidis was the predominant serovar associated with these outbreaks. Eggs and 
meat products were the most important sources. 
The second most common cause of outbreaks in 2004 was Campylobacter. Outbreaks 
of campylobacteriosis were reported by 13 MS and Norway, and C. jejuni was the species 
most commonly reported in outbreaks were speciation was carried out. The majority of 
Campylobacter outbreaks, with a known aetiology, were associated with broiler meat 
and water. 
Other major causes of foodborne outbreaks in the EU were pathogenic E. coli, Yersinia 
spp. and foodborne viruses. 
Only a few foodborne outbreaks caused by parasites were reported. Outbreaks caused 
by Trichinella were reported by the new MS Lithuania and Poland. The sources of these 
outbreaks were pig or wild boar meat. The largest outbreak reported in 2004 was reported 
by Norway, involving 1,300 people infected with Giardia by drinking contaminated water. 
MS were requested to provide any outbreak data available. Data received was generally 
complete and of a high quality. However, these data differed between MS and some 
data quality issues were identiﬁed. Some MS, particularly the most populous, provided 
aggregated data for outbreaks. This meant that details on locations and sources of 
outbreaks were not available for the majority of outbreaks. 
Most MS identiﬁed the need for a centralised and coordinated system for outbreak data 
collection within their countries. As these systems improve, an increase in the number 
of identiﬁed and reported outbreaks may be expected.
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5.13. Sources of outbreak data
A foodborne outbreak is deﬁned by the Zoonoses Directive 2003/99/EC as ‘an 
incidence, observed under given circumstances, of two or more human cases of the 
same disease and/or infection, or a situation in which the observed number of cases 
exceeds the expected number and where the cases are linked, or are probably linked, 
to the same food source’.
Data was received from 20 MS and Norway. All new MS reported outbreaks in 2004. 
No data were available from France, Italy, Luxembourg and Malta. Data quality varied 
between countries. Some countries entered a line listing of outbreaks others reported 
aggregated data. As such detailed analysis is limited.
Fourteen MS and Norway provided information on their outbreak reporting systems. 
All reported systems of national data collection through centralised reporting and most 
MS had mandatory reporting systems. The completeness of these outbreak-reporting 
systems depends on two components: the ability to detect outbreaks at the local level 
followed by reporting to the national authority. Most MS indicated that outbreaks are 
under-reported due to these two factors.
Levels of evidence
Ultimately a foodborne disease outbreak investigation will identify the source of the 
aetiological agent i.e. the contaminated raw product. This will usually require a combination 
of microbiological and epidemiological evidence. Without this evidence the source 
of infection is ‘suspected’. In 2004, the information on ‘source’, ‘suspected’ and 
‘conﬁrmed’ evidence is reported in an inconsistent way as no harmonised deﬁnitions 
have been agreed on so far.
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APPENDIX 1
Appendix Table BR1. Notiﬁcation of Brucella in humans, animals and food, 2004
Notiﬁable in humans 
since
Notiﬁable in animals 
since
Notiﬁable in food  
since
Austria 19471 1957 1975
Belgium <1999 1978 2004
Cyprus 1983 - -
Czech Republic yes yes -
Denmark no4 19203 -
Estonia 1947 1962 no
Finland 1995 1920’s 1920’s
France yes7 - -
Germany yes yes -
Greece yes 1972 -
Hungary 1950 1928 no
Ireland 1948 - -
Italy 1990 1954 1929
Latvia 1974 yes -
Lithuania 1957 >30 years -
Luxembourg - - -
Malta - - -
Norway 19756 1903 no
Poland yes 1951 -
Portugal yes yes -
Slovakia yes no no
Slovenia yes <19912 2003
Spain 1943 1952 1952
Sweden 2004 yes no
The Netherlands yes yes yes
United Kingdom 19965,6 1971 1989
1.  In Austria, notiﬁable since 14 April 1913, re-proclaimed 12 June 1947, adapted on 28 April 1950.
2. In Slovenia, the year of independence. The disease was notiﬁable before 1991.
3. In Denmark, only clinical cases are notiﬁable.
4. In Denmark, only imported cases registered.
5.  In United Kingdom, reportable under Reporting of Injuries, Disease and Dangerous Occurrences. 
Regulations – applies to all work related activities but not to all incidents.
6. In Norway and the United Kingdom, imported or laboratory infected cases occur.
7. In France, mainly imported cases.
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Appendix Table EH1. Echinococcus monitoring programmes and diagnostic methods 
in humans and/or animals, 2004   
Country Type of data Diagnostic methods Monitoring, treatment, etc.
Austria Laboratory conﬁrmed Histopathology, ultrasound, 
X-ray, computed tomography, 
serology or combo serology 
DNA (PCR)
-
Belgium - - Information campaign  
in wooded areas about 
consumption of berries
Cyprus - - Scheme to treat dogs with 
Pranziquantel, surveillance of 
humans cases to evaluate 
the prev. programs in animals
Czech Republic - - -
Denmark Laboratory conﬁrmed Abdominal CT Scan, 
serology, histopathology
-
Estonia Laboratory conﬁrmed - -
Finland Laboratory conﬁrmed - Treatment required for 
imported dogs and cats, 
recommended for hunting 
dogs before and after 
hunting season
France Voluntary surveillance - Survey evaluating  
transmission from pet 
animals to man
Germany - - -
Greece - Xray/echo+sero investigation -
Hungary Laboratory conﬁrmed Western blot -
Ireland - - -
Italy - - -
Latvia Laboratory conﬁrmed/
monthly
Serology -
Lithuania Laboratory conﬁrmed Histopathology, imaging, 
serology
-
Luxembourg - - -
Norway Laboratory conﬁrmed Serology and histopathology -
Poland Laboratory conﬁrmed Serology and histopathology -
Portugal - -
Slovakia Laboratory conﬁrmed Serology and histopathology -
Slovenia - - -
Spain - - Control of annual infection in 
animals from endemic regions
Sweden Laboratory conﬁrmed, 
passive case ﬁnding
Serology and histopathology -
The Netherlands Laboratory conﬁrmed Serology -
United Kingdom Voluntary reporting - -
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Appendix Table EH2. Notiﬁcation of Echinococcus in humans, animals and food, 2004
Notiﬁable in humans 
since
Notiﬁable in animals 
since
Notiﬁable in food 
since
Austria 2004 1994 1994
Belgium <1999 1998 2004
Cyprus - - -
Czech Republic yes no -
Denmark no (2005) yes -
Estonia 1986 2000 2000
Finland 1995 19951 19951
France no - -
Germany yes - -
Greece yes 1980
Hungary 1960 no 1984
Ireland 2004 - -
Italy 1990 no 1964
Latvia 1999 yes -
Lithuania 1990 yes -
Luxemburg - - -
Malta - - -
Norway 2003 1985 1965
Poland - - -
Portugal yes yes -
Slovakia yes yes2 no
Slovenia 1949 19913 2003
Spain 1982 1994 1994
Sweden 2004 yes yes
The Netherlands no yes yes
United Kingdom no no no
1. In Finland, notiﬁable also before 1995, but legislation changed in 1995.
2. In Slovakia, only clinical cases.
3. In Slovenia, the year of independence, however this disease was notiﬁable before 1991.
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Appendix Table LI1. Monitoring programmes and diagnostic methods for Listeria 
monocytogenes, 2004
Country Surveillance Frequency and type of samples HACCP
Austria No monitoring programme.  
Surveys by the local authorities
- yes
Belgium Monitoring programme started  
in 2004
Fresh meat and ﬁnal products 
sampled weekly
-
Cyprus - - -
Czech 
Republic
Monitoring according to the  
Decree of the Ministry of Health  
No. 132/2004 Coll
- yes
Denmark No monitoring programme.  
Surveys by the local authorities
- -
Estonia No monitoring programme.  
Surveys by the local authorities
Random sampling -
Finland Survey on smoked and  
marinated ﬁsh 
Random sampling -
France - - -
Germany Monitoring, surveys and own-control - -
Greece No monitoring programme.  
Surveys by the local authorities
Routine and target sampling -
Hungary Monitoring milk products (EU requi-
rements) based on Directive 92/46
- -
Ireland - - -
Italy - - yes
Latvia No monitoring programme.  
Surveys by the local authorities
Random sampling yes
Lithuania - - -
Luxembourg - - -
Malta Survey on cheese - -
Norway Monitoring milk products  
(EU requirements)
Soft cheeses and fresh milk cheeses. 
1 sample out of every 20 batchs
-
Survey of imported products Soft cheeses
Poland - - -
Portugal Surveillance in raw milk and  
milk cheese
- -
Slovakia No monitoring programme.  
Surveys by the local authorities
- -
Slovenia No monitoring programme.  
Surveys by the local authorities
- yes
Spain - - -
Sweden No ofﬁcial programme.  
Surveys by the local authorities
Depend on survey random 
sampling
The Netherlands - - -
United 
Kingdom
No monitoring programme.  
National and regional surveys  
by the local authorities
Depend on survey surveys
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Appendix Table LI1. Monitoring programmes and diagnostic methods for Listeria 
monocytogenes, 2004 (cntd.)
Country Diagnostic method Survey on 
cheeses from 
raw and 
thermised milk1
Human diagnostic
Austria ISO 11290-1:1996 
(E):1996,1998
- Isolation of L. monocytogenes from blood, 
cerebral spinal ﬂuid, vaginal swabs
Belgium Afnor validated VIDAS LMO2 
followed by a chromogenic 
medium
- -
Cyprus - - -
Czech 
Republic
ISO 11290-1:1996 
(E):1996,1998
yes -
Denmark - yes Bacteriology
Estonia NMKL 136, 2004 
ISO 11290-1:1996 
(E):1996,1998
- Isolation of L. monocytogenes  
from blood and cerebral spinal ﬂuid
Finland ISO 11290-1:1996 
(E):1996,1998
yes Bacteriological culture
France - - -
Germany - - Isolation of L. monocytogenes  
from blood and cerebral spinal ﬂuid
Greece - - -
Hungary - - Isolation of L. monocytogenes  
from blood and cerebral spinal ﬂuid
Ireland - - -
Italy - - -
Latvia ISO 11290-1:1996 
(E):1996,1998
- Microbiological identiﬁcation
Lithuania - - Isolation of L. monocytogenes  
from blood and cerebral spinal ﬂuid
Luxembourg - - -
Malta - - -
Norway NMKL 136 - Isolation of L. monocytogenes  
from blood and cerebral spinal ﬂuid
Poland - - Isolation of L. monocytogenes  
from blood and cerebral spinal 
ﬂuid, articular or pericardial ﬂuid
Portugal ISO 11290 - -
Slovakia ISO 11290 - Isolation of L. monocytogenes  
from blood and cerebral spinal ﬂuid
Slovenia ISO 11290-1:1996 
(E):1996,1998
- -
Spain - - -
Sweden NMKL 136:2004,  
SLO METHOD
- Isolation of L. monocytogenes  
from blood and cerebral spinal ﬂuid
The Netherlands - - -
United 
Kingdom
- yes Culture
1.  Commission Recommendation 2004/24/EC, made under Article 14(3) of the Ofﬁcial Control of Foodstuffs 
Directive 89/397/EEC required MS to assess the microbiological quality of cheeses made from raw 
and thermised milk at production and rerail level.
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Appendix Table LI2. Notiﬁcation of Listeria in humans, animals and food, 2004
Notiﬁable in humans 
since
Notiﬁable in animals 
since
Notiﬁable in food 
since
Austria 19471 no 1975
Belgium <19992 1998 2004
Cyprus no - -
Czech Republic yes no -
Denmark 1993 no -
Estonia 2003 2000 2000
Finland 1995 19953 no4
France yes - -
Germany yes yes -
Greece yes 1980 -
Hungary 1998 no 2003
Ireland 2004 - -
Italy 1990 no 1962
Latvia 1990 yes 2003
Lithuania 1998 >30 years -
Luxembourg - - -
Malta yes - -
Norway 1975 1965 no
Poland yes - -
Portugal yes no -
Slovakia yes yes 2000
Slovenia 1977 19915 2003
Spain 19826 1994 1994
Sweden >30 years7 yes no
The Netherlands no yes yes
United Kingdom no no no
1. In Austria, notiﬁable since 14 April 1913, re-proclaimed 12 June 1947, adapted on 28 April 1950.
2. In Belgium, in the Flemish Community.
3. In Finland, notiﬁable also before 1995, but legislation changed in 1995.
4.  In Finland, food business operator has to notify to the competent authority, but there is no central 
notiﬁcation system.
5. In Slovenia, the year of independence, however this disease was notiﬁable before 1991.
6. In Spain, only hospitalised cases are notiﬁable.
7. In Sweden, only clinical cases notiﬁable.
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Appendix Table PO1. Human population per 100,000, 1999-2004
2004 2003 2002 2001 2000 1999
Austria 81,401 81,022 80,651 80,209 80,022 79,825
Belgium 103,964 103,558 103,097 102,634 102,391 102,138
Cyprus 7,304 7,151 7,055 6,975 6,905 6,829
Czech Republic 102,115 102,033 102,064 102,320 102,781 102,896
Denmark 53,976 53,835 53,684 53,492 53,300 53,136
Estonia 13,510 13,560 13,612 13,670 13,721 13,792
Finland 52,197 52,063 51,949 51,811 51,713 51,596
France 599,007 596,350 593,425 590,427 587,487 584,966
Germany 825,317 825,367 824,403 822,595 821,635 820,370
Greece 110,411 110,064 109,687 109,312 109,038 108,614
Hungary 101,167 101,424 101,749 102,003 102,216 102,534
Ireland 40,277 39,637 38,999 38,330 37,778 37,322
Italy 578,882 573,211 569,937 569,677 569,295 569,136
Latvia 23,192 23,315 23,458 23,643 23,817 23,992
Lithuania 34,459 34,626 34,756 34,870 35,121 35,364
Luxembourg 4,516 4,483 4,441 4,390 4,336 4,274
Malta 3,999 3,973 3,946 3,914 3,802 3,785
Poland 381,906 382,185 382,422 382,540 386,536 386,670
Portugal 104,747 104,075 103,293 102,567 101,950 101,489
Slovakia 53,801 53,792 53,790 53,788 53,987 53,934
Slovenia 19,964 19,950 19,940 19,901 19,878 19,783
Spain 423,453 415,506 408,505 403,764 399,607 397,244
Sweden 89,757 89,408 89,091 88,828 88,614 88,543
The Netherlands 162,580 161,926 161,053 159,871 158,640 157,602
United Kingdom 596,731 593,289 591,399 598,628 596,234 593,911
EU-Total 4,568,633 4,545,803 4,526,406 4,520,159 4,510,804 4,499,745
Norway 45,775 45,523 45,241 45,034 44,785 44,453
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Appendix Table PO2. Animal populations, 2004
Cattle Ducks Broilers Laying hens Total  
Gallus gallus
Austria 2,050,991 - 55,475,388 - 56,025,203
Belgium 2,781,676 33,949 27,873,988 14,364,922 50,947,719
Cyprus 62,201 66,540 16,569,000 415,000 -
Czech,Republic 1,428,329 3,224,065 176,009,350 7,513,650 185,724,385
Denmark 1,734,501 - 21,927,907 4,032,492 25,960,399
Estonia 253,149 - - - 2,197,359
Finland 951,900 1,826 5,573,229 3,069,195 10,405,204
France 19,200,0003 - - - -
Germany 13,031,000 2,626,0003 54,611,0003 38,965,0003 109,793,0003
Greece 870,691 15,316 112,000,000 6,227,830 -
Hungary 721,000 2,702,000 23,554,000 12,233,002 39,067,000
Ireland - - - - -
Italy 6,309,034 - 96,708,7186 44,781,1666 171,343,3246
Latvia 376,547 117 1,060,267 1,584,927 2,778,936
Lithuania 916,715 46,739 24,000,000 2,300,000 26,728,000
Luxembourg 183,367 - - - 79,162
Malta 19,662 - 1,340,000 539,000 1,887,000
Norway 936,600 64,7002 42,851,7002 2,469,2002 -
Poland 5,649,362 1,696,700 118,264,000 39,469,000 165,154,000
Portugal 1,389,911 4,000,000 205,000,000 154,000 -
Slovakia 559,054 9,000 20,800,000 2,500,000 25,580,000
Slovenia3 478,331 20,304 2,604,304 1,387,408 -
Spain 6,537,780 - 606,563,5002,7 494,144,000 632,370,7002,7,
Sweden 1,606,6743 44,2722 5,905,6793 4,497,6783 -
The Netherlands2 1,960,000 6,126,000 397,046,000 12,149,000 409,295,000
United Kingdom 10,603,000 2,392,523 119,912,000 29,662,000 919,940,0002
1. Meat production animals.
2. Number slaughtered only.
3. 2003 data.
4. Sheep and Goats .
5. 2002 data.
6. 2000 data.
7. 2001 data. Appendix Table PO2. Animal populations, 2004.
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Appendix Table PO2. Animal populations, 2004 (cntd.)
Geese Goats Pigs Sheep Solipeds Turkeys
Austria - 55,523 3,125,361 327,163 - 1,875,950
Belgium 4,834 37,666 5,662,440 214,612 - 498,146
Cyprus - 309,675 468,314 242,926 - 1,144,001 
Czech Republic 257,079 18,912 3,126,539 115,852 20,371 837,418
Denmark - 19,598 13,251,064 200,762 - 490,930
Estonia - 1,616 369,192 39,192 4,155 -
Finland 1,841 759 1,435,000 72,000 24,200 535,289
France - 1,176,000 15,046,000 5,461,0652 24,4332 -
Germany 384,0003 - 26,335,000 2,713,000 525,0003 10,604,0003
Greece 9,313 3,070,033 2,096,754 5,328,102 53,556 212,500
Hungary 2,427,000 74,000 4,287,000 1,397,000 67,000 5,454,000
Ireland - - - - - -
Italy 356,8876 8,589,8144,3 8,614,016 - 184,7316 12,937,4906
Latvia 795 14,500 340,296 35,699 17,700 91
Lithuania 52,437 7,112 1,057,358 34,292 63,587 98,438
Luxembourg - 1,970 83,432 9,792 3,405 -
Malta - 6,583 53,300 13,103 2,136
Norway 2602 71,000 1,469,2002 2,412,700 2,0002 1,035,2002
Poland 3,796,400 53,940 13,104,000 216,707 320,000 10,824,900
Portugal - 2,856,5204 - - - 4,582,000
Slovakia 6,000 2,299 2,230,707 261,269 52 150,000
Slovenia3 3,862 28,690 607,881 119,631 16,879 310,285
Spain - 3,046,7165 23,517,7415 23,813,1735 238,0965 91,199,6002,7
Sweden 29,0672 5,5093 1,903,1263 448,3083 271,0003 285,6963
The Netherlands2 - 20,000 14,340,000 620,000 2,000 2,210,000
United Kingdom 157,6903 92,000 5,161,000 35,890,000 299,886 7,521,9673
1. Meat production animals.
2. Number slaughtered only.
3. 2003 data.
4. Sheep and Goats .
5. 2002 data.
6. 2000 data.
7. 2001 data.
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Appendix Table PO3a. Animal herd populations, 2004
2004 Cattle Ducks Farmed Deer Farmed Reindeer
Herds Holdings Flocks Holdings Herds Holdings Herds Holdings
Austria - 86,034 - - - - - -
Belgium - 44,555 - 31 - 2,965 - -
Cyprus 370 370 - - - - - -
Czech Republic - 27,806 - 35 - 265 - -
Denmark 32,412 - - - - - - -
Estonia 9,382 9,382 - - - - - -
Finland - 22,882 - 135 - 7 - 5,243
France - 282,009 - - - - - -
Germany - - - - - - - -
Greece - 37,384 1,000 - 34 - - -
Hungary - 26,218 - 314 - - - -
Ireland - - - - - - - -
Italy 185,615 152,633 - - - - - -
Latvia 71,799 70,860 1 1 28 28 0 0
Lithuania - 195,226 - 2 - 0 - 0
Luxembourg - - - - - - - -
Malta - 420 0 0 0 0 0 0
Norway - 22,500 - 5 - 67 - -
Poland 882,761 - - - 32 - - -
Portugal - 90,292 - - - 173 - -
Slovakia - 18,312 - - - - - -
Slovenia - 46,736 - 2,373 - - - -
Spain - 246,862 - 490 - 69 - -
Sweden 27,905 - - - 609 - - 932
The Netherlands - 38,358 - - - - - -
United Kingdom - 110,462 - - - - - -
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Appendix Table PO3a. Animal herd populations, 2004 (cntd.)
2004 Farmed Wild Boars Gallus gallus Geese Goats
Herds Holdings Flocks Holdings Flocks Holdings Flocks Holdings
Austria - - 3,987 1,300 - - - 10,946
Belgium - - - 2,284 - 8 - 13,736
Cyprus - - 23 19 - - - -
Czech Republic - - - 360 - 13 - 731
Denmark - - 719 783 - - 2,632 -
Estonia - - 101 59 - - - 237
Finland - 50 - 2,041 - 111 - 1,072
France - - - - - - - 27,286
Germany - - - - - - - -
Greece 170 - 269 224 - - 22,520 -
Hungary - - 3,343 1,605 - 453 - -
Ireland - - - - - - - -
Italy - - - 521,539 - 31,263 - -
Latvia - 0 136 28 2 2 1,751 1,751
Lithuania - 0 - 198,778 - 1 - 3,665
Luxembourg - - - - - - - -
Malta 0 0 - 302 0 0 - 1,865
Norway - - - 1,357 - - - 1,090
Poland 9 - 211,787 - 14,859 - 14,582 -
Portugal - - - - - - - -
Slovakia - - - - - - - 489
Slovenia - - - - - 713 - 3,974
Spain - - - 12,029 - 178 - 84,063
Sweden - - - - - - 518 -
The Netherlands - - - 2,769 - - - 4,532
United Kingdom - - - - - - - -
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Appendix Table PO3b. Animal herd populations, 2004
Guinea Fowl Ostriches Pigs Rabbits
Herds Holdings Flocks Holdings Herds Holdings Herds Holdings
Austria - - - - - 51,265 - -
Belgium - - - - - 10,614 - -
Cyprus - - - - 115 115 - -
Czech Republic - - - - - 10,311 - -
Denmark - - - - 18,483 - - -
Estonia - - - - - 374 - -
Finland - - - - - 3,357 - -
France - - - - - 59,549 - -
Germany - - - - - - - -
Greece - - 175 - 4,365 - 12,050 -
Hungary - - - - - 253,150 - -
Ireland - - - - - - - -
Italy - 14,532 - - 195,325 - - -
Latvia - - - - 2,543 2,543 - -
Lithuania - - - - - 169,200 - -
Luxembourg - - - - - - - -
Malta - - - - - 157 - -
Norway - - - - - 3,762 - -
Poland - - - - 625,392 - - -
Portugal - - - - - - - -
Slovakia - - - - - 6,326 - -
Slovenia - 241 - 74 - 39,484 - -
Spain - - - - - 86,572 - 5,499
Sweden - - - - 3,669 - - -
The Netherlands - - - - - 10,038 - -
United Kingdom - - - - - 10,375 - -
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Appendix Table PO3b. Animal herd populations, 2004 (cntd.)
 
Sheep Sheep and goats Solipeds Turkeys
Flocks Holdings Herds Holdings Herds Holdings Flocks Holdings
Austria - 16,941 - - - - 246 133
Belgium - 31,405 - - - - - 63
Cyprus - - 4,173 4,173 - - - -
Czech Republic - 3,828 - - - 7,300 - 118
Denmark 10,617 - - - - - 50 -
Estonia - 1,564 - - - - - -
Finland - - - - - 4,641 - 139
France - 95,665 - - - - - -
Germany - - - - - - - -
Greece 64,632 - 39,008 - 30,134 - 35 -
Hungary - 18,613 - - - - - 407
Ireland - - - - - - - -
Italy - - 119,807 - 48,661 - 35,132 -
Latvia 3,454 3,454 - - 9,252 - 2 2
Lithuania - 2,630 - - - 54,647 - 3
Luxembourg - - - - - - - -
Malta - 1,865 - - - 1,946 0 0
Norway 17,439 - - - - - - 70
Poland - - - - 28,000 - 19,544 -
Portugal - - - 70,977 - - - -
Slovakia - 4,129 - - - - - -
Slovenia - 5,281 - - - 4,728 - 1,365
Spain - 141,984 - - - 48,750 - 810
Sweden 7,639 - - - 16,310 - - 1,056
The Netherlands - 14,396 - - - - - 92
United Kingdom - 88,775 - - - - - -
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Appendix Table RA1. Vaccination programmes for rabies in animals, 2004
Country Vaccination programmes 
in pets
Vaccination programmes in wildlife 
Austria - Since 1991, oral vaccines distributed to foxes twice a 
year. The programme is approved and co-ﬁnanced by  
EU (2003/849/EC).
Belgium Compulsory vaccination  
of dogs and cats in the 
south and if staying at 
public campgrounds
Oral vaccines were distributed until 2003.
Cyprus - -
Czech Republic Compulsory vaccination  
of carnevores in captivity
In 1989, oral vaccination of foxes in some districts.  
In 2003, covers the whole country except for rabies free 
districts. Since 2004, vaccination twice a year by air in 
selected areas, mainly along the border with Poland  
and Slovakia. The programme is approved and will be 
co-ﬁnanced by EU (2003/849/EC).
Denmark - -
Estonia Compulsory vaccination  
of dogs and cats
In 2004, oral vaccines were distributed twice on one island. 
From 2005, a vaccination programme covering half the 
country has been approved and will be co-ﬁnanced by EU.
Finland Vaccination in dogs and 
cats is recommended
Since 1991, Oral vaccines distributed to foxes and 
racoon dogs twice a year along the russian border  
by ﬂight. Since 2004, twice a year. The programme  
is approved and co-ﬁnanced by EU (2003/849/EC).
France - Oral vaccines distributed to foxes will start again in 2005.
Germany - Oral vaccines distributed to foxes twice a year by ﬂight. The 
programme is approved and co-ﬁnanced by EU (2003/849/EC).
Greece Compulsory vaccination  
of dogs
-
Hungary Compulsory vaccination  
of dogs
Since 2004, oral vaccines distributed to foxes twice  
a year by ﬂight. The programme started in 1997.
Ireland - -
Italy - Oral vaccines distributed to foxes in the Region Friuli 
Venezia Giulia.
Latvia - Oral vaccines distributed to foxes twice a year by ﬂight. The 
programme is approved and co-ﬁnanced by EU (2003/849/EC).
Lithuania Compulsory vaccination  
of dogs and cats
Since 1995, oral vaccines distributed to foxes twice a 
year by ﬂight.
Luxembourg - Oral vaccines distributed to foxes will start in 2005.
Malta - -
Norway Vaccination of dogs and 
cats being brought in and 
out of the country
-
Poland Vaccination programme  
for dogs since 1949
Since 2002, oral vaccines distributed to foxes twice a year 
by ﬂight. The programme is approved and co-ﬁnanced  
by EU (2003/849/EC). 
Portugal Compulsory vaccination  
of dogs since 1925
-
Slovakia Compulsory vaccination  
of domestic carnivores
Oral vaccines distributed to foxes twice a year by ﬂight. The 
programme is approved and co-ﬁnanced by EU (2003/849/EC).
Slovenia Compulsory vaccination  
of dogs since 1947
Since 1995, Oral vaccines distributed to foxes twice a year 
by ﬂight. The programme is approved and co-ﬁnanced  
by EU (2003/849/EC).
Spain - From 2004, compulsery surveillance according to 
Directive 03/99/EEC.
Sweden Vaccination of dogs and 
cats being brought in and 
out of the country
-
The Netherlands - -
United Kingdom - -
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Appendix Table RA2. Type of samples and diagnostic methods used when diagnosing 
rabies in humans and animals, 2004
Humans Animals
Type of sample Diagnostic test Type of 
sample
Diagnostic test
Austria Liquor, smears from 
pharynx, swab from 
conjuntivae, biopsy at 
the nape of the neck 
and serum
FAT, immunohisto-
chemistry, RT-PCR
Brain FAT, mouse inoculation 
test
Belgium - - Brain FAT
Cyprus - - Brain Histopathology
Czech Republic - - Brain FAT
Denmark Blood samples, skin 
biopsy from neck
- Brain FAT, Virus isolation
Estonia - - Brain FAT
Finland - Human: cultivation, 
serology, antigen-test, 
direct microscopy. 
Brain FAT, cell culture
France - - - -
Germany - - - FAT, cell culture
Greece - - - -
Hungary Cerebrospinal ﬂuid, 
blood
Isolation of virus, 
antigen detection, 
mouse inoculation 
method, FAT
- -
Ireland - - - -
Italy - - Brain Flourescent antibody 
test (FAT), smears
Latvia - Elisa Brain FAT, mouse inoculation 
test 
Lithuania Cerebrospinal ﬂuid, 
saliva
Isolation of virus, 
antigen detection, 
mouse inoculation test, 
ELISA, PCR.
- -
Luxembourg - - - -
Malta - - - -
Norway Cerebrospinal ﬂuid, 
salvia, if postmortem: 
brain tissue
Isolation of virus, 
antigen detection
Brain FAT, mouse inoculation 
test 
Poland Cerebrospinal ﬂuid, 
saliva
Isolation of virus, 
antigen detection
- FAT, mouse inoculation 
test, RFFIT
Portugal - - - -
Slovakia Cerebrospinal ﬂuid, 
saliva
Isolation of virus, 
antigen detection
- FAT, ELISA, PCR, FAVN 
Slovenia - - - -
Spain - - Brain 
tissue/
blood
FAT, ELISA
Sweden - Serology, antigen 
detection, isolation  
of virus
Brain 
tissue
FAT, mouse inoculation 
test
The Netherlands - - - -
United Kingdom - - - FAT, mouse inoculation 
test, histology, PCR
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Appendix Table RA3. Notiﬁcation of rabies in humans and animals, and Ofﬁcial 
Rabies Free status, 2004
Notiﬁable in 
humans since
Notiﬁable in 
animals since
Ofﬁcial Rabies Free Status (ORF)
Austria 1947 1957
Belgium <1999 1883 ORF by WHO recommendation (2001)
Cyprus 2004 yes Rabies free
Czech Republic yes 1999
Denmark 1964 1920
Estonia 1946 1950
Finland 1995 1922 ORF by WHO recommendation (1991), 
considered free in accordance to OIE 
France yes yes ORF by OIE (2001)
Germany yes yes
Greece yes 1936 Rabies free
Hungary 1950 1928
Ireland 1976 - ORF by OIE
Italy 1990 1954
Latvia 1974 yes
Lithuania 1957 <1975
Luxembourg - - ORF by OIE (2003)
Malta - - Rabies free since 1911
Norway 1975 1965 The mainland is ORF by OIE
Poland - 1927
Portugal - yes
Slovakia yes yes
Slovenia 1949 19911
Spain 1901 1952 The mainland and islands are considered 
rabies free
Sweden <1975 yes Rabies free since 1886
The Netherlands yes yes (dogs)
United Kingdom yes yes ORF by OIE
1. In Slovenia, the year of independence, however, this disease was notiﬁable before 1991.
APPENDIX 1
b169_EFSA_int_02_03_06.indd   227 2/03/06   15:18:07
228The EFSA Journal 2005 – 310
Appendix Table SA1. Surveillance systems on Salmonella in feedingstuffs, 2004
Country Surveillance 
compulsory
Domestic raw feed material Imported raw feed material  
(EU and Non-EU countries)
Animal Vegetable Animal Vegetable
Austria Yes Each farm, processing plant  
and retailer are sampled at least 
twice per year
Each farm, processing plant  
and retailer are sampled at least 
twice per year
Belgium Yes Ofﬁcial monitoring - -
Cyprus - - - - -
Czech Republic - - - - -
Denmark Yes Targeted 
sampling
Targeted 
sampling
Targeted 
sampling
Targeted 
sampling
Estonia Yes Monitoring Monitoring - -
Finland Yes Self control systems based  
on requirements of legislation
Random 
sampling
Every consign-
ment is sampled
- - - - Non-EU: 2 samples per 50.000 kg 
in every bulk, truck, container
France - Monitoring plad 5/97-5/98, 
number of samples determined  
in proportion to tonnage used
- -
Germany Yes - - Samples are 
taken by ofﬁcial 
labs. At least 25 
samples per batch
-
Greece - Targeted  
and routine 
sampling
Targeted  
and routine 
sampling
- -
Hungary - - - - -
Ireland Yes Compulsory sampling regime 
drawn up in accordance with 
Council Directive 95/53/EC
Compulsory sampling regime 
drawn up in accordance with 
Council Directive 95/53/EC
Italy Yes - Ofﬁcial control as 
well as HACCP 
or own check  
by the industry
- -
Latvia No HACCP or own check by  
the industry
- -
Lithuania - - - - -
Luxembourg - - - - -
Malta - - - - -
Norway Yes Own check programme based  
on requirements of legislation. 
Random sampling by the ofﬁcial 
surveillance programme
Controlled  
at Border 
Inspection Posts 
(predominantly 
pet feed)
x
Poland - - - - -
Portugal - - - - -
Slovakia - - - - -
Slovenia Yes Ofﬁcial target sampling and  
own check programme based  
on HACCP by the industry
Ofﬁcial target sampling and  
own check programme based  
on HACCP by the industry
Spain Yes Monitoring Monitoring - -
x -:  routinely performed.
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Appendix Table SA1. Surveillance systems on Salmonella in feedingstuffs, 2004 (cntd.)
Country Process control Compound feed
Cattle Pig Poultry
Austria x Each farm, processing plant and retailer are sampled at least 
twice per year 
Belgium - x x x
Cyprus - - - -
Czech Republic - - - -
Denmark Targeted sampling - - -
Estonia - Monitoring Monitoring Monitoring
Finland x Self control systems based on requirements of legislation.  
Final products: random ofﬁcial sampling
- - - - -
France - 1/10 000 tons, monitoring plan 97/98
Germany - 
 
 
- - -
Greece - 
 
- - ISO 6571, ISO 6580 
(Broilers)
Hungary - - - -
Ireland - x x x
Italy - 
 
 
Ofﬁcial control as well as HACCP or own check by the industry
Latvia HACCP or own 
check by the 
industry
HACCP or own check by the industry
Lithuania - - - -
Luxembourg - - - -
Malta - - - -
Norway Own check 
programme based 
on HACCP by the 
industry
All complete feedingstuffs must be subject to heat treatment2
Poland - - - -
Portugal - -
Slovakia - - - -
Slovenia Ofﬁcial target 
sampling and own 
check programme 
based on HACCP 
by the industry
- - -
Spain - Monitoring Monitoring Monitoring
x -: routinely performed.
2.  In Norway, establishments producing feed are required to establish own check programme based on 
HACCP. In addition, random samples are collected through an ofﬁcial surveillance programme.
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Appendix Table SA1. Surveillance systems on Salmonella in feedingstuffs, 2004 (cntd.)
Country Surveillance 
compulsory
Domestic raw feed material Imported raw feed material  
(EU and Non-EU countries)
Animal Vegetable Animal Vegetable
Spain Yes Monitoring Monitoring - -
Sweden Yes All consignments have to be 
sampled 
All consignments have to be 
sampled  
 
 
 
The Netherlands Yes Own control - -
United Kingdom 
(Great Britain)
- Sampling of rendered material is 
required if the rendered material 
is intended for use in livestock 
feedingstuffs; reportable
Tested 
according to a 
risk assessment
-
United Kingdom 
(Northern Ireland)
- - x -
x -: routinely performed.
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Appendix Table SA1. Surveillance systems on Salmonella in feedingstuffs, 2004 (cntd.)
Country Process control Compound feed
Cattle Pig Poultry
Spain - Monitoring Monitoring Monitoring
Sweden Own check 
programme based 
on the HACCP 
principles1 and 
ofﬁcial targeted 
control
All consignments have to be sampled 
The Netherlands - Routine testing - -
United Kingdom 
(Great Britain)
Codes of practice 
for control is applied 
as part of the 
HACCP process
x x x
United Kingdom 
(Northern Ireland)
- x x x
x -: routinely performed.
1.  In Sweden, feed mills producing feedingstuffs for poultry a minimum of ﬁve samples per week, feed 
mills producing feedingstuffs for ruminants, pigs or horses two samples a week.
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Appendix Table SA2. Salmonella monitoring programmes in poultry breeders 
(Gallus gallus), 2004
Countries, running a monitoring or control programme described in the Directive 92/117/EEC
Follow the Directive A, CZ1, DK, D, FIN, F, GR, IRL, I, LV, N, NL, P, S, SK, SLO, ES, UK
For additional sampling see 
Table SA3
DK, FIN, F, N, NL, S, UK
Sampling of day-old chicks for 
egg production is voluntary
P
Requirement according to Directive 92/117/EEC
Day old chicks Rearing period Production period
Dead chickens/ 
destroyed chickens (20)
4 weeks faecal samples 
(60) 
Every 2 weeks dead chickens 
(50) or
Samples from the 
incide of the delivery 
boxes (internal lining/
paper/crate material)
2 weeks before 
moving
faecal samples 
(60)
Ofﬁcial sampling 
every 8 weeks
meconium 
samples (250)
Countries running a monitoring or control programme using a sampling scheme based on 
Directive 92/117/EEC
Belgium Inner lining of delivery 
boxes and blood
age of 16 weeks Faecal samples 
(60)
Every 6 weeks 
(60)
Faecal samples 
at farm
(all: domestic and 
imported)
- all ﬂocks litter 4 times a year Salmonella 
control: dead  
in shell chicks, 
ﬂuff, meconium 
(pooled samples)
- imported reared 
hens and cocks 
pooled faecal 
samples
4 times a year Hygiene control 
of hatcheries
Before arrival at 
slaughterhouse 
(2 weeks before 
slaughter)
60 faecal 
samples 
Estonia Egg production: 
Meconium (250 chicks) 
or 50 dead chicks. 
Meat production:
Dead chicks and inner 
lining of delevery boxes 
(10/ﬂock or batch)
5-6 weeks or 2 
weeks (ﬂocks for 
egg production, 
3 weeks (ﬂocks 
for meat 
production) 
before moving
Faecal samples 
(number of 
samples depend 
on ﬂock size)
20-24 weeks 
and 98-104 
weeks
Faecal samples 
(number of 
samples depend 
on ﬂock size)
Diagnostic methods used
ISO 6579:2002 B, CR, DK, EST, GR, I, LV, PL, SK, SLO, ES, NL,
NMKL No 71:1999 N, S
Modiﬁed ISO 6579:2002 UK
ISO 6580 GR
AFNOR NF U 47 100 and 47 101 F
Countries not providing detailed information about monitoring programmes
No information available CY, LT, M
Directive 92/117/EEC is the 
basis for the compulsery 
control of S. Enteritidis and  
S. Typhimurium in breeding 
ﬂocks and in hactheries
H
Luxembourg does not have 
any breeding ﬂocks
L
A monitoring programme is 
running in the Beira Litoral region
P
 
1.  In Czech Republic, number of faecal samples collected in the rearing and production period depend 
on ﬂock size. During the production period no dead chicks or meconium samples are collected. 
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Appendix Table SA3. Salmonella monitoring programmes in poultry breeders (Gallus 
gallus), 2004 – additional sampling
Day old chicks Rearing period Production period
Austria At week 12 Faecal 
samples (60)
Every 4 weeks Boot swabs
Denmark 1 week Dead chickens 
(40) 
Every week 2 pairs of sock 
samples
2 and 8 weeks 2 pair sock 
samples1
Hatcheries: after 
each hatch (1-4 
hatchers may be 
pooled)
At least 25g wet 
dust per hatcher
2 weeks 
before moving
Blood samples 
(60)
France Meconium 2 weeks 
before moving
Gauze swabs At 2 weeks 
interval
Internal linings of 
hatchery boxes
Every 8 weeks Faecal samples 
on holdings
Finland At 2 weeks 
interval
Internal linings of 
hatchery boxes
Every 8 weeks Faecal samples 
on holdings
Norway Grandparents: 
1-2, 4 and  
9-11 weeks
Faecal 
samples (60)
Grandparents: At 
hatchery: every 2 
weeks. At farm: 
Every 4 weeks
At hatchery: 
Meconium (250). 
At farm: faecal 
samples (60)
Parents: At hatche-
ry: every 2 weeks
The Netherlands Leaﬂets (40) max.21 d 
before transfer
Cloacal swabs 
(150)
From 20 weeks 
every 4 weeks
Cloacal swabs, 
6x25/ﬂock
Hatchery Fluff samples (25g)/ 
hatching entity
Leaﬂets (40) 4 weeks Cloacal swabs 
(60)
From 20-22 weeks 
or 22-24 weeks 
every 9 weeks
max.21 d 
before transfer
Cloacal swabs 
(150)
No vaccination Blood samples 
1% of ﬂock  
(30-60)/flock
Decision on 
vaccination
Vaccination Cloacal swabs, 
6x25/ﬂock 
From week 26 
and on
Fluff samples, 
every hatch, 
every machine
Sweden Grandparents: 
1-2 and 9-11 
weeks
Dead chicks 
(10) and faecal 
samples (60)
Every month Faecal samples 
(60)
UK Grandparents 
supply ﬂocks: 
Every week, 
ofﬁcial samples 
every 4 weeks. 
Grandparents: 
Every week, 
Ofﬁcial sampling 
every 4 weeks
Parent supply 
ﬂocks: Every  
2 weeks, ofﬁcial 
samples every  
8 weeks
1.  A “sock-sample“ consists of elastic cotton tubes pulled over the collector’s boots. While walking 
through the poultry house, the cotton tubes absorb faecal droppings. Two pairs of “sock-samples” 
analysed as one pool has shown to be just as effective in detecting Salmonella as 60 faecal samples. 
In addition, the sampling method is easier to perform.
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Appendix Table SA4. Control measures taken in poultry breeder ﬂocks in case of 
Salmonella infection, 2004
Serovars covered
All Serovars A, DK, FIN, S1, N1, NL
S. Enteritidis and S. Typhimurium EST5, F, D, IRL, UK, E, EL, N-IRL
Restrictions on the ﬂock
After conﬁrmation A, LV, NL, N-IRL, PL
Immediately following suspicion A, DK, EST, F, FIN, S, N, IRL, SLO, UK
Chicks already delivered covered by restrictions N
Consequence for the ﬂock
Treatment SLO
Slaughter B, DK, GR, F, IRL, N-IRL, PL, UK
Restrictions for the delivery of hatching eggs A2, B4, EL, F, LV4, N, NL, DK2, PL4, SLO
Slaughter and heat treatment A, D, FIN, NL3
Destruction S, N
Other consequences 
Feedingstuffs are restricted  
(heat treatment or destruction)
S, DK, SLO
Disposal of manure restricted F, FIN, N, S, UK, DK, PL, SLO
Cleaning and disinfection
Obligatory A, B, DK, EST, F, FIN, S, IRL, N, NL, PL, SLO, UK
Negative bacteriological result required before 
restocking
A, DK, EST, F, FIN, IRL, N, NL, SLO, S, UK
Requirement of an empty period A (14 days), F (lower than 30 days), N (30 days)
Further investigations
Epidemiological investigation is always started FIN, F, N, S, IRL, NL, UK, N-IRL
Feed suppliers are always included in  
the investigation
FIN, N, S, IRL, NL, UK
Contact herds are included in the investigation FIN, F, IRL, N, NL, S, UK
Vaccination
Mandatory A
Recommended B
Permitted CY, DK6, SLO, ES, UK
Prohibited EST, FIN, LV, N, S, 
1.  In Norway and Sweden, for invasive serovars and non-invasive serovars different control strategies 
are applied.
2. Destruction of the hatching eggs.
3.  In the Netherlands, only ﬂocks that are positive for S. Enteritidis or S. Typhimurium are obligatory 
slaughtered.
4. Destruction of incubated eggs, not yet incubated eggs may be pasteurised.
5. In Estonia, additional serotypes: S. Dublin, S. Newport, S. Choleraesuis.
6.  In Denmark, no vaccination occurs, as no vaccinations have been approved by The Danish Veterinary 
and Food Administration.
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Appendix Table SA5. Salmonella monitoring programmes in laying hens (Gallus gallus) 
producing table eggs, 2004
Day old chicks Rearing period
Type of sample
Samples from the incide of 
the delivery boxes; internal 
lining/paper/crate material
CZ (10), DK (10), F, 
LV, PL, SLO8, S
Faecal samples CZ10, DK1,2, EST10, 
FIN (60), F (60), LV, 
N (60), NL (24-60), 
PL, SK, S (90)5
Dead chickens A (50, )CZ (max 
60), DK (20), EST 
(50), GR, LV, SK, 
SLO8, S (10), UK
Blood samples DK2, NL (24-60)10
Meconium A (250), EST (250), 
F, PL, SK, S (250), 
UK
sock samples (2)  
and dust swab (1)
F
Fluff, environmental samples 
and others
UK Faecal swabs (26-60) IRL10
Sock/boot swabs PL
Dead chicks or faecal/
bedding sample
SLO8
Frequency of sampling
Each delivery DK, LV, SK, SLO, 
UK9
At 3 weeks/12 weeks DK
Every ﬂock CZ, F, S At 4 weeks and 2 weeks 
before transfer
N, SK,
Voluntary PL At 5-6 weeks and 2 weeks 
before transfer
EST
At 2 weeks before transfer FIN, F, LV, PL, S
Max 21 days before transfer NL
At 8 and 16 weeks SLO7
Monthly private 6 IRL
At 4 weeks CZ
Diagnostic methods used through out the production
ISO 6579 (2002) A,B, CZ, EST, FIN, GR, I, LV, PL, SK, ES
NMKL No 71:1999 FIN, N, S
AFNOR NF 47 100 and 47 101 F
The method described in the 
O.I.E. manual, 5th ed., 2004
SLO
Buffered Peptone water P
Various bacteriological DK, LT, UK
No information CY, D, H, IRL, L, M
Strategies in countries with no ofﬁcial sampling strategies, 2004
Have voluntary sampling A
Farms >5000 birds are required 
to sample 3 weeks prior to 
slaughter. Faecal samples 
(60) are taken with swabs/by 
hand or boot swabs (2)
B
No sampling strategies I, P11, ES
Sampling of day old chicks 
as the monitoring procedure 
for layer breeder parent ﬂocks
UK
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Appendix Table SA5. Salmonella monitoring programmes in laying hens (Gallus gallus) 
producing table eggs, 2004 (cntd.)
Production period Before slaughter at the farm
Type of sample
Faecal samples A, (60), CZ10, DK, 
EST10, FIN (60), LV, 
N (60), PL, SK, S 
(60-90)5
Faecal samples (60) B, FIN, F, N
Egg samples10, and sock 
samples (2) or faecal 
samples (60)
DK Faecal samples EST10, PL, SK,  
S (60 or 90)
Feacal samples (60),  
or swabs/sock samples (2) 
and dust swab (1)
F Swabs (at) A, B, IRL
Dust swabs (26-60) IRL10 Sock/boot swabs PL
Blood samples and faecal 
samples (vaccination)
NL (24-60)10
Sock/boot swabs PL
Dead chicks or faecal/
bedding sample
SLO
Frequency of sampling
Every 9 weeks3 or 3 times4 DK Prior to slaughter B, F, FIN, N
Three times FIN3 2-4 weeks before  
to slaughter 
S
At 25 - 30 and 48 - 52 weeks N, S5 4 weeks before slaughter LV
At 30 and 50 weeks LV 1-2 weeks before slaughter PL
At 20-24 weeks and  
98-104 weeks
EST 2 weeks before slaughter EST
At 24, 40 and 55 weeks F
Max 9 weeks before 
slaughter
NL
Every 15-20 weeks PL
Every 2 weeks SK
Once yearly ofﬁcial and 
monthly private6
IRL
Every 12 weeks, 60 feacal 
samples
A
Every 12 weeks CZ
Note: Monitoring is not compulsory by Directive 92/117/EEC.
“( )”: numbers in brackets are number of samples taken.
1.  In Denmark, at 3 weeks: 5 pairs of socks or 300 faecal samples. Flocks<200 animals: 2 pairs of sock 
samples or 60 faecal samples.
2.  In Denmark, at 12 weeks: Flock >500 animals: 60 blood samples, and 5 pairs of socks or 300 faecal 
samples. Flocks with 200-499 animals: 55 blood samples and 5 pairs of sock sample. Flocks<200 
animals: Blood samples, and 2 pairs of sock samples or 60 fa.
3.  In Denmark, for eggs sold to authorised egg-packing stations.
4.  In Denmark, for eggs sold at barn-yard sale or hobby poultry keeping.
5.  In Sweden, samples are collected from all holdings placing eggs on the market and holdings>200 layers 
not placing eggs on the market.
6. In Ireland, routine as part of National Salmonella Monitoring scheme .
7. In Slovenia, only holdings with more than 200 laying hens.
8.  In Slovenia, additional samples will be collected any time in case of more than 0.5% mortality per day.
9.  In UK, every 2 weeks by operator at hatchery, and ofﬁcially every 8 weeks at hatchery as the monitoring 
procedure for layer breeder parent ﬂocks.
10. Number of samples depend on ﬂock size.
11. In Portugal, a surveillance programme is running in one region (Beira Lotoral).
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Appendix Table SA6. Measures taken in laying hens (Gallus gallus) producing table 
eggs in case of Salmonella infections, 2004
Serovars covered
All Serovars DK, FIN, N1, S1
S. Enteritidis and S. Typhimurium CZ, EST, F6, NL, IRL, PL, SK
Restrictions on the ﬂock
Immediately following suspicion DK, EST, F, FIN, IRL, N, NL, PL, SLO, S 
Eggs covered by restrictions already on the basis of suspicion DK, F, FIN, IRL, N, NL, PL, S
Consequence for the ﬂock
Recovery or slaughter I
Slaughtered GR, IRL5, PL, SK
Slaughtered and heat treated FIN, S3
Sanitary slaughter F, N3
Destruction CY, CZ, DK, N2, S2
Slaughter or destruction EST
Treatment with antibiotics A3, CZ, EST, PL, SLO
Consequence for the table eggs
Destruction CY, EST, N2, FIN2, S2
Heat treatment (pasteurisation) A, B, CZ, DK, F, FIN3, IRL4, NL4, S3
Destruction or heat treatment N3, PL, SK
Other consequences 
Feedingstuffs are restricted (heat treatment or destruction) DK, EST, FIN, SLO, S
Disposal of manure restricted EST, FIN, N, PL, SK, SLO, S
Cleaning and disinfection
Obligatory B, EST, F, FIN, DK, IRL, N, NL, PL,  
SK, SLO, S
Negative bacteriological result required before restocking F, FIN, IRL, N, NL, DK, SLO, S
Requirement of an empty period F, N (30 days)
Further investigations
Epidemiological investigation is always started EST, F, FIN, IRL, N, NL, S, UK
Feed suppliers are always included in the investigation EST, FIN, IRL, N, NL, S 
Contact herds are included in the investigation EST, FIN, IRL, N, NL, S
Intensiﬁcation of the examination of non-infected ﬂocks on the 
same farm
DK, F, IRL, N, NL, S
Vaccination
Mandatory H
Recommended A8, B
Permitted DK7, CZ, F, SK, ES9, UK
Prohibited EST, FIN, LV, N, S
Note: No measures are ﬁxed in Directive 92/117/EEC.
1.  In Norway and Sweden, for invasive serovars and non-invasive serovars different control strategies are 
applied. However, this is not practised in Sweden.
2. Invasive Salmonella.
3. Non-invasive Salmonella.
4. Eggs are pasteurised until the ﬂock is destroyed.
5.  In Ireland, as agreed with industry as part of Salmonella Control programme and as a condition of 
National Egg Quality Assurance Scheme.
6.  In France, during the rearing period, S. Typhimurium and S. Enteritidis are included. During the table 
egg production period in holdings placing their eggs on the market via an egg packing centre, only 
S. Enteritidis is included.
7.  In Denmark, no vaccination occurs, as no vaccines have been approved by The Danish Veterinary and 
Food Administration.
8. In Austria, vaccination against S. Enteritidis recommended.
9. In Spain, only in rearing period.
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Appendix Table SA7. Salmonella monitoring programmes in broiler ﬂocks 
(Gallus gallus), 2004
Day old chicks Before slaughter at farm At slaughter  
(ﬂock based approach)
Type of sample
Samples from the 
incide of the delivery 
boxes, internal lining/ 
paper/crate material
DK (10), 
EST (10), 
PL, S (10)
Faecal samples FIN (60), 
LV, N 
(60), SK, 
S (30 or 
60)1, UK4
Neck skin samples N (>−1),  
S (4000/
year), 
UK1
Dead chicks A (50), 
DK (20), 
EST, SK, 
S (20), 
UK
Sock samples DK (5), 
UK1
Cloacal swabs (30), 
caecum (1)
I5
Leaﬂets (40) NL Faecal samples  
or sock samples
B (60 or 
2), NL 
(60 or 2), 
PL
Dust (at hatchery) DK Cloacal swabs A(9)2 Caecum swabs  
(30)/ﬂock and breast 
skin (1)/batch
NL
Meconium A (250), 
PL, SK, 
S (250), 
UK
Faecal samples  
or cloacal swabs
EST1
Bedding SLO
Ceaca (30) or organs 
(10)
S1
Dust swabs F
Frequency of sampling
Each delivery DK, SK At 5-6 weeks EST
Each batch NL, EST 3 weeks before 
slaughter
A, B6 Each ﬂock I5, N
Each ﬂock S 2-3 weeks before 
slaughter
DK Each ﬂock/batch NL, UK
Every 2 week at 
hatchery, every 8 
weeks ofﬁcial sampling
A, UK 1-2 weeks before 
slaughter
EST, S, 
PL, UK3
1 week before 
slaughter
LV
1-3 weeks before 
slaughter
N
Twice a year and at 
least 3 weeks before 
slaughter
SLO
Note: Monitoring is not compulsory by Directive 92/117/EEC .
In this table priority is given to farm based approaches; sample based approaches at slaughterhouse 
may be described in Table SA9.
“( )”: Numbers in brackets are number of samples taken.
1. Number of samples depend on ﬂock size.
2 In Austria, broilers and spent hens.
3 In UK, private sampling.
4. In UK, the industry commonly tests ﬂocks one to two weeks before slaughter.
5. In Italy, a monitoring programme is running in the Veneto Region of Italy.
6. In Belgium, only farms >5000 birds are required to sample .
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Appendix Table SA7. Salmonella monitoring programmes in broiler ﬂocks 
(Gallus gallus), 2004 (cntd.)
Diagnostic methods
ISO 6579 (2002) B, EST, FIN, GR, LV, PL, SK, UK
Modiﬁed ISO 6579 (2002) A
Various bacteriological methods DK, LT, UK
NMKL No 71:1999 FIN, N, S
Method in accordance with the 
O.I.E. manual, 5th ed., 2004
SLO
Strategies in countries with no ofﬁcial monitoring, 2004
No ofﬁcial sampling strategies CZ, ES
Private monitoring: 2500 neckskin 
samples/house/year and carcass 
sampling at the slaughterhouse
I
A monitoring programme is 
running in the Beira Litoral region
P
Note: Monitoring is not compulsory by Directive 92/117/EEC .
In this table priority is given to farm based approaches; sample based approaches at slaughterhouse 
may be described in Table SA9.
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Appendix Table SA8. Measures taken in broilers (Gallus gallus) in case of Salmonella 
infections, 2004
Serovars covered
All Serovars A, DK, FIN, S1, N1, NL
S. Enteritidis and S. Typhimurium EST, IRL, LV, SK, UK
Restrictions on the ﬂock
Immediately following suspicion DK, EST, FIN, LV, N, NL, SLO, S
Consequence for the ﬂock
Slaughter SK
Slaughtered and heat treated A, FIN, S1
Sanitary slaughter B, DK, IRL, LV, N3, NL, UK-IRL
Destruction FIN, LV, N2, S2
Slaughter or destruction EST
Treatment with antibiotics A, (EST), SLO
Other consequence
Feedingstuffs are restricted (heat treatment  
or destruction)
EST, S, SLO
Disposal of manure restricted EST, FIN, LV, N, SK, SLO, S
Cleaning and disinfection
Obligatory A, DK, EST, FIN, LV, N, NL, SLO, S
Negative bacteriological result required before restocking DK, EST, FIN, NL, N, SLO, S 
Requirement of an empty period A (14 days), N (30 days)
Further investigations
Epidemiological investigation is always started EST, FIN, IRL, N, S, UK-GB
Feed suppliers are always included in the investigation EST, FIN, IRL, N, NL, S
Contact herds are included in the investigation EST, FIN, N, S
Breeding ﬂock that contributed to the hatch will be traced IRL, N, NL, UK, S
Vaccination
Mandatory
Recommended
Permitted A, CZ, DK4, SK, UK
Prohibited EST, FIN, LV, N, S
Note: No measures ﬁxed in Directive 92/117/EEC.
1.  In Norway and Sweden, for invasive serovars and non-invasive serovars different control strategies 
are applied.
2. Invasive Salmonella.
3. Non-invasive Salmonella.
4.  In Denmark, no vaccination occurs, as no vacines have been approved by The Danish Veterinary and 
Food Administration.
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Appendix Table SA9. Salmonella monitoring programmes in broilers and poultry 
meat products (Gallus gallus), 2004
Slaughterhouse and cutting 
plant
Processing plants Poultry meat and meat 
products at retail
Type of sample
Neck skin samples B6  
(100-300/
matrix), 
CZ (15), 
IRL, N 
(Slaughter-
house), S1
Depend on survey  
or own-control plans
DK3, S3 Depend on survey  
or own-control plans
DK3, S3
Cuts of meat  
(close to packaging)
DK9 Fresh meat, minced 
meat, ﬁnal products
EST, LV Fresh meat B6  
(100-300/
matrix), 
NL, SLO 
(100/
year)5
Fresh meat LV, SLO Final product CZ, IRL 
(twice 
per year)
Fresh meat,  
ﬁnal products
EST, LV
Carcass swabs IRL Fresh meat IRL, N7 Final product CZ, D
At cutting plants: 
Crushed meat 
samples4
FIN1, N1, 
S1
HACCP A, CZ, I, 
SLO
Survey − whole 
chickens
UK2
Neck skin samples, 
cuts of meat, scrap 
cuttings
EST Environmental 
samples
EST
Chicken breasts, cutting 
meat, minced meat
B6 (100-
300/matrix)
HACCP A, CZ, I, 
SLO
Breast skin samples NL
HACCP A, CZ, I, 
SLO
Frequency
Weekly B, CZ Weekly CZ Random and continuous CZ, EST
All ﬂocks IRL Surveys or own-control DK3, S3 Survey or own-control DK3, S3
Every batch DK8, N 
(slaugh-
terhouse)
20% of consignments 
from EEA, all  
consignments from 
third country
N7 Monitoring D, IRL
Random and continuous EST, FIN Random and continuous EST Yearly monitoring NL
Continuous LV Continuous LV Continuous LV, UK
Monthly SLO Routine IRL February-June SLO
Daily in major 
slaughterhouses
S
Note: Monitoring is not compulsory by Directive 92/117/EEC.
In this table priority is given to sample based approaches; farm based approaches at slaughterhouse 
may be described in Table SA7.
“( )”: Numbers in brackets are number of samples taken.
1. Sample size and frequency depend on slaughterhouse or cutting plant capacity.
2. In UK, survey from Wales and Northern Ireland.
3. Sampling by local authorities.
4. Samples collected from cleaning tools, tables etc.
5.  In Slovenia, monitoring is based on results from previous years. Samples are collected proportional 
with the human population in the country.
6.  In Belgium, a monitoring programme based on matrixes of carcasses, meat preparation and ﬁllets of 
broilers was carried out in 2004.
7. In Norway, only imported meat are sampled.
8.  In Denmark, a batch is deﬁned as the meat from animals slaughtered between two cleanings and 
disinfections of the processing equipment.
9.  In Denmark, ante-mortem negative batches: 4 pools of 10 samples of cuts of meat. Ante-mortem 
positive batches: 12 pools of 5 samples of cuts of meat.
APPENDIX 1
b169_EFSA_int_02_03_06.indd   241 2/03/06   15:18:12
242The EFSA Journal 2005 – 310
Appendix Table SA9. Salmonella monitoring programmes in broilers and poultry 
meat products (Gallus gallus), 2004 (cntd.)
Diagnostic methods
Modiﬁed ISO 6579:1999 A, D, I
ISO 17025 B, I
Belgian ofﬁcial method  
SP-VG-M002
B
ISO 6579:2002 CZ, EST, FIN, I, LV, 
SLO, S
Depend on the laboratory  
and/or survey
DK
NMKL No 71:1999 EST, FIN, N, S
Any approved method according 
to Comm. Decision 2003/470
S
Note: Monitoring is not compulsory by Directive 92/117/EEC.
In this table priority is given to sample based approaches; farm based approaches at slaughterhouse 
may be described in Table SA7.
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Appendix Table SA10. Salmonella monitoring programmes in turkey breeders, 2004
Day old chicks Rearing period Production period
Sampling scheme following the provisions of Directive 92/117/EEC
Dead 
chickens/
destroyed 
chickens
LV, N(20), 
PL (20), 
SK(20), 
S (10)
4 and 2 
weeks before 
moving
Faecal 
samples
FIN (60), 
LV, N (60), 
PL (60), 
SK (60)
Every  
2 weeks
Dead 
chickens (50)
PL, SK
Samples from 
the internal 
linings of the 
delivery boxes
FIN (10), 
LV, N, 
PL, SK, 
S
4 and 2 
weeks before 
moving
Faecal 
samples (60), 
caecal 
samples (10)
 S Every 2 
weeks
Meconium 
samples at the 
hatchery (250) 
or dead chick-
ens (10-50)
N
Meconium S (250) Every 2 
weeks
Faecal 
samples
LV4
Every month Faecal 
samples (60), 
caecal 
samples (10)
S
Ofﬁcial 
sampling 
every 8 
weeks
Meconium 
samples at 
the hatchery 
(250)
LV3, PL, 
SK, S
At hatchery: 
every 2 
weeks
Samples from 
the internal 
linings of the 
delivery boxes
FIN (5)
At holding: 
every 8 weeks
Faecal 
samples
FIN (60)
Other schemes
Swabs/faeces CZ1 Swabs/faeces CZ1 Swabs/faeces CZ1
Internal lining 
papers of 
delivery  
boxes (5)
F Every 4 
weeks
On farm: 
Faecal and 
litter samples 
(60), dust 
swab2 (1)
F Every 4 
weeks
On farm: 
Faecal and 
litter samples 
(60), dust 
swab2 (1)
F
Samples from 
the lorry and 
max 1 week 
after arrival: 
Wooswool 
samples
NL 5 weeks, 26 
weeks
Cloacal 
swabs or 
coecal 
droppings, 
30/ﬂock
NL Every 4 
weeks
In hatchery: 
Environmental 
swab5 (1)
F
Sample 
scheme 
approved by 
EU (Decision 
96/389/EC)
IRL Sample 
scheme 
approved by 
EU (Decision 
96/389/EC)
IRL Every 4 weeks 
30 coecal 
droppings  
or stocking 
samples
Faecal 
samples
NL
Hatchery, 
every hatch, 
every machine
Fluff samples 
every hatch
NL
Sample 
scheme 
approved by 
EU (Decision 
96/389/EC)
IRL
Hatchery Samples of 
imported eggs
A
“( )”: Number in brackets represent number of samples.
1. In Czech Rep., only clinically ill or suspected animals are sampled.
2.  In France, 1 gauze swab (the sampling method consists in wiping 5 different sites of the poultry house).
3.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of 1000 
eggs or more.
4.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of 
less than 1000 eggs.
5.  In France, 1 gauze swab (the sampling method consists in wiping the wall of the hatching cabinets or 
the lining pads of 5 different hatching trays).
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Appendix Table SA10. Salmonella monitoring programmes in turkey breeders, 2004
Diagnostic methods used
ISO 6579:2002 CZ, FIN, LV, PL
NMKL No 71:1999 FIN, N, S
Countries not providing detailed information about monitoring programmes
No information available CY, F, D, GR, H, IRL, LT, L, M, P, SLO, ES
No ofﬁcial surveillance 
programme
B, CZ, DK, I, NL, UK
No turkey breeder ﬂocks 
present
A, EST
“( )”: Number in brackets represent number of samples.
1. In Czech Rep., only clinically ill or suspected animals are sampled.
2.  In France, 1 gauze swab (the sampling method consists in wiping 5 different sites of the poultry house).
3.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of 1000 
eggs or more.
4.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of 
less than 1000 eggs.
5.  In France, 1 gauze swab (the sampling method consists in wiping the wall of the hatching cabinets or 
the lining pads of 5 different hatching trays).
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Appendix Table SA11. Salmonella monitoring programmes in turkeys – production 
level, 2004
Day old chicks Rearing period and before 
slaughter (related to the ﬂock) 
At slaughter  
(related to the ﬂock)
Type of sample
Litter samples NL Faecal samples FIN (60), 
N (60), 
NL, S (90)
Neck skin samples N, IRL3, S
Dust/fluff IRL Sock samples DK (5)2 Cloacal swabs (30)  
and caecum (1)
I5
Sampling based  
on the directive
PL Sampling based  
on the directive
PL Carcasses (1 ﬂock per 
cycle=205 per annum)
IRL
Swabs/faeces CZ1 Cloacal swabs A (9) Swabs/faeces CZ1
Swabs/faeces CZ1
Dust swabs F
Frequency of sampling
Every two months IRL 2-3 weeks  
before slaughter
DK2
1-2 weeks  
before slaughter
S, PL
Every ﬂock FIN
Max 3 weeks  
before slaughter
A
1-3 weeks  
before slaughter
N
Max 4 weeks  
before slaughter
NL
Diagnostic methods used
ISO 6579:2002 CZ, FIN, LV, PL
NMKL No 71:1999 FIN, N, S
Modiﬁed ISO 6579:2002 A
Countries not providing detailed information about monitoring programmes
No information available A, CY, D, GR, H, LT, L, M, P, SK, SLO, ES
No ofﬁcial surveillance programme B, CZ, I, UK
No turkey production ﬂocks present EST
Note: In this table priority is given to farm based approaches; sample based approaches at slaughterhouse 
may be described in Table SA12.
“( )”: Numbers in brackets are number of samples.
1. In Czech Rep., only clinically ill or suspected animals are sampled.
2.  In Denmark, since March 2004 turkeys are no longer slaughtered, as the only major turkey slaughter-
house closed.
3. In Ireland, private samples by individual plants.
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Appendix Table SA12. Salmonella monitoring programmes in turkey meat and turkey 
meat products, 2004
Turkeys at slaughter and  
at cutting plants
Processing plants Turkey meat and meat 
products at retail
Type of sample
Carcasses IRL Crushed meat FIN2, N4, 
S4
Routine sampling IRL
Cuts of meat (batches 
close to packing)
DK1 Depend on survey DK6 Depend on survey DK6, S6
Fresh meat FIN2, 4, 
LV, SLO
Fresh meat, minced 
meat, ﬁnal products
LV Fresh meat,  
ﬁnal products
EST, LV
Neck skin samples CZ (15), 
S, IRL, N4
Final product CZ, IRL Environmental 
samples
EST
HACCP A, CZ, I, 
SLO
HACCP A, CZ, I, 
SLO
Fresh meat SLO 
(100/
year)3
Final product CZ, D
HACCP A, CZ, I, 
SLO
Frequency
Every Batch DK5, N Twice yearly IRL Surveys DK
Weekly CZ Weekly CZ Random and  
continuous
CZ, EST
Random FIN Surveys DK Continuous LV
Continuous LV Continuous LV Monitoring D
Monthly SLO February-March SLO
Daily on major 
slaughterhouses
S
Diagnostic methods
Modiﬁed ISO 6579:1999 A, D, I
ISO 6579:2002 CZ, EST, FIN, I, LV, SLO
Depend on the laboratory  
and/or survey
DK
NMKL No 71:1999 N, FIN
ISO 17025 I
Note: In this table priority is given to sample based approaches; farm based approaches at slaughterhouse 
may be described in Table SA11.
“( )”: Numbers in brackets are number of samples taken.
1.  In Denmark, ante-mortem negative batches: 4 pools of 10 samples of cuts of meat. Ante-mortem 
positive batches: 12 pools of 5 samples of cuts of meat.
2.  In Finland, crushed meat from cleaning tools, tables etc.; similar approach for ducks, geese and 
guinea fowl.
3.  In Slovenia, monitoring is based on results from previous years. Samples are collected proportional 
with the human population in the country.
4. Sample size and frequency depend on slaughterhouse capacity.
5.  In Denmark, a batch is deﬁned as the meat from animals slaughtered between two cleanings and 
disinfections of the processing equipment.
6. In Denmark, sampling by local authorities.
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Appendix Table SA13. Salmonella monitoring programmes in duck breeders, 2004
Day old chicks Rearing period Production period
Sampling scheme following the provisions of Directive 92/117/EEC
Dead chickens LV, S, 
N, 
PL,SK
4 and 2 weeks 
before moving
Faecal 
samples
LV,  
N (60),  
PL (60), 
SK (60), 
S (60)
Every 2 weeks Dead chickens 
(50)
PL, SK
Samples from 
the internal 
linings of the 
delivery boxes
LV, S, 
N, 
PL,SK
4 and 2 weeks 
before moving
Caecal 
samples (10)
S Every 2 weeks Meconium 
samples at the 
hatchery (250) 
or dead chick-
ens (10-50)
N
Meconium S (250) Every 2 weeks Faecal samples LV4
Each ﬂock is 
sampled six 
times a year 
in accordance 
with plan 
approved by 
Decision 
96/389/EC
IRL Each ﬂock is 
sampled six 
times a year in 
accordance with 
plan approved 
by Decision 
96/389/EC
IRL Once a month Faecal 
samples
S (60)
Ofﬁcial 
sampling  
every 8 weeks
Meconium 
samples at the 
hatchery (250)
LV3, S, 
PL, SK
Other schemes
Internal lining 
papers of 
delivery  
boxes (5)
F At 2, 10 weeks 
and 2 weeks 
before moving
On farm: 
Faecal and 
litter samples 
(10), dust 
swab2 (1)
F Every 2 month On farm: 
Faecal and 
litter samples 
(10), dust 
swab2 (1)
F
Swabs/faeces CZ1 Swabs/faeces CZ1 In hatchery: 
Environmental 
swab5 (1)
F
Swabs/faeces CZ1
Diagnostic methods used
ISO 6579:2002 CZ, LV, PL
NMKL No 71:1999 N, S
Countries not providing detailed information about monitoring programmes
No information available A, CY, FIN, F, D, GR, H, IRL, LT, L, M, NL, P, SLO, ES
No ofﬁcial surveillance 
programme
B, CZ, DK, I, UK
No duck breeder ﬂocks 
present
EST
“( )”: Number in brackets represent number of samples.
1. In Czech Rep., only clinically ill or suspected animals are sampled.
2.  In France, 1 gauze swab (the sampling method consists in wiping 5 different sites of the poultry house).
3.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of 1000 
eggs or more.
4.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of less 
than 1000 eggs.
5.  In France, 1 gauze swab (the sampling method consists in wiping the wall of the hatching cabinets or 
the lining pads of 5 different hatching trays).
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Appendix Table SA14. Salmonella monitoring programmes in geese breeders, 2004
Day old chicks Rearing period Production period
Sampling scheme following the provisions of Directive 92/117/EEC
Dead chickens LV, S, 
N, PL, 
SK
4 and 2 weeks 
before moving
Faecal 
samples
LV,  
N (60), 
PL (60), 
SK(60), 
S (60)
Every 2 weeks Dead chickens 
(50)
PL, SK
Samples from 
the internal 
linings of the 
delivery boxes
LV, S, 
N, PL, 
SK
4 and 2 weeks 
before moving
Caecal 
samples (10)
S Every 2 weeks Meconium 
samples at the 
hatchery (250) 
or dead chick-
ens (10-50)
N
Meconium S (250) Every 2 weeks Faecal 
samples
LV4
Once a month Faecal 
samples
S (60)
Ofﬁcial 
sampling every 
8 weeks
Meconium 
samples at the 
hatchery (250)
LV3, 
PL, SK
Other schemes
Internal lining 
papers of  
delivery  
boxes (5)
F At 2, 10 weeks 
and 2 weeks 
before moving
On farm: 
Faecal and 
litter samples 
(10), dust 
swab2 (1)
F Every 2 month On farm: 
Faecal and 
litter samples 
(10), dust 
swab2 (1)
F
Swabs/faeces CZ1 Swabs/faeces CZ1 In hatchery: 
Environmental 
swab5 (1)
F
Swabs/faeces CZ1
Diagnostic methods used
ISO 6579:2002 CZ, LV, PL
NMKL No 71:1999 N, S
Countries not providing detailed information about monitoring programmes
No information 
available
A, CY, FIN, D, GR, H, IRL, LT, L, M, NL, P, SLO, ES
No ofﬁcial surveillance 
programme
B, CZ, DK, I, UK
No geese breeder 
ﬂocks present
EST
“( )”: Number in brackets represents number of samples.
1. In Czech Rep., only clinically ill or suspected animals are sampled.
2.  In France, 1 gauze swab (the sampling method consists in wiping 5 different sites of the poultry house).
3.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of 1000 
eggs or more.
4.  In Latvia, breeding ﬂocks whose eggs are hatched at a hatchery with a total incubator capacity of less 
than 1000 eggs.
5.  In France, 1 gauze swab (the sampling method consists in wiping the wall of the hatching cabinets or 
the lining pads of 5 different hatching trays).
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Appendix Table SA15. Salmonella monitoring programmes in ducks and geese – 
production level, 2004
Day old chicks Rearing period and before 
slaughter (related to the ﬂock)
At slaughter  
(related to the ﬂock)
Type of sample
Faecal/swabs CZ1 Faecal samples (60) N, S Carcass samples IRL
Sampling based on  
the directive
PL Faecal/swabs CZ1 Faecal/swabs CZ1
Sock swabs DK (5)2 Sampling based  
on the directive
PL
Sampling based on 
the directive
PL Neck skin samples A3, N, S
Cloacal swabs A Carcasses (1 ﬂock per 
cycle=205 per annum)
IRL
Frequency of sampling
2-3 weeks  
before slaughter
DK
1-2 weeks  
before slaughter
S, PL
1-3 weeks  
before slaughter
N
max. 3 weeks  
before slaughter
A
Diagnostic methods used
ISO 6579:2002 CZ, LV, PL
NMKL No 71:1999 N, S
Countries not providing detailed information about monitoring programmes
No information available A, CY, FIN, F, D, GR, H, LT, L, M, NL, P, SK, SLO, ES
No ofﬁcial surveillance programme B, CZ, DK, I, UK
No duck and geese production 
ﬂocks present
EST
“( )”: Numbers in brackets represent number of samples.
1. In Czech Rep., only clinically ill or suspected animals are sampled.
2. In Denmark, samples are mainly in the duck production, as production of geese is limited.
3.  In Austria, ﬂocks with positive ﬁndings in cloacal swabs (and if the carcasses is not subject to heat-treatment).
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Appendix Table SA16. Salmonella monitoring programmes in pigs, 2004
Breeding and multiplying herds Fattening herds – at farm Fattening herds – at slaughter
Type of sample
Blood samples DK(10), Faecal samples A, EST6, 
NL, S
Carcass swabs B, DK, 
N6,8, S6
Pen faecal samples DK3 Faecal samples  
or swabs
CZ1 Lymph nodes FIN7,  
N6,8, S6
Faecal samples  
or swabs
CZ1 Pen faecal samples DK2,6, 
FIN
Meat juice DK4,  
UK10
Faecal samples EST6, 
FIN5, N, S
Carcass/rectal swabs/
litter/feed
SLO1 Pen faecal samples DK2, 6
Carcass/rectal swabs/
litter/feed
SLO1 Faecal samples  
or swabs
CZ1
Frequency of sampling
Monthly DK Clinical suspicion N, S Random samples N, FIN7, S
Once a year – all herds FIN 
(3000), N 
Random samples NL Continuous B, DK, 
FIN, N, S
Once a year – all elite 
breeding herds. Twice  
a year – all sow pools
S
Diagnostic methods
Modiﬁed ISO 6579 (2002) A
ISO 6579 (2002) CZ, EST, FIN, GR, NL, SK
Mix ELISA DK, UK
Bacteriology DK, SLO
NMKL No 71:1999 FIN, N, S
Strategies in countries with no ofﬁcial sampling stratetegies, 2004
No ofﬁcial monitoring B, CY, CZ, GR, I9, PL, SK, UK
Clinically ill or suspected animals 
are sampled
PL, SK, SLO, UK
Note: Monitoring is not compulsory by Directive 92/117/EEC .
In this table priority is given to farm based approaches; sample based approaches at slaughterhouse 
may be described in Table SA18.
“( )”: Numbers in brackets are number of samples taken.
1. Only clinically ill or suspected animals are sampled.
2.  In Denmark, level 2 (herds with a higher proportion of reactors) and level 3 (herds with an unacceptable 
high proportion of reactors) herds, max. two samples per year.
3. In Denmark, if the herd reaches Salmonella-index 5 or above, max. two samples per year.
4. In Denmark, all herds producing more than 200 pigs for slaughter per year are monitored.
5.  In Finland, all pigs sent to semen collection centres have to be examined for Salmonella with negative results.
6. Number of samples depend on herd size.
7.  In Finland, 3000 samples from fattening pigs and 3000 samples from sows annually, stratiﬁed 
sampling procedure.
8. In Norway, sows from multiplying herds are sampled in the same way as slaughter pigs at slaughter.
9. In Italy, a monitoring programme is running in the Veneto Region.
10. In UK, sampling is voluntary.
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Appendix Table SA17. Measures taken in pig herds in case of Salmonella infections 
or Salmonella ﬁndings, 2004
Serovars covered
All Serovars A7, DK, EST, FIN, S, N, UK
Only S. Enteritidis, S. Typhimurium CZ, N-IRL
Restrictions on the farm
Animal movement prohibited FIN, S, N
Isolation of Salmonella positive animals EST, FIN, N
Person contacts restricted EST, S, N
Advise to the farm for controlling the infection FIN, S, N, SLO, UK
Consequence for slaughter animals
Slaughterhouse is informed on positive animals EST, N, S
Sanitary slaughter DK (level 3 herds)3, EST, FIN, N4, S4
Contaminated food withdrawn from market N, S6
Treatment with antibiotics EST
Other consequences 
Feedingstuffs are restricted (heat treatment or destruction) S, SLO
Treatment of manure/sludge EST, DK (level 3 herds), SLO, S, N
Public health advice N-IRL
Cleaning and disinfection obligatory EST, FIN, N, SLO, S
Repeated negative testing necessary before lifting  
the restrictions1
EST, FIN, S, N
Reduction in payment for positive slaughter pigs DK
Further investigations
Epidemiological investigation is always started B, DK (level 2+3), EST, FIN, N, SLO, S
Feed suppliers are always included in the investigation EST, N, S
Contact herds are included in the investigation N, S
Vaccination
Permitted CZ, UK
No vaccination occurs A, B2, DK2, S
Prohibited EST, FIN, N
Note: No measures ﬁxed in Directive 92/117/EEC.
1. Typically, two consecutive samplings one month apart.
2. No vaccine has been approved.
3.  In Denmark, hot water treatment of all carcasses from MRDT 104 positive herds with a Salmonella 
index above 20.
4. In Norway and Sweden, autopsy is collected from all sanitary slaughtered animals.
5. In Estonia, S. Enteritidis, S. Typhimurium, S. Dublin, S. Newport and S. Cholerasuis are notiﬁable.
6. In Sweden, carcasses contaminated with Salmonella are unﬁt for human consumption.
7.  In Austria, the carcasses contaminated with Salmonella are unﬁt for human consumption and must be 
removed. In all slaughtered animals descending from the same holding a post-mortem bacteriological 
examination has to be initiated.
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Appendix Table SA18. Salmonella monitoring programmes in pigs and pig meat, 2004 
Slaughterhouse and cutting plant Processing plants Pork and pork products at retail
Type of sample
Surface swabs B6 (100-
300/
matrix), 
CZ, DK2, 
EST1, 
FIN2, N 
(3000 
year)2, S2
Crushed meat 
samples
 N7, 8 Regional programmes UK-GB
Lymphnodes N (3000/
year), S2
Depend on survey  
or own-control plans
DK3, S3 Depend on survey or 
own-control plans
DK3, S3
Caecal samples UK-GB Minced meat B6 (100-
300/matrix)
Cutting and minced 
meat samples
B6 (100-
300/
matrix)
Fresh meat N4 Final product CZ, D
Crushed meat samples7 FIN2, N 
(cutting 
plant)2,  
S (cutting 
plant)2
Final product CZ, IRL 
(twice 
per year)
Fresh meat,  
ﬁnal products
EST, LV
Environmental samples EST Fresh meat, minced 
meat, ﬁnal products
EST Environmental 
samples
EST
Fresh meat EST2, H, 
SLO
Environmental 
samples
EST Fresh meat NL, SLO 
(100/
year)8
Surface swabs H
HACCP A, CZ, I, 
SLO
HACCP A, CZ, I, 
SLO
HACCP A, CZ, I, 
SLO
Frequency
Weekly B Continuous LV May-August SLO
Every 2 weeks CZ Random and 
continuous
CZ, EST, 
H5
Continuous LV
Random and  
continuous
EST, FIN, 
H5, N, S
20% of consignments 
from EEA, all consign-
ments from third country
N4 Weekly B
Continuous DK2 Surveys or  
own-control
DK3, S3 Random and  
continuous
CZ, EST
1 sample per 2000 
animal slaughtered
SLO Monitoring D, IRL
Random sample evenly 
distributed over the 
working day, week  
and quarter of the year 
– survey in 2003
UK (GB) Sampling according to 
the Council Directive 
95/65/EC
N Survey or own-control DK3, S3
Yearly monitoring NL
Note: Monitoring is not compulsory by Directive 92/117/EEC.
In this table priority is given to sample based approaches; farm based approaches at slaughterhouse 
may be described in Table SA16.
“( )”: Numbers in brackets are number of samples taken.
1. Sample frequency depend on annual number of pigs slaughtered.
2. Sample size and frequency depend on slaughterhouse capacity.
3. Sampling by local authorities.
4. In Norway, imported meat.
5. In Hungary, sampling strategy is based on the previous years production.
6.  In Belgium, a monitoring programme based on matrixes of carcasses, cuts and minced meat of pork 
was carried out in 2004.
7. Samples collected from cutting equipment, cleaning tools, tables etc.
8.  In Slovenia, monitoring is based on results from previous years. Samples are collected proportional 
with the human population in the country.
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Appendix Table SA18. Salmonella monitoring programmes in pigs and pig meat, 
2004 (cntd.) 
Slaughterhouse and cutting plant Processing plants Pork and pork products at retail
Diagnostic methods
Modiﬁed ISO 6579:1999 A, D, I CY
ISO 17025 B, I
Belgian ofﬁcial method SP-VG-
M002
B
ISO 6579:2002 CZ, EST, FIN, H, I, LV, SLO, S
Depend on the laboratory and/or 
survey
DK
NMKL No 71:1999 FIN, N, S
Any approved method according 
to Comm. Decision 2003/470
S
Note: Monitoring is not compulsory by Directive 92/117/EEC.
In this table priority is given to sample based approaches; farm based approaches at slaughterhouse 
may be described in Table SA16.
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Appendix Table SA19. Salmonella monitoring programmes in cattle, 2004
Breeding herds Cattle – at farm Cattle – at slaughter
Type of sample
Faecal samples FIN5 Faecal samples DK3, EST4, 
FIN, D1, 
NL, N1, 
UK-GB7
Lymph nodes FIN (3000/
year), S,  
N (3000/
year)4
Faecal samples  
or swabs
CZ1 Carcass swabs B, DK,  
N (3000/
year)4, S4
Bulk milk DK2 Blood DK
Carcass/rectal swabs/
littre/feed
SLO1 Faecal samples  
and organ samples
D1
Organ samples EST,  
UK-GB7
Faecal samples  
or swabs
CZ1
Frequency of sampling
Once a year – all herds FIN 
(3000)
Every three months DK Random samples FIN, N, S
Once a year NL Once every 21 days-5 
months
DK
Clinical suspecion S Continuous S
Diagnostic methods used trough the production
Modiﬁed ISO 6579 (2002) A, F, S
ISO 6579 (2002) CZ, EST, FIN, GR, SK
Mix-ELISA DK
Bacteriology DK, SLO, UK-GB
NMKL No 71:1999 FIN, N, S
Strategies in countries with no ofﬁcial sampling strategies, 2004
No ofﬁcial monitoring B, CY, CZ, GR, I6, PL, SK, UK
Clinically ill or suspected 
animals are sampled
PL, SK, UK
Note: Monitoring is not compulsory by Directive 92/117/EEC.
In this table priority is given to farm based approaches; sample based approaches at slaughterhouse 
may be described in Table SA21.
1. Only clinically ill or suspected animals are sampled.
2. In Denmark, serological testing; control programme for S. Dublin in dairy herds.
3. In Denmark, when requested by the farmer.
4. Number of samples depend on herd size.
5.  In Finland, all animals sent to semen collection centres have to be examined for Salmonella with 
negative results.
6. In Italy, a monitoring programme is running in the Veneto Region.
7. In UK-GB, sampling is voluntary.
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Appendix Table SA20. Measures which may be taken in cattle herds in case of 
Salmonella infections or Salmonella ﬁndings, 2004
Serovars covered
All Serovars A6,DK, EST, FIN, N, S, UK
Only S. Enteritidis, S. Typhimurium CZ
Restrictions on the farm
Animal movement prohibited FIN, DK (MR S. Typhimurium DT 104), 
S, N
Isolation of Salmonella positive animals EST, FIN, N, S
Person contacts restricted EST, N, S
Restriction on marketing of milk N, S
Pasteurisation of milk obligatory EST, N, S
Advise to the farm for controlling the infection DK, FIN, N, SLO, S, UK-GB
Consequence for slaughter animals
Slaughterhouse is informed on positive animals EST, FIN, N, S
Sanitary slaughter EST, DK, FIN, N, S4
Contaminated food withdrawn from the market S3
Destruction of positive animals D
Treatment with antibiotics EST
Other consequences 
Feedingstuffs are restricted (heat treatment or destruction) SLO, S
Treatment of manure/sludge EST, DK, N, SLO, S
Cleaning and disinfection obligatory EST, FIN, N, S
Repeated negative testing necessary before lifting the 
restrictions2
EST, DK, FIN, N, S
Public health advise UK-NI
Further investigations
Epidemiological investigation is always started DK (MR S. Typhimurium DT 104), 
EST, FIN, N, SLO, S, UK-NI5
Feed suppliers are always included in the investigation EST, S, N
Contact herds are included in the investigation DK (MR S. Typhimurium DT 104), N, S
Vaccination
Permitted CZ, D, UK-GB (S. Dublin)
No vaccination occurs A, B1, DK1, S
Prohibited EST, FIN, N
Note: No measures ﬁxed in Directive 92/117/EEC.
1. No vaccine has been approved.
2. Typically, two consecutive samplings one month apart.
3. In Sweden, carcasses contaminated with Salmonella are unﬁt for human consumption.
4. In Sweden, autopsys is collected from all sanitary slaughtered animals.
5. In UK-NI, when S. Enteritidis, S. Typhimurium is isolated, or any serotype is isolated in milk.
6.  In Austria, the carcasses contaminated with Salmonella are unﬁt for human consumption and must be 
removed. In all slaughtered animals descending from the same holding a post-mortem bacteriological 
examination has to be initiated.
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Appendix Table SA21. Salmonella monitoring programmes in cattle and bovine 
meat, 2004
Slaughterhouse and cutting plant Processing plants Beef at retail
Type of sample
Surface swabs B6 (100-
300/
matrix), 
CZ, DK2, 
EST1, 
FIN2,  
N (3000/
year)2, S2 
Depend on survey  
or own-control plans
DK7, S7 Depend on survey  
or own-control plans
DK7, S7
Lymph nodes N (3000/
year)2, S2
Crushed meat 
samples
N3,4 Minced beef B6 (100-
300/
matrix)
Fresh meat EST2, H Fresh meat, minced 
meat, ﬁnal products
EST Fresh meat,  
ﬁnal products
EST, H
Crushed meat 
samples3
FIN2, N2, 
S2
Scrapings S Fresh meat NL
Faeces from rectum GB Fresh meat N5 Final product CZ, D
Minced beef B6 (100-
300/
matrix)
Final product CZ, H Regional programmes UK
HACCP A, CZ,  
H, I
HACCP A, CZ,  
H, I
HACCP A, CZ, I
Frequency
Daily, weekly, monthly 
or twice annually
S 20% of consignments 
from EEA, all 
consignments  
from third country
N5 Weekly B
Weekly B Random and 
continuous
CZ, EST, 
H
Random and  
continuous
CZ, EST, 
H
Every 2 weeks CZ Surveys or own-control DK7, S7 Monitoring D, IRL7
Random and  
continuous
EST, FIN, 
N
Surveys or own-control DK7, S7
Continuous DK2
Diagnostic methods
Modiﬁed ISO 6579:1999 A, D, I
ISO 17025 B, I
Belgian ofﬁcial method  
SP-VG-M002
B
ISO 6579:2002 CZ, EST, FIN, H, I, S
Depend on the laboratory  
and/or survey
DK
NMKL No 71:1999 FIN, N
Note: Monitoring is not compulsory by Directive 92/117/EEC.
In this table priority is given to sample based approaches; farm based approaches at slaughterhouse 
may be described in Table SA19.
“( )”: Numbers in brackets are number of samples taken.
1. Sample frequency depend on annual number of cattle slaughtered.
2. Sample size and frequency depend on slaughterhouse and cuttingplant capacity.
3. Samples collected from cutting equipment, cleaning tools, tables etc.
4. In Norway, sampling according to the Council Directive 95/65/EC.
5. In Norway, imported meat.
6.  In Belgium, a monitoring programme based on matrixes of carcasses, cuts and minced meat of beef 
was carried out in 2004.
7. Sampling by local authorities.
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Appendix Table SA22. Countries providing data on serovars and phagetypes of 
S. Enteritidis and S. Typhimurium
Humans Cattle Pigs Gallus gallus
Country Serovars Phage-
typing1
Serovars Phage-
typing
Serovars Phage-
typing
Serovars Phage-
typing
Austria x x x x x x x x
Belgium x x x x x
Cyprus x No data on animals 
Czech republic x x x x x x x
Denmark x x x x x x x x
Estonia x x x x
Finland x x x x x x x x
France o x
Germany o x x x x x x
Greece x x x
Hungary x x x x x x
Ireland x x
Italy o x x x x x x
Latvia x No data on animals 
Lithuania x x x x
Luxembourg No data 
available
Malta x No data on animals 
The Netherlands x x x x x x x x
Norway2 x No data on animals 
Poland o x x x
Portugal o
Slovakia o x x x x x x
Slovenia x x
Spain x x
Sweden x x x x
United Kingdom x x x x x x x
x: complete serotype/phagetype distribution.
o: typing only speciﬁed to S. Enteritidis, S. Typhimurium, Salmonella other.
1. Phagetyping: S. Enteritidis and/or S.Typhimurium phagetyping.
2.  In Norway, S. Enteritidis was not found in animals. The S. Typhimurium found were, with few exceptions, 
not phagetyped.
APPENDIX 1
b169_EFSA_int_02_03_06.indd   257 2/03/06   15:18:17
258The EFSA Journal 2005 – 310
Appendix Table SA22. Countries providing data on serovars and phagetypes of 
S. Enteritidis and S. Typhimurium (cntd.)
Other poultry Beef Pork Broiler meat Other poultry 
meat
Country Serovars Phage-
typing
Serovars Phage-
typing
Serovars Phage-
typing
Serovars Phage-
typing
Serovars Phage-
typing
Austria x x x x x x x x
Belgium x x
Cyprus
Czech republic x x x x x
Denmark x x x x x x x
Estonia x x x x x
Finland x x x x x
France
Germany x x x x x x x
Greece x x
Hungary x x x x x x x x x
Ireland x x x x x x x x
Italy x x x x x x x x x x
Latvia
Lithuania x x x x
Luxembourg
Malta
The Netherlands x x
Norway2
Poland x
Portugal
Slovakia x x x x
Slovenia x x x
Spain
Sweden
United Kingdom x x x
x: complete serotype/phagetype distribution.
o: typing only speciﬁed to S. Enteritidis, S. Typhimurium, Salmonella other.
1. Phagetyping: S. Enteritidis and/or S.Typhimurium phagetyping.
2.  In Norway, S. Enteritidis was not found in animals. The S. Typhimurium found were, with few exceptions, 
not phagetyped.
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Appendix Table SA23. Notiﬁcation on Salmonella in humans, Gallus gallus, other 
animals and food, 2004
Notiﬁable in 
humans since
Notiﬁable in Gallus 
gallus since
Notiﬁable in other 
animals since
Notiﬁable in  
food since
Austria 19471, 2 19983 19944 1975
Belgium <1999 1998 1998 2004
Cyprus yes yes yes -
Czech Republic yes yes yes -
Denmark 1979 no 19934 -
Estonia 1958 20009 20009 2000
Finland 1995 1970’s 1970’s 1970’s
France no yes10 - -
Germany yes - yes -
Greece yes 1992 1980 -
Hungary 1959 no no 1984
Ireland 1948 - - yes8
Italy 1990 1954 1954 1962
Latvia 1958 yes yes 2002
Lithuania 1962 yes yes -
Luxembourg - - - -
Malta - - - -
Norway 1975 1965 1965 19956
Poland - 199911 - -
Portugal yes yes yes -
Slovakia yes 2004 yes4 2000
Slovenia 1949 19917 19917 2003
Spain 19825 1994 1994 1994
Sweden 1968 1961 1961 1961
The Netherlands no yes yes -
United Kingdom - 1989 1989 no
1. In Austria, notiﬁable since 14 April 1913, re-proclaimed 12 June 1947, adapted on 28 April 1950.
2. In Austria, clinical cases notiﬁable since 1996.
3.  In Austria, detection of S. Enteritidis, S. Typhimurium, S. Pullorum and S. Gallinarum notiﬁable in 
breeding animals.
4. Clinical cases notiﬁable.
5. In Spain, only hospitalised cases are notiﬁable.
6. In Norway, only those detected in the national control programme.
7. In Slovenia, the year of independence, however this disease was notiﬁable before 1991.
8. In Ireland, detection of S. Enteritidis and S. Typhimurium is notiﬁable.
9.  In Estonia, S. Enteritidis, S. Typhimurium, S. Dublin, S. Newport and S. Cholerasuis are notiﬁable.
10. In France, in breeding ﬂocks and laying hens, S. Enteritidis and S. Typhimurium, only.
11. In Poland, S. Enteritidis, S. Typhimurium, S. Pullorum and S. Gallinarum are notiﬁable in poultry.
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Appendix Table TB1. Notiﬁcation of tuberculosis in humans, Gallus gallus, other 
animals and food, 2004
Notiﬁable in 
humans since
Notiﬁable in Gallus 
gallus since
Notiﬁable in other 
animals since
Notiﬁable in  
food since
Austria 1947/20047 - 1909/19997 -
Belgium <1999 1998 1963 2004
Cyprus - - - -
Czech Republic yes yes yes -
Denmark 1905 1993 19206 -
Estonia 1950 1962 1962 no
Finland 19951 19951 1902 1902
France yes - - -
Germany yes yes yes -
Greece yes - 1936 (bovine) -
Hungary 1946 no yes (bovine) no
Ireland 1948 - - -
Italy 1990 - 1954 1928
Latvia yes yes yes -
Lithuania 1990 yes yes -
Luxembourg - - - -
Malta - - - -
Norway 1900 1965 1894 18942
Poland - - - -
Portugal yes yes yes -
Slovakia yes no yes -
Slovenia 1949 - 19913 2003
Spain 19488 - 1952 1952
Sweden >30 years ago yes yes -
The Netherlands yes no 1999 -
United Kingdom yes - >19844 -
1. In Finland, notiﬁable also before 1995, but legislation changed in 1995.
2. In Norway, mandatory meat inspection at slaughterhouse.
3. In Slovenia, the year of independence. The disease was notiﬁable before 1991.
4.  In the United Kingdom, the ﬁrst TB Orders were passed in 1913 and 1925 to remove clinically ill cattle.
In deer, TB has been notiﬁable since 1st June 1989. From 2005, TB will become notiﬁable in all mammals 
except man.
6. In Denmark, only clinical cases are notiﬁable.
7.  In Austria, M. bovis notiﬁable since 2004 in humans and since 1999 in animals, M. tuberculosis notiﬁable 
since 1947 in humans and since 1909 in animals.
8. In Spain, only hospitalised cases are notiﬁable.
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Appendix Table TB-BR1. Status as Ofﬁcially free of bovine brucellosis (OBF), 
ofﬁcially free of B. melitensis in sheep and goats (ObmF) and ofﬁcially free of 
bovine tuberculosis (OTF)
Bovine brucellosis Brucella melitensis Bovine 
tuber-
culosis
OBF1 since Comments ObmF2 since Comments OTF3 since
Austria 1999 - 2001 - 1999
Belgium 2003 - 2001 - 2003
Cyprus no Never detected in domes-
tic animals, imported 
cases in 1921 and 1932
no Eradication programme -
Czech Republic 2004 Eradication programme 
terminated in 1964
2004 Never detected 2004
Denmark 1980 No cases since 1962 1979 Never detected 1980
Estonia no No cases since 1961, 
Surveillance according to 
EC legislation in 2004
no No cases since 1962, 
surveillance of breeding 
herds
no
Finland 1994 No cases since 1960 1994 Never detected 1994
France no - 2001 (64 
departe-
ments)
- yes
Germany 2000 - 2000 - 1997
Greece no Eradication programme. 
Thessaloniki area  
is eradication and 
vaccination area for 
Bovine brucellosis, only
no Eradication programme 
on Islands, vaccination 
on the mainland 
-
Hungary no Declared free by OIE  
in 1985 
2004 Never detected no
Ireland no - yes Never detected -
Italy  yes (22 
provinces)
Vaccination in two areas 
(Monti Nebrodi in Sicily 
and Caserta in Campania) 
yes (20 
provinces)
Vaccination in Sicily yes (6 
provinces)
Latvia no No cases since 1963 no Never detected -
Lithuania no Yes, according to OIE 
demands
no Yes, according to  
OIE demands
no
Luxemburg 1999 No cases since 1999 yes - 1996
Malta no No cases since 1996 no No cases since 1996 -
Norway 1994 No cases since 1953 1994 Never detected 1994
Poland no - no Surveillance of breeding 
herds, B. Melitensis 
never detected
-
Portugal 2002 
(Azores)
Eradication programme, 
vaccination only in 
exceptional situations
2002 
(Azores)
Eradication programmes, 
regional vaccination
-
Slovakia no OBF in 2005 2004 - no
Slovenia no Yes, according to OIE 
demands. No cases 
since 1961
no ObmF in 2005 no
Spain no Eradication programmes, 
vaccination in high risk areas
2001 
(Canaries)
Eradication programmes, 
vaccination in high risk areas
-
Sweden 1995 No cases since 1957 1994 - 1995
The Netherlands 1996 - 1993 Never detected yes
United Kingdom 1985 (GB) - 1991 Never detected no
1.  OBF according to Council Directive 64/432/EEC as amended by Council Directive 97/12/EC and 
Commision Decisions 93/52/EEC, 2003/467/EC and 2004/320/EC.
2.  ObmF according to Council Directive 91/68/EEC and Commision Decisions 93/52/EEC, 94/877/EEC, 
2003/467/EC and 2004/320/EC.
3.  OTF according to Council Directive 64/432/EEC as amended by Council Directive 97/12/EC and 
regulation (EC) 1226/2002, and Commission Decision 2003/467/EEC.
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Appendix Table TO1. Monitoring and diagnostics for Toxoplasmosis in humans and 
animals, 2004
Country Humans Animals
Type of cases reported Monitoring Monitoring
Austria - Serological screening  
of pregnant women 
-
Belgium - - -
Cyprus EU-recommended 
(clinical+lab)
- -
Czech Republic EU-recommended 
(clinical+lab)
- -
Denmark Only congenital reported Since 1999 nationwide 
neonatal screening
-
Estonia EU-recommended 
(clinical+lab)
No monitoring -
Finland Lab-conﬁrmed clinical cases - -
France - - -
Germany Only congenital cases 
reported
- -
Greece Only congenital cases 
reported
- Animals data from routine 
diagnostics
Hungary Lab-conﬁrmed - -
Ireland EU-recommended 
(clinical+lab)
- -
Italy - - Data from local and general 
control programme and 
research
Latvia Lab conﬁrmed clinical 
cases
- Animals data from routine 
diagnostics
Lithuania Lab conﬁrmed clinical 
cases and congenital cases
- -
Luxembourg - - -
Malta - - -
Norway Lab-conﬁrmed Encephalitic 
cases since 1975. Other 
notiﬁcation stopped 1995
- -
Poland Lab conﬁrmed clinical cases No monitoring No monitoring in animals
Portugal - - -
Slovakia - No monitoring -
Slovenia EU-recommended 
(clinical+lab)
Routine serological screening 
of pregnant women 
-
Spain - Surveillance according  
to Directive 2003/99/EC
-
Sweden Notiﬁcation stopped  
July 2004
- -
The Netherlands - No monitoring -
United Kingdom Lab conﬁrmed clinical 
cases
Voluntary lab reporting 
except from Scotland 
(notiﬁcation)
Vaccine available for sheep
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Appendix Table TO2. Notiﬁcation and monitoring of Toxoplasma in humans, 
animals and food, 2004
Notiﬁable in humans 
since
Notiﬁable in animals 
since
Notiﬁable in food  
since
Austria no no no
Belgium <19991 1998 2004
Cyprus no (from 2005) - -
Czech Republic yes no -
Denmark no no -
Estonia 1997 no 2000
Finland 1995 19952 no3
France no - -
Germany yes (congenital cases) yes -
Greece yes (congenital cases) - -
Hungary 1967 no -
Ireland 2004 - -
Italy 1990 no -
Latvia 1996 yes -
Lithuania yes (congenital cases 
since 1999) >30 years -
Luxembourg - - -
Malta - - -
Norway no4 1965 no
Poland - - -
Portugal - no -
Slovakia no no no
Slovenia 1977 19915 2003
Spain 19826 1994 1994
Sweden no no no
The Netherlands no yes yes
United Kingdom 1990 (Scotland) no no
1. In Belgium, the French Community.
2. In Finland, also notiﬁable before 1995, but legislation changed in 1995.
3.  In Finland, food business operator has to notify to the competent authority, but there is no central 
notiﬁcation system.
4. In Norway, encephalitis cases have been notiﬁable since 1975.
5. In Slovenia, the year of independence. The disease was notiﬁable before 1991.
6. In Spain, only hospitalised cases are notiﬁable.
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Appendix Table TR1. Diagnostic methods and monitoring programmes for 
Trichinella, 2004
Humans Animals Animals – 
monitoring 
programmes
Diagnostic 
methods
Diagnostic methods Meat inspection 
at slaughter
Other monitoring
Austria Serology (ELISA ), 
Western Blot
Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses, 
farmed wild boars
Wild boars: monitoring 
scheme
Belgium Directive 77/96/EEC 
(digestion method)
Pigs for export, 
horses, wild boar
Other wildlife 
monitored when 
relevant
Cyprus EU recommenda-
tions
Directive 77/96/EEC 
(digestion method)
Pigs (started  
in 2004, 80% 
examined)
Czech Republic - Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses,  
wild boars
Other wildlife 
monitored when 
relevant
Denmark Serology, 
histopathology
Directive 77/96/EEC 
(digestion method)
Pigs and horses 
slaughtered at 
export approved 
slaughter houses, 
all wild boars
Estonia Clinical symptoms, 
eosinophilia
Digestion or compres-
sion method
Pigs, horses, wild 
boars
Other wildlife 
monitored when 
relevant
Finland Serology, 
histopathology
Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses, wild 
boars
France Immunoﬂuores-
cence
Digestion method Pigs, horses Wild boars: sampling 
are carried out as a 
survey
Germany Serology (ELISA), 
histopathology
Directive 77/96/EEC 
(digestion method)  
and PCR
Pigs, horses,  
wild boars
Other wildlife 
monitored when 
relevant
Greece - Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs
Hungary Serology (ELISA ), 
histopathology, 
Western Blot
Directive 77/96/EEC 
(digestion method)
Pigs, horses, wild 
boars
Other wildlife 
monitored when 
relevant
Ireland - - - -
Italy - Directive 77/96/EEC 
(digestion method)
Pigs
Latvia Serology (ELISA) Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses, wild 
boars
Home slaughtering: 
The owner is responsi-
ble for ensuring control
Lithuania Serology, (ELISA) - - -
Luxembourg - Directive 77/96/EEC 
(digestion or compres-
sion method)
Wild boar Pigs and horses: risk 
assessment scheme
Malta - Compression method Horses Pigs: random on  
the slaughter line
The Netherlands - Directive 77/96/EEC 
(digestion method)
Pigs, horses
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Appendix Table TR1. Diagnostic methods and monitoring programmes for 
Trichinella, 2004 (cntd.)
Humans Animals Animals – 
monitoring 
programmes
Diagnostic 
methods
Diagnostic methods Meat inspection 
at slaughter
Other monitoring
Norway Serology and 
histopathology
Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses, wild 
boars, badgers, 
bears
Foxes: occasionally
Poland Serology and 
histopathology
Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses,  
wild boars
Portugal - digestion or compres-
sion method
Some pigs at  
meat inspection
Slovakia - Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses,  
wild boars
Other wildlife 
monitored when 
relevant
Slovenia - Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, horses,  
wild boars
Other wildlife 
monitored when 
relevant
Spain - Directive 77/96/EEC 
(digestion or compres-
sion method)
Pigs, hunted 
wildlife
Sweden Serology  
(ELISA/IFL)
Directive 77/96/EEC 
(digestion method)
Pigs, horses,  
wild boars, bears
Other wildlife 
monitored when 
relevant
United Kingdom - Directive 77/96/EEC 
(digestion method)
Pigs, horses
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Appendix Table TR2. Notiﬁcation of Trichinella in humans, animals and food, 2004
Notiﬁable in 
humans since
Notiﬁable in 
animals since
Notiﬁable in 
food since
Follow the 
directives3
Austria 1947 1994 Pigs, horses,  wild boars, 1994 yes
Belgium <19991 1998 - 2004 yes
Cyprus no (2005) yes Pigs - yes
Czech Republic yes yes Pigs, horses, wild boars, other wildlife - yes
Denmark no 19202 Pigs, horses,  wild boars - yes
Estonia 1945 2000 Pig, horses, wild boars, other wildlife 2000 yes
Finland 1995 1930 Pigs, horses 1930 yes
France no - - - -
Germany yes yes Pig, horses, wild boars, other wildlife - yes
Greece yes 1980 Pigs 1977 yes
Hungary 1960 no Pigs, horses, nutria, wild boars 1984 yes
Ireland 2004 - - - -
Italy 1990 - Pigs 1958 yes
Latvia 1988 yes Pigs, horses - yes
Lithuania 1990 >30 years - - yes
Luxembourg - - Pigs, wild boar - yes
Malta - - Pigs (random), horses - -
Norway 1975 1965 Pigs, horses, wild boars, badger, bears 1965 yes
Poland 2001 1928 Pigs, horses,  wild boars - yes
Portugal yes yes - yes -
Slovakia yes yes All animals for human consumption 2000 yes
Slovenia 1949 1991 Pigs, horses,  wild boars, bears 2003 yes
Spain 1948 1952 Pigs, wild boars 1952 yes
Sweden >30 years yes Pigs, horses,  wild boars, bears yes yes
The Netherlands yes yes Pigs, horses, ruminants - yes
United Kingdom no 1980 Pigs, horses yes yes
1. In Belgium, the Flemish Community.
2. In Denmark, only clinical cases are notiﬁable.
3. Directive 64/433/EEC and/or Directive 77/96/EEC.
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Appendix Table VT1. Surveys and monitoring of VTEC in animals and food, 2004
ANIMALS
Country Agent Time and place 
of investigation
Type of sample Sample size/frequency
Austria VTEC Monitoring at 
slaughterhouse
Faecal sample 350 bovine animals, and 100 
sheep and goats sampled 
evenly over the study period
Belgium E. coli O157 Monitoring at 
slaughterhouse
Carcass, faecal 
sample
Trace back to the farm in 
cases of O157 positive 
samples
Denmark E. coli O157 Monitoring at 
slaughterhouse
Faecal samples 
from calves
One animal (149 examined) 
per randomly selected herd
Finland E. coli O157 Monitoring at 
slaughterhouse
Faecal sample Sampling distributed 
throughout the year, based on 
slaughter capacity and herd
Norway E. coli O157 Monitoring at 
slaughterhouse
Carcass swabs 1 out of 150 slaughtered cattle 
and goats, 1 out of 1000 
slaughtered sheep
Spain VTEC Farm in Galicia, 
otherwise abattoir 
Faecal swabs Different surveys
Sweden E. coli O1571 Monitoring at farm Faecal and/or milk 
ﬁlter sample
Trace back of human VTEC, 
up to 100 samples per farm, 
focusing on young stock
E. coli O1571 Monitoring at 
slaughterhouse
Carcass swabs Trace back of human VTEC
FOOD
Austria VTEC Food enterprises 
(restaurants, 
dairies, retail)
Random sampling according 
to number of food enterprises 
per province, each business is 
sampled at least once per year
Belgium E. coli O157 Monitoring 
program
Beef carcass 
swabs
Weekly collection
Czech Republic VTEC Ofﬁcial controls, 
at retail
Meat 28 samples collected 
randomly 
Norway E. coli O157 At slaughterhouse Carcass swabs 1 out of 150 cattle, 1out of 
150 goats and 1 out of 1000 
sheep were sampled randomly
Spain E. coli O157 At retail Red/mixed meat, 
fruits, vegetables, 
juice
Samples collected from May-
Aug based on population of 
cities over 10,000 residents
Sweden VTEC At slaughterhouse 
or retail
Beef, cheese, 
vegetables
Domestic and imported food, 
testing for serotypes O157, 
O111, O103, O26
1.  In Sweden, O157 or other serotypes that are suspected of being associated with human cases of 
VTEC infection.
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Appendix Table VT2. Notiﬁcation of VTEC in humans, animals and food, 2004
Notiﬁable in humans 
since
Notiﬁable in animals 
since
Notiﬁable in food  
since
Austria 19471, 2 no 1975
Belgium <1999 no (from 2005) 2004
Cyprus - - -
Czech Republic yes no -
Denmark 2000 + HUS (EHEC) no -
Estonia 1958 (EHEC) 2000 2000
Finland 1998 20043 no4
France no - -
Germany yes - -
Greece yes (EHEC) - -
Hungary 1998 no -
Ireland 2004 (EHEC) - -
Italy 1990 no 1962
Latvia 1999 yes6 2004
Lithuania 2004 >30 years -
Luxembourg - - -
Malta - - -
Norway 1995 no no
Poland - - -
Portugal - - -
Slovakia yes no 2000
Slovenia 1995 19915 2003
Spain yes7 1994 1994
Sweden 20048 yes9 no
The Netherlands yes no yes
United Kingdom no no no
1. In Austria, notiﬁable since 14 April 1913, re-proclaimed 12 June 1947, adapted on 28 April 1950.
2. In Austria, clinical cases notiﬁable since 1996.
3. In Finland, only notiﬁable in cattle.
4.  In Finland, food business operator has to notify to the competent authority, but there is no central 
notiﬁcation system.
5. In Slovenia, the year of independence. The disease was notiﬁable before 1991.
6. In Latvia, only clinical cases notiﬁable.
7. In Spain, only hospitalised cases are notiﬁable.
8. In Sweden, only if suspected associated with human VTEC infection.
9. In Sweden, before only infection with VTEC O157 was notiﬁable.
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Appendix Table YE1. Notiﬁcation of Yersinia in humans, animals and food, 2004
Notiﬁable in humans 
since
Notiﬁable in animals 
since
Notiﬁable in food 
since
Austria 19471, 2 no 1975
Belgium <19995 1998 2004
Cyprus - - -
Czech Republic yes no -
Denmark 1979 no -
Estonia 1982 no yes
Finland 1995 no no3
France no - -
Germany yes - -
Greece - - -
Hungary 1998 no -
Ireland 2004 - -
Italy 1990 no 1962
Latvia 1988 yes4 -
Lithuania 1985 >30 years -
Luxembourg - - -
Malta - - -
Norway 1992 no no
Poland - - no
Portugal - no -
Slovakia yes no 2000
Slovenia 1995 19916 2003
Spain yes7 1994 1994
Sweden 1996 no no
The Netherlands no yes yes
United Kingdom no no no
1. In Austria, notiﬁable since 14 April 1913, re-proclaimed 12 June 1947, adapted on 28 April 1950.
2. In Austria, clinical cases notiﬁable since 1996.
3.  In Finland, food business operator has to notify to the competent authority, but there is no central 
notiﬁcation system.
4. In Latvia, only clinical cases notiﬁable.
5. In the Flemish Community.
6. In Slovenia, the year of independence. The disease was notiﬁable before 1991.
7. In Spain, only hospitalised cases are notiﬁable.
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Appendix Table CA1. Campylobacter monitoring, surveys and diagnostic methods 
used for humans, animals and food, 2004
Humans Gallus gallus
Sample type Diagnostic Sample type Diagnostic
Austria Faecal Bacteriology At slaughter Bacteriology
- - Cattle and pig: colon in cattle at ﬁrst 
enrichment
Czech Republic - - - -
Denmark Faecal Bacteriology At slaughter: cloacal swabs PCR
- - At farm1: cloacal swabs Bacteriology
Estonia Faecal Bacteriology - -
France - - At slaughter: caecal content Multiplex PCR
Finland - Bacteriology At slaughter: neck skin NMKL 119:1990 
w/no enrichment
- - At slaughter4: caecal content Bacteriology
Germany - Bacteriology, 
ELISA
- -
Hungary Faecal Bacteriology, 
biochemical
- -
Italy - - At slaughter1: cloacal swabs  
+ ceacal samples
Bacteriology
Latvia Faecal Bacteriology - -
Lithuania - Bacteriology - -
Norway - Bacteriology At the farm, before slaughter: 
faecal samples
NMKL 119:1990 
w/no enrichment
- Bacteriology At slaughter: caecum swabs NMKL 119:1990 
w/no enrichment
Portugal - - - -
Slovakia - Bacteriology - -
Slovenia - Serological and 
biochemical
- -
Spain - - Faecal ISO 6579:2002
Sweden Faecal  
and blood
Bacteriology At slaughter: cloacal and  
neck skin
NMKL 119:1990
The Netherlands - - At the farm, before slaughter: 
faecal samples2
Bacteriology
- - At the farm, twice/year:  
Faecal drops3
Bacteriology
- - At slaughter: caecum samples3 Bacteriology
United Kingdom - Bacteriology - -
1. Samples collected in context of a monitoring programme of antimicrobial resistance.
2. In The Netherlands, surveillance project.
3. In The Netherlands, plan of approach, PVE.
4. In Finland, study from June to November.
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Appendix Table CA1. Campylobacter monitoring, surveys and diagnostic methods 
used for humans, animals and food, 2004 (cntd.)
Broiler meat Other food
Sample type Diagnostic Sample type Diagnostic
Austria - - - ISO 10272:1995
- - - -
Czech Republic At slaughter: fresh meat  
At retail: minced meat
ISO 10272:1995 Poultry meat, 
fresh, at retail
ISO 10272:1995
Denmark Depends on survey - Food from 
poultry: meat
-
- - - -
Estonia At slaughter: neck skin 
Retail/processing: fresh meat
NMKL 119:1990, 
ISO 10272:1995
Retail:  
Cheeses
NMKL 119:1990, 
ISO 10272:1995
France At slaughter: neck skin - - -
Finland At retail: fresh meat NMKL 119:1990, 
modiﬁed
Cheeses NMKL 119:1990, 
modiﬁed
- - - -
Germany - - - Comparable to 
ISO 10272
Hungary - - - -
Italy - - - -
Latvia Fresh meat ISO 10272:1995 - -
Lithuania - - - -
Norway At retail: fresh meat NMKL 119:1990 - -
 - - - -
Portugal - - - ISO 10272, typing 
by Lior method
Slovakia - STN ISO 10 272 - -
Slovenia Fresh meat ISO 10272:1995 - -
Spain - - - -
Sweden At retail NMKL 119:1990 - -
The Netherlands - - - -
 - - - -
- - - -
United Kingdom At retail, fresh refrigerated ISO 10272:1995 Cheeses Enrichment 
method
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Appendix Table CA2. Notiﬁcation on Campylobacter in humans, animals and food, 2004
Notiﬁable in humans 
since
Notiﬁable in animals 
since
Notiﬁable in food  
since
Austria 19471, 2 no 1975
Belgium <1999 1998 2004
Cyprus yes - -
Czech Republic yes no -
Denmark 1979 no no
Estonia 1988 2000 yes9
Finland 1995 20043 no4
France no - -
Germany no - -
Greece yes no -
Hungary 1998 no no
Ireland 2004 - -
Italy 1990 no 1962
Latvia 1999 yes5 2004
Lithuania 1990 >30 years -
Luxembourg - - -
Malta - - -
Norway 1991 yes8 yes8
Poland - - -
Portugal - no -
Slovakia 1980’s no 2000
Slovenia 1977 19916 2003
Spain 19827 1994 1994
Sweden 1989 no no
The Netherlands no yes yes
United Kingdom no no no
1. In Austria, notiﬁable since 14 April 1913, re-proclaimed 12 June 1947, adapted on 28 April 1950.
2. In Austria, clinical cases notiﬁable since 1996.
3. In Finland, Campylobacter notiﬁable in Gallus gallus only.
4.  In Finland, food business operator has to notify to the competent authority, but there is no central 
notiﬁcation system.
5. In Latvia, only clinical cases notiﬁable.
6. In Slovenia, the year of independence, however, this disease was notiﬁable before 1991.
7. In Spain, only hospitalised cases are notiﬁable.
8. In Norway, only positive samples from Gallus gallus detected in the national control programme.
9. In Estonia, only C. jejuni.
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APPENDIX 2
List of Abbreviations
- no information available
% Pos Percent Positive
DT Deﬁnite Type
EBL European Bat Lyssavirus
EEC European Economic Committee
EHEC Enterohemorrhagic Escherichia coli
ELISA Enzyme-Linked Immunosorbent Assay
EU European Union
FAT Fluorescent Antibody Test
MS Member States
N Number of cases or Number of samples tested
n.a. not available
Pos Positive samples
PT Phage Type
OBF Ofﬁcially Brucellosis Free
ObmF Ofﬁcially Brucella melitensis Free
O.I.E.  Organization Mondiale de la Santé Animale 
(World Organization for Animal Health)
ORF Ofﬁcially Rabies Free
OTF Ofﬁcially Tuberculosis Free
PCR Polymerase Chain Reaction
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List of Reporting Countries
Country Country 
Abbreviations 
A Austria
B Belgium
CY Cyprus
CZ Czech Republic
DK Denmark
EST Estonia
FIN Finland
F France
D Germany
GR Greece
H Hungary
IRL Ireland
I Italy
LV Latvia
LT Lithuania
L Luxembourg
M Malta
N Norway
PL Poland
P Portugal
SK Slovakia
SLO Slovenia
ES Spain
S Sweden
NL The Netherlands
UK United Kingdom
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MS Classiﬁcations
EU-25 All MS
 
EU-15 (Old MS) Austria
 Belgium
 Denmark
 Finland
 France
 Germany
 Greece
 Ireland
 Italy
 Luxembourg
 Portugal
 Spain
 Sweden
 The Netherlands
 United Kingdom
  
EU-10 (New MS) Cyprus
 Czech Republic
 Estonia
 Hungary
 Latvia
 Lithuania
 Malta
 Poland
 Slovakia
 Slovenia
 
Non-MS Norway
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